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Abstract
While incidence rates are increasing for many cancers in Puerto Rico, mortality
rates are declining (Torres-Cintron, et al. 2010), resulting in growing numbers of
survivors and creating a situation in which long-term survivorship concerns are
beginning to emerge as priorities. The importance of quality-of-life among survivors of
cancer is increasingly being recognized among healthcare providers, although there
remains a gap in knowledge of how young adult survivors cope with long-term treatmentrelated physical effects, such as infertility, and of the impact of cancer on survivors’
social relationships and future goals.
Because understandings of “cancer survivorship,” as well as of reproduction,
vary according to cultural context, this study examined the physical and social impact of
cancer on young adults in Puerto Rico, and specifically the importance of parenthood. A
media analysis of women’s magazines, key informant interviews with ten cancer
researchers, as well as in-depth, semi-structured interviews with 23 young adult cancer
survivors, 16 healthcare providers, nine cancer advocates, and two members of the
clergy were conducted in order to shed light on the lived experiences, needs, and
concerns of young Puerto Rican cancer survivors.

ix

Chapter One:
Introduction
While incidence rates are increasing for many cancers in Puerto Rico, mortality
rates are declining (Torres-Cintron, et al. 2010), resulting in growing numbers of
survivors and creating a situation in which long-term survivorship concerns are
beginning to emerge as priorities. The importance of quality-of-life among survivors of
cancer is increasingly being recognized among healthcare providers, although there
remains a gap in knowledge of how young adult survivors cope with long-term treatmentrelated physical effects, such as infertility, and of the impact of cancer on survivors’
social relationships and future goals. Because understandings of “cancer survivorship,”
as well as of reproduction, vary according to cultural context, this study examined the
physical and social impact of cancer on young adults in Puerto Rico, and specifically the
importance of parenthood. A media analysis of women’s magazines, key informant
interviews with ten cancer researchers, and in-depth, semi-structured interviews with 23
young adult cancer survivors, 16 healthcare providers, nine cancer advocates, and two
members of the clergy were conducted in order to shed light on the lived experiences,
needs, and concerns of young Puerto Rican cancer survivors.
This chapter will first provide a brief summary of the problem background and
context, offering information on cancer in Puerto Rico, long-term side effects of
treatment such as infertility, and survivorship. It then presents an overview of the study
design, research questions, and definitions of key terms, and concludes by summarizing
the content of the forthcoming chapters.

1

BACKGROUND AND CONTEXT
Between 2005 and 2009, over 9,000 people under the age of 49 were diagnosed
with cancer in Puerto Rico (Figueroa-Vallés, et al. 2012). Cancer is the second-leading
cause of death in Puerto Rico (PAHO 2000; Figueroa-Vallés, et al. 2012) and the
leading cause in men aged 50 to 69 and in women aged 30 to 69 (Ortiz and Cruz-Correa
2010). Unfortunately, Puerto Rican health reform efforts in the last two decades have
resulted in decreased access to quality care, despite high levels of insurance coverage
(PAHO 2007), and lower rates of screening, especially for cervical cancer (Ortiz, et al.
2010). Incidence rates are on the rise, but fortunately, mortality rates are simultaneously
declining (Figueroa-Vallés, et al. 2012; Torres-Cintron, et al. 2010). Coinciding with
these trends, medical and epidemiological cancer research is garnering more attention,
reflected by two institutional collaborations between US-based cancer centers and
Puerto Rican medical schools (Ortiz and Cruz-Correa 2010; Ríos 2010). However,
research that attends to the quality-of-life of cancer survivors by identifying their needs,
concerns, and perspectives, is still scarce and increasingly warranted.
Recurrence-free survival is never fully guaranteed for a cancer survivor. In
addition, biomedical treatments for cancer can result in both long-term and late effects1.
Depending on the cancer, the type of chemotherapeutic agents, and the location of
radiation and surgery, survivors are at risk for secondary cancers caused by the
treatment itself, as well as heart problems, immune system suppression, endocrine
disruption, and neurological and cognitive impacts (Aziz 2007). Survivors also suffer
from higher rates of infertility, premature ovarian failure, osteoporosis, chronic fatigue,
chronic pain, sexual dysfunction, peripheral nerve damage, depression, distress and

1

In the context of cancer, researchers make a distinction between long-term effects and late
effects of treatment. Long-term effects refer to those that begin during treatment and continue
after it is finished. Late effects arise after treatment is over, sometimes years or decades later
(Aziz and Rosland 2003; Aziz 2007). See Chapter Two for a more detailed discussion of this.
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anxiety (Aziz 2007)—which are less life-threatening conditions but no less disruptive.
Co-morbid conditions arising after treatment, such as metabolic syndrome, can have
significant effects, and some, such as obesity, have been linked to cancer recurrence
(Aziz 2007; Chlewbowski, et al. 2002; Freedland, et al. 2004; Nuver, et al. 2002).
This study focuses on one of the most common side effects of treatment among
young people: infertility. Although exact figures are unknown, it is estimated that
reproductive-aged women stand a 40 to 80 percent chance and men a 30 to 70 percent
chance of infertility resulting from cancer treatments, depending upon the therapy used
and the patient’s age (Lee, et al. 2006). Studies conducted in the US have
demonstrated that large percentages of newly diagnosed patients are not informed of
the risks that cancer treatment poses to their reproductive capacities, and do not receive
information about or referrals for fertility-related services from their oncologists (Schover,
et al. 1999; Schover, et al. 2002a, 2002b). Many survivors learn about their fertility
status years later after attempts at having children have failed. These inconsistencies
exist despite the fact that research in Western countries has demonstrated the
importance that cancer patients and survivors attach to both fertility and the potential for
future parenthood (Dunn and Steginga 2000; Loscalzo and Clark 2007; Schover, et al.
2002a, 2002b). In addition, numerous options exist for patients who want to maximize
their chances of having biological children after cancer treatment (Quinn, et al. 2008).
These options include pre-treatment fertility preservation methods—such as egg,
embryo, and sperm freezing—and post-treatment methods, which include adoption,
surrogacy, and egg/embryo/sperm donation (Fertile Hope 2013).
Infertility and the other long-term side effects of treatment are increasingly being
acknowledged in the United States under the umbrella term of “cancer survivorship.”
The term “cancer survivor” was coined in 1985 by a physician after his own cancer
treatment, and has since gained currency (Feuerstein 2007; Kaiser 2008), with the
3

cancer survivorship movement generating momentum primarily in the late 1990s (Park,
et al. 2009). At its essence, survivorship refers to the long-term health and well-being of
people who have been diagnosed with and/or treated for cancer, and views posttreatment quality-of-life and follow-up care as essential components of cancer care
(NCCS 2013). This more holistic framework represents a deviation from an exclusive
focus in the past on physical survival above all else (NCCS 2013; Quinn, et al. 2007),
and comes partly as a result of increasing survival rates in recent decades (Oktay and
Meirow 2007). Zebrack (2000) offers a helpful definition of the concept, stating that the
term “has come to represent the state or process of living after a diagnosis of cancer,
regardless of how long a person lives. It is a framework used by many healthcare
professionals, researchers, and cancer survivors to understand not only the physical but
also the social, psychological, and spiritual/existential impact of cancer on one’s life and
for the remainder of one’s life” (2000:239).
Because of the lingering concerns of recurrence and the need for oftentimes lifelong monitoring of the survivor’s body and emotional state for any late effects of
treatment, the premise behind the idea of survivorship is that life after cancer is an
ongoing process. It is a life in which the role of cancer and its late effects must be
constantly negotiated but can never be fully erased. The concepts of survivorship and
survivor identity have served as a source of cohesion for many people who have
experienced cancer, but the particular terminology and the discourses that are attached
to it, such as the idea of “cancer as a gift” or the need for positive thinking as a way to
maintain control over the illness experience, are seen by some as largely a North
American cultural creation (cf., DiGiacomo and Sumalla 2011; Stoller 2004; 2008).
Further, with some notable exceptions (cf., Buki, et al. 2008; Casillas, Zebrack, and
Zeltzer 2006), the impact of infertility has primarily been researched among middle- or
upper-class, white cancer survivors, at least in the US.
4

The Puerto Rican cancer literature is dominated by epidemiological work with
negligible contributions by social scientists. Understandably, social science on the
island focuses strongly on questions of politics and identity (Bates, et al. 1997; cf.,
Duany 2002, 2005, 2006), but there exists an almost surprising lack of attention to health
issues on the island. In fact, social scientists more commonly investigate health issues
among mainland Puerto Ricans than among island-dwelling residents (cf., Goldman, et
al. 2009). This is a situation in need of redress, and Puerto Rican researchers have
ratified the importance of studying survivorship and quality-of-life issues, including
fertility (Antonia 2010 and Flores 2010, personal communication). It is important to
formulate a local model of cancer survivorship, since, as Bates and colleagues (1997)
point out, biomedicine in Puerto Rico differs in significant ways from how it is practiced in
the US, with consequences for patients’ experiences of health, illness coping strategies,
and access to healthcare.
This project thus situates cancer survivorship, fertility, and reproductive decisionmaking and choice in Puerto Rico, which is a critical research site for several reasons.
First, cancer is a major burden on the island, individually, socially, and economically, and
work on the sociocultural aspects of cancer is scarce. Second, as a US territory, Puerto
Rico is entitled to many of the federal programs to which states have access; however,
in general, the levels of federal contribution for these programs are dramatically low. For
example, the federal government contributed $219 million to Puerto Rico’s Medicaid
program in 2005; however, if it had used the same calculation that it does for states—
which takes into account poverty rates—the contribution would have been $1.7 billion.
The island government must then make up the difference (Hayashi, et al. 2009).
Meanwhile, the effects of recent health reform efforts (la Reforma) have eroded the
quality of the healthcare system in general, even while expanding access to insurance
coverage (PAHO 2007). This frequently leads wealthier Puerto Ricans to seek
5

healthcare in the mainland, leaving oftentimes sub-optimal access to cancer and
infertility treatment for residents with fewer economic resources.
Third, Puerto Rico was the site of decades-long experimentation in birth control
and a notorious sterilization campaign to reduce the island’s population and ostensibly to
improve its economic condition (Briggs 2002; Lopez 2008): the cultural memory of these
events have implications for a study on reproductive choice. For example, throughout
the course of the twentieth century, the official discourse among both Puerto Rican and
American officials was that Puerto Rico had an overpopulation problem that was
responsible for its high rates of poverty (Briggs 2002). Numerous programs were
undertaken to reduce the island’s population, such as the encouragement of migration to
the US and a massive sterilization push (Lopez 2008). Thus, institutional focus was on
reducing population rather than addressing, for example, infertility as a social or medical
problem (cf., Inhorn 2003).
In sum, Puerto Rico presents an important setting in which to investigate the
intersection of cancer survivorship and reproduction, given its simultaneous ties to a
major world economic power, restricted access to high-quality healthcare, and a
combination of social and cultural factors that limit access to both cancer care and
reproductive technologies, especially among working-class patients and survivors.
RESEARCH DESIGN AND RESEARCH QUESTIONS
“Long-term survivorship” is an evolving concept that has been elaborated to a
large extent in the mainland US through the work of advocacy groups such as the
National Coalition for Cancer Survivorship and the Lance Armstrong Foundation (now
named Livestrong), and it includes cancer-related infertility and parenthood as one of its
topics of concern. Because of the intimate connection between these areas—i.e., longterm survivorship and cancer-related infertility—this project investigates not only
6

reproduction in the context of cancer, but also the cultural construction of long-term
survivorship on the island. Thus, the project strives to document both the meanings of
cancer and cancer-related infertility in Puerto Rico, and how they are handled in the
biomedical cancer care system and advocacy circles. The research questions guiding
this dissertation include:
1. Cultural Context of Survivorship and Reproduction: What is the social, cultural,
political, and economic context of cancer care and infertility care in Puerto Rico,
given its historical relationship to the United States? This question considers the
structure of the Puerto Rican healthcare and insurance system, including federal
laws and policies; accessibility and affordability of cancer and infertility care; cultural
representations of cancer; and cultural features that may play a significant role in the
issue, such as the influence of the Catholic Church, the dominant religious institution
on the island.
2. Survivor Perspective: How are survivorship concerns (broadly) and
fertility/reproductive concerns (specifically) conceptualized in individual survivors’
lives? How is long-term survivorship constructed in terms of survivors’ desires and
plans for parenthood? This question considers the illness history of survivors,
cultural frameworks for understanding cancer and recovery processes, experience
with parenthood in the context of a life-threatening disease (including use of fertility
preservation technologies), and interaction with the healthcare system, including
survivors’ relationships with providers.
3. Healthcare Provider and Advocacy Perspective: How are survivorship concerns
(broadly) and fertility/reproductive concerns (specifically) incorporated into cancer
care services in Puerto Rico? How are they addressed by advocacy organizations
operating in Puerto Rico? This question considers the perspective of healthcare
providers and cancer advocates regarding the attention given to survivorship
concerns, specifically infertility and fertility preservation, in medical practice and to
their patients’ lives, the barriers to more widespread use of fertility preservation, and
patient-provider communication. It also considers the role of cancer advocates and
non-governmental organizations (NGOs) within Puerto Rico and the construction of
survivorship espoused by both mainstream and grassroots groups.
The broader impact of this study lies fundamentally in its concern with a
population that has historically been neglected in previous social research on cancer
survivorship and with the long-term impacts of treatment and medical surveillance. Little
research in Puerto Rico has been published to date on cancer survivorship, infertility,
and parenthood. Thus, in order to create a new conceptual framework for this topic, this
7

research draws from three theoretical lines of inquiry: survivorship and illness identity,
the anthropology of reproduction, and infertility and reproductive technologies. The
study seeks to extend the concept of stratified reproduction, which highlights how
reproduction among some groups of people is encouraged, while among other groups it
is devalued (e.g., Ginsburg and Rapp 1995; Colen 1986). It does this by examining how
sick role and illness identity are evaluated in terms of reproductive privilege, and asking
how cancer survivors are allowed or able to procreate. Furthermore, it contributes to the
literature on the cross-cultural experience of infertility and parenthood (Inhorn 2003, van
Balen and Inhorn 2002; Culley 2009), particularly in the context of long-term, lifethreatening disease. Finally, it examines local models of cancer survivorship in Puerto
Rico—meaning the ideas, practices, and values surrounding cancer that are shared in a
cultural group (cf. Coreil, et al. 2004, 2012; Frank 2003; Mathews 2000).
DEFINITION OF KEY TERMS
I will be using several key terms throughout the dissertation relating to both
cancer survivorship and infertility, and it is important to mark a definitional starting point.
Patients, Survivors, and Survivorship
Authors define “cancer survivor” and “survivorship” quite differently across
diverse fields of research. Although I use these terms throughout the course of this
dissertation, I do not use them uncritically. The term “survivor” has been critiqued both
inside and outside the cancer advocacy movement; however, the fact of the matter is
that, at this moment, there exists no satisfactory alternative term that does not conjure
up even greater problems (i.e., victim).
The issue of temporality is important when discussing survivors. The official
government definition of survivorship, via the National Cancer Institute, is that it begins
the day of diagnosis (NCI 2013), a definition that is maintained by many mainstream
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organizations, such as the American Cancer Society, the Susan G. Komen Foundation,
and Livestrong. The National Coalition of Cancer Survivorship (NCCS) deliberately
chose this new benchmark in 1986 in order to draw attention to the long-term
consequences of treatment and the need for ongoing care. As the quote below notes,
the five-year mark has historically been conceptualized as the point at which people may
be considered survivors; however, it is misleading because some cancers—most notably
breast cancer—can recur years after this point:
“Dispensing with the outdated medical definition of a survivor that required someone to
remain disease-free for a minimum of 5 years after treatment to earn this status, [NCCS]
coalition members argued convincingly in 1986 that a person could call him- or herself a
survivor from the moment of diagnosis and for the remainder of life. This, they
successfully argued, was the only way to ensure that the focus of care, and cancerrelated decisions, would be on achieving a full and meaningful future life, worth living, for
the individual. That definition revolutionized cancer care” (Rowland and Ganz 2011).

While the strategic purpose behind this timeframe is compelling, I will deviate from it
slightly in this writing. For the purposes of this dissertation it is useful to distinguish
between two time periods—in-treatment and off-treatment—because the issues
confronting individuals in these respective phases differs considerably. This study
focuses on the needs of those post-treatment; thus, in order to maintain a conceptual
clarity it is necessary to retain a pragmatic distinction between patient and survivor.
“Survivor” will be retained to refer to people who have finished cancer treatment. In
reference to people who are still on treatment for cancer, I will use the word “patient.”
Similarly, I use the word “survivorship” in a pragmatic way, although the term
may conjure certain metaphors and discourses surrounding life after cancer (for
example, that is a “blessing in disguise”). However, for simplicity and brevity, I will retain
the word “survivorship” to refer to the time period post-cancer treatment. I will
distinguish the instances in which I use it in its more political, meaning-laden
interpretation in order to make it clear for the reader, using the terms “survivorship
concept” or “survivorship framework” to denote what it has come to mean over time.
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Infertility, Fertility Preservation, and Assisted Reproductive Technologies
Infertility is technically defined as the inability to achieve a pregnancy after one
year of unprotected sex (NIH 2012). This raises an important definitional quandary.
Cancer patients who just finished treatment may not be considered “infertile” by this
definition even if women have gone through premature ovarian failure and men are
azoospermic (i.e., if they have low levels of sperm in the semen), because they may not
have actively attempted to get pregnant for one year prior. This has implications for
insurance consideration—even in states where some insurance coverage for infertility is
mandated, newly diagnosed cancer patients seeking fertility preservation do not qualify
because they are technically not yet infertile. Intricacies aside, since I am not
concentrating on the actual medical conditions whereby male and female cancer
patients become infertile (such as ovarian failure) and thus it is not important to use the
exact terminologies of those conditions, I will retain the use of the word “infertility” to
refer to instances in which it is presumed that someone will not be able to have children,
whether or not they have been having unprotected sex for a year.
“Fertility preservation” will refer to any of the cohort of technologies currently
available to help cancer patients retain their ability to procreate or to prevent damage to
their existing reproductive capabilities. “Post-treatment parenthood options” will refer to
the cohort of options available after treatment is over to facilitate parenthood, and
includes the use of donated gametes (eggs, embryos, or sperm), surrogacy, and
adoption. “Assisted reproductive technologies,” or ARTs for short, is reproductive
technology that facilitates pregnancy by artificial means, either wholly or partially.
OVERVIEW OF CHAPTERS
Chapter Two, Research on Cancer Survivorship, Infertility, and Fertility
Preservation, presents an overview of the literature on cancer and fertility from diverse
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fields, given the shortage of anthropological work on this topic. It concentrates primarily
on the psycho-oncology literature since much of the research has been undertaken in
that field. The chapter addresses the impact of cancer treatment on the bodies and
reproductive capacities of men and women, fertility preservation and parenthood options
available both prior to and following treatment, and current research that is concerned
with the psychological and social aspects of cancer-related infertility.
Chapter Three, Theoretical Perspectives on Cancer Survivorship and
Reproduction, turns to the perspective from anthropological and, when appropriate,
sociological work. It situates cancer survivorship and cancer-related infertility in a
broader theoretical context, considering three lines of inquiry: scholarly writing on cancer
survivorship, illness identity, and narratives; the anthropology of reproduction,
particularly stratified reproduction; and infertility and assisted reproductive technologies
(ARTs). Major topics in each area of theoretical work are summarized, and the chapter
concludes with a brief discussion on the project’s location within these areas and its
potential to extend them.
Chapter Four, Methods and Demographics, discusses the specific objectives of
the research project, overall research design, and the methods employed to answer the
primary research questions. The study included two phases: an ethnographic content
analysis of media representations of cancer, and ethnographic interviews with cancer
survivors, healthcare providers, advocates, and members of the clergy. The chapter first
reviews the methods used in previous research on cancer, survivorship, and fertility,
including both strengths and potential areas for expansion. A description of the
methodological design, data collection methods and analysis techniques follows, and the
chapter concludes by discussing ethical issues, research challenges, and limitations.
Chapter Five, Research Setting, presents an overview of Puerto Rican history
and a snapshot of its political-economic and socio-cultural context. It then proceeds to
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offer a more in-depth exploration of the healthcare system, and specific issues that are
relevant for a study on cancer and reproduction—notably the trend towards medical
tourism, the role of the Catholic Church in reproduction-related matters, emerging cancer
research in Puerto Rico, and the current fertility-related services available on the island.
Chapter Six, entitled Cancer in the Public Eye: Representations of Cancer in
Women’s Magazines, is the first of the four chapters that present the results of the study.
This chapter discusses results from the media analysis concerning public perceptions
about cancer. These findings are drawn from an analysis of articles with a major focus
on cancer in three women’s magazines; it examines both current items as well as
articles spanning the years from 1995 to 2010.
Chapter Seven, entitled The Meanings of Cancer in Puerto Rico, continues the
task begun by Chapter Six by presenting the themes about the meanings of cancer from
the interview data. It first addresses this topic broadly, looking at research participants’
perceptions about the public image of cancer survivors in Puerto Rico. It then goes on
to discuss the survivorship concept that is used and promoted by the Puerto Rican
chapters of large, mainstream, US-based cancer advocacy groups operating on the
island. The central question in this section is how post-cancer life is constructed in
survivors’ minds and lives, and the extent to which it reflects the mainstream
survivorship discourse. The last section considers the elements that add to a local
construction of cancer in Puerto Rico.
Chapter Eight, Reproduction, Infertility, and the Healthcare Interaction, presents
and discusses the research findings related to these topics. First, provider and advocate
perspectives on cancer-related infertility are offered, including the extent to which it is
addressed in the clinic and barriers that restrict access to fertility preservation. The
chapter then examines the perspectives of survivors regarding the importance of the
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issue, patient-provider communication experiences, and the degree to which cancer has
shaped their parenthood goals, desires, and abilities.
The fourth results chapter, Chapter Nine—Health Status, Healthcare, and
Cancer-Related Services—reports on treatment- and healthcare-related issues that
emerged as major themes in the interviews and that have not yet been addressed in the
other chapters. It moves in a back-and-forth manner, alternating between the
perspectives of providers, advocates, and survivors. It first details the self-described
health status of survivors, touching upon their health concerns and conditions. It then
proceeds to discuss the overall perceptions that providers and advocates hold regarding
survivors’ main medical and social issues. It examines health system-related issues,
such as patient-provider communication, and an evaluation of gaps in the medical
system. The perspectives of the clergy are presented last, as those interviews pulled
together many of the disparate themes surfacing throughout the results.
Chapter Ten, Discussion, Recommendations and Conclusions, is the final
chapter. It presents a detailed synthesis and discussion of the findings from the media
analysis, key informant interviews, and semi-structured interviews. The chapter also ties
the findings to previous literature as well as to the study’s research questions, outlining
gaps in our current understanding. This chapter concludes by offering a set of
recommendations grounded both in the literature and the insights of the participants, and
posing future avenues for research.
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Chapter Two:
Research on Cancer Survivorship, Infertility, and Fertility Preservation1
The concept of survivorship itself, cancer-related reproductive issues, and
cultural aspects of infertility have not been well-studied in populations outside of white,
middle- and upper-class groups in the mainland US. The present study explored these
issues among survivors, healthcare providers, advocates, and clergy in Puerto Rico in
order to develop a more comprehensive understanding of lived experience following a
life-threatening disease. The goal of this chapter is thus to provide an overview of the
literature on cancer and fertility from diverse fields, given the shortage of anthropological
work on this specific topic. It will concentrate primarily on the psycho-oncology literature
since much of the research has been undertaken in this field. Topics include the impact
of cancer treatment in general and on reproductive capacity in particular, parenthood
options available prior to and after treatment, and research examining psychological and
social aspects of the issue.
CANCER SURVIVORSHIP
“Cancer survivorship” as a general concept has been gaining increased attention
in the United States (Feuerstein 2007; Kaiser 2008), and, as noted in the introductory
chapter, represents an expansion of the traditional biomedical focus on physical survival
from cancer. Mortality rates for all cancers combined have declined in recent decades,
reflecting “progress in the prevention, early detection, and treatment of cancer” (Jemal,
et al. 2004:4). This decline is most evident in the pediatric population where the five1

Portions of this chapter have been previously published (Vindrola Padros, Mitu, and Dyer 2012)
and are utilized here with permission of the publisher.
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year survival rate now approaches approximately 80 percent (Smith and Hare 2004),
whereas prior to the 1960s, a diagnosis of childhood cancer was nearly always fatal
(Jemal, et al. 2004). Ness and Gurney (2007) argue that this improvement, stemming
from the incorporation of more effective chemotherapies into existing treatment regimens
(Jemal, et al. 2004), is “one of the greatest success stories of the late twentieth century”
(Ness and Gurney 2007:280). Indeed, now one in every 1,000 Americans is a childhood
cancer survivor (Knopman, et al. 2010).
This success, however, comes with a high price. One of the foci of the
survivorship movement involves calling attention to the many long-term physical,
psychological, and social repercussions of cancer treatment, and the need for continued,
life-long screening following treatment. Researchers distinguish between long-term side
effects of treatment and late effects of treatment (Aziz and Rowland 2003; Aziz 2007).
Long-term effects denote those that begin during the primary treatment for cancer and
continue for a long-term period of time after the treatment has ended, sometimes for the
balance of life. An example of this might be permanent, premature ovarian failure that
begins during treatment. Late effects, on the other hand, are those that arise after
treatment has ended, often after the passage of many years. Most late effects manifest
sometime before the 10-year survival mark but can emerge years after that point.
Secondary cancers, known as secondary malignant neoplasms (SMN) in the medical
literature, are one of the most common late effects of treatment and are notoriously
difficult to treat as they are side effects of the treatment therapies themselves (i.e.,
radiation therapy or chemotherapy) (Zhang, et al. 2012). Other potential late effects
include cardiomyopathy or congestive heart failure, immune-suppression, endocrine
disruption, and neurological or cognitive impairments. Aziz (2007) notes that the “most
frequently observed medical sequelae include endocrine complications, growth hormone
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deficiency, primary hypothyroidism, primary ovarian failure, cardiac dysfunction,
neurocognitive deficits, and second cancers” (2007:422).
While the life-threatening effects often inspire the most concern among survivors,
it is important to highlight other physical effects that can have a significant and
detrimental impact on a survivor’s quality-of-life. These may include chronic fatigue,
sexual dysfunction, pain, peripheral neuropathy, and cataracts, in addition to site-specific
concerns, such as lymphedema in breast cancer survivors2 (Aziz 2007). According to
Aziz (2007), late and long-term effects can be grouped into five categories: (a) systemspecific (i.e., damage to body systems, such as the immune system); (b) secondary
malignant neoplasms, as described above; (c) functional changes (for example,
lymphedema and fatigue); (d) cosmetic changes (i.e., changes in hair, skin, or body
weight); and (e) associated co-morbidities (i.e., osteoporosis, hypertension, or metabolic
syndrome). The ascertainment of survivors’ risks of late and long-term effects is highly
individual for several reasons: different treatment modalities present different risks of
side effects both during and after treatment, many treatments use a complex
combination of therapies, and the “risk factors for late effects may act independently or
synergistically” (Aziz 2007:422). An excerpt from the Institute of Medicine’s (IOM)
seminal report on survivorship, From Cancer Patient to Cancer Survivor: Lost in
Transition (2005) highlights the implications of this variation:
"To illustrate the range of late effects and the diversity of the cancer survivor population,
one could consider the individual who had an early-stage melanoma successfully
removed, leaving an inconspicuous scar, to have had cancer with minimum late effects
and impact on life. Such a person would have concerns regarding subsequent risk of
cancer, but likely would not suffer serious long-term health effects of treatment. At the
other extreme might be an individual with a hematological cancer undergoing intensive
chemotherapy followed by a bone marrow transplant. Such a person would face
substantial long-term health problems associated with treatment" (2005:75).
2

Underarm lymph nodes are often removed as part of surgery for breast cancer (PubMed Health
2012a). In ten to 15 percent of breast cancer patients and survivors, this removal causes
lymphedema, which is swelling due to blocked drainage in the lymph system. It can be treated
with various techniques, including massage and the use of lymphedema sleeves (a compression
stocking that prevents fluid build-up in the affected area).
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While long-term and late effects were once studied primarily with regards to
childhood cancer survivors, researchers have recently begun to address the need for
more comprehensive studies of such effects in survivors diagnosed in adolescence,
young adulthood and older adulthood. As Aziz (2007) argues, cancer survivors
diagnosed in their 30s and 40s “may need specific attention for premature menopause;
issues relating to sexuality and intimacy; use of estrogen replacement therapy;
prevention of neurocognitive, cardiac and other sequelae of chemotherapy; and
prevention of coronary artery disease and osteoporosis” (2007:423) in addition to the
treatment-specific risks outlined above.
Non-medical sequelae have equally profound impacts on survivors’ lives.
Distress is common among cancer survivors, which was defined by the Institute of
Medicine (2005) as:
“A ‘multi-factorial unpleasant emotional experience of a psychological (cognitive,
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability to
cope effectively with cancer, its physical symptoms, and its treatment. Distress extends
along a continuum, ranging from common normal feelings of vulnerability, sadness, and
fears to problems that can become disabling, such as depression, anxiety, panic, social
isolation, and existential and spiritual crisis' (NCCN, 1999). Distress may be experienced
as a reaction to the disease and its treatment and also as a result of the consequences of
the disease on employment, health insurance, and social functioning, including family
relationships” (2005:70).

Howard-Anderson and colleagues (2012), for example, found higher levels of depressive
symptoms and lower measures of quality-of-life among young breast cancer survivors, in
addition to specific concerns regarding premature menopause, infertility, weight gain,
and physical inactivity. Many studies report higher levels of anxiety and depression
among cancer survivors, and they consistently “report ongoing struggles to achieve a
balance in their lives and a sense of wholeness and life purpose after a life-altering
experience [Ferrell 2004]” (IOM 2005:66). Similarly, Deyell and colleagues (2012) found
that survivors of childhood, adolescent or young adult cancers were significantly more
likely to fill prescriptions for antidepressants than age-matched controls.
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Relationships are impacted by the cancer experience, and it is increasingly
recognized that cancer survivorship involves the entire family (Aziz 2007; IOM 2005).
Family members are emotional supports for the survivor and often serve as caregivers
both during and after treatment; yet, their needs are frequently neglected (Adams, et al.
2009; Hoffman 2004). Social outcomes following cancer are understudied, but reports
from the Childhood Cancer Survivor Study have found that childhood cancer survivors
are less likely to be married as young adults (Gurney, et al. 2009), and consistently cite
relationships, marriage, and sexuality as major concerns. Similar issues were found for
young adult cancer survivors diagnosed between age 20 and 39: they were less likely to
be married and more likely to be divorced or separated (Kirchhoff, et al. 2012a).
Financial hardship is more common among survivors than non-survivors even
after the cost of cancer treatment is taken into account, and the ultimate cause of this is
unclear (Aziz 2007). It could be, for example, that chronic health problems limit
participation in work activities or higher-paying occupations with accompanying higher
stress levels, such as medicine or law. Childhood cancer survivors are more likely to be
unemployed than their sibling counterparts (Gurney, et al. 2009). Health insurance is a
pervasive concern; until the Patient Protection and Affordable Care Act of 2010 takes
effect, cancer survivors still encounter barriers to health insurance coverage through preexisting conditions exclusionary clauses (Hoffman 2004). Young adult survivors have
much higher uninsured rates than older survivors as they age out of their parents’ health
insurance and may not be able to obtain work with health benefits (Kirchhoff, et al.
2012b). Kirchhoff and colleagues (2012b), using the CDC’s 2009 Behavioral Risk Factor
Surveillance System data, report that young adult survivors are more likely to forego
medical care because of costs than age-matched controls. Finally, securing life
insurance is highly difficult and often impossible for cancer survivors, which contributes
to the overall financial stress and vulnerability of the family (Hoffman 2004).
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Although attention to the problems facing young cancer survivors is critical, it is
also important to maintain awareness that the picture is not as bleak as these data may
appear. In many psychosocial studies, survivors report quite positive benefits and a high
quality-of-life (Zebrack, et al. 2012). For example, Ganz and colleagues (2002)
surveyed breast cancer survivors between one and five years post-diagnosis and then
again between five and ten years post-diagnosis. Participants reported excellent
physical and emotional well-being (interestingly, well-being was greater if they had not
received systemic treatment such as chemotherapy). Zebrack and colleagues (2012)
note that previous studies have found that cancer affects survivors’ lives in the following
ways: “(1) life perspective (e.g., altered priorities, greater joy or appreciation for one’s
life, greater sense of meaning, enhanced religious or spiritual beliefs); (2) relationships
(e.g., greater appreciation for one’s relationships, greater sense of intimacy, enhanced
emotional expressiveness, increased sensitivity to others); and (3) self-perception (e.g.,
sense of emotional growth, strength, self-reliance)” (2012:631). The study found that
childhood cancer survivors had higher levels of perceived positive impact from cancer
than their siblings, but this varied by gender, ethnicity, type of cancer, specific
treatments, age at diagnosis, and the time elapsed since diagnosis. Specifically,
survivors who were female, non-white, older when diagnosed, and were closer to the
time of treatment reported higher perceived positive impact (Zebrack, et al. 2012). Parry
(2003) conducted a qualitative study with cancer survivors to explore the impact of living
with uncertainty; she found that despite the ability of uncertainty to cause distress and
anxiety, “it can also be a catalyst for growth, a deepened appreciation for life, greater
awareness of life purpose, development of confidence and resilience, and optimism”
(2003:227). Figure 2.1 below is a quality-of-life conceptual model that outlines all of the
varied domains of concern relevant for cancer survivors.
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Figure 2.1. Quality-of-Life Model Applied to Cancer Survivors (Reproduced from IOM 2005:68)
Physical Well-Being and Symptoms
Functional Activities
Strength/Fatigue
Sleep and Rest
Overall Physical Health
Fertility
Pain

Psychological Well-Being
Control
Anxiety, Depression
Enjoyment/Leisure
Fear of Recurrence
Cognition/Attention
Distress of Diagnosis and Tx Control

CANCER SURVIVORSHIP
Physical Well-Being and Symptoms
Family Distress
Roles and Relationships
Affection/Sexual Function
Appearance
Enjoyment
Isolation
Finances
Work

Spiritual Well-Being
Meaning of Illness
Religiosity
Transcendence
Hope
Uncertainty
Inner Strength

MEDICAL ASPECTS OF CANCER-RELATED INFERTILITY AND FERTILITY
PRESERVATION
One of the common, yet little-addressed, side effects of cancer treatment among
reproductive-age survivors is compromised fertility or infertility. Many of the biomedical
treatments for cancer can impair fertility or cause infertility among both male and female
reproductive-age cancer patients (Oktay and Meirow 2007). The treatments most likely
to cause infertility include certain classes of chemotherapies (primarily alkylating
agents), radiation to the pelvic and abdominal regions, surgery to the reproductive
organs, and bone marrow/stem cell transplants. These agents are termed gonadotoxic
because they interfere with rapidly dividing cells (as many cancer treatments do), and
can have a deleterious effect on the gonads (i.e., testicles and ovaries) (Sklar 1995).
Patients undergoing stem cell and bone marrow transplantation (BMT) suffer the highest
rates of infertility based on the pre-transplant therapy required—either total body
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irradiation (TBI)3 or high doses of chemotherapy. Studies have shown that female
patients undergoing TBI prior to BMT have almost a 100 percent rate of developing
acute ovarian failure (Sklar 1995), and male patients experience an 80 percent rate of
permanent failure (Socie, et al. 2003). Given that approximately 55,000 individuals
under age 35 are diagnosed with cancer per year, this side effect has the potential for a
large public health impact (Knopman, et al. 2010). It is important to reiterate that, in
most cases, cancer-related infertility is not cancer-specific, as it is the treatments that
harm the reproductive system and not strictly the cancer itself. However, there are
exceptions: for instance, certain male cancers (such as testicular cancer and Hodgkin’s
disease) can decrease sperm count (Knopman, et al. 2010).
Knopman and colleagues (2010) note that three factors determine whether or not
a patient is likely to experience infertility post-treatment: age at treatment, type of
treatment agent, and dose. These factors vary slightly between men and women: for
example, pre-pubertal boys are more sensitive to gonadotoxic drugs than post-pubertal
boys or adult males, while pre-pubertal females are less sensitive to those same agents.
With females, generally the younger the patient is, the more likely she is to recover
ovarian function because she has a greater ovarian follicle reserve (Knopman, et al.
2010; Sklar 2005). Similarly, the closer to menopause at the time of treatment, the more
likely she is to experience premature ovarian failure.
Infertility can be immediate or may occur many years following treatment. Sklar
(2005) defines acute ovarian failure as the “loss of ovarian function that arises during or
shortly after the completion of cancer therapy. By contrast, the term premature
menopause refers to the loss of ovarian function that occurs years after completion of

3

TBI, referring to radiotherapy of the entire body, is given as preparation for bone marrow or
stem cell transplantation. It kills cancer cells throughout the body—especially in areas not easily
reached by chemotherapy—and in allogeneic transplants (involving a healthy donor and a
recipient), it also serves to lower the immune system to prevent graft-versus-host disease.
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cancer therapy following a window of normal functioning” (2005:26). One early landmark
study found that women who had been treated for cancer in their adolescence (between
13 and 19 years old) who did not suffer from acute ovarian failure immediately after
treatment later experienced a rate of premature menopause that was four times greater
than the general population (Byrne, et al. 1992).
Fertility Preservation and Post-Treatment Parenthood Options
Despite the impact of cancer treatment on both male and female fertility, a
number of options exist for individuals undergoing cancer treatment to become parents,
either biologically or socially (see Table 2.1 below). A cohort of technologies termed
fertility preservation techniques has been given widespread attention in the last several
years; these are technologies that allow men and women to freeze their gametes or
tissues prior to the beginning of treatment (Ajala, et al. 2010; Fertile Hope 2013;
Maltaris, et al. 2006). Sperm banking, embryo cryopreservation (the freezing of fertilized
eggs), and now egg cryopreservation (the freezing of unfertilized eggs)4 are considered
routine; other technologies such as ovarian tissue cryopreservation and testicular tissue
cryopreservation are still in investigational stages (Fertile Hope 2013; Maltaris, et al.
2006; Oktay and Meirow 2007). Most of these technologies require the use of artificial
insemination (IUI) or in-vitro fertilization (IVF) at a later point when the survivor would like
to use the frozen materials.
A few options exist to safeguard the fertility of patients undergoing treatment.
Two of them—ovarian shielding and testicular shielding—are standard-of-care, while

4

The American Society for Reproductive Medicine (ASRM) lifted egg freezing’s investigational
status in October 2012, concluding after an extensive review that egg freezing “demonstrate[s]
acceptable success rates in young highly selected populations.” The chair of the ASRM Practice
Committee, who authored the report, cautioned “while a careful review of the literature indicates
egg freezing is a valid technique for young women for whom it is medically indicated, we cannot
at this time endorse its widespread elective use to delay childbearing. This technology may not be
appropriate for the older woman who desires to postpone reproduction” (ASRM 2012a).
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ovarian suppression 5 is still in investigational stages. In addition to fertility preservation
and during-treatment procedures, a number of post-treatment parenthood options exist
as well, such as adoption (Fertile Hope 2013). The term third-party reproduction
encompasses the use of donor gametes, such as donor embryos, eggs, or sperm, and
traditional or gestational surrogacy. Donor eggs or sperm can be combined with the
survivor’s partner’s gamete, so that one partner would be biologically related to the
offspring; otherwise, donor embryos can be used. Many of these options are only
possible using either IUI or IVF, and thus can be quite costly. Table 2.1, divided into the
appropriate time periods—pre-treatment (fertility preservation), during treatment, and
post-treatment—details all of these parenthood options, including information on cost.
Table 2.1. Parenthood Options for Cancer Patients and Survivors (Adapted from Fertile
Hope 2013)

PRE-TREATMENT

DURING
TREATMENT

POST-TREATMENT

For Women
Embryo freezing

Ovarian shielding

The freezing of eggs that
have been fertilized with
sperm (either donor’s or
partner’s). Hormonal
stimulation necessary, avg
cost is $10K + medications
($2,500-5K)

For abdominal/pelvic
radiation, external
shields are placed
over the ovaries to
reduce exposure. Avg
cost unknown, often
covered by insurance

Egg (oocyte) freezing
The freezing of unfertilized
eggs. Hormonal stimulation
necessary, avg cost is $8K +
medications ($2,500-5K)

Ovarian tissue freezing*
The removal and freezing of
part of an ovary. No
hormonal stimulation
needed, the only option
available for prepubescent
girls, avg cost is $12,000

Donor embryos
Embryos from another couple can be used
in place of survivor’s and partner’s egg and
sperm. Avg cost of embryos is $2,0007,000 plus the necessary procedures and
medications used to achieve pregnancy
(such as IVF)

Donor eggs

Ovarian
suppression*
A drug treatment that
suppresses ovarian
function during
chemotherapy in
order to reduce
damage to the
follicles. Avg cost is
$500 per monthly
injection for length of
treatment

5

Unfertilized eggs from a donor can be
paired with the partner’s or another donor’s
sperm. The cost of a full cycle of IVF with
donor eggs ranges between $14K-40K

Surrogacy: Gestational/traditional
Gestational surrogacy refers to a female
surrogate who carries someone’s
pregnancy but is not genetically related to
it. Traditional surrogacy involves a female
surrogate who has (usually) been
inseminated with the male partner’s sperm
and carries the baby to term. Costs,
depending on the arrangement, range from

The idea behind ovarian suppression is that follicles are less vulnerable to gonadotoxic drugs if
they are in a quiescent state. The effectiveness of this treatment, which involves administering
ovarian-suppressing drugs during chemotherapy, is still controversial (Partridge 2012).
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$10K-100K; in many states it is banned.

Ovarian transposition
For cancers needing pelvic
radiation, ovaries are
surgically moved out of the
radiation field to minimize
potential damage. Avg cost
unknown but often covered
by insurance

Adoption
Avg cost is $2K-35K, depending on
whether it is domestic or international or
through public or private agencies

Natural conception (if possible), or
assisted reproductive technologies to
use frozen eggs, embryos, or tissue
For donor/banked eggs and embryos, two
options exist:
1. In Intrauterine Insemination (IUI), sperm
is injected directly into a woman’s uterus at
the time of ovulation; it can be performed
during a natural cycle or with fertility drugs.
Avg cost is $300-700 per cycle plus
medications (usually an extra $1,500-4K).
2. During In Vitro Fertilization (IVF), an egg
and sperm are fertilized in the lab, and
implanted directly into the woman’s uterus.
Avg cost of 1 cycle is $12,400 (ASRM).
Ovarian tissue must be transplanted back
into the body—avg cost $10K-15K plus the
cost of an IVF cycle.

Radical trachelectomy*
A fertility-sparing surgery for
early-stage cervical cancer in
which the cervix is removed
but the uterus is left intact.
Avg cost is unknown but
often covered by insurance.

For Men
Donor sperm

Sperm banking
The freezing of sperm. Avg
cost is $1,500 for 3
donations and a year of
storage

Testicular sperm
extraction
A surgical procedure in
which sperm is extracted
directly from testicular tissue
if mature sperm are not
present in semen; they can
then be frozen or used for
IVF immediately. Avg cost is
$6,000-16,000

Testicular shielding
For radiation to the
abdominal and pelvic
region, external
shields can be placed
over the testicles in
order to reduce
exposure. Avg cost is
unknown but often
covered by insurance

Use of donor’s sperm instead of survivor’s
sperm. Intrauterine insemination (IUI) is
generally used to achieve pregnancy in the
female partner, avg cost of donor sperm is
$3K-5K +fees for add’l procedures (i.e, IUI)

Adoption
Avg cost is $2,000-35,000, depending on
whether it is domestic or international or
through public or private agencies

Natural conception (if possible) or
assisted reproductive technologies to
use frozen sperm or tissue

Testicular tissue freezing*
The surgical removal and
freezing of testicular tissue,
often the only option for
prepubescent boys but still
highly experimental. Avg cost
is unknown

Two options exist for donor/banked sperm:
1. Intrauterine Insemination (IUI) (see
section for Women).
2. IVF (see section for Women).

* Denotes investigational procedures. As noted above, egg freezing was considered
investigational until October 2012 when the designation was lifted by the ASRM.
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Studies have demonstrated differences in childbirth outcomes between cancer
survivors and the general population—for example, cancer survivors reproduce less and
have fewer live births (Cvancarova, et al. 2008; Green, et al. 2002; Green, et al. 2003).
Related to this, two major concerns regarding cancer survivors’ reproduction are
offspring health and pregnancy’s role in cancer recurrence (Knopman, et al. 2010).
Several studies to date have shown no ill effects or congenital abnormalities in the
offspring of survivors, although survivors tend to have, on average, more preterm births
and babies with slightly lower birth weights (Fossa, et al. 2005; Nagarajan and Robison
2005). Likewise, it is generally accepted that pregnancy and childbearing do not affect
the survivor’s health negatively; for instance, recurrence rates are not higher in this
population (Knopman, et al. 2010; Nagarajan and Robison 2005). However, additional
work is sorely needed in this area. The latter issue has been studied particularly with
breast cancer survivors because a sub-type of these cancers are estrogen-sensitive—
meaning that estrogen causes these tumors to grow—and there is a concern that
pregnancy hormones may fuel the growth of the cancer. However, this has not been
substantiated, and in fact, data show that survivors who bear children actually fare better
in terms of health outcomes (Knopman, et al. 2010). For example, in one study (Gelber,
et al. 2001), breast cancer survivors who became pregnant had higher survival rates
than matched controls (92 percent were alive five years later and 86 percent at ten
years, versus 85 percent and 74 percent, respectively, for the controls).
Two potential explanations for this may exist. The first is selection bias: women
with better prognoses and earlier-stage disease are more likely to get pregnant and thus
would be more likely to survive regardless of pregnancy, a bias that is termed the
“healthy mother effect” (Sankila, et al. 1994). The second option is that pregnancy may
confer a slightly protective biological effect for female cancer survivors, the mechanism
of which is unexplained to date (Gelber, et al. 2001). The degree to which these two
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possibilities explain the higher survival rates among survivors who have delivered
children is unknown, and, as Sankila and colleagues (1994) note, since a “controlled,
prospective trial is not acceptable, the problem will remain.” Nevertheless, general
scientific consensus holds that pregnancy is safe for breast cancer survivors, although
they should be advised to wait for at least two years following treatment and individual
health status must be taken into account (Knopman, et al. 2010).
Accordingly, the major professional associations for the respective fields
involved, the American Society for Clinical Oncology (ASCO) and the American Society
for Reproductive Medicine (ASRM), have released guidelines that detail how providers
should address the issue of cancer-related infertility with their patients (American Society
for Reproductive Medicine 2005; Lee, et al. 2006). The ASCO guidelines offer a threepart recommendation relating only to the use of fertility preservation techniques with
cancer patients. They recommend that oncologists (1) inform patients about the
potential fertility risks of cancer treatment; (2) be prepared to answer questions
regarding safety of pregnancy (for parent and offspring) and potential interference of
fertility preservation with cancer treatment; and (3) refer patients as appropriate to both
reproductive and psychosocial specialists (Lee, et al. 2006). Similarly, the ASRM
guidelines strongly recommend that oncologists inform patients about fertility risks and
refer to appropriate specialists (ASRM 2005).
PSYCHOLOGICAL AND SOCIOCULTURAL ASPECTS OF CANCER-RELATED
INFERTILITY AND FERTILITY PRESERVATION
Oncofertility, as a new discipline, emerged to address issues of fertility in cancer
patients and survivors. It is interdisciplinary in scope, involving such diverse fields as
“oncology, pediatrics, reproductive science and medicine, biomechanics, material
science, mathematics, social science, bioethics, religion, policy research, reproductive
health law, cognitive and learning science” (Woodruff 2007:3). The overall goal of the
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field of oncofertility is to advance three stated gaps in the science of cancer and fertility
(Woodruff 2007). According to Woodruff (2007), the primary need is to build and make
available better information for healthcare practitioners to provide to patients and
survivors that can more accurately communicate their risk for infertility. This risk is still
largely unknown by many; according to Woodruff (2007), this has partly resulted from
imprecise data about the gonadotoxicity of particular cancer treatments and because this
area falls between the cracks of two medical specialties—oncology and reproductive
endocrinology. In particular, she states: “the information delivery gap still exists because
medical oncologists are not aware of the precise reproductive threats of their treatments
on reproductive outcomes and clinical reproductive endocrinologists do not routinely
treat cancer patients. Moreover, new drugs and multi-drug treatments pose a particular
problem to clear information exchange” (2007:9).
Second, as noted above, the “data gap” references the need for more research
on the precise impact of various treatments on fertility (which in turn can be
communicated to patients), given patients’ particular treatment regimens and the specific
chemotherapeutic agents to which they are exposed (Woodruff 2007). Woodruff notes
that several challenges exist in producing this data: the variability of treatment regimens
and patient ages, the continual introduction of new cancer drugs, and “the inconsistency
with which patients are treated within and between cancer centers and the need to
evaluate ovarian function over an extended period of time” (2007:9).
Third, the “option gap” speaks to the lack of suitable and effective fertility
preservation options, particularly for female patients (Woodruff 2007). Sperm banking
remains the gold standard for men and is fairly cost- and time-effective; for example,
sperm banking averages $1,500 for three donations and a year of storage, and—
depending on the health of the patient—it can be successfully accomplished within a day
or two before treatment. However, options for women, especially women without male
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partners, remain very costly, time-intensive, invasive and unreliable. For example,
embryo and egg freezing each require several weeks to implement before cancer
treatment can begin; they also requires daily hormonal injections to stimulate egg
development and maturation and a surgical procedure to extract the mature eggs from
the ovaries. They cost roughly $8,000 and $10,000, respectively, plus the cost of the
hormonal injections, which range between $2,500 and $5,000. Ovarian tissue freezing,
ranging between $6,000 and $16,000, requires the surgical removal of either the whole
ovary or pieces of it prior to cryopreservation. Women without male partners must either
elect to use egg freezing, which has lower success rates than embryo freezing, or they
must use a sperm donor to create embryos—presenting a difficult decision between
lower success rates for egg freezing versus genetic non-relatedness to a future partner
for embryo freezing.
Although cancer-related infertility has not been studied in anthropology and is
understudied in the social sciences in general, the research conducted to date has
indeed shed valuable light on diverse aspects and exposed numerous critical paths for
future investigation. As explained in detail below, existing research has tended to focus
largely on individual aspects and experience, such as patient knowledge and attitudes
(e.g., Schover, et al. 2002a; Zebrack 2004); practitioner behaviors and referral practices
(e.g., Quinn, et al. 2009b); barriers (both individual-level and structural) that constrain
patients’ use of and knowledge about fertility preservation options (e.g., King, et al.
2008a; 2008b; Quinn, et al. 2008); and patient characteristics that may impact usage of
fertility preservation options (e.g., Snyder 2007). Fertility preservation has been the
focus of a large proportion of these studies; less studied are post-treatment parenthood
options used by cancer survivors, such as third-party reproduction and adoption.
Research in these areas will be briefly outlined below, followed by a discussion of the
legal and ethical implications of cancer and reproduction, and future research directions.
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Infertility and Patient Preferences
Research has demonstrated the importance that cancer patients and survivors
attach to both fertility and the potential for future parenthood (Dunn and Steginga 2000;
Loscalzo and Clark 2007; Schover, et al. 2002a; Schover, et al. 2002b; Schover, et al.
1999; Schover 1999; Schover 2005; Snyder 2007; Zebrack 2004). In a landmark study
investigating cancer-related concerns and quality-of-life, both male and female survivors
ranked ability to have children as a chief concern (Loscalzo and Clark 2007). This
concern also varies depending upon the age and the patient’s life stage at diagnosis,
and perceptions of infertility as a problem change over time (Connell, et al. 2006).
Indeed, fertility often takes on more importance as survivors get older (Chapple, et al.
2007), although one study found that younger adolescent patients are just as likely to
think about future life plans as older adolescents and were equally interested in fertility
preservation (Burns, et al. 2006). This “supports the idea that even younger adolescents
are able to look past their cancer diagnosis and their immediate future to make decisions
now that will be important in adulthood” (Burns, et al. 2006:353), underscoring the need
for appropriate counseling and discussion of options at the outset.
Findings from the oncology and reproductive medicine literature clearly suggest
that infertility is a significant cause of distress for patients and survivors (Partridge, et al.
2004; Sonmezer and Oktay 2006), and that fertility preservation can provide a measure
of hope and optimism for the future in the midst of an overwhelming diagnosis (Nieman,
et al. 2007; Tschudin and Bitzer 2009). Conversely, cancer-related infertility has been
associated with negative psychological outcomes post-treatment, such as depression
and anxiety (Carter, et al. 2005; Duffy and Allen 2009; Wenzel, et al. 2005). This is
unsurprising given that infertility by itself can provoke high levels of distress; as Duffy
and Allen (2009) note, the combination of cancer and fertility can place “great stress on
the patient, partner, and family. Even for persons who may have not planned to have
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children, the threat of infertility can result in a deep sense of loss and anger” (Duffy and
Allen 2009). Carter and colleagues (2005) found marked levels of depression and
distress in infertile gynecological cancer survivors that persisted for at least a year
following treatment—approximately 40 percent met the diagnostic criteria for clinical
depression. In addition, the “majority of the participants [75 percent] felt slight or some
sense of meaninglessness in their lives without their own genetic child, with [25 percent]
finding the meaninglessness to be marked or overwhelming” (2005:93). Interestingly,
Wenzel and colleagues (2005) found that women who had had a child prior to cancer but
were subsequently infertile following treatment reported more distress about infertility
than infertile survivors who had not had any children before cancer, suggesting a need
for further research to explain this dynamic.
Fertility Preservation: Patient Knowledge, Attitudes and Practices
Several studies have documented cancer patients’ knowledge, attitudes and
practices regarding fertility preservation in particular. A recent review of the literature
(Tschudin and Bitzer 2009) cited inconsistent levels of knowledge among patients and
survivors about their own fertility status and whether they might be able to have
biological children someday, and about the fertility risks of cancer treatment in general.
Patients frequently report not being informed by their healthcare providers about
infertility as a possible treatment side effect or about potential fertility preservation
options (Schover, et al. 2002a; Zebrack 2004)—for example, in one study, 40 percent of
male patients did not recall being informed about this by their providers (Schover, et al.
2002a), and in another, only half of the sample was able to remember a healthcare
provider mentioning the fertility risks of their treatment (Zebrack 2004). Although there is
the possibility of recall bias—especially when considering the psychological stress of
receiving information about infertility at the same time as the cancer diagnosis itself
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(Burns, et al. 2006)—the finding of low recall has been relatively consistent across
studies. Finally, data on the actual use of these technologies by cancer patients and
survivors (both fertility preservation and post-treatment parenthood options) are virtually
non-existent (Zebrack 2004).
Fertility Preservation: Provider Knowledge, Attitudes and Practices
Despite the importance that patients and survivors attach to fertility and
parenthood, research describing the ways this issue has historically been handled in the
clinical setting reflects a clear discrepancy. A good deal of research has been primarily
concerned with documenting provider knowledge, attitudes, and referral practices
regarding cancer-related infertility. First, studies with both oncologists (Quinn, et al.
2007; Quinn, et al. 2008) and other providers (King, et al. 2008a; 2008b) have reported
limited knowledge about fertility risks, available options and cost, the appropriateness of
specific options for their patients, and the existence of fertility resources including clinics.
Regarding attitudes, a number of research studies have reported that oncologists still
rate fertility preservation as a lower priority for discussion (Bradlyn, et al. 2004; Quinn, et
al. 2007; Vadaparampil, et al. 2008), and maintain a narrow focus on survival to the
exclusion of potential long-term effects such as infertility (Quinn, et al. 2008).
Barriers to Communication, Referral and Use of Fertility Preservation
Patient-provider communication has primarily been assessed on three levels:
whether or not providers are (1) informing their patients about infertility as a possible
side effect; (2) informing their patients about potential fertility preservation technologies
available to them prior to the initiation of treatment; and (3) giving their patients
appropriate referrals for these technologies if desired. As noted above, patients and
survivors frequently report not being informed about infertility as a possible treatment
side effect or about fertility preservation options. In one study, only 51 percent of male
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patients were offered sperm banking as an option (Schover, et al. 2002a). Another
study indicated that while 91 percent of surveyed oncologists believed that sperm
banking should be offered to all eligible men, only 10 percent reported that they in fact
always did so (Schover, et al. 2002b).
Several reasons have been proposed for this low rate of risk disclosure. A
number of studies have focused upon the barriers to patient-provider communication
about fertility risks and options, and the subsequent use of these options. Scholars
argue that the practitioners’ knowledge gap, cited above, is a major barrier to discussing
this issue with patients (Quinn, et al. 2007). Other barriers cited are provider discomfort
with such a sensitive topic and a hesitancy to deliver additional bad news on top of a
cancer diagnosis, the above-referenced perception among providers that fertility is not
patients’ top priority, and individual-level patient characteristics that lead providers to
view them as “ineligible” for fertility preservation (e.g., HIV-positive status or advanced
stage of disease) (Quinn, et al. 2007). Physicians’ continual focus on survival to the
exclusion of long-term quality-of-life issues has been a frequent research finding (Quinn,
et al. 2008), as has role ambiguity in terms of who holds the responsibility for having this
conversation—physicians or support staff (Quinn, et al. 2007; King, et al. 2008).
Barriers at the level of the healthcare system have also been cited as
impediments that providers face in addressing fertility preservation with patients. As
noted above, the type of cancer and stage of disease at diagnosis plays a large role in
the fertility preservation options available to patients: treatment must often be started
immediately, and some of the options available to women take several weeks to carry
out (Sonmezer and Oktay 2006). Moreover, the reality of the current healthcare delivery
system does not leave time for extended conversations between physician and patient,
and physicians frequently report that they must prioritize which conversations to have,
and leave the rest to support staff (Quinn, et al. 2007).
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These barriers also impact subsequent physician referrals to appropriate
services. Quinn and colleagues (2009b) found that approximately half of oncologists did
not refer eligible patients to fertility or reproductive endocrinology clinics in accordance
with the established ASCO guidelines. In that study, female oncologists were more
likely to make referrals, as were oncologists who expressed favorable attitudes about
fertility preservation and whose patients inquired about it. These findings are important
to note because provider communication about fertility risks and options plays a very
influential role in subsequent patient decision-making about using fertility preservation
technologies (Achille, et al. 2006). The authors suggest training other healthcare team
members to make referrals in order to alleviate the time pressure on physicians (Quinn,
et al. 2009), a strategy that has also been discussed elsewhere. Specifically, it has been
suggested that oncology nurses (Clayton, et al. 2008; King, et al. 2008a) and oncology
social workers (King, et al. 2008b) are in a convenient position to discuss infertility and
fertility preservation with patients, and to make referrals for services. In particular, King
and colleagues (2008a) found that oncology nurses are in an ideal position to initiate this
conversation with their patients and their study participants generally believed that it was
within their role to do so, although much role confusion does exist between physicians
and nurses on this topic.
Beyond barriers at the level of the healthcare system and the logistical
complexities of beginning treatment in the midst of decision-making about fertility
preservation, a fewer number of studies have focused on structural issues that constrain
patients’ and survivors’ use of technologies, both pre-treatment and post-treatment. All
of these procedures are very costly, especially when combined with the prospect of
cancer treatment expenses: sperm banking averages $1,500 for three donations and
one year of storage, and embryo cryopreservation can cost upwards of $10,000 (Fertile
Hope 2013). Additionally, most fertility procedures are not covered by insurance;
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several states have an insurance mandate to cover some infertility procedures but the
majority do not (Jenkins 2005; Quinn, et al. 2011). Moreover, it is important to note that
fertility preservation does not fit the criteria for “infertility,” usually defined as
unsuccessful attempts to conceive for at least one year, and thus would be ineligible for
infertility insurance coverage even in those states that mandate it. Several authors note
that a perception of the high cost of fertility treatments is a determining factor in whether
or not providers broach the topic with patients they perceive as not able to afford it (King,
et al. 2008a; Quinn, et al. 2009b).
Patient Characteristics
A small but important body of work has addressed how certain patient
characteristics—namely, gender, ethnicity and age—can influence the decisions made
regarding medical treatment and fertility preservation and can serve to create different
scenarios for patients. Expanding this line of inquiry remains a critical direction for future
research; this review exposes the need for more attention to these issues.
Woodruff (2007) suggests that gender impacts the experience of cancer-related
infertility on three levels. From a technological standpoint, fewer fertility preservation
options exist for women: sperm banking can take place more quickly, is far cheaper,
relatively more reliable and much less invasive than any fertility preservation option
available for women. This reality in turn impacts how providers choose to communicate
information about fertility risks posed by medical treatments to female cancer patients.
Subsequently, because of perceptions about time involved, cost, and effectiveness of
the female options, providers are less likely to inform female patients about them.
Furthermore, Snyder (2007) argues that the gender of physicians does in fact affect the
clinical encounter and can impact what topics are raised (or not raised) (Snyder 2007;
Tabenkin, et al. 2004). For example, one study monitoring time spent on patient–
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physician communication about various components of a clinic visit, such as health
behavior counseling, information about procedures, and answering patient questions,
found that male physicians were more likely to address issues differently according to
patient gender than female physicians (Tabenkin, et al. 2004). Male physicians tended
to counsel male patients on nutrition, substance abuse, health promotion, and exercise
for longer periods of time than they did for female patients (Tabenkin, et al. 2004).
Although reasons for this discrepancy are unknown, authors speculated that physician
age, years in practice, and education were influences. Relating to fertility preservation
specifically, as noted above, Quinn and colleagues (2009) found that female oncologists
were more likely to provide referrals to their patients for services. Finally, social science
research has suggested that “women and men do in fact experience infertility differently”
(Snyder 2007:141), and that infertility as a general experience (apart from cancer) can
impact women more strongly because of social expectations of motherhood, the
associated stigma of childlessness, and the fact that women’s bodies are most often the
site for infertility treatments—whether the cause is male infertility or not (Inhorn 2003;
Whiteford and Gonzalez 1995).
Social scientists have posited that the current disparities evident in cancer care
will be reproduced in situations of cancer-related infertility (Jenkins 2005; Snyder 2007;
Woodruff 2007) and survivorship care in general (Casillas and Ayanian 2011; Guidry, et
al. 2005). In other words, emerging disparities in access to fertility preservation, posttreatment parenthood options, and post-treatment healthcare are likely to parallel
existing ethnic disparities in cancer incidence and mortality, access to preventive
measures, and access to quality treatment. Jenkins (2005) notes that very little research
has been conducted illuminating the specific issues of infertility and use of ART by
minority cancer patients; however, social science work has clarified some of the
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complexities inherent in health disparities in general and identified some of their root
political, economic, and social causes (Gravlee 2009; Williams and Collins 2002). For
example, one study investigating the impact of physician bias on subsequent
recommendation for cardiac catheterization found that physicians were less likely to
recommend the appropriate treatment for African American patients (Schulman, et al.
2002). This is salient to cancer-related infertility because a “lack of information
regarding possible infertility and treatment options is the major [factor in] cancer patients
not taking steps (such as sperm banking) to help safeguard their future fertility”
(Woodruff 2007:6). As noted above, the type and method of communication about
fertility preservation is a critical factor in whether patients follow through with the given
recommendations (Achille, et al. 2006). Thus, lack of appropriate information and
referrals delivered to ethnic minority patients will have later implications for disparities in
reaching family-building goals (Woodruff 2007).
Age remains an important factor in determining available fertility preservation
options. Prior to puberty, the only options available for both girls and boys involve tissue
removal—specifically, ovarian tissue freezing and testicular tissue freezing. These
procedures are experimental, invasive, and expensive, and neither guarantees future
fertility (Lee, et al. 2006). Consent issues are particularly salient here: under age 18,
children can only assent to procedures (ASRM 2005), and thus parents must be the final
decision-makers about fertility preservation, an emotional decision in the middle of a
child’s cancer diagnosis (Vindrola Padros 2011; Vindrola Padros, Mitu, and Dyer 2012).
Post-Treatment Parenthood Options
A number of parenthood options exist for cancer survivors if their treatment has
left them infertile or unable to carry a pregnancy to term. The term “third-party
reproduction” refers to donor sperm, eggs, or embryos, and traditional or gestational
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surrogacy (Rosen 2005), and constitutes the range of options available to post-treatment
survivors in addition to adoption. However, despite the existence of these options, the
bulk of the research on cancer, fertility and parenthood has focused almost exclusively
on fertility preservation: very few studies have addressed the social aspects of thirdparty reproduction and rates of utilization among cancer survivors are unknown. One
exception is Rosen (2005), whose study on adoption agencies’ views on cancer
survivors uncovered potential discrimination. The author conducted a telephone survey
of cancer organizations, adoption agencies, and adoption specialists to determine the
range of information provided to cancer patients and survivors about adoption and thirdparty reproduction, and barriers to utilization of these options. She found that “cancer
organizations did not know whether cancer [was] a barrier to adoption; what a survivor
need[ed] to do to adopt; or whether or not a cancer survivor should disclose their cancer
history to the adoption agency, home study worker, etc. They could not identify
resources for a survivor experiencing discrimination or adoption agencies that [were]
cancer-friendly” (Rosen 2005:91). Indeed, agencies did not desire to be perceived as
‘cancer-friendly’ because that might adversely impact their international adoptions, since
many countries through which they arrange adoptions regard cancer as incurable and
are thus unwilling to consider the applications of survivors (Rosen 2005).
Findings from outside the cancer literature that address the effects of third-party
reproductive options on resultant family dynamics and child behavior are encouraging
and represent another exception to the lack of research on third-party reproduction. For
example, Golombok and colleagues (2002) found that parents of children conceived
through donor insemination and IVF displayed more warmth and emotional connection
than parents of children conceived naturally. Another example is work that has focused
on the complex issue of disclosure in relation to in third-party reproduction: findings from
diverse disciplines have found that, although the nature of these practices tends to
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encourage secrecy and anonymity (Becker 2002; Inhorn and Birenbaum-Carmeli 2008),
disclosing families may display more positive and harmonious parent-child relationships
overall than non-disclosing families (Lycett, et al. 2004).
Legal and Ethical Aspects of Cancer-Related Infertility
Ethical and legal issues surrounding fertility preservation and third-party
reproduction for cancer survivors abound. The specific issues are numerous: first,
participants in these debates are concerned with the experimental nature of many of the
technologies available, and question if it is ethical to offer expensive and unreliable
procedures to cancer patients at a time when they may not be able to afford the cost and
time required before beginning treatment (Robertson 2005). Second, they raise the
conundrum of whether or not it is morally or ethically appropriate to screen embryos for
cancer genes (for example, preimplantation genetic diagnosis for BRCA gene mutation
carriers) (Friedman and Kramer 2005; Menon, et al. 2007; Quinn, et al. 2009a). Other
scholars are concerned with the responsibility of the healthcare providers in relation to
disclosure of the side effects of treatment and referral options, and the use of informed
consent (Backhus and Zoloth 2007).
Thus, ethical debates surrounding fertility preservation for cancer patients have
tended to predominate in much of the research and current discourse on the topic. This
may be the case because, on a broader level, this scenario raises thorny questions
related to how family and kinship are defined, including the normative limits of
individuals’ power to “select” their own child, and ownership of genetic material. An
example of the former is surrogacy: many US states restrict this practice because it
clouds the issue of who the baby’s legal mother is (the surrogate, the “owner” of the
eggs, or the woman who raises the child) (Inhorn and Birenbaum-Carmli 2008).
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A productive example of the latter concern is posthumous reproduction. It is a
plausible scenario that cancer patients who do undergo fertility preservation procedures
may not survive long enough to use their stored gametes; therefore, an ongoing debate
both inside and outside oncofertility has been the use, ownership, and disposal of these
gametes (Robertson 2005; Stegmann 2010). Ethicists and lawyers, including the official
guidelines on fertility preservation from the American Society for Reproductive Medicine,
have strongly advocated for the use of directives to reduce confusion in cases of
posthumous reproduction; in the event that the patient dies, these forms would either
direct the gametes to be destroyed or allow for a specified individual to use them (ASRM
2005; Robertson 2005). The ASRM guidelines observe that “the legal system has
recognized that the person’s prior wishes about disposition of reproductive material is
controlling after death” (ASRM 2005:1626). In the case of pediatric patients, a multilevel process of informed consent and assent is recommended; however, the ethics of
using the stored gametes or tissue of children, no matter what consent procedures
utilized, is much disputed (Stegmann 2010). For example, if gametes are considered to
be legal property, then by extension, deceased children’s gametes are considered
parental property because minors cannot legally own property before the age of 18.
Stegmann (2010) notes that “most courts worldwide have been reluctant to rule on this
matter” (3), and that the lack of clear reproductive laws has created loopholes through
which parents have obtained their deceased children’s gametes to use for procreation.
SUMMARY
Continuously improving treatments have extended the survival rates of cancer
patients, leading to an emerging paradigm termed survivorship. In this paradigm, focus
has shifted from “survival at all costs” to one in which long-term quality-of-life is not only
considered, but deemed a high priority. Cancer survivors face a variety of risks for long39

term and late effects of treatment, and among young adults, infertility is one of the most
common. At the same tim, a variety of means offer possibilities for young cancer
patients and survivors to become parents, ranging from fertility preservation procedures
undertaken before treatment, to post-treatment parenthood options encompassing thirdparty reproduction techniques and adoption. While these options do exist, however,
access to them is constrained by a variety of factors, including low rates of physician
disclosure about infertility as a potential side effect and referrals to fertility clinics,
logistical and practical challenges of the procedures themselves (such as the
requirement of several weeks’ time prior to treatment for embryo or egg freezing), and
high cost and lack of insurance coverage. Likewise, accessing post-treatment
parenthood options, such as adoption, can be exacerbated by high cost, lack of
insurance coverage, and the possibility of discrimination against individuals with a
history of cancer. Nevertheless, the shift in perception from cancer as a “death
sentence” to a chronic, manageable disease leaves open the possibility of reproduction
and parenthood despite infertility as a common side effect.
As is evident from the review above, most of the research on cancer survivorship
and treatment-related fertility has occurred outside of anthropology, and has focused
primarily on US populations in which the concept of survivorship originated and has
been most developed. The following chapter considers theoretical concepts from
anthropology—and, when appropriate, sociology—that can deepen our understanding of
the broader social factors and cultural contexts of survivorship and infertility.
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Chapter Three:
Theoretical Perspectives on Cancer Survivorship and Reproduction
The examination of parenthood and infertility in the context of cancer and
survivorship provides a compelling case for studying the politics of reproduction. As the
lives of cancer survivors continue to be redefined both by public discourse and by the
medical system, they must grapple with new prospects for their futures that have been
circumscribed by cancer and its treatment-related effects. The topic holds promising
ability to shed light on the complexities of how improving treatment and survival rates
impact and perhaps expand the futures imagined by survivors, including the question of
whether or not to have children.
Little work to date has been undertaken by anthropologists that specifically
investigates cancer-related infertility or develops a theory to understand it. Thus, this
research must pull from related strands of theoretical work in anthropology and other
social sciences. Specifically, it is situated at the intersection of scholarly writing on
cancer survivorship and illness identity; the anthropology of reproduction, particularly
stratified reproduction; and infertility and assisted reproductive technologies (ARTs).
This chapter focuses on the broader picture that the social sciences have painted, and
summarizes major foci in each of these theoretical areas. The chapter concludes with a
brief discussion of the project’s location within these theoretical lines of inquiry and its
potential to extend them.
The underlying premise upon which this chapter is based is that the emerging
survivorship paradigm (which takes a more holistic view of post-treatment quality-of-life,
rather than maintaining an exclusive focus on survival at all costs) may impact survivors’
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lives by allowing for an imagined future with more possibilities than that conferred by
cancer’s historic conception as a death sentence. This view of cancer as a chronic,
manageable disease presents young survivors with the possibilities of having children
one day; yet, at the same time, survivorship is an ambiguous, liminal state of being in
which one is neither completely “sick,” nor completely “well.”
CANCER SURVIVORSHIP: ILLNESS IDENTITY AND REPRODUCTIVE DECISIONMAKING
This section begins with an exploration into the anthropological concept of the
sick role and the sociological and psychological concept of illness identity, tracing their
relevance to the emerging concept of survivorship. It then addresses the ways in which
theorists have conceptualized the experience of survivorship—or what it means to live in
a liminal state, challenged by the threat of recurrence and treatment effects—and the
overarching, dominant discourses of survivorship that are beginning to circulate.
Cancer Survivorship and Illness Identity
Anthropologists have long been concerned with a concept known as the “sick
role”—defined as a state of being through which a person communicates that he or she
is sick, which serves as a recognition and acknowledgement of illness (Ember and
Ember 2004). Originally formulated by sociologist Talcott Parsons in what later has
been critiqued as a representation of a response to acute rather than chronic illness
(Crossley 1998; Glenton 2003), medical anthropologists have examined and expanded
understandings of the sick role over the course of several decades (Kleinman 1980). As
Ember and Ember (2004) note, the sick role is an integral part of the illness experience:
“The sick role is a mode of communication and the first step in the healing process
because it is the acknowledgement of illness or abnormality. In assuming the sick role,
the individual communicates several important messages: the first is a wish to be
absolved of regular duties; second, a desire to validate illness via a healer; and third, an
acknowledgment that this is not a normal or usual state” (Ember and Ember 2004:201).
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This concept is important to this dissertation through a related body of work,
conducted primarily in other social science disciplines, on identities related to cancer and
the survivorship discourse. Although anthropologists have written much about cancer in
terms of lived experience (e.g., McMullin 2008), cultural models (e.g., Chavez, et al.
1995; Hunt 1998), metaphors (e.g., McMullin and Weiner 2008; Weiss 1997), and
structural aspects related to disparities in incidence, access to care and mortality (e.g.,
Balshem 1993; Craddock Lee 2008), they have not engaged with the idea of
“survivorship” to the same extent (Stoller 2004; 2008). Although little has been written
about this changing paradigm in anthropology, it is a fruitful area of unexplored research
precisely because of its relevance to the sick role. The concept of survivorship, indexing
a long-term process, can be productive in a re-consideration of the sick role concept.
Accordingly, the next section draws from sociology and psychology, the disciplines in
which much of this theoretical writing has been conducted.
The Seasons of Survival
The term “cancer survivor” was coined in 1985 by a physician treated for cancer
who went on to help found the National Coalition of Cancer Survivorship (NCCS). In an
influential thought-piece published in the New England Journal of Medicine, Seasons of
Survival, Fitzhugh Mullan (1985) delineated what he believed were the three seasons of
survival through which an individual with cancer passes. The first is acute survivorship,
during the diagnosis and treatment phase. Extended survivorship refers to the period of
time immediately following treatment, and permanent survivorship denotes long-term
survivorship when cancer is in remission.
It was not until the late 1990s that the cancer survivorship movement began to
gain increased momentum (Park, et al. 2009), perhaps because at the time of Mullan’s
writing, survival rates were lower and “the ‘ethos’ of cancer was that it [was] a ‘death
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sentence’” (Deimling, et al. 2007:758). Thus, it was perhaps an inappropriate concept to
emphasize at that point in time. Now, with increasing survival rates especially among
children, the paradigm of cancer treatment itself is evolving from a “seek-and-destroy
mindset” (Aziz and Rowland 2003:250) to one that takes into account qualify-of-life.
A recent editorial in Cure Today, a magazine for cancer patients and survivors,
called for a re-evaluation of the three-stage survival process given the 25 years of
research and experience that had occurred since Mullan formulated the original concept.
Miller (2009) argued that an intermediary stage exists between the acute and extended
periods of survivorship, which he termed transitional survivorship, or “the difficult time
when celebration is blended with worry and loss as a patient pulls away from the
treatment team” (2009:NP). Additionally, he added to the permanent survivorship
category an acknowledgement of the long-term health implications of cancer treatment
and the threat of secondary cancer development as continual worries for survivors
despite their “cancer-free” status. This is indeed an improvement over Mullan’s initial
rendering of the survivorship concept; however, there are notable shortcomings in these
formulations of survivorship. Although the stages idea has become quite popular, it
does not take into account the dynamic nature or fluidity of long-term engagement with
cancer, nor the variation in how people identity themselves, and at what point in the
illness process they adopt the survivor label (if at all).
Deimling and colleagues (2007) note that “an important part of this shift in
orientation has been a transformation of the language and labels used to identify those
who have had cancer. Terms such as ‘cancer victim’ or ‘cancer patient,’ which were the
traditional labels used to denote someone with this diagnosis, have been all but replaced
by the term ‘cancer survivor’” (2007:758-9). While the term “survivorship” is used most
often in relation to cancer, it has begun indexing a state or experience that many people
can share—from heart attack survivors, to survivors of natural disasters (Peck 2008).
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Further, despite the term’s association with life-threatening incidents, “others have
extended the definition to include those who have lived through a life-altering event”
(Peck 2008:91, emphasis mine). Thus, “these myriad conceptualizations define who is a
survivor but do not address the qualities, characteristics, and shared experiences that
lead one to a state of survivorship” (2008:91). This gap—in the general understanding
of the characteristics of survivorship—is useful for our purposes in generating a broader
understanding of the concept. Going on to overview the nursing and social science
literature on the topic, Peck argues that there are six distinct characteristics of the nature
of survivorship (not related solely to cancer survivorship; indeed, many of these themes
arise in non-cancer literature). These characteristics include, first, a confrontation with
mortality (a life-threatening disease is not required—the author notes that even minor
procedures can force people to confront their own mortality); second, isolation and
alienation from others and from previously existing support systems; third, a need for
support, including organized support groups as well as more informal support networks;
fourth, a “search for meaning through the lived experience” (2008:94); fifth, a need to
reprioritize lives and values; and sixth, a continued sense of vulnerability. In cancer, she
notes that this last characteristic frequently manifests itself through recurrence worries1.
Survivorship and Identity
While Little and colleagues (2002) argue that acute illness has a “sick role,” with
all its attendant responsibilities and expectations, none such clearly-defined identity or
1

On a related note, the “Damocles Syndrome” has frequently been used to refer to the
unpredictability of life after cancer. A foundation’s website describes this phenomenon:
“According to the Greek legend, Damocles, a courtier to the tyrant Dionysius, the Elder of
Syracuse, extravagantly praised his sovereign, who invited him to a sumptuous feast. However,
during the entertainment, Damocles looked up and saw that Dionysius had seated him directly
beneath a sword that was suspended from the ceiling by a thread. For Damocles, this sword was
a symbol of the precariousness of life and how one's fortune could shift from being in favor at
court to falling out of favor, causing the sword to fall down one's head. For people who have had
cancer, that sword represents the frailty and precarious nature of life itself. They continue to
believe that the threat of recurring cancer and consequently, the threat of death, is always
looming over them” (Oral Cancer Foundation 2010).
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role exists for individuals with chronic or long-term illness. Indeed, much is unknown
about the complexities and identity issues of long-term survivors, as most of the
research has been based on survivors newly transitioning from treatment (Deimling, et
al. 2007). This is a critical gap, given that many late effects do not begin to emerge until
between five and ten years post-treatment. The changing public perception of cancer,
referenced above, from death sentence to manageable chronic disease then impacts the
ways in which survivors view themselves and their future (Deimling, et al. 2007:759).
Some work on survivor identity has been undertaken by sociologists and
psychologists. Identity theory has been invoked to understand “the process of adopting
illness-related identities and the implications that these identities have for the self”
(Deimling, et al. 2007:759). In their work on identity formation among survivors with
cancer, Zebrack (2000) and Park and colleagues (2009) argue that the challenging
process of dealing with cancer and its long-term effects requires the formation of a new
self-identity because cancer disrupts normal life trajectories and social roles. The
authors argue that it is a considerable challenge for individuals with cancer to integrate
the idea of long-term confrontation with cancer into their existing self-concept (Zebrack
2000). Others have found that cancer identity and role do change throughout the
survival stages (Buki, et al. 2008; Zebrack 2000).
It has been argued that the process of adopting the cancer survivor identity can
confer beneficial effects and positively impact a survivor’s quality-of-life, fostering
changes in health prevention and maintenance behaviors, higher self-esteem, and a
reprioritization of valued social roles and activities. It can also potentially serve as a
“buffer [from] a preoccupation with cancer-related worries, and thus, play a role in
reducing anxiety and depression” (Deimling, et al. 2007:760). Some authors have found
that adoption of the “survivor” identity, rather than “victim” or “patient” or more neutral
terminology such as “person with cancer,” is associated with greater psychological well46

being and coping skills (Bellizi and Blank 2007; Harwood and Sparks 2003; Park, et al.
2009).
A fewer number of authors have focused on why some people with cancer
explicitly reject the survivor label (Frank 2003; Mathews 2000, 2008). Sociologist Arthur
Frank (2003) has studied the use of the term among individuals with cancer; among
those who resist its usage, he has identified a discomfort with the connotation of the
word survivor that implies that cancer is definitively “over” or “accomplished.” Instead,
he has written, these individuals “realize how capricious the difference of physical
survival is” (Frank 2003:251). In a study by Mathews (2000, 2008) on the formation of
an African American breast cancer support group, members of the group conceptualized
themselves as being “saved” from cancer in a religious sense, versus having overcome
the cancer themselves. Thus, they too rejected the survivor label and the implication of
individual accomplishment that it can hold for some.
Experiencing Survivorship
Sociologists have productively examined different formulations of survivorship:
one such formulation is that of survivorship as a cultural tool—an approach that posits
that “survivorship is a tool that women can use to frame their disease experience”
(Swidler 1986; 2001, as cited in Kaiser 2008:79). Kaiser (2008) found that breast cancer
survivors drew selectively from the circulating survivorship discourse, using bits and
pieces that might pertain more relevantly to their own lives. A few accepted the survivor
identity in whole, while still others sought to completely distance themselves from it.
Complementarily, sociologist Frank (2003) describes survivorship as “craftwork,”
a mode of living in which survivors “consciously construct their lives and the meaning of
cancer” (Kaiser 2008:79). Instead of a singular focus on “survival” that the survivorship
concept maintains, craftwork, on the other hand, denotes a continuously self-conscious
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working and re-working of one’s life in accordance with the limitations of long-term
engagement with a disease and the effects of treatment. More than merely coping with
illness, craftwork is “an embodied, exacting skill at building something or making
something work in a precise way” (Frank 2003:251). This concept is useful in that it
takes into account the creative and adaptive way that survivors live their lives following
treatment, and how life priorities change and are re-worked by accommodating the
constraints imposed by cancer or its treatment.
A relevant idea within the health literature has been the inherent liminality of the
cancer experience (Stoller 2004). Classically understood as a temporary state
experienced by an individual as they are passing from one role to another (Turner 1969),
liminality references the disorienting and confusing experience of being “betwixt and
between” states. Anthropologists have applied the idea of “persistent liminality” to health
events such as kidney transplantation (Crowley-Matoka 2005), in which the sufferer is
rendered “permanently unclassifiable in terms of the formal social roles they hoped to
reclaim” (2005:827). This idea is highly relevant when applied to the experience of
cancer survivorship (Little, et al. 1998; Thompson 2007). An individual who has gone
through cancer treatment lives always with the prospect of recurrence or the emergence
of late effects, and is thus never fully “well.” However, when not in active treatment, life
can go on somewhat normally; thus, the individual is neither fully sick. The idea of
persistent liminality correlates well with sociologist Frank’s description of the “remission
society” (Frank 1997; 2009). The remission society refers to any illness (not just cancer)
in which the sufferers get better but are never considered healthy—just in remission. He
describes this society: “members of the remission society do not use one passport [to
get from the land of the sick to the land of the well]. Instead they are on permanent visa
status, that visa requiring periodic renewal. The triumph of modernistic medicine is to
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allow increasing numbers of people who would have been dead to enjoy this visa status,
living in the world of the healthy even if always subject to expulsion” (2009:186).
Bury (1982, 2001) has conceptualized life with chronic illness as “biographical
disruption,” in which a diagnosis of illness significantly disrupts an individual’s life and
requires a reexamination of one’s present and future. This idea has been expanded
upon in recent years—for example, Sinding and Wiernikowski (2008) argue that chronic
illness does not always represent a biographical disruption. Rather, the situation is more
nuanced, and chronic illness can serve as “biographically reinforcing” or “continuous”
depending upon an individual’s social context, history of struggle, life expectations and
physical health status.
Discourses of Cancer Survivorship
In a related vein, Little and colleagues (2002) argue that while cancer used to be
“shrouded in social silence” (2002:170), an increasing number of discourses surrounding
it has begun to circulate. However, he cautions that:
While “the emergence of this discourse means that those who become ill with cancer can
expect some degree of acceptance and understanding…the same cannot be said,
however, about all those who survive cancer. Despite the interest that is often generated
by stories of survival—survival at sea or in times of war, for example—there still remain
unresolved tensions for those who have lived beyond the acute phase of extreme
experience” (2002:170, emphasis mine).

This quote indexes the lack of attention that has been paid to survivor narratives and
identity in favor of illness narratives and identity (Kaiser 2008), and it parallels the limited
medical knowledge on the long-term and late effects of cancer treatment.
Instead of the more nuanced interpretation of survivor identity and the
survivorship experience, what has predominated in much psychosocial research to date
has been a focus on post-traumatic stress disorder (PTSD) as a framework through
which to interpret survivor behaviors and identities (Little, et al. 2002) (see, for example,
Kangas, et al. 2005). An exemplar of this type of research is Madan-Swain and
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colleagues’ (2000) study on identity in adolescent survivors of cancer. Using a PTSD
framework, the authors argue that adolescents with cancer more often have a foreclosed
identity status than healthy peers, meaning that they commit prematurely to a particular
value system before they have had a chance to explore other systems. This foreclosure
is interpreted as an adaptive technique, allowing the adolescents a sense of security and
continuity in an otherwise chaotic time period; however, this foreclosed identity status
was linked to PTSD symptoms. In a rebuttal of this orientation, Little and colleagues
(2002) observed that the situation of survivors is often more complex than simply dealing
with post-traumatic stress: they observe that although a PTSD framework has been
central to much survivorship research thus far, they believe that existential dilemmas
more accurately speak to the tensions pervading survivors’ lives. Cancer can be seen
as an ‘extreme experience’ with consequences that continue for years afterwards; as
they note, “extreme experience is extreme because it leaves no aspect of identity
untouched” (2002:176).
Several authors have productively examined narratives of cancer survivorship.
Frank (2003) posits two master narratives in relation to survivorship in particular: the
Schweitzer narrative, otherwise known as the model of extensive responsibility, and the
limited liability narrative. Exemplified by Lance Armstrong, the narrative of extensive
responsibility denotes the belief that “suffering is the call to and preparation for works of
further service” (2003:249). This narrative can explain why many survivors of cancer
and other major illnesses often report a sense of obligation or responsibility to “give
back,” or to help others in the same predicament. As Frank (2003) summarizes, “from
those who have suffered most, something more is then required” (2003:249). On the
other hand, as its name implies, the limited liability narrative references the cancer
experience as something to be quickly overcome and forgotten—a “bump in the road.”
As he writes, this narrative is “the restitution story of illness, in which the end of the story
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is that the ill person’s life before illness is restored and illness can be forgotten” (Frank
2003:250). The impact of cancer on one’s self-identity and life trajectories is minimal;
thus, the individual is not forced to grapple with existential quandaries and can return
quickly to his or her pre-cancer life.
Discourses of breast cancer survivorship in particular, which help to structure
public understandings of individuals with cancer, employ themes of personal
transformation, triumphalism, and a sisterhood of survivors (Coreil, et al. 2012; Gray and
Doan 1990; Honea 1997). Breast cancer survivors are depicted as empowered,
advocacy-oriented, with unshakable positive views on life derived from their inspirational
transformations following cancer (King 2006). The image of the ultrafeminine woman,
“immaculately groomed and seemingly at peace with the world” (King 2006:102),
dominates public portrayals of breast cancer survivors. As some writers argue, this has
led to a narrow range of acceptable expression and behavior for other survivors
(Ehrenreich 2001; 2009). Beyond breast cancer, the “warrior” discourse is a notable
one, evident in the National Cancer Institute’s “War on Cancer” as well as advocacy
organizations that frame an encounter with cancer as a battle to be fought and a foe to
be conquered. Lance Armstrong and his “livestrong” mentality is a quintessential
example of this type of framing (Stoller 2008).
It is useful here to discuss work highlighting the potential negative repercussions
of the expectations generated by some of the dominant survivorship discourses (cf., Bell
2010; Deimling, et al. 2007). For example, Deimling and colleagues (2007) note:
“Even among those who are likely to survive cancer, the expectations created by the
survivorship orientation risks creating a ‘blame the victim’ situation where individuals feel
overly responsible for their own survival. This may become especially problematic for
individuals who experience a recurrence, which reduces the probability of permanent
survivorship. Some individuals may then feel that treatment failure, if it occurs, is
somehow ‘their fault’” (2007:764).
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As this quote demonstrates, the warrior discourse—which positions cancer as a battle—
equates survival with personal victory. Perhaps inevitably, this positions those who die
from the disease as perhaps not having “battled well enough” (cf., Stoller 2004).
However, it must be noted that dominant discourses do not uniformly dictate
public understandings of cancer. Indeed, areas of critique and resistance are
commonplace and often provide the most interesting perspectives on life after cancer.
Wilkinson and Kitzinger (2000) found that many participants in their study on breast
cancer patients challenged important aspects of the optimism discourse. Participants in
another study humorously derided key aspects of several discourses, most notably the
equation of survivorship with an accomplishment for which survivors are personally
responsible (Sinding 2011; cf., Sinding and Gray 2005).
Illness and Reproduction
The increasing survival rates and improving treatment modalities have made
“survivorship” possible, allowed focus on long-term quality-of-life issues, and have
shifted understandings of cancer from that of acute life-threatening illness to one that
requires chronic, long-term attention. Given these shifting constructions, one might
expect research to tackle the social and cultural ramifications of this changing illness
category, and how survivors’ horizons—including the prospect of parenthood—may
expand or shift because of the expectation of longer survival. However, anthropological
literature does not yet exist on how changing paradigms of survivorship have impacted
reproductive decision-making and desire for parenthood among individuals with a history
of cancer.2 Parallels must be sought in diseases that have experienced similar
increases in treatment effectiveness.

2

A related issue is parenting while dealing with a life-threatening disease. See, for example, Bell
and Ristovski-Slijepcevic’s (2011) examination of mothering and metastatic cancer.
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One potential area in which to look for this incipient research is HIV/AIDS.
HIV/AIDS provides a compelling parallel because survival rates have dramatically
improved due to the introduction of highly active anti-retroviral therapy (HAART) in the
mid-1990s (Delaney 2006). In concert with greatly reduced risk of vertical transmission
with appropriate therapy, HAART has created scenarios in which HIV-positive individuals
have a much longer expectation of survival, and thus may be more apt to contemplate
pregnancy and childbearing (de Silveira Rossi, et al. 2005; Spriggs and Charles 2003).
It is probable that these desires existed prior to the introduction of HAART; however,
research has only begun keeping pace. Eighty percent of HIV-positive women are of
reproductive-age (Delvaux and Nostlinger 2007); thus, it is not surprising that large
proportions of individuals living with HIV desire children and intend to have them (Myer,
et al. 2005; Santos, et al. 2002). In fact, one US-based study reported that 28 percent of
surveyed HIV-positive individuals desired children in the future (Chen, et al. 2001).
Perinatally-infected children (i.e., those who became infected through their
mothers during pregnancy or birth), once not expected to mature to adolescence, are
now living beyond adolescence and are faced with a decision that most providers did not
predict would be relevant: pregnancy and childbearing (Levine, et al. 2006). One study
reported that 70 percent of surveyed perinatally-infected adolescents intended to have
children (Ezeanolue, et al. 2006). The authors concluded that despite the limited
research, the consensus is that individuals with HIV do in fact desire children, and that
“knowledge of HIV status has no association with decisions to plan a pregnancy” (722).
Reproductive decision-making is highly complex and context-specific, and illness
is only one of many considerations (Levine and Neveloff Dubler 1990). However, it can
be a highly influential one: reproduction in the context of illness and potentially long-term
disease necessarily features an “interplay between sociocultural norms and biomedical
considerations” (Kirshenbaum, et al. 2004:111), including perception of risk (Levine and
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Neveloff Dubler 1990). These norms, which may depict parenthood and particularly
motherhood as defining components of identity (for the individual as well as on cultural
and national levels), are powerful. Investigation of these situations can be productive
from two perspectives: it has the potential to shed light not only on the effect of illness in
people’s lives, but also on the power and features of reproductive norms. It is this latter
topic that we now turn to, in an examination of the cultural aspects of reproduction.
THE ANTHROPOLOGY OF REPRODUCTION
It is possible to trace the history of social science research on reproduction from
a position of neglect to a veritable explosion of studies since the 1980s. Articles have
dissected nearly every aspect of reproduction, from menstruation (e.g., Buckley and
Gottlieb 1988), to family planning and contraception (e.g., Tober, et al. 2006),
menopause (e.g., Lock 2001) and abortion (e.g., Ginsburg 1998). Key to the maturation
of writings on reproduction has been the recognition of its relationship to many facets of
culture, such as kinship and other social relationships, and in linking reproduction with
global power structures and stratification (Browner and Sargent 2011; Thompson 2002).
Centering Reproduction
In their seminal work on the anthropology of reproduction, Ginsburg and Rapp
(1995) argue that reproduction must be placed at the center of social theory. They
maintain that “by using reproduction as an entry point to the study of social life, we can
see how cultures are produced (or contested) as people imagine and enable the creation
of the next generation” (1995:1-2). This more intensive focus on reproduction came at a
productive moment in time in which medical anthropology intersected with other
disciplines, most importantly feminist and science studies (Rapp 2001). Franklin (1995)
echoes Malinowski (1929) when she observes that “the anthropological axiom that what
a culture believes about conception serves as a particularly useful analogue for
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understanding how it defines other things […] Beliefs about procreation are themselves
foundational to a range of cultural definitions concerning parenthood and kinship, gender
and sexual difference, inheritance, and descent” (1995:335-336). Indeed, reproduction
can provide anthropologists with a useful starting point for understanding multiple
aspects of culture and providing a solid foundation for the formulation of social theory.
Franklin and Ragone (1998) observe that reproduction was an “obsessive
interest” in early anthropology (in a narrow sense), and that anthropologists were
intensely interested in kinship and procreation as a lens toward examining social
organization. This interest, however, merely extended to “physical paternity” (1998:2)
and reproduction was seen as innately natural (i.e., the “facts of life”), feminine and
private. They note that “primary among these factors [that ensured the tunnel vision
regarding reproduction were] the relegation of ‘reproduction’ to a domain of ‘natural’ or
biological facts that were (and often continue to be) considered prior to, and separate
from, sociality” (1998:2).
Feminist anthropological writing such as Conceiving the New World Order and
subsequent work (Browner and Sargent 2011; Franklin 1995; Franklin and Ragone
1998; Martin 2001 [1987, 1992]; Rapp 2001) represented a revisioning of
anthropological investigation into reproduction, moving away from historical analysis of
the narrow “natural history of human reproduction over the life cycle” framework
(Ginsburg and Rapp 1995:1). Given that early research was very culture-specific, these
scholars call for an expanded notion of reproduction research to include both local
experience and global processes—and the introduction of power relationships and
inequality that shapes reproduction throughout the world. Ginsburg and Rapp (1995)
offer a helpful definition of local and global: “local is not defined by geographical
boundaries but is understood as any small-scale arena in which social meanings are
informed and adjusted through negotiated, face-to-face interaction” (1995:9). Global, on
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the other hand, refers to “transnational or global processes … through which specific
arenas of knowledge and power escape the communities of their creation to be
embraced by or imposed on people beyond those communities. When such ideas flow
from the West to the Third World, the process is often implicitly read as a modernist
narrative that presumes Westernization as the inevitable outcome” (1995:9-10). This
linkage of power and reproduction is seen by some as the culminating achievement of a
decade or more of feminist-oriented theorizing (Thompson 2002).
Stratified Reproduction
Along with this new vision of anthropological inquiry into the domain of
reproduction, the concept of stratified reproduction was examined and expanded
(Ginsburg and Rapp 1995). Initially formulated by Colen (1986; 1989; 1990; 1995),
stratified reproduction refers to “the power relations by which some categories of people
are empowered to nurture and reproduce, while others are disempowered…[it asks] who
is normatively entitled to refuse childbearing, to be a parent, to be a caretaker, to have
other caretakers for their children, to give nurture or to give culture (or both)” (Ginsburg
and Rapp 1995:3). Rapp (2001) argues that researching stigmatized parenting (such as
gay parenting) is a necessary endeavor and can be highly fruitful in clarifying social
norms and expectations regarding “proper” reproduction.
This concept is reflected in recent debates about whether or not HIV-positive
individuals should have access to reproductive technologies (Spriggs and Charles
2003), and has been applied to a variety of situations ranging from pre-implantation
genetic diagnosis (PGD) (Browner and Press 1995; Rapp 1999) to female-headed
households (Mullings 1995). For example, Browner and Press (1995) argue that PGD
as a strategy to prevent the birth of babies with congenital abnormalities represents one
instance of stratified reproduction, and the reasoning underlying the purpose of the
56

technology has linkages with the historical eugenics movement. Although the blatant
eugenics policies of the early and mid-twentieth century would likely encounter fierce
resistance today, ideas about the “proper” people in society continue. Indeed, the
debate regarding HIV+ individuals’ use of ARTs is currently raging, with charges that
conceiving a child under these circumstances is morally wrong, despite the low rate of
vertical transmission with appropriate medical intervention (Spriggs and Charles 2003).
People with disabilities bore a large burden of the eugenics movement in the
mid-20th century, and were the victims of forced sterilization following the Buck v. Bell
Supreme Court case legalizing the involuntary sterilization of “epileptics and the feebleminded.” To this day, disabled people face social norms and legal actions that challenge
their ability to parent and undermine their caretaker roles. For example, the National
Council on Disability released a 2012 report entitled Rocking the Cradle: Ensuring the
Rights of Parents with Disabilities and their Children; among other things, it reveals that
13 percent of disabled parents reported discrimination in child custody cases based on
their disability (NCD 2012).
Another recent example in which the concept of stratified reproduction is evident
is in regard to immigrants and reproduction, and popular constructions of Latina
immigrants as overly fertile “hyperbreeders.” Chavez (2004) argues that “discourses
that construct people with ‘dangerous,’ ‘pathological,’ and ‘abnormal’ reproductive
behaviors are not simply of academic interest” (2004:173) but instead have serious
ramifications. One such consequence was the “Save Our State” movement in California,
which culminated in Proposition 187—this policy attempted to restrict the numbers of
undocumented immigrants by denying them critical social services like prenatal care and
education (Chavez 2004) because of the perception that the population was increasing
too rapidly.
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Reproduction and the State
One of the important angles that authors have adopted in studies of reproduction
is questioning the role of the state in regulating reproduction (Birenbaum-Carmeli and
Dirnfield 2008; Kahn 2000; Krause and Marchesi 2007; Lock and Nguyen 2010).
Birenbaum-Carmeli and Dirnfield (2008) point out that “[state policies] shape people’s
conduct, but they go beyond external behavior, to influence perceptions and
subjectivities, in ways that have medical, legal, economic and moral implications, and
that encourage and legitimize certain life trajectories over others” (2008:183).
For example, Krause and Marchesi (2007) researched fertility politics in Italy,
long known as the “Wild West” in reproductive medicine. They examined Italy’s
pronatalism and paradoxical support of two seemingly opposite pieces of recent
legislation: (1) a “baby bonus” bill that financially rewarded Italian and EU citizens for
having a child, and (2) a bill that drastically limited existing and currently-offered ART
services. Given Italy’s extremely low fertility rate (1.2 births per woman) and public and
scientific outcry over it, these two laws seem to encourage opposite outcomes—
increasing birth on the one hand, but limiting the ways in which it can be accomplished
on the other. Upon closer inspection, however, the authors argue that the two laws
actually seek to do the same thing—they are, in fact, delineating the type of family
created. The first bill, the baby bonus law, favors Italian and EU citizens and ignores the
prospects of immigration for supplementing low fertility rates, thereby boosting
population numbers (which has been a strategy taken by other EU nations and
oftentimes the US3). The second bill, the Vatican-supported ART law, restricts use of
these procedures to heterosexual co-habiting couples that would both share the genetic
3

An example in which the US turned to immigration to boost population numbers comes from the
severe labor shortage experienced during WWII. The federal government responded by
loosening the strict immigration policies in force, especially for Mexican and Chinese workers.
Fairchild (2004) argues that US immigration policy has been alternatingly inclusional and
exclusional based in good part on the demands of the economy.
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material of the baby. An obvious consequence of this is that gay couples are excluded
from using ARTs to have children. Taken together, these two laws ensure the birthing of
the “right” type of citizen by rewarding Italian and EU births and outlawing ART
procedures that threaten notions of the “proper” family, motherhood and fatherhood (i.e.,
heterosexual couples in co-habiting unions who do not use donor gametes).
Israel is another unique case, as it is well-known for its institutionalized support of
ART and procreation. The government of Israel fully subsidizes IVF and all other ARTs
to any Israeli woman (married or not) until she has two children with her current partner.
Israel is one of the least restrictive countries in terms of access to ARTs (BirenbaumCarmeli and Dirnfield 2008; Kahn 2000), and Israeli fertility scientists are known for
conducting some of the most cutting-edge research in the world. These policies lie in
stark contrast to the difficulties of utilizing adoption, either domestic or international, and
the restricted access to contraceptives and abortion in the country. Scholars tie these
deeply pronatalist state policies to a number of factors, including the need to buffer
against the Palestinian population or the replacement of Jews lost during the Holocaust,
but all have at heart Jewish childbearing as a form of nation-building.
In a study looking at public perception of reproductive technologies, BirenbaumCarmeli and Dirnfield (2008) go further in tying state policies to citizens’ acceptance and
perceptions of them—they interpreted the largely favorable perspectives of the policy of
on all sides (including women undergoing IVF) as “closely related to the encouragement
implied in the extensive state funding of IVF and in the Jewish Israeli tradition of
pronatalism, which may account for the virtual absence of critical public debate on the
subject” (2008:182). This near-universal acceptance exists despite the fact that IVF is
intensive, time-consuming and invasive, and carries health risks for the woman,
including ovarian hyper-stimulation syndrome, multiple births resulting in low birth-weight
and premature babies, pregnancy-induced hypertension, tearing or bleeding, hormone
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treatment sensitivity, and the theoretical (but still unconfirmed) risk of breast cancer
through repeated exposure to hormonal stimulation. As Birenbaum-Carmeli and
Dirnfield (2008) note, “potential IVF complications have always been downplayed in the
Israeli discourse. The dissenting voices of one or two physicians who have emphasized
the treatments ‘weightiness’ were dismissed as aiming to cut state costs at the expense
of individual’s welfare” (2008:185; Birenbaum-Carmeli 2004). Thus, the example of
Israel highlights the relationship and congruity between the goals of the state and
reproduction of citizens: offering free IVF fulfills the need to “produce” Israeli (and
presumably Jewish-only) citizens to ensure national stability and viability.
INFERTILITY AND ASSISTED REPRODUCTIVE TECHNOLOGIES
Infertility
As a subset of research on reproduction, the topics of infertility and ARTs have
productively been used by scholars to examine stratified reproduction (Inhorn and
Birenbaum-Carmeli 2008). This refers specifically to the historic marginalization and
devaluation of the reproductive potential of certain groups, while the reproduction of
other groups, such as the wealthy and the powerful, is assisted through easier access to
technologies (Culley 2009; Culley, et al. 2009; van Balen and Inhorn 2002). Further, the
study of infertility represents a lens through which other important issues can be
analyzed, such as gender and religious norms, and changing notions of kinship. These
issues will be explored in detail below.
Population Control versus Infertility
High rates of infertility (defined as the inability to conceive after one year of
unprotected intercourse) exist around the world, with between eight and 12 percent of all
couples worldwide being affected (Inhorn 2003). The highest rates, however, are
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reported to exist in the “infertility belt” of central and southern Africa—particularly
Botswana, Namibia, Zimbabwe, Cameroon, and Lesotho (Inhorn 2003; Lock and
Nguyen 2010).4 In what Inhorn (1994; 2003) refers to as the fertility-infertility dialectic, in
countries that are most affected by a high prevalence of infertility, high rates of fertility
often exist in juxtaposition; thus, high rates of infertility and fertility coexist in the same
place. As an unfortunate consequence, this leads to a lack of recognition that infertility
is a social and medical problem in need of redress. Furthermore, those areas of the
world most affected by the fertility-infertility dialectic—such as the infertility belt nations—
have long histories of population control interventions by health agencies and NGOs
based in wealthier nations (Lane 1994; Lock and Nguyen 2010; van Balen and Inhorn
2002). Thus, in developing countries, infertility treatment is often treated as a non-issue
by scholars, funding agencies, and government officials alike because these regions
have historically been viewed as overpopulated (Inhorn 2003; Lock and Nguyen 2010).
Importantly, the way in which infertility is defined as a problem also dictates
governmental monetary response and references the debate over whether having
children is considered a basic human right: if infertility is constructed as a medical
problem, it is within the purview of the government to subsidize treatment; however, if it
is a social problem (i.e., “involuntary childlessness”), it is a personal responsibility
(Sandelowski and de Lacey 2002; van Balen and Inhorn 2002). The medicalization of
infertility, and the construction of the infertile body as physically flawed (Greil 2002), can
ultimately position infertility treatment as medically necessary—and thus insurable.
4

It should be noted that the existence of the “infertility belt” has been challenged by some
authors; for example, Nancy Hunt (2001) argues that most studies relating to the high subSaharan infertility rate have actually been based on research in only two countries with high
infertility rates—specifically, the Belgian Congo and Central African Republic. The situation in
these countries was then generalized to sub-Saharan Africa. Related to this and the difficulty of
measuring infertility rates, Lock and Nguyen (2010) argue that infertility is measured very
differently in most studies; indeed, there has been no uniform way of measuring infertility that is
applied consistently across studies. Thus, although infertility is indeed a significant public health
problem throughout the world, in both industralized and developing countries, there are vexing
challenges to accurately measuring and documenting the scope of the problem.
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Accordingly, in some locations, patient advocacy groups promote the idea of infertility as
a medical problem in order to pressure national or private insurance programs to cover
its treatment (van Balen 2002; Dyer, Mitu and Vindrola Padros 2012).
Anthropologists who focus on infertility have called for increased attention to the
subject, citing a “scholarly lacuna” (Inhorn 2003) in social science that echoes the lack of
attention to the issue in general. Existing anthropological work that has addressed
infertility in global health context has focused on making infertility in developing countries
visible, countering the view that it is not a priority, and advancing knowledge of how
infertility is experienced and suffered in individuals’ lives (van Balen and Inhorn 2002;
e.g. Feldman-Savelsberg 2002; Sundby 2002; van Balen and Gerrits 2001).
Recently, infertility researchers have argued that the scholarly inattention to
infertility in developing nations, as discussed above, parallels the dearth of research
focusing on infertility among minority and lower-income populations in developed
countries, namely the US (Culley 2009). Inhorn and colleagues (2009) cite infertility in
minority populations as a consummate example of stratified reproduction because of the
lack of recognition that it is a problem (2009:182) and because of disparities in access to
infertility care (Greil, et al. 2011) as will be discussed below. Although the differences in
infertility prevalence by ethnic groups are not clear, there is cause to assume that
infertility is greater among minorities than among Caucasian populations: several studies
have pointed to higher rates of infertility among African American and Latina women in
the US (Bitler and Schmidt 2006; Culley 2009). This bias has extended to social
research on these issues, which has focused almost entirely on the middle- and upperclass Caucasian clients of infertility clinics (Culley 2009).
Conversely, research and funding priorities for reproductive issues among
minority individuals in developed countries have focused on population control and
reduction, paralleling the situation in non-Western countries referenced above (Lane
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1994). This pattern seems to respond to the iconic image of the African American and
Latina “hyperbreeder” who is perceived to be in need of reproductive control rather than
access, and whose over-fertility threatens to squeeze the country’s precious resources
(Culley 2009)—especially welfare resources. Culley and colleagues (2009) observe that
“the idea of fertility treatment in less developed countries of the world often evokes
feelings of disbelief and discomfort, since the dominant image of such societies is that of
‘over-population’. There are those who suggest that similar feelings pervade public
perceptions of marginalized communities in Western societies and that a desire to limit
the reproductive capacity of such groups has been more apparent than any effort to
assist procreative choice” (2009:10). A prominent case in point is the history of
sterilization abuse in Puerto Rico, a region long regarded as overpopulated: US
lawmakers, doctors, and researchers embarked on a decades-long project to sterilize
large numbers of Puerto Rican women with or without consent, and to insert sterilization
as one of the primary forms of birth control available to islanders (Lopez 1998, 2008).5
Tellingly, no research can be located that discusses infertility or ART in Puerto Rico.
Few studies on Latino/a perceptions and beliefs about infertility have been
conducted in the US. One of the few, a study conducted by Becker and colleagues
(2006), aimed to research infertility in a population that they considered doublyignored—low-income Latinos. Again, because Latinos in the US are considered a “highfertility” population, the presence of infertility is not considered a major problem in the
medical community. However, individual repercussions of infertility are vast: through
interviewing couples attending a low-income infertility clinic in San Francisco, the
authors found that long-term infertility was seen to jeopardize the success of the
marriage/partnership and many participants considered those marriages destined for
failure. Because “a child was the basis of the marital relationship…[it] was thought to
5

This will be elaborated on in Chapter Five: Research Setting.
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create a bond between the couple and legitimize the relationship” (2006:883).
Accordingly, couples began attempting to conceive immediately after marriage or when
they began considering themselves as a couple.
Assisted Reproductive Technologies
Given the gap in research on the experience of infertility among different
populations, it is notable that much work has been undertaken in anthropology on the
complexities and intricacies of assisted reproductive technologies (Inhorn and
Birenbaum-Carmeli 2008). As will be discussed below, some of these writings have
extended the above discussion on inattention to infertility as a problem among lowincome and minority Americans to inequalities in access to assisted reproductive
technologies (Inhorn, et al. 2009; Inhorn and Birenbaum-Carmeli 2008; Lock and
Nguyen 2010; Steinberg 1997). Others have addressed the gendered aspects of
treatment (Clark, et al. 2007; Inhorn and Birenbaum-Carmeli 2008; Thompson 2002;
Whiteford and Gonzalez 1995), the role of religion in the regulation and use of infertility
care (Bonaccorso 2009; Jenkins 2002; Kahn 2000; Raspberry 2009; Roberts 2006;
Roberts 2007), and the ways in which our traditional notions of kinship have been deeply
troubled by the development of these technologies (Bonaccorso 2009; Edwards, et al.
1999; Franklin 1995; Strathern 1992; Strathern 1995).
Inequalities in Access to Care
Inhorn, Ceballo, and Nachtigall (2009) have noted that “minority infertility serves
as a case par excellence of ‘stratified reproduction’” (2009:182). This is reflected in
steep inequalities in access to available infertility treatments both in the US and
worldwide, manifested in race- and class-based disparities. ARTs are very expensive,
prohibitively so for the majority of individuals who might benefit from their use; thus, they
are ultimately available solely for the elites in both non-Western contexts and most
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Western settings (Inhorn 2001; Inhorn and Birenbaum-Carmeli 2008; Lock and Nguyen
2010). Indeed, in one study conducted at the Brigham and Women’s Hospital infertility
clinic in Boston, Jain and Hornstein (2005) found that patients with household incomes
over $100,000 comprised over 60 percent of the clinic population. This compares with
just 18 percent of individuals at this income level in the general population (Inhorn, et al.
2009; Jain and Hornstein 2005). According to the American Society for Reproductive
Medicine, the average cost of one cycle of IVF in a US clinic is $12,400 (ASRM 2013),
roughly a quarter of the country’s annual median household income of $50,054 (Census
Bureau 2011)6. Medicaid does not cover infertility treatments, only contraception,
leading one author to remark that “public characterizations in the United States divide
women into “those for whom contraception is available if only they’d use it and those for
whom there are infertility treatments” (Cussins 1998:73, as cited in Greil, et al. 2011:2).
While recent research increasingly suggests higher infertility prevalence rates
among women of color in the US, it also demonstrates lower levels of infertility treatment
utilization (Greil, et al. 2011). While some studies have found no difference in utilization
rates once insurance coverage and socioeconomic status are controlled for (see
Chandra and Stephen 2010), other studies have found that differences along ethnic lines
remain even after controlling for those variables (Bitler and Schmidt 2006).
Steinberg (1997) equates the current situation of access to ART to a eugenics
logic. Eugenics operates through the social control of reproduction, and Steinberg
argues that ART is no exception. Surveying Britain’s infertility clinics’ eligibility criteria,
Steinberg found that clinics define eligible patients in strictly heterosexist terms by
restricting service to married or almost-married heterosexual couples. The clinics

6

Generally insurance does not cover ARTs, except in the 15 states that have insurance
mandates. These states require insurance companies to either cover or offer coverage for
infertility diagnosis and/or treatment (NCSL 2012). See Chapter Two for a more complete
breakdown of costs associated with ARTs (including fertility preservation).
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maintain the right to restrict access to those who they do not deem ‘fit’ to undergo
treatment. Fitness is defined broadly, and can encompass psychological or emotional
health, financial soundness, or physical health and age. This is similar to the eligibility
restrictions in US clinics (Inhorn and Birenbaum-Carmeli 2008). She concludes:
“Considered within the context of the historical role of the medical profession as an agent
of social control, particularly in the context of sexuality, notions of ‘breeding’, and the
construction of common sense discourses of ‘proper’ family, the findings in this survey
raise important questions about the conditions for women’s reproductive choice and
autonomy and about the re(production) of those conditions through the specific
professional practices examined here” (1997:33).

Gendered Aspects of Infertility and ARTs
It is important to note that infertility and ARTs have very gendered dimensions
(Lock and Nguyen 2010). Numerous authors have argued that infertility tends to affect
women on a much greater scale, both physically as well as socially, for a number of
reasons (Clark, et al. 2007; Inhorn and Birenbaum-Carmeli 2008). First, women are the
main recipients of medical interventions, and their bodies are most often the site of
diagnostics and treatment7 regardless of whose infertility is being treated—the man’s or
the woman’s. Even though male factor infertility accounts for half of the cases of
infertility globally, as Inhorn (2003) notes, it is most frequently the bodies of women upon
which medical treatments for infertility are enacted via nvasive procedures.
This medical reality served as one of the main points of objection for feminists in
the 1970s and 80s who critiqued these new technologies as just another set of tools for

7

In fertility preservation, options for female cancer patients are highly invasive, involving vaginal
ultrasounds, egg extraction via the vagina, and weeks of hormonal stimulation—versus sperm
banking for men, which can be completed in one day. Infertility diagnostics reflect a similar trend:
common diagnostic tests for female infertility include a hysterosalpingogram (an x-ray of the
fallopian tubes, which involves inserting a catheter through the cervix and enough contrast to fill
the uterus and fallopian tubes), a transvaginal ultrasound (which involves an ultrasound probe
inserted into the vagina), hysteroscopy (in which a scope is inserted through the cervix to check
the inside of the uterus), and laparoscopy of the pelvic cavity to assess for endometriosis and
other conditions, and extensive bloodwork (ASRM 2012b). In contrast, diagnostic testing for male
factor infertility primarily includes a semen analysis and bloodwork (ASRM 2012c).
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patriarchal control over women’s bodies via reproduction. According to this view, ARTs
did not offer women “reproductive options” so much as reinforce the mandatory nature of
childbearing and women’s inherent maternal role (Sandelowski and de Lacey 2002;
Thompson 2002). Women who used ARTs to achieve pregnancy were sometimes
characterized as “cultural dupes.” The paradoxical aspect of this argument is made
clear by van Balen and Inhorn’s (2002) comment: “this feminist discourse [ultimately]
proved oppressive in its own right: feminist or otherwise ‘emancipated’ women who were
experiencing infertility problems found it difficult to reveal their child desire and were
forced to hide their infertility-treatment seeing from others” (2002:15)8.
From another perspective, other authors have argued that, especially in cultures
where a woman’s only access to higher social status and power is through childbearing,
access to reproductive technologies can offer women protection from adverse social
outcomes (Inhorn 2003; Lock and Nguyen 2010). Many authors writing on infertility in
developing countries argue that women generally bear the social burden of infertility to a
larger degree than men (Clark, et al. 2007; Inhorn 2003; Lock and Nguyen 2010;
Whiteford and Gonzalez 1995). In some societies, women may be subject to divorce,
abandonment or social ostracism if she does not bear children (Inhorn 2003). In these
instances, motherhood is a mandatory status and women pay dearly if it is not achieved.
In the US, social norms concerning motherhood have led some authors to argue that
there is a greater psychological burden on the female partners of an infertile couple
(Lock and Nguyen 2010). Infertility among women sharpens feelings of alienation,
personal failure, and low self-esteem, while for men, infertility challenges masculinity,
sexuality, sexual potency, power and responsibility (Clark, et al. 2007; Gannon, et al.
8

As Thompson (2002) appropriately writes, “infertility poses a prima facie tension for feminists
[…] The paradox of infertility for feminism, then, is this: feminists are well-placed to understand
the special burden involuntary childlessness places on women, but they are ambivalent about
supporting women who seek infertility treatments because it seems to lend implicit support to
conventional gender roles and gendered stratification” (2002:52).
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2004). A number of studies have revealed a tendency for the female partner to take the
blame for her male partner’s infertility in order to spare him the public questioning
regarding sexual potency and masculinity (Becker, et al. 2006; Clark, et al. 2007).
Whiteford and Gonzalez (1995) argue that our pronatalist society creates an
enormous amount of pressure for women (and, to a lesser extent, couples) to reproduce.
Their study questioned why some women seem to be utterly consumed by having a child
“even to the detriment of their own health, marriage and financial status” (1995:27), and
why the social identity of the woman is so greatly challenged, “polluting her other
accomplishments” (30) and negating other aspects of her life. They observe that “two
primary procreative norms predominate in North American society. One is that all
married couples should reproduce; the other is that all married couples should want to
reproduce. These norms (extensively documented in the literature), in conjunction with
‘pro-birth’ governmental policies (i.e., income tax deductions) that encourage
reproduction and reward the image of parenthood, form the basis of a pronatalist
society” (1995:28). Although infertility is considered by many authors to be stigmatized
as a physical disability, they believe that in the US it has to do with the inability to fulfill a
critical social norm—motherhood (Whiteford and Gonzalez 1995).
Religion and ARTs
A critical aspect of the context surrounding ART, although understudied, is the
role of religious beliefs and institutions. Inhorn and Birenbaum-Carmeli (2008) observe
that in the US, moral dilemmas are usually tackled by ethicists and lawyers, while
outside of Euro-American settings religion generally holds more sway in determining the
morality and acceptability of particular technologies. The role of religion in regulating
access to and perception of ART has been investigated by a number of authors
(Bonaccorso 2009; Jenkins 2002; Kahn 2000; Raspberry 2009; Roberts 2006; 2007).
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For example, in Egypt, Islam expressly forbids gamete donation, surrogacy and formal
adoption, and—while encouraging the use of IVF and other ARTs by infertile couples—it
restricts family-building to options that produce biological ties. Inhorn (2003) observes:
The mixing of relations that these arrangements imply “severs blood ties between parents
and their offspring; confuses issues of paternity, descent and inheritance; and leads to
potentially incestuous marriages of the children of unknown egg or sperm donors” (1847).

Although religious traditions have displayed a variety of interpretations regarding
the ethical basis of ARTs, Catholicism is the only major world religion to have enacted a
unilateral ban on in vitro fertilization (IVF) (Roberts 2006). Of course, this restriction is
interpreted differently by nations, as reflected through the technologies’ varying levels of
insertion into national health systems. For example, until very recently Costa Rica was
alone in following the restriction to the letter and banning IVF9 (Roberts 2006). In
Ecuador, on the other hand, infertility specialists have integrated Catholic symbols and
traditions as core elements of their practices—for example, by hanging crosses in visible
areas of the infertility clinics (Roberts 2006). IVF specialists do not see themselves as
“playing God” or tampering with the natural order; rather, they view themselves as
“God’s helpers” or assistants. Indeed, God has final power to decide if the technologies
will succeed in producing a pregnancy or not. Accordingly, Ecuador does not have the
kind of controversy swirling around IVF that other Latin American countries do and the
industry is very sparingly regulated, in contrast to other nations such as Italy. 10 In the
case of Puerto Rico, all ART procedures are legal and so is surrogacy, paralleling the
unregulated nature of reproductive technologies in most US states (CBHD 2010).
Although no known literature to date has documented the influence of the Catholic
9

On December 20, 2012, the Inter-American Court of Human Rights ruled that Costa Rica’s
Supreme Court-issued ban on IVF was a violation of human rights. The judges noted that “the
decision to become a parent is part of the right to privacy and includes, in this case, the decision
to be a mother or father in the genetic or biological sense.” The government of Costa Rica will
spend $360,000 compensating the 18 couples who originally brought the lawsuit and have
promised to reinstate the practice of assisted reproduction in the country (Tico Times 2013).

10

See Chapter Five for a discussion of the situation in Puerto Rico.
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Church on the fertility clinics and services in Puerto Rico, from this study a preliminary
conclusion can be drawn: despite “official” disapproval by the Catholic Church, the
existence of infertility-related stigma, and the secrecy with which clients seek infertility
services, no widespread public condemnation of ARTs was apparent.
Kinship Transformations
A further area of anthropological research under the umbrella of infertility has
focused on how ARTs complicate notions of kinship, a central concern of anthropology
(Bonaccorso 2009; Edwards, et al. 1999; Franklin 1995; Strathern 1992; Strathern
1995). Franklin (1995:335-6) argues in reference to ARTs that:
“to modify the processes of reproduction or genetic inheritance is to make unprecedented
interventions into human reproductive futures and thus, inevitably, into key definitions of
humanity itself. Through reproductive assistance, for example, procreation is separated
not only from sexuality but from the body, and fertilization is achieved technologically.”

Research on ARTs has tremendous power to contribute to social theory through a reexamination of kinship (Ginsburg and Rapp 1995). As Bonaccorso (2009) observes,
ARTs have a way of “throw[ing] certain kinship notions into relief” (2008:xvi) and, as will
be discussed below, challenging what we believe it means to be related.
As referenced above, anthropology maintained a near-obsession with
reproduction and kinship for much of the late 19th and 20th centuries, albeit with a narrow
focus. However, Marilyn Strathern’s pioneering work in the early 1990s led to a
reexamination of how kinship and ARTs intersect, and essentially how the new
technologies can destabilize our existing notions of kinship and the “so-called
nature/culture intersection” (Inhorn and Birenbaum-Carmeli 2008:182; Strathern 1992),
or, as some authors refer to it, the natural “facts of life” (Strathern 1992, 1995; Franklin
and Ragone 1998; Lock and Nguyen 2010). Euro-American kinship has always been
based on “blood” and the act of procreation (Schneider 1980); however, in the past few
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decades it has started shifting to an emphasis on genetic ties (Strathern 1995). Drawing
upon Strathern’s pioneering work, Lock and Nguyen (2010:265) observe that:
“The nuclear family and intergenerational ties of blood are in theory understood as
‘natural, indisputable, and prior to everything else.’ […] In contrast to many other parts of
the world where social relations, often regardless of whether or not blood or marital ties
are involved, are given priority over biological connections in establishing kin, in Europe
and North America, from the end of the 19th century, the idea of nature has increasingly
become biologized, reinforcing and molecularizing, by means of genetics, a belief in
‘natural’ kinship as primary. However, technological innovation forces us to consider,
usually with mixed feelings of anxiety and hope, what is now made visible—entirely new
conjunctions of bodies and machines.”

Strathern (1995) argues that knowledge displacement has always been a central feature
in culture—we acquire new knowledge that displaces old knowledge—but knowledge
displacement concerning the “natural facts” of life is even more destabilizing. As noted
above, historically anthropology has presumed a biological basis for kinship and ignored
the social basis; it is only until recently that anthropologists have begun to examine
biological versus social parenthood. To this end, Strathern (1992) argues that “ARTs
have created a new convention, the distinction between social and biological parenting,
out of an old one, kinship as the social construction of natural facts” (1992:27-28).
In their review of anthropological work on ARTs and culture change, Inhorn and
Birenbaum-Carmeli (2008) observe that two major findings have emerged from an
anthropological reexaminations of kinship in relation to ARTs. First, there has been a
marginalization of alternative forms of parenting, such as adoption, because infertile
couples now embark on “a relentless quest to produce biogenetically related offspring
through the ART-assisted manipulation of their own gametes” (Inhorn and BirenbaumCarmeli 2008:182) as a response to an increasing emphasis on genetics in
constructions of kinship. Second, they note that ARTs have “led to more dynamic
notions of ‘kinning’” (Inhorn and Birenbaum-Carmeli 2008:182; Howell 2006) as a result
of the resultant ambiguity concerning new family formations. This ambiguity is
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particularly apparent with gamete (egg and sperm) donations and surrogacy11: for
example, the authors argue that surrogacy “threatens dominant Western ideologies that
presume an indissoluble mother-child bond, gradually deconstructing motherhood into
genetic, birth, adoptive and surrogate maternities, with the potential for three ‘biological’
mothers to a single child” (2008:182). The moral confusion surrounding these new
family forms speaks to Strathern’s observation of the especially destabilizing effects of
knowledge displacement concerning such “natural facts” and is reflected in the myriad of
regulations, laws, and ethical debates over these technologies in the US and abroad.
To this I add a third consequence: the increasing presentation by the
medical/infertility community and perception by the wider public of human reproduction
as naturally flawed and inefficient (Franklin 1995). In an influential argument, Franklin
(1995) observes that a “central principle of achieved-conception narratives [is] that
‘nature needs a helping hand’” (1995:329). Fertilization—or the sperm entering the egg
(i.e., physical merging)—is delineated from conception, or the exchange of genetic
material between the gametes. Further, the portrayal of (female) reproduction as
fundamentally inadequate and flawed has a long history, and is not new to the field of
assisted reproduction: rather, “the idea that female reproductive capacity is badly
designed and in need of medical and technological assistance is as old as the use of
forceps” (Franklin 1995:335). If reproduction, and especially female reproduction, is
constructed as naturally flawed, then the medicalization of fertility becomes necessary.
POTENTIAL THEORETICAL CONTRIBUTIONS OF THIS RESEARCH
Little anthropological work has been published to date on the intersection
between cancer, survivorship, and fertility. Accordingly, the research that provides the
11

As outlined in Chapter Two, there are two types of surrogacy. Gestational surrogacy refers to a
female surrogate who carries someone’s pregnancy but is not genetically related to the fetus.
Traditional surrogacy involves a female surrogate who has (usually) been inseminated with the
male partner’s sperm and carries the baby to term.
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basis for this dissertation draws from the above outlined theoretical lines of inquiry—
survivorship and illness identity; the anthropology of reproduction; infertility and
reproductive technologies—in order to create a new conceptual framework for this topic.
The dissertation accomplishes this in three important ways. First, it uses
Ginsburg and Rapp’s (1995) formulation of the concept of stratified reproduction,
wherein certain groups of people are empowered to reproduce while others groups are
discouraged, by considering how cancer survivors are allowed or able to procreate.
ARTs are very expensive, rarely covered by insurance and thus not widely accessible to
patients or survivors. Furthermore, research has demonstrated that cancer patients are
often not informed of the effects of cancer treatment on their reproductive capacities—
either at all, or with enough time to do anything about it (see Chapter Two). In this way,
their future parenthood is devalued. Accordingly, this project extends Ginsburg and
Rapp’s (1995) conception of stratified reproduction by examining how sick role and
illness identity are evaluated in terms of reproductive privilege. This contribution
specifically draws upon the formulations of survivor identity discussed above.
Second, large gaps in the literature have been identified relating to the
experience of survivorship and infertility in populations outside of middle- and upperclass Caucasians in the US. Since this study was carried out in Puerto Rico, it
contributes to the scholarly work on how minority groups in Western societies are unable
to access ARTs, and how the social consequences of infertility among these groups may
be neglected because of “hyperbreeder” stereotypes and ideas about overpopulation
(Culley 2009). Ginsburg and Rapp (1995) argue that “comparative studies are essential
to any cultural understanding of the impact of biomedical technology on fundamental
social categories and of challenges to that technology” (1995:291). It also helps fill a
critical gap in the literature on how “survivorship” is experienced outside of the US and
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whether the survivor identity is a salient concept in a different cultural context (Kaiser
2008; Mathews, et al. 1994).
Finally, Snyder (2007) notes that most infertility research has been conducted
with healthy couples and relatively scant research has focused on those with illnesses or
chronic disease: this research responds to this gap by asking how the experience of
infertility or the desire for parenthood changes when one is confronted with a lifethreatening disease. Research on reproductive decision-making in the context of
chronic disease can illuminate both sociocultural norms regarding reproduction and
parenthood, as well as experience and constructions of illness.
SUMMARY
The survivorship concept necessarily occurs in a cultural context, and elucidating
this concept (and the “survivor identity” that draws from it) is a condition for any
anthropological research into long-term cancer survival and quality-of-life. This study’s
location at the intersection of diverse strands of theoretical work endow it with the
possibility of contributing to the many scientific gaps in this topic: investigating (1)
stratified reproduction in terms of illness identity and sick role; (2) the experience of
survivorship, infertility, and technologies cross-culturally; and (3) the negotiation between
desires for and norms regarding parenthood and experience of long-term engagement
with cancer and its long-term effects.
The next chapter will now turn to the methodology of the current study, outlining
the research design, data collection and analysis methods, ethical oversight, and study
limitations, as well as information on participant demographics.
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Chapter Four:
Methods and Demographic Information
This research explores survivorship and reproduction among cancer survivors in
Puerto Rico, specifically examining issues of decision-making surrounding parenting and
infertility, and how reproduction among cancer survivors is constructed in Puerto Rican
society. The study proceeded in two sequential phases: first, an ethnographic content
analysis of cancer depictions in the media, and second, ethnographic interviews—
specifically, unstructured key informant interviews and semi-structured interviews with
four defined groups (survivors, healthcare providers, advocates, and clergy). In order to
lay the groundwork for the justification of method selection, this chapter first reviews the
predominant methods used in previous research on cancer, survivorship, and fertility,
including both strengths and potential areas for expansion. A description of the research
design, data collection methods and analysis techniques follows, and the chapter
concludes with a discussion of ethical issues, challenges and study limitations.
METHODS USED IN SIMILAR RESEARCH
It is important to document the types of methods used in research on similar
topics in order to more clearly identify neglected areas and potential avenues for the
present study’s contribution. This section first examines past studies on media
representations of cancer and survivorship as one avenue through which to understand
the cultural aspects of cancer, then moves on to explore the predominant methods used
in psychosocial oncofertility research.
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Media Representations of Cancer and Survivorship
A principal objective of this dissertation research is to understand the cultural
aspects and norms regarding cancer in Puerto Rican society. Previous scholars have
utilized media analysis for this aim, revealing important findings about portrayals of
cancer in North America. Indeed, Clarke (2006) notes that “observing and interpreting
media content provides a reflexive window into fundamental values and meanings
regarding health, illness, and medicine” (2006:593). Although a full treatment of the
anthropological approach to media studies is beyond the scope of this project, its most
important proposition is that media is rooted in culture (Bird 1992)—media is culturally
constructed, arising from the cultural context and shaping it by its messages (Bird 2003).
Media scholars differentiate between frames and themes. Sociologist David
Altheide (1996) defines frames as “the focus, a parameter or boundary, for discussing a
particular event. Frames focus on what will be discussed, how it will be discussed, and
above all, how it will not be discussed” (Altheide 1996:31). Clarke and Everest (2006)
argue that three frames tend to dominate media coverage of health issues. The first is
the medicalization approach, in which all illness conditions as well as the maintenance of
health are appropriated under the paradigm of biomedicine in the “context of the
diminution of the social control functions of religious, legal, familial, and other
institutions” (2006:2592). Second, the political economic (also termed social-structural)
frame considers the role of social structures and context in health and disease, including
class divisions, poverty, racism, and pollution. Finally, the lifestyle frame focuses upon
individual responsibility, and the impact of lifestyle choices on the body.
On the other hand, themes—while related—can best be described as recurring
“theses” (Altheide 1996:31) rather than the explicit perspective from which the text is
compiled—what Clark and Everest (2006) have termed “manifest” versus “latent”
content. Altheide (1996:31) notes:
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“Theoretically, frames and themes are crucial in defining situations and provide much of
the rationale for document analysis. These are the most powerful features of public
information, and the study of their origins, how they change over time, and their taken-forgranted use in everyday life is essential to understanding the relevance of communication
media for our lives.”

Media scholars have taken up the topic of how cancer is portrayed in various
media outlets, and how this may reflect existing ideas and stereotypes about cancer
(Clarke 2005; Stryker, et al. 2007). Consequently, analyses of the portrayal of cancer in
two common sources—newspapers and magazines—have led to important findings.
For example, some researchers have found that cancer information is represented and
delivered differently in mainstream North American newspapers than in those targeting
ethnic minorities. Stryker and colleagues (2007) reported that less information on
cancer treatment is printed in ethnic newspapers in the US than in mainstream
newspapers; interestingly however, ethnic newspapers tend to include more information
on education and prevention and to present clinical trials in a more neutral fashion. In a
Canadian study, ethnic newspapers, even more than mainstream newspapers, were
found to devote a disproportionate amount of coverage to breast cancer relative to the
actual causes of cancer death in Canada (Hoffman-Goetz and Friedman 2005).
Other studies investigating the portrayal of cancer in magazines have
documented that cancer is often portrayed as inevitable, is written about in conjunction
with fear and terror, is referenced with war and fighting metaphors (Clarke and Everest
2006), is linked to genetic and/or biological causes rather than to social determinants
(Clarke and van Amerom 2008), and is stigmatized (Clarke 2005). One study focused
on the frequent use of celebrities as “spokespeople” for cancer, portraying them as
successful and strong in the face of a diagnosis (Clarke and van Amerom 2008). The
inclusion of celebrities, and the writers’ emphasis on their character traits as important to
their success in fighting cancer, resonates with an across-the-board emphasis on
individual aspects of health and disease—rather than on social determinants.
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Overall, these studies have argued that journalists are responsible for
perpetuating fatalistic beliefs about cancer (Niederdeppe, et al. 2010); maintaining an
over-emphasis on the role of “lifestyle” factors in cancer development (Jensen, et al.
2010 ); paying more attention to certain cancers (e.g., breast cancer) to the exclusion of
others (e.g., lung cancer) (Hoffman-Goetz and Friedman 2005; Kromm, et al. 2007;
Larson, et al. 2009; Slater, et al. 2008); and advancing a stereotyped, feminized
portrayal of breast cancer patients (Andsager, et al. 2000). One study looking
specifically at the portrayal of cancer survivors in print news stories found that “fear and
a lack of confidence in cancer screening practices” (Kromm, et al. 2007:298) were
prominent themes in survivors’ quotes, although survivors were generally represented as
heroic, positive, transformed warriors. This finding led the authors to speculate on the
existence of a “hierarchy of survivorship” (Kromm, et al. 2007), asking: “If media
accounts shape public understanding of survivorship, do we run the risk that those who
do not fit the very positive image being displayed are then viewed as survivors ‘in name
only’?” (2007:304). Thus, if some people with cancer do not maintain a continuously
positive attitude or become a volunteer fully immersed in the cancer advocacy world, the
portrayals routinely displayed in the media may serve to marginalize those survivors who
do not fit this idealized stereotype of how to live one’s life post-cancer.
Cancer and Fertility
Shifting attention from studies addressing representations of cancer in the media
to research that specifically addresses oncofertility, research from the social sciences,
public health, and medical sciences (including oncology) have heavily relied upon
quantitative, survey-based methods in social and psychological research into cancer and
fertility. In a recent review of the literature, Tschudin and Bitzer (2009) identified 24
articles published between 1999 and 2008 that addressed some aspect of cancer and
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fertility among reproductive-age survivors. Sixteen articles out of the 24 (66 percent)
utilized only quantitative methods, while seven (29 percent) were purely qualitative and
one study used mixed qualitative and quantitative methods (4 percent). In order to
consider articles published more recently than Tschudin and Bitzer’s (2009) review, the
current project identified ten additional articles published between 2008 and 2010—the
year in which this research project began—and an additional six that were not included
in Tschudin and Bitzer’s review but had been published prior to 2008. Seven of these
were qualitative studies, while nine were quantitative. Tables A1 and A2 (Appendix A)
present all of the articles reviewed. Although informal, this review provides important
information on the types of research employed in oncofertility thus far.
The most common method of data collection among these 40 articles was selfadministered, postal questionnaires. Other quantitative methods included online surveys
and interviewer-administered questionnaires. Qualitative methods were primarily semistructured interviews and focus groups. Taken as a whole, the studies tended to focus
predominantly on the knowledge, attitudes, and behaviors of either patients or providers,
and have lent valuable insight into the psychological and social dimensions of cancerrelated fertility issues. For example, it is clear through these studies that parenthood
and fertility are of high importance to patients and survivors, that patient-provider
communication about this topic is hindered on a number of levels—not least of which is
lack of provider knowledge about both infertility as a side effect as well as appropriate
options, and that patients must contend with formidable barriers to utilizing fertility
preservation techniques, such as high cost and time commitment (Dunn and Steginga
2000; Loscalzo and Clark 2007; Schover, et al. 1999; 2002a; 2002b; Zebrack 2004).
In a review of the role of social sciences in oncofertility, Snyder (2007) notes that
the initial research conducted into the issue has necessarily been at a micro-level, which
focuses on individual or interpersonal factors: she argues that this focus on “individual79

level experiences and decision-making processes [has been necessary] because so little
is known about the fertility concerns of those with cancer, how they make fertilityconserving treatment choices, and their survivorship experiences regarding parenthood
and family planning” (2007:146). However, she argues that, as this scholarship
expands, a focus on meso- and macro-levels of analysis takes on critical importance—
with meso-level referring to social phenomena at the level of community or institution,
and macro-level pertaining to large-scale social phenomena. For example, research
may focus on how providers integrate new medical technologies into their practice, or on
the effect of policy on patients’ access to these new technologies, respectively.
Accordingly, the initial review of the literature provided above has revealed several
critical future directions for research. First, none of the studies as of yet have taken an
ethnographic approach to researching cancer and fertility, examining the sociocultural
and political-economic context of the issue. Few take into account issues of class,
gender, and ethnicity and how these variables impact perception of the problem, access
to treatment and technologies, and communication with providers. Nearly all have taken
as their primary focus the individual-level aspects of cancer and fertility, such as patientprovider interaction and use of technologies.
Second, the studies reviewed thus far tend to focus on the perspectives of one
group, such as patients only, to the exclusion of other significant actors whose
perspectives are critical in rendering a more holistic picture. This dissertation responds
to the idea that this is an appropriate time for ethnographic research focusing on class,
gender, and ethnicity issues, as well as the sociocultural and political-economic context
in which cancer treatment and survivorship is embedded. Qualitative research is critical
for providing the richly-detailed interpretation of survivors’ experiences that is missing in
so much of the existing literature. Accordingly, the results of this study are wellpositioned to build upon this prior research and contribute to filling these identified gaps.
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RESEARCH DESIGN
Epistemological Approach
This study’s epistemological approach is best described by LeCompte and
Schensul’s (1999) concept of paradigmatic synthesis, drawing from both critical and
interpretive or phenomenological traditions in social sciences, and articulated by Lock
and Scheper-Hughes (1996) as the critical-interpretive approach in medical
anthropology. As they note, “a critical-interpretive approach seeks to go beyond a
culturally sensitive presentation to reveal the contingency of power and knowledge in
both their creation of and relationship to the culturally constructed individual body” (1996:
68). Thus, the study is first informed by a critical perspective—particularly medical
anthropology and feminist anthropology—and takes into account the overall societal
power structures and their relationship to individual lives. This is a crucial perspective for
a research site such as Puerto Rico, with its history of political colonialism by the US and
in which questions of identity and autonomy are at the forefront of daily life. It examines
how this political relationship structures the provision of healthcare and ultimately the
population’s health, and it accounts for the intersections of gender, class, and race. At
the same time, however, the research questions themselves call for an interpretive
approach, one that investigates individual experiences of cancer survivorship and the
meanings that people construct about illness and health. This approach posits that
“shared constructs and meanings [are] ‘situated’; that is, they are located in or affected
by the social, political, cultural, economic, ethnic, age, gender and other contextual
characteristics of those who espouse them” (LeCompte and Schensul 1999:49). The
study is interpretive from the outset; the core of the study lies with survivors’ local, lived
experiences, and then moves outward, placing those experiences in a cultural, social,
political and economic context—linking the individual and the structures.
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Methodological Approach
Creswell (2007) argues that researchers often use a combination of
methodologies depending on the appropriateness of particular methodological tools to
their research questions. As such, the overall methodological framework for this study is
drawn from ethnography and grounded theory. While the study is not an “ethnography”
in a traditional sense, it utilizes ethnographic methods to explore cancer survivorship as
it is culturally constructed and experienced by survivors in Puerto Rico. Similarly, the
study relies on ethnographic content analysis for the media analysis. This methodology
allows the researcher to “define the problem when it is complex and embedded in
multiple systems or sectors” (LeCompte and Schensul 1999:29), and it is appropriate
because the aim of the research is discovery rather than hypothesis-testing. Further,
ethnographic research is ideal for studies that focus upon the local population’s broader
social and political-economic context; thus, the local or mid-range theories developed
through ethnography can be linked to “what happens locally and regional, national, and
global events, politics, and political-economic structures” (Schensul, et al. 1999:7).
A modified grounded theory approach was employed for the analysis of the
interview data. Initially developed and elaborated by sociologists (Glaser and Strauss
1967; Strauss and Corbin 1990), variants of the original approach have been utilized in a
vast array of disciplines (Creswell 2007) such as psychology, health sciences,
education, and other social sciences. LeCompte and Schensul (1999) argue that this
type of analytic approach, which in anthropology goes by other names such as recursive
analysis or domain and structural analysis, is particularly well-suited for ethnographic
research. Grounded theory’s inductive and deductive perspective complements
ethnography’s exploratory character, thus aiding in the development of local and midrange theories.
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DATA COLLECTION METHODS
Data collection was carried out in two locations in Puerto Rico between June
2011 and January 2012. Several data collection methods were employed: the first
phase consisted of an analysis of three women’s magazines articles addressing cancer,
while the second phase included unstructured key informant interviews with ten cancer
researchers, and semi-structured interviews with 16 healthcare professionals (hereafter
referred to as ‘providers’), 23 survivors, nine NGO staff members or advocates (referred
to as ‘advocates’), and two members of the Catholic clergy. See Table 4.1 below for the
relationship of the research questions to the specific methods used.
Table 4.1. Research Questions and Corresponding Data Collection Methods

Research Question
RQ1: Cultural Context of
Survivorship and
Reproduction

Methods Employed
Primary: Background research into La Reforma (PR Medicaid
system reform), insurance, and the existence of practice guidelines
on both fertility preservation and survivorship care; media analysis;
key informant interviews (n=10); healthcare professional interviews
(n=16); NGO staff and advocate interviews (n=9), and clergy
interviews (n=2). Secondary: survivor interviews (n=23)
RQ2: Survivor Perspective Primary: Survivor interviews (n=23). Secondary: advocate
interviews (n=9); clergy interviews (n=2); provider interviews (n=16)
RQ3: Healthcare Provider Primary: Provider interviews (n=16); advocate interviews (n=9)
and Advocacy Perspective
Content Analysis of Women’s Magazines
Research Question 1 outlines an important objective of this dissertation research:
to document cultural representations of cancer and of patients/survivors. The analysis of
media depictions of cancer is a crucial tool for this aim: anthropologists have argued that
media outlets are a critical element in formulating understandings about the modern
world (Bird 2003, 2005, 2009; Edwards 1994; Ginsburg and Rapp 1995). Bird (2009)
argues that “anthropology today can no longer dismiss media as external forces acting
upon distant ‘cultures,’ but rather that they are inextricably embedded in culture,
reflecting and reshaping it in an ongoing process” (2009:2). Therefore, examining media
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content regarding health and illness can provide a glimpse into core societal values and
meaning-making (Clarke 2006), and is a critical means through which to answer
questions about how cancer is constructed in Puerto Rican society.
Despite the plethora of research on depictions of cancer in newspapers, there
are drawbacks to the selection of this outlet, including their temporary nature and lower
circulation rates (Clarke and Everest 2006). Clarke and Everest (2006) argue instead
that magazines provide a more useful source for the examination of the interaction of
culture, health, and illness. Specifically, magazines “tend to be more permanent than
most newspaper, television or radio reports, inexpensive, ubiquitous (e.g., office waiting
rooms and supermarket checkout counters), and in widespread circulation” (2006:2593).
As a media outlet, magazines reach proportionately more people than newspapers or
other outlets; thus, magazines—and specifically those targeting women—offer a solid
venue through which to analyze cultural representations of cancer.
Domains
The media analysis conducted here largely addresses the first research question
(the cultural context of survivorship and reproduction). The domains—meaning a “set of
items, behaviors, beliefs or events defined by a cultural group as belonging to the same
category of things: a basic unit of meaning that shapes how people conceptually
organize their worlds” (Schensul, et al. 1999:6)—that were investigated using this
method include survivorship, the portrayed characteristics of cancer as a disease, and
reproduction in relation to cancer. The results provided background information on
cultural perceptions of cancer that helped to structure the design of the interview guides.
Ultimately, these data were combined with that extracted from the interviews in order to
assess how views of cancer (in general) and views of cancer survivors’ reproduction
(specifically) may ultimately impact cancer survivors’ plans and options for parenthood.
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Sampling Approach
The original plan for this study included the analysis of the three highestcirculating women’s magazines in Puerto Rico. Magazine articles with a major focus on
cancer would be collected through a total of four years—1995, 2000, 2005, 2010—in a
period spanning 15 years (from January 1, 1995 through December 31, 2010). This 15year time parameter was selected because of the assertion in the cancer literature that
“survivorship” as a concept gained increased momentum and recognition during the late
1990s (Park, et al. 2009). Analyzing articles from four years instead of fifteen would
allow for a manageable sample of articles while retaining the ability to assess trends
over time (following the methodology of Clarke and Everest [2006]).
The three highest-circulating women’s magazines in Puerto Rico are Imagen
(PR), Caras (PR), and Vanidades (Argentina). Cosmopolitan en Español is the fourth
highest-circulating magazine in Puerto Rico and was to be used in the event that any of
the other three were unavailable. Many avenues to gain access to the above magazines
were explored. Unfortunately, it proved impossible to locate full sets of the original four
magazines through existing libraries in Puerto Rico and the US; for example, they were
unavailable through either the USF or University of Puerto Rico Library and Inter-Library
Loan, the San Juan and Ponce public libraries, and the libraries of private universities
such as the Ponce School of Medicine, Universidad del Sagrado Corazón, or the
Catholic University of Puerto Rico. One of the project contacts—a recently-retired
medical research librarian—was unable to locate them through her island-wide network
of contacts. Online, archived resources do not exist, either through the publisher or the
magazine itself. Although an online database for English-language magazines does
exist, which allows a researcher to locate an exact article on a topic, there is no Spanishlanguage counterpart. Requests through PR- and US-based publishers and distributors
proved unsuccessful—a purchase of back issues was prohibitively expensive.
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Ultimately, the majority of the required back issues of Imagen were obtained
through the Universidad del Sagrado Corazón, a private university in San Juan, while
the missing issues were located in the National Archives of Puerto Rico in San Juan.
Twenty-three out of the 25 issues of Vanidades 2008—the most recent year available—
were obtained through the University of Puerto Rico-Carolina campus. The 2010 issues
of Cosmopolitan (English: US), from USF Libraries Online were substituted. Despite the
unavailability of the back issues of Caras and Vanidades, Imagen can be used as a
sufficient proxy to account for media representations of cancer in those years and to
assess trends. Additionally, the availability of three current magazines—Vanidades,
Imagen, and Cosmopolitan—allowed for a more complete analysis of the contemporary
representations in those media. Thus, the sampling strategy enables both a depth and
breadth of analysis. Table 4.2 below outlines the magazine data collected.
Table 4.2. Magazines and Years Sampled
Magazine Sampled
Years
Imagen (PR)
1995, 2000, 2005, 2010 (48 of 48 issues)
Cosmopolitan (US)
2010 (12 of 12 issues)
Vanidades (Argentina)
2008 (23 of 25 issues)
Cancer-related items were identified in a straightforward manner. Articles, news
blurbs, or advertisements focusing on cancer of any kind were the focus of the analysis;
cancer did not have to be the sole theme of the article, but it had to be included as a
major topic. The hard copy of every issue of Imagen and Vanidades was reviewed
page-by-page; items that appeared even marginally relevant were read in their entirety.
The procedure differed slightly for Cosmopolitan since the back issues of that magazine
were available in an online, searchable database. In this case, the keyword “cancer”
was searched, and any corresponding articles retrieved and reviewed. Since I evaluated
the English language version of Cosmopolitan (the Spanish language version was
unavailable), all of their articles—a total of 13—were published in English.
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Data Analysis Procedures
Ethnographic content analysis (ECA) as set forth by Altheide (1987; 1996)
applies the central principles and aims of ethnography to the analysis of documents. It is
a reflexive process that dovetails with grounded theory, as conceptualized by Glaser and
Strauss (1967) and Strauss and Corbin (1990), in that it encourages a constant
comparative method of analysis (Altheide 1987). ECA uses the investigator as the main
tool of research, and it is tailored to discover the meanings of the message that is
“assumed to be reflected in various modes of information exchange, format, rhythm and
style, e.g., aural and visual style, as well as in the context of the report itself, and other
nuances” (Altheide 1987:68; 1996). In contrast to quantitative content analysis, ECA
emphasizes discovery rather than verification of hypotheses although it can also be used
for that purpose, considers narrative description and uses a textual analysis instead of
statistical analysis, and allows the concepts to emerge during the course of the research
(Altheide 1987; 1996). Because this study is exploratory and interested in the latent
themes (Clarke and Everest 2006) relating to cancer’s portrayal in the media, all of
ECA’s characteristics made it a highly appropriate analytical method to select.
Altheide (1996) delineates a 12-step process for the ethnographic analysis of
documents that broadly encompass problem identification and familiarization (steps 1, 2
and 3); identification of variables for data collection (4); formulation, testing, and revision
of a protocol (5, 6); delineation of a sampling strategy (7); collection of data (8); data
analysis (including comparison between extreme and typical cases) (9, 10); theme
integration (11); and write-up of results (12). This study followed all of the procedures
set forth. The codebook was developed both inductively, after a thorough re-reading of
the texts, and deductively, utilizing themes from the literature on cancer-related
magazine coverage.

87

Ethnographic Interviews
Ethnographic interviews were selected as the primary means of data collection.
Two specific types of ethnographic interviews were used in this study: (1) unstructured
interviews with ten cancer researchers who served as key informants, and (2) 50 semistructured interviews employed with four distinct groups of participants: survivors (n=23),
healthcare providers (n=16), cancer advocates (n=9), and clergy members (n=2).
According to Schensul and colleagues (1999), these two types of interviews are
important components of ethnographic studies. Unstructured interviews are employed at
the formative stages for five primary purposes:
To (1) “explore undefined domains in the formative conceptual model; (2) identify new
domains; (3) break down domains into component factors and sub-factors; (4) obtain
orienting information about the context and history of the study and the study site; and (5)
build understanding and positive relationships between the interviewer and the person
being interviewed” (1999:121-2).

The unstructured framework allows for a full breadth of information to be extracted. This
was the type of interview employed with the key informants, where the objective was to
gain as much information as possible on a variety of topics in order to inform the semistructured inquiry with the survivors, providers, advocates and clergy. The open-ended
nature of the questions allowed participants to answer broadly to the inquiries.
Semi-structured interviews are also open-ended, but their questions have been
informed by the domain identification from the unstructured interviews and thus are
intended to produce more focused data (Schensul, et al. 1999). Purposes of semistructured interviews are four-fold: to (1) “further clarify the central domains and factors
in the study; (2) operationalize factors into variables; (3) develop preliminary hypotheses;
and (4) develop a qualitative base for the construction of an ethnographic survey”
(Schensul, et al. 1999:149-50). Objectives 1 to 3 are particularly relevant for this study,
which does not include an ethnographic survey. Because this study was exploratory and
did not seek to test hypotheses at this stage, the use of both unstructured and semi88

structured interviews was an appropriate choice and allowed for a depth and breadth of
data to emerge on the experiences of survivors in Puerto Rico. Detailed information
about the participants of these interviews is included below.
Unstructured Key Informant Interviews
As referenced above, a total of ten cancer researchers on the island served as
key informants for the research, both prior to the initiation of data collection as well as
during the process itself. These informants were all directly involved in a range of
cancer research activities on the island, including basic, sociocultural, psychological, and
epidemiological research. In some cases, researchers served as ongoing consultants to
this study, answering questions and talking at length about related issues. Others were
contacted one to two times in order to gather information about specific issues, such as
the ongoing problems with Medicaid access, support resources available on the island,
the state of Puerto Rican cancer research, and cancer trends on Vieques—a small
Puerto Rican island that was the site of US military bomb testing for decades. As a
whole, these communications were critical in helping to formulate initial interview guides,
give direction to the background research on the Puerto Rican healthcare system,
suggest further contacts with people working in the field, and answer culturally-based
questions about the challenges and nuances of conducting research on the island.
Interview Procedures
Excluding one key informant with whom I met on an on-going basis through
meetings and conversations lasting a few minutes to two hours, most interviews with key
informants lasted an average of one hour. In all cases, they were conducted in the
informants’ professional offices. They were not tape-recorded, although extensive notes
were written and consulted throughout the course of the project.
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Participant Selection/Recruitment
Key informants were recruited through snowball sampling and selected because
of professional expertise in the particular areas stated above. They were contacted
either via email or telephone, informed about the study, and queried about whether they
were willing to meet to discuss their work.
Demographic Information
Some of the standard demographic indicators, such as age, self-identified
ethnicity, and income level, were not collected for the key informants. Nine of the
informants had doctoral or medical degrees (PhD or MD). All were employed in either
universities or hospitals: specifically, schools of medicine (n=3), a university-affiliated
Cancer Center (n=3), School of Public Health (n=1), School of Social Work (n=1), a nonuniversity-affiliated Cancer Center (n=1), and a primary school (n=1).
Semi-Structured Interviews: Survivors, Healthcare Providers, NGO Staff and
Advocates, and Clergy
A total of 50 ethnographic interviews were conducted with four distinct groups:
survivors, healthcare providers, NGO staff and advocates, and clergy. These interviews
sought to address all three research questions, and primarily the last two: elucidating the
sociocultural, political-economic context of Puerto Rico and the role of religious
institutions; clarifying the survivor perspective on survivorship, parenthood and fertility;
and exploring the healthcare provider and advocacy perspective on the same constructs.
Interview Procedures
All interviews were conducted using semi-structured, open-ended interview
guides that were tailored for use with each group (see Appendix B). The guides were
developed using input from key informants, the media analysis, a preliminary literature
review, and personal past research with cancer survivors. Six guides were ultimately
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developed: (A) survivors; (B) oncology professionals, including oncologists and oncology
nurses; (C) infertility specialists, including reproductive endocrinologists and
andrologists; (D) gynecologists; (E) NGO staff and advocates; and (F) clergy. Guides B,
C, and D used the same foundational questions but several specialty-specific questions
were inserted in order to tailor them for use with different practitioners. All guides began
by using drafts, which were refined both by pre-testing with two or three members of
each group and by expert review by key informants and doctoral committee members.
Special attention was paid to culturally-appropriate translation of the interview
items and informed consent documents. The draft guide and informed consents were
first translated from English into Spanish by the researcher and were then corrected by a
male Puerto Rican anthropologist who is a native Spanish-speaker. The revised,
translated guide was then double-checked for relevance and accuracy by a Puerto Rican
woman, also an anthropologist and native Spanish-speaker, before using with the
groups. Any problems encountered in the interview process with comprehension or
interpretation of items were resolved through additional conversation and co-editing.
In order to mitigate any potential misunderstandings or missed meanings relating
to my incomplete knowledge of the Spanish language, these two same anthropologists
assisted with the conduct of the interviews1. The female anthropologist and myself
conducted all Spanish-language interviews together. In order to achieve gendermatching between the interviewee and interviewer, the male anthropologist conducted
the Spanish-language interviews alone with the three male survivors interviewed. This
strategy was advised by several key informants in order to minimize male participants’
discomfort or hesitation sharing sensitive information or personal stories with a woman.

1

Please see “A Note about Language and Communication” later in this chapter for a more critical
discussion of the impact of language barriers.
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Roughly half of the interviews were conducted in Spanish. With bilingual
(English and Spanish) participants, the language of their choice was used. English was
used in 8 of the 10 key informant interviews, 14 out of the 16 provider interviews, 5 of the
9 advocate interviews, and 5 out of the 23 survivor interviews.
Domains and Participant Selection/Recruitment
Survivors. A total of 23 in-depth, semi-structured interviews were conducted
with both male (n=3) and female (n=20) reproductive-aged cancer survivors at various
stages post-diagnosis. This sample size was selected for two reasons: first, there is
difficulty in locating survivors due to both cancer stigma and the stigma of infertility, welldocumented in Latin America (Ombelet, et al. 2008). Second, because the study is
exploratory, its goal is depth; therefore, a limited number of in-depth interviews with
survivors was more desirable. The interview guide addressed the following domains:
meanings of cancer and survivorship, physical impacts of treatment, experiences of
healthcare, reproduction, future plans, religious beliefs, and family.
Survivors were recruited primarily through snowball sampling, supplemented by
clinic-based recruitment. Inclusion criteria consisted of a prior diagnosis for cancer (any
type), male or female, reproductive-aged (diagnosed and treated before the age of 45),
and off active treatment for cancer. Contact with various support group leaders was
made through local cancer advocates, who in turn passed along the information to their
constituents. In two cases, I was asked to present the objectives and goals of the study
to the support group, and these presentations generated interest among potential
participants. In other cases, support group leaders came upon the information from
acquaintances, and they in turn passed it along to their members, who contacted me if
interested. Several of the participants had heard about the study from women who had
already participated. Finally, with the support of a staff member of a public cancer
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hospital, I was able to recruit several of its survivors who were off-treatment and
returning for follow-up care at the hospital.
Interviews ranged between 30 and 90 minutes, with an average of 54 minutes,
and took place at a location of the interviewee’s convenience. This was in most cases
the participants’ homes, but interviews were also conducted in public places, such as
parks, shopping mall food courts, work offices, and a private hospital office. Two
interviews were conducted over the phone because of the participants’ preference.
Demographic Information: Twenty of the participants were women, and three
were men. All interviews except one were conducted in the San Juan metropolitan area,
with the one exception located on the northern coast in the Arecibo metropolitan area.
Participants’ declared ethnicity reflected diverse categories. Upon being asked about
their ethnic identification, five survivors answered “Puerto Rican” or “Boricua,” three each
answered “Black” or “Latino/a”, two “Blanca” (or White), two “Hispanic,” two “Latina and
Puerto Rican” (or Boricua), and one each, respectively, answered “Black Caribbean,”
“Hybrid (Spain, African, Arab and Indian),” “Blanca/Puerto Rican,” “White Latina,” and
“Hispanic/Latino.” Occupations were diverse, and the only pattern to emerge was that
several reported themselves as housewives (four). The rest held different occupations,
such as engineer, pastry chef, professor, accountant, bank teller, secretary, teacher,
pharmacy technician, physical therapist, and graduate student, among others. The
remaining demographic information is summarized in Table 4.3 below.
Table 4.3. Demographic Characteristics of Survivor Sample
SURVIVOR GROUP
N=23

DEMOGRAPHIC VARIABLES

Sex

Female
Male

20 (87%)
3 (13%)

Age at Interview

Mean
Median
Range

43.43 years
44 years
27-73 years
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Age at Diagnosis

Mean
Median
Range

33.61 years
35 years
13-45 years

Number of
Children

Mean
Range

1.83
0-4

Number of
Household
Members

Mean
Range

2.78
1-5

Marital Status

Single (no partner)
Living with Partner
Married
Separated
Divorced
Widowed

2
1
9
3
8
0

8 (35%)
5 (22%)

Religious
Affiliation

Catholic
Christian (non-specified
denomination)
Baptist
Espiritista
Pentecostal
Evangelical
None or Non-Practicing
Unknown

3
1
1
1
2
2

(13%)
(4%)
(4%)
(4%)
(9%)
(9%)

Annual
Household
Income

$0-$5,000
$5,000-10,000
$10,000-15,000
$15,000-20,000
$20,000-30,000
$30,000-40,000
$40,000-50,000
$50,000-60,000
$60,000-70,000
> $70,000

1
3
1
6
2
4
1
0
1
4

(4%)
(13%)
(4%)
(26%)
(9%)
(17%)
(4%)
(0%)
(4%)
(17%)

Insurance Status
(at Interview)

Public
Private
None

6 (26%)
16 (70%)
1 (4%)

Insurance Status
(at Diagnosis)

Public
Private
None

4 (17%)
19 (83%)
0 (0%)

Years of
Education

High School/GED
Some College or
Technical School
College Degree
Advanced Degree

1 (4%)
3 (13%)

(9%)
(4%)
(39%)
(13%)
(35%)
(0%)

16 (70%)
3 (13%)
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The majority had a breast cancer diagnosis (16), while three had been diagnosed with
lymphoma, two with uterine cancer, two with thyroid cancer, one with colon cancer, one
with angiosarcoma, one with melanoma, and one with oral squamous cell carcinoma.
Note that these diagnoses are not mutually exclusive: four participants had been
diagnosed with two types of cancer: breast/uterine (one), breast/thyroid (two), and
lymphoma/melanoma (one). Three participants had also had recurrences of their
primary diagnoses. Stage at diagnosis2 varied: four had been diagnosed at Stage 1, six
at Stage 2, five at Stage 3, and two at Stage 4. Six did not remember their disease
stage at diagnosis. The majority (16) had been diagnosed because they were
experiencing symptoms and sought a doctor’s opinion: 13 had felt a mass or a lump, and
three others were experiencing pain or bleeding. Six others were diagnosed in the
course of a routine mammogram or other screening, and one participant’s cancer was
detected accidentally, in the course of surgery for another condition.
Fifteen participants had received some type of chemotherapy. Nearly all
participants had had some type of surgery, and some had had several surgeries: eight
had received a mastectomy, six a lumpectomy, and three an unspecified breast surgery.
Seven others had undergone surgery for another type of cancer. Fifteen received
2

According to the National Cancer Institute (2012), cancer staging “describes the severity of a
person’s cancer based on the extent of the original (primary) tumor and whether or not cancer
has spread in the body,” and is used in both treatment planning and estimation of a patient’s
prognosis. Generally, an earlier stage at diagnosis corresponds to higher survival rates and a
better prognosis. While staging varies between types of cancer, the table below indicates the
general framework based on the size of the primary tumor, presence/absence of disease in lymph
nodes, and the extent of spread (metastases) to distant organs:
Table 4.4. Stages of Cancer
Stage

Definition

Stage 0

Carcinoma in situ.

Stage I,
Stage II, and
Stage III

Higher numbers indicate more extensive disease: Larger tumor size and/or spread
of the cancer beyond the organ in which it first developed to nearby lymph nodes
and/or organs adjacent to the location of the primary tumor.

Stage IV

The cancer has spread to another organ(s).

Reproduced from NCI (2012)
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radiation. Nine participants, all breast cancer survivors, had received hormonal therapy,
while two participants had received Herceptin, a monoclonal antibody treatment that
interferes with cancer cell production in Her-2-positive breast tumors. Calculating the
mean time since treatment was difficult given that (1) several participants had had
recurrences or secondary diagnoses, and (2) it was necessary to take into account the
length of time for hormonal therapy for breast cancer, which often extends for five years
following treatment such as chemotherapy or radiation. Given this, four different
numbers were calculated and are presented in Table 4.5 below. First, for the whole
sample (n=23), the length of time (in months) since participants’ first diagnosis, and time
since the end of the first treatment, was calculated. Second, for the whole sample
(n=23), the time since participants’ most recent and since diagnosis, and the time since
the end of the most recent treatment, is displayed; the resultant number takes into
account the several recurrences and secondary diagnoses.
Table 4.5. Time (Months/Years) since First and Most Recent Diagnoses and End of
Treatment (n=23)

Months
Since:
Mean
Median
Range

First Dx
115.2 (9.6 yrs)
84 (7 yrs)
.25-33.5 (3 mo33.5 yrs)

Finishing First
Tx
89 (7.41 yrs)
54 (4.5 yrs)
0-360 (0-30 yrs)

Most Recent Dx
86 (7.2 yrs)
78 (6.5 yrs)
1-288 (1 mo-24
yrs)

Finishing Most
Recent Tx
62.9 (5.24 yrs)
36 (3 yrs)
0-264 (0-22 yrs)

Healthcare Professionals. Healthcare providers are often the gateway for
information about cancer treatment side effects, including long-term side effects such as
infertility. Research has documented low levels of patient-provider communication about
infertility (Schover, et al. 2002b) and fertility preservation techniques (Quinn, et al. 2007),
and low levels of awareness among patients about the potential reproductive side effects
of treatment (Schover, et al. 1999; 2002a). Thus, it is critical to gain the providers’
perspectives on the issue. A total of 16 semi-structured interviews were conducted with
four types of healthcare professionals who had regular contact with cancer patients or
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survivors through their practice: fertility specialists, oncologists, oncology nurses, and
gynecologists. Interview questions focused on their knowledge of fertility problems
following cancer treatment, perspectives on patient-provider communication,
professional role, and the importance they accord to these issues.
Fifteen of the healthcare providers were recruited through contacts made at the
Ponce School of Medicine and through key informants. The remaining participant was
referred to me by an advocate participating in the study. These providers were
purposively selected to represent certain specialties (for example, anyone in the small
infertility field in Puerto Rico), and because of their reputations addressing some of these
issues (for example, a member of the Puerto Rico oncology association who had
previously worked on oncofertility issues).
Interviews ranged from 22 to 65 minutes, with an average of 43 minutes, and
took place at a location of the participants’ convenience, in all cases their clinics or
offices. Inclusion criteria consisted of: (1) a specialization of gynecology, oncology,
oncology nursing, or infertility; (2) a medical or nursing degree; (3) ages between 18 and
75; (4) serving the profession in Puerto Rico at the time of the interview (i.e., not retired);
and (5) routine contact with cancer patients or survivors as part of their clinical practice.
Demographic Information: The provider group included six oncologists, two
oncology nurses, five infertility specialists, and three gynecologists. Thirteen providers
were located in San Juan; two oncologists were located in Ponce, a two-hour drive from
San Juan, and one gynecologist was located in Mayaguez, a three-to-four hour drive
from San Juan. Twelve were men and four were women. The mean age of the sample
was 46.8 years, with a median of 43 and a range of 34 to 67. Seven participants
declared themselves “Puerto Rican” when asked about their ethnicity, while the
remaining responses were varied: Hispanic/Puerto Rican (three), Hispanic (two), White
(one), Latina (one), White Hispanic (one), and Mexican (one). Most had attended
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medical school in Puerto Rico, although there was some variation: eight had received
the totality of their medical training on the island, while six had received part of it in a US
institution, such as a fellowship at MD Anderson Cancer Center in Houston, TX. Two
others had attended medical school in another country. Mean time since graduation
from medical school was 17.6 years, with a median of 16.5 years.
There are four fertility clinics in Puerto Rico. The current study included
interviews with five fertility physicians on the island: two obstetrician-gynecologists with
Board-certification in Reproductive Endocrinology and Infertility (REI), two obstetriciangynecologists with Board-eligibility in REI, and one Board-certified andrologist.
Oncologist participants included both physicians in private practice and in research or
teaching hospitals, such as the University of Puerto Rico Comprehensive Cancer
Center, Auxilio Mutuo Cancer Center, and the Veterans’ Hospital. Three gynecologists
were interviewed: one in private practice, a professor of OB/GYN at a major public
university, and a hospital-based surgical gynecologist/oncologist. One oncology nurse
worked in a well-known private cancer center, while the other worked at a private clinic.
NGO Staff and Advocates. A total of nine interviews were conducted with staff
and volunteers from various non-governmental patient advocacy organizations. These
interviews addressed the role of cancer advocacy organizations in Puerto Rico;
organizational activities and messaging, especially concerning survivorship, fertility or
parenthood; long-term follow-up care; and collaborations with providers. Advocates
were chosen purposively to represent both the major advocacy organizations in Puerto
Rico—such as the Susan G. Komen for the Cure, and the American Cancer Society—as
well as smaller grassroots organizations. A high-level representative from each of the
major organizations and the leaders of several smaller grassroots groups were
interviewed. Their names and contact information were obtained from key informants,
contacts at the Ponce School of Medicine, and personal connections.
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Interviews lasted between 20 and 73 minutes with an average of 50 minutes.
The majority of interviews were conducted in the personal offices of the participants,
while the rest took place in public spaces, such as library conference rooms or a
shopping mall food court. One was conducted over the telephone because of the
participant’s preference. Inclusion criteria for the NGO staff and advocates included: (1)
current involvement in or ties to cancer advocacy organizations in Puerto Rico; and (2)
ages between 18 and 75.
Demographic Information: The mean age was 55.25 years, with a median of
54.5 years. On average, participants had 1.5 children, with a range of zero to three.
Three identified ethnically as Puerto Rican, three as Hispanic, and two as Latina (one
was unknown). Advocates were generally well-educated: one had a Bachelor’s degree,
three held Master’s degrees, one held a doctorate and two more were in the process of
obtaining a doctorate. The educational status of one was unknown. Two advocates
were based in Ponce while the rest were in the San Juan metropolitan area.
Although nine advocates were officially interviewed, one of the oncology nurses
was also the leader of a support group based through her clinic. Therefore, she was
also asked the advocate-oriented questions. Accordingly, ten organizations or services
are represented in these discussions. The majority of these advocates (eight) served as
volunteers in their role, while the remaining two were formally employed. Years of
involvement in their respective organization ranged from three to 24. With the exception
of one advocate who worked with approximately two to four cases per month, all the rest
worked with either cancer patients or survivors on some level on a daily, routine basis.
Six of the advocates had been diagnosed with cancer themselves in the past, one had
had a tumor removed that turned out to be benign, and three had not had cancer.
Clergy. Interviews were conducted with two members of the clergy in the
Catholic Church, in order to illuminate the role of the religious institutions in the
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regulation of access to reproductive technologies, their standpoint on parenthood among
survivors, and their role in the spiritual care of patients and survivors. Because of the
prominent role of the Catholic Church in Puerto Rico, and because of the Vatican’s wellknown stance against many reproductive technologies, these interviews provided an
important piece of the overall picture of survivorship in Puerto Rico. Inclusion criteria
consisted of: (1) involvement in the Catholic Church as a member of the clergy in Puerto
Rico; (2) currently serving the profession (not retired); and (3) between the ages of 18
and 75. The two Catholic priests were recruited from a personal contact because of
their well-regarded reputations, openness to social research, and frequent work on
health-related topics. Both interviews were conducted in the clergy members’ private
church offices and lasted an average of 70 minutes.
Demographic Information: Both priests served parishes in the San Juan
metropolitan area. Congregation sizes differed: while one parish served 14,000 people,
the other served between 1,000 to 1,500 people. One priest was 68 years old, while the
other was 56. Both identified as Puerto Rican, and both held doctorates—one in a
theology-related discipline and the other in education.
Data Analysis Procedures
All semi-structured interviews were tape-recorded and transcribed verbatim for
further analysis. All transcripts and notes were entered into MaxQDA, a qualitative
analysis software program. A grounded theory approach was utilized in the analysis
(Bernard 2006; Glaser and Strauss 1967; Strauss and Corbin 1990), capturing codes
that were generated inductively through a thorough reading of the transcripts (for
example, the ways in which having had cancer has impacted participants’ desires for
children), and applying codes developed deductively through knowledge of themes in
the literature (for example, barriers to patient-provider communication about fertility
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problems). Transcripts were coded using the constant comparative method and
analyzed for commonly expressed themes. Field notes and interview notes from both
the key informant and semi-structured interviews were incorporated into the analysis in
order to aid in identifying general patterns and themes. Once identified, these patterns
and relationships were then used to build larger theoretical models. The different types
of interviews (healthcare provider, survivor, NGO staff member, and clergy) were
analyzed using the same codebook so as to enable comparisons to be drawn about
similar issues among all four groups. However, because the interview guides differed
and the type of information gathered from each interview group varied, several codes
were used almost exclusively for certain groups and not others.
A note about language as related to data analysis is in order. It was important to
catch subtleties in the transcription and coding; thus, I enlisted the help of native
Spanish-speakers to assist me with these tasks. As a native English speaker, I
transcribed all English-language interviews, while a native Spanish-speaker transcribed
all Spanish-language interviews in order to ensure accuracy of the transcription.
Similarly, I coded all interviews, both Spanish and English, but I enlisted the help of a
second coder—the male Puerto Rican anthropologist who had conducted the interviews
with the male survivors—to assist me with the Spanish interviews. He coded the
Spanish interviews using the codebook that I developed, in order to catch subtleties that
I had missed; we resolved differences through meetings and dialogue.
Ensuring Validity and Reliability
Validity and reliability are special concerns for ethnographers, as traditional
notions of these concepts were developed for use in positivist research, and a direct
translation to ethnographic research is neither appropriate nor possible (Schensul, et al.
1999). The authors argue that two of the distinctive traits of ethnography—that is, the
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researcher as the main instrument of data collection, and the fact that data is collected in
natural field settings without the control that laboratory or clinical research can maintain
over conditions—require attention to strategies for controlling bias and enhancing data
accuracy. Schensul and colleagues’ (1999) discussion of validity and reliability is
especially relevant to this study as it addresses applied ethnographic research; thus, I
have drawn upon their recommendations in conceptualizing relevant validity and
reliability issues and ways to mitigate risks.
Ethnography tends to have high internal validity overall because of the amount of
time that ethnographers spend in the field with their participants, “getting to know people
well and allowing for both continuous data analysis and opportunities to refine constructs
in ways that ensure a match between scientific categories and participant realities”
(Schensul, et al. 1999:276). However, one potential threat to internal validity in this
study is observer effects, in which participants do not give entirely truthful accounts or
behave differently in front of the researcher. The authors advocate several approaches
for minimizing the chances of observer effects that were subsequently employed in this
dissertation research, including increasing familiarity with participants, ensuring
comfortable and hospitable interview locations, gender-matching with participants, pilottesting the guides to ensure the question clarity, and seeking feedback on the written
analysis before dissemination.
External validity refers to the generalizability of the research and the theoretical
frameworks developed. In this case, Schensul and colleagues (1999) recommend an
emphasis on translatability, advocating for a “position that both recognizes the
uniqueness of the cultures that ethnographers study, and also makes it possible for
other researchers to make use of their results” (1999:285). To this end, authors must
describe in clear detail the methods, terminology, concepts and results, and document
any historical events or researcher interaction that may have affected the results.
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The authors note that reliability is not as big a concern in exploratory
ethnographic research, as the intent is to discover a range of new information rather
than to test hypotheses—thus, duplication is not an aim of exploratory research.
However, several strategies can be utilized to ensure reliability of results, including a
rigorous documentation of the methodological process (including sampling, research
situation and context, formulation of interview questions, and analysis process),
description of the exact nature of the researcher-participant relationship, and use of
other data to confirm exploratory results (Schensul, et al. 1999).
Feedback and Dissemination
After the data analysis, a draft of the preliminary results was circulated to
selected participants and key informants who had voiced interest in giving feedback.
This feedback was critically important and incorporated into the final write-up. An
executive summary is currently under revision and will be disseminated to all participants
and any interested parties when complete.
ETHICAL ISSUES
Ethical Conduct with Human Subjects
This research project was reviewed and approved by the University of South
Florida Institutional Review Board (IRB) on April 4, 2011. Subsequent modification
amendments were approved June 6, 2011; July 25, 2011; October 14, 2011; December
6, 2011; January 12, 2012; and February 17, 2012. These amendments included the
addition of two research sites, revisions to and translation of the instruments, addition of
key personnel, and modification of recruitment materials. A Continuing Review was
approved on March 7, 2012 for the period April 4, 2012 to April 4, 2013, and again on
March 6, 2013 for the period April 4, 2013 to April 4, 2014.
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Two research sites were added to the IRB during the course of this research
project: the Ponce School of Medicine (Ponce, Puerto Rico) and Hospital Oncológico
(San Juan, Puerto Rico). First, from June through August 2011 (10 weeks), I
participated in a student rotation between the H. Lee Moffitt Cancer Center and
Research Institute, in Tampa, FL, and the Ponce School of Medicine, in Ponce, Puerto
Rico. This rotation is a yearly summer program offered through an NIH U56
collaborative grant between the two institutions, which focuses on creating “effective
working relationships between the leadership and investigators from both institutions” in
four basic areas of cancer care, including cancer education, training of students and
researchers, and community outreach (MCC 2010). My mentor during the rotation, as
well as several other investigators with whom I worked during that time, are extensively
involved in socio-behavioral cancer research in Puerto Rico and have professional
networks that extend throughout the island. As a student–trainee, I was permitted to use
this rotation to facilitate the initiation of the dissertation research—for example, by
developing relationships with new contacts, familiarizing myself with the setting before
beginning formal data collection, and attending meetings and presentations.
Additionally, I was involved in several research projects being conducted at PSM
through which I was exposed to the inner workings of cancer research. Although I did
not formally recruit survivors to interview through PSM, I obtained permission to conduct
interviews with affiliated providers and advocates in the offices of the research buildings.
Hospital Oncológico at Centro Medico, in Rio Piedras, Puerto Rico, was added
as a second research site later in the period of data collection. During the course of the
research, it became clear that the group of survivors I wished to interview were difficult
to locate, for reasons that will be discussed later in this chapter3. Through the help of
one of my research assistants, I was able to form a working relationship with the Medical
3

See the section on “Recruitment Challenges” later in this chapter.
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Director of the hospital, which ultimately allowed me to recruit survivors from their clinics.
Hospital Oncológico is the largest cancer treatment hospital on the island, and as a
public hospital it serves primarily low-income individuals on the state-sponsored
Medicaid plan, la Reforma. Approval was obtained from both the USF Institutional
Review Board and Hospital Oncológico’s Ethics Board to implement clinic-based
recruiting at their facility. In this setting, flyers were distributed to survivors in the waiting
rooms of the clinic, and interested parties approached us to get more information about
participation. At that point, we determined eligibility and were able to conduct the
interviews in a private office at the hospital while the participants waited to see their
doctors for follow-up care.
Informed Consent Procedures
IRB-approved procedures regarding informed consent were employed
throughout the data collection phase of this study. Participation was completely
voluntary in all phases. At the initial contact, the study objectives and the nature of
participation in the study were explained to the participants. If, at that point, the potential
participant was interested and willing to meet, a time was set up to conduct the
interview. Several days, and in some cases one to two weeks, elapsed between the
initial conversation and the scheduled interview, which allowed ample time for the
participants to reconsider their participation. At the scheduled interview time,
participants were asked to decide whether or not to participate upon hearing a second
description of the study and explanation of the interview process. An IRB-approved,
written informed consent form was read and given to in-person interview participants for
their signature prior to the beginning of every interview, allowing time for questions and
the option of refusing to participate in the project. Willing participants were then asked to
sign the consent form, after which the interview began. In the case of the three
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telephone interview participants, documentation of informed consent was waived via an
IRB modification request. However, in each case, an IRB-approved consent script was
read to the participants over the telephone before the interview began, and they were
asked to verbally give their consent. Prior to the call, an electronic version of the
approved consent document was emailed to the participants for their records and
review. Participants preferred receiving an emailed copy versus a hard copy, although
this was also available to be mailed.
Comprehension was ensured in multiple ways. First, no jargon was used in the
description of the research or in the informed consent documents. Second, unlimited
time was given before the interview to discuss concerns, questions or issues with the
research. Third, participants were continually reminded that they were free to withdraw
from the research project at any time without consequence even if their interview had
already been conducted, in which case their data would not have been used in the
analysis or write-up of the dissertation.
Confidentiality
The confidentiality of participants was protected through several means. Primary
data were obtained from participants in the form of recorded and transcribed interviews
and self-reported demographic data. To protect confidentiality, all content was stored in
a locked filing cabinet in a private office and a password-protected personal computer.
Each participant was assigned an arbitrary numerical code in place of their name, which
was linked to the demographic and interview data. Only one file exists that contains
both the participant names and numerical codes, and it is stored in a passwordprotected computer available only to the PI. No names were recorded on interview
guides, and the signed informed consent forms are stored separately from the raw data.
Only members of the study team can see the raw data.
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Compensation
One group of participants, the cancer survivors, were provided with a $20 gift
card to a local store (a choice of either Wal-Mart or Marshalls) as an incentive to
participate and as a token of appreciation for sharing personal life experiences. The gift
cards were given to the survivors after the interview ended, although participants were
aware of the provision of gift cards beforehand. No problems were encountered with this
technique. The other groups of interview participants—healthcare providers, cancer
organization staff members/advocates and clergy—were not provided with incentives as
they were interviewed in their professional capacities, and in general were not being
asked to share personal experiences as part of the study.
Disclosure of Infertility Risks
There are several ethical issues inherent to studying the experiences of cancer
survivors in Puerto Rico. The first and most prominent dilemma relates to access to
standard of care treatment. While statistics are unavailable regarding the extent to
which patients in Puerto Rico are informed of potential impacts on their reproductive
capacities, an inference can be made given the currently available information from USbased studies: this research has demonstrated that patients are frequently not informed
of these risks by their providers, nor are they offered information on or referrals for
fertility preservation options. Results from this dissertation indicate that this is the case
in Puerto Rico as well, or perhaps more so, given the negative effects of the health
reform on quality of care4, the higher rates of poverty and lower median household
income in Puerto Rico, and the smaller number of fertility specialists who actually offer
fertility preservation techniques on the island as compared to the mainland US.

4

See Chapter Five for a more detailed discussion of the Puerto Rican Medicaid reform.
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This has created a potential scenario in which survivors who may have never
heard of long-term side effects of treatment, particularly infertility, would be interviewed.
Given this, the PI should not have been the one to inform them of this fact, and to
potentially create undue harm and psychological distress during the interview process.
Open-ended interviewing with probing is well-positioned to elicit survivors’ perspectives,
beliefs, desires and plans for the future without creating the uncomfortable and risky
scenario of informing them for the first time about late effects and infertility (cf.,
Schensul, et al. 1999). Schensul and colleagues (1999:155) recommend that, when
researching sensitive topics, the questions should be organized temporally (from early to
recent), by complexity (simplest questions first), by domain, by level of abstraction (from
least to most abstract), and by level of threat (least sensitive to most sensitive). Thus,
the first few questions in the interview guide were necessarily general and addressed
survivors’ experiences with cancer and following treatment. Probes as needed allowed
the researcher to ascertain the participants’ level of knowledge regarding potential longterm effects and fertility status, and whether and how that information should be followed
up. I asked the participants if they desired to have children and if this desire had been
affected by having had cancer—this line of questioning tended to elicit any information
as to their fertility status. Further, participants were asked what their doctors had told
them about what they could expect post-treatment and what kind of follow-up care was
recommended, if any, which also in some cases drew out information about their
knowledge of effects. Thus, this strategy was effective to some extent; however, there
were instances in which participants’ knowledge about their own infertility and risks
associated with treatment were unclear, and would have benefited from direct
questioning. If extensive probing did not elicit further information about it, it was
necessary to proceed to the next question.
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Psychological Risks Related to Sensitive Questions
A second issue concerns the psychological risks inherent to interviews about a
sensitive topic. Because recounting a personal history with cancer can be a deeply
emotional experience, it was expected that some participants might become distressed
during the interview itself. While this did not occur during interviewing, it was necessary
to develop strategies at the beginning for mitigating this risk. Lee and Renzetti (1990)
set forth a list of categories of sensitive research topics that are more likely to cause
participant distress, including those that focus on a very personal experience, illegal or
stigmatized activities, the interests of people in power, or are sacred to the participant or
religious in nature. The first category—a deeply personal experience—is relevant for
this project, and necessitates attention to how risk to participants can be minimized.
In addressing the conduct of qualitative interviews on sensitive topics, much of
the literature focuses upon interviewer skill in reducing the psychological harm, distress
and anxiety that can be created by recounting upsetting experiences. Interviewer
sensitivity to distress is paramount, and includes attention to non-verbal cues of distress
(such as repeatedly being late to interviews) that are developed out of familiarity with the
research topic and experience with interviewing (Corbin and Morse 2003; Kavanaugh
and Ayres 1998). Other recommendations include taking breaks during the interview if
necessary, frequently reaffirming consent to continue the interview process, focusing on
the needs of participants, stopping the interview if necessary, never leaving the
participant in a high state of distress, and following up with distressed participants after
one or two days to ensure that they have recovered (Corbin and Morse 2003). In
addition to employing these techniques, I prepared a handout with a list of psychological
resources and hotlines for participants who became upset and wanted further guidance.
Corbin and Morse (2003) observe that qualitative interviews, and in particular
unstructured interviews, contain the “very essence of trust and conversational intimacy
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that creates both the potential threats […] and at the same time makes them potentially
therapeutic as well as essential data collection tools” (2003:338). Many benefits of
qualitative interviews have been noted in the literature, including catharsis; fostering
sense of purpose, self-awareness, and empowerment; encouraging emotional healing,
and validation (Corbin and Morse 2003; Hutchinson, et al. 1994; Kavanaugh and Ayres
1998). Because open-ended interviews allow the participant to direct the flow of the
conversation and control the course of the interview more so than structured interviews,
they can serve to mitigate some of the inherent power issues present in researcherparticipant relationships. This was especially important for this study because of Puerto
Rico’s colonial relationship and history of exploitation at the hands of scientists.
Positionality of Researcher
Identity as an American/Outside Researcher
Conducting a study in a colony of the United States raises quandaries that are
not easily resolved. The Puerto Rican/US relationship carries a complicated history of
dependence, oppression, migration, and bi-directional cultural transmission.
Resentments against US policy do simmer, yet at the same Puerto Ricans interact with
the US on a routine basis, whether through relatives that have migrated, or through
televisions shows, movies, tourists, imported goods, politicians and government leaders.
Many seek education or jobs in the mainland themselves, leaving and/or returning as
both personal lives and the larger economies dictate. It is not surprising that the majority
of anthropological research in Puerto Rico tends to deal with issues of identity and
politics. I was always aware of my status as an American who was coming to conduct
research in Puerto Rico—given historical events, this is a sensitive position and I was as
careful as possible to avoid behaving in stereotypically aggressive “American” ways. My
participation through the Ponce School of Medicine training program, as well as pre110

research meetings and conversations with supportive cancer researchers on the island,
validated the usefulness of this project and hence my purpose in being there.
A Note on Language and Communication
On a related note, given my position as a life-long learner of the Spanish
language, with an incomplete yet evolving grasp of subtlety and slang, it was critical to
have a checks-and-balance system in place to ensure proper understanding. To this
end, the help of two Puerto Rican anthropologists, both native Spanish-speakers, was
enlisted during the course of the data collection and analysis. They assisted in the
formulation and translation of the interview guides, participated in many of the
recruitment activities, assisted in the Spanish-language interviews, and served as extra
coders during the analysis phase. This arrangement helped to ensure good
communication and minimize misunderstandings; they also served as cultural brokers,
introducing me to contacts and helpful community members that improved the
effectiveness of the data collection. Ideally, I would have liked to rely on them less for
language help and I must allow for the fact that I often missed linguistic subtleties and
nuance; accordingly, this is an important study limitation. However, the significance of
this limitation was kept in check by the measures described above.
Identity as a Survivor/Previous Employee of Cancer Advocacy Organizations
Another aspect of my personal experience that bears review and must be taken
into account in this project is my personal history as an adolescent cancer survivor. This
history impacted the course of my Master’s thesis work with cervical cancer survivors
(Dyer 2008), particularly in the beginning, in two ways. First, many aspects of my own
identity are intertwined with my cancer experience, and I found that some of my
unproblematically-held assumptions about “cancer survivorship” were constantly
challenged. For example, I have always identified myself as a cancer “survivor,” and
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had, for the most part, taken this label for granted when referencing myself and others.
Most other people I knew who have had cancer do the same. Thus, it came as a
surprise when, within the first few interviews conducted for my thesis, this label was
resisted and critiqued. A hierarchy of cancer experiences appeared, with those people
who had gone through the most difficult treatments positioned at the top of the ladder.
They were, at least in some people’s minds, the “real” survivors and the ones most
deserving of that designation. Additionally, the adoption of that label for many
participants was a very deliberate decision made at a particular time, and it spoke
volumes about the meaning that that experience held for them. Although these types of
realizations were surprising to me at the time, they allowed me to reflect more deeply,
critically, and positively on my own beliefs and experiences, and to try to apply these
considerations back to my own research and interactions with the participants.
Second, I had to devote much thought and attention to whether or not I should
disclose this piece of information about myself to participants—and if so, how I should go
about doing it. In the end, I opted for disclosing it in the beginning of the interview before
the informed consent, while emphasizing the motivation behind these interviews: that my
own experience had made me interested in hearing other people’s stories. For the most
part, this mutual sharing was a very positive experience and I believe that it helped put
the women (and myself) at ease. Rarely did it have one of the effects that I had been
concerned about—specifically, having the interview turned around on me. Overall, I
believe that both this sharing and questioning of my own experience strengthened my
research project by increasing its reflexivity, and, I hope, by allowing women to feel more
comfortable sharing an exceedingly private and often painful experience with a stranger.
Having worked through this process during the Master’s thesis, I was comfortable
allowing the same boundaries during the dissertation research project. Similarly, the
mutual sharing was, by and large, a beneficial process and one that I believe
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participants appreciated. In some ways, it seemed to reassure them that my intentions
with the research were positive, and that their participation and effort would be put to
good use; interestingly, sometimes it served as a counterpoint to the suspicion created
by my American-ness, and answered their question of “why are you here?”
RESEARCH LIMITATIONS
This study suffered from several research challenges that may have limited the
explanatory power of its findings. First, the media analysis was limited by the inability to
find all years of the highest-circulating women’s magazines. Archived issues of two out
of the three magazines that were originally selected for sampling over four years (1995,
2000, 2005, and 2010) were completely unavailable. However, adequate and suitable
proxies were located: the availability of Imagen for all four years provided an adequate
opportunity to assess trends over time that served as proxies for the other two
magazines. Further, using the 2008 issues of Vanidades was close enough to 2010 that
it was a suitable replacement. While using the English-language Cosmopolitan was not
ideal, it did afford the opportunity to assess the topics addressed in that magazine.
This study also suffered from sampling limitations, and ultimately participants
were most likely skewed towards those interested in the topic. This is probably most
evident in the oncologist interviews; doctors are obviously busy people, and the only
ones with (unpaid) time to spare were those with a particular interest in the topic. Young
survivors were quite difficult to recruit and many different recruitment strategies were
implemented. This was a finding in and of itself: a number of young survivors were
uncomfortable speaking about, or even recalling, their experience with cancer. They
were still so upset by it that they could not emotionally handle an interview—even though
in some of these cases, their treatment had occurred many years prior. This reflects a
common challenge facing researchers who are investigating stigmatized diseases, and
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accordingly, the survivors who were interested may have held, as a group, more positive
ideas about the cancer experience than what occurs in the general population. At the
least, the range of variation was likely lower. I will also hazard an educated guess that
these participants held more positive views about the likely benefits of participation, or
felt a special obligation to be involved.5
Because of my difficulties recruiting younger survivors, the survivor sample
ended up including more participants on the older end of the 21 to 45 age spectrum.
Many of these participants were married and had completed their childbearing prior to
their cancer diagnosis. Accordingly, this resulted in some disconnect between the
interviews with providers, which were principally about fertility and fertility preservation,
and the interviews with survivors, which were more comprehensive and included indepth discussions about their lived experience with cancer apart from fertility and
reproductive issues. Moreover, I was unable to broach direct questions about fertility
preservation because of the potential to cause distress in survivors who did not already
know about the risk of infertility or the existence of fertility preservation options prior to
the interview. Discussion of these questions depended upon subtle probing and indirect
questioning to assess their level of knowledge first, which could then be followed up with
direct conversation. By its nature this strategy limits the conclusions drawn from these
results regarding the exact percentage of survivors who were educated about fertility by
their physicians. While this is unfortunate, the data obtained do yield important
reproduction-related findings among the survivors, and point to areas of future research.
SUMMARY
This research was a qualitative, exploratory study using a critical-interpretive
epistemological approach. Drawing from ethnography and grounded theory in its
5

This may in particular relate to the theme that emerged in these interviews about the importance
of helping others as an impact of the cancer experience, discussed in Chapter Seven.
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methodological design, several data collection methods were employed to answer the
research questions. An ethnographic content analysis was conducted using three
women’s magazines in order to examine media representations and public images of
cancer. Unstructured key informant interviews with cancer researchers, and semistructured interviews with cancer survivors, healthcare providers, cancer advocates, and
members of the clergy addressed the beliefs, practices, and context surrounding
survivorship and cancer-related infertility in Puerto Rico.
The next chapter, Research Setting, provides an in-depth description of the
social, cultural, political and economic context of Puerto Rico. The chapter will also
focus on cancer statistics and current research, in order to provide an overview of the
local context before the subsequent chapters delve into the study results.
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Chapter Five:
Research Setting1
Puerto Rico represents a critical site for the expansion of cancer survivorship
research outside of middle- and upper-class populations in the mainland US. The
importance of this setting lies in the juxtaposition of several factors: its unique political
relationship to the US as an official territory, barriers in access to care resulting from the
recent health reform, and cultural features—such as religion—that may play a role in
influencing perceptions of medical technologies and long-term survival from cancer.
This chapter first presents an overview of Puerto Rican history and a snapshot of its
political-economic and socio-cultural context. It then proceeds to offer a more in-depth
exploration of the healthcare system, and specific issues that are relevant for a study on
cancer and reproduction—notably the trend towards medical tourism, the role of the
Catholic Church in reproduction-related matters, emerging cancer research in Puerto
Rico, and the current fertility-related services available on the island.
A BRIEF HISTORY OF PUERTO RICO
The archipelago of Puerto Rico is the smallest of the Greater Antilles islands, and
contains three continuously inhabited islands: the main island of Puerto Rico, Culebra,
and Vieques. Lying in the northeastern Caribbean Sea, east of Hispaniola and west of
the US Virgin Islands, Puerto Rico has a landmass of 3,420 square miles—roughly 110
miles long by 40 miles wide. Coastal plains characterize the southern and northern

1

Portions of this chapter have been previously published (Dyer, Mitu, and Vindrola Padros 2012)
and are utilized here under the fair dealings exception of UK copyright law.
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portions of the island, while mountain ranges compose the interior (World Factbook
2010). Puerto Rico is famous for its biodiversity, notable for such a small land mass.
Until the arrival of the Spanish in 1493, Puerto Rico was inhabited by the Taíno,
an indigenous group that lived throughout the western Caribbean islands (Haslip-Viera
2001; Rivera Ramos 2002). Disease, oppression, and expulsion to other islands
claimed the lives of most Taíno in only a few decades, and although the cultural legacy
of the Taíno people lives on through food, place names, dance, and occasionally
claimed ancestry, it has been traditionally accepted by historians that the group is extinct
(Rivera Ramos 2001).
The Spanish occupied Puerto Rico from 1508 until 1898, when the colony was
ceded to the US after Spain’s loss in the Spanish-American War. It has remained an
unincorporated territory under American rule, and since 1952 has been a
Commonwealth of the US (or associated free state) (Cabán 1993). Puerto Ricans are
US citizens, although they cannot vote in federal elections, there is no voting member of
Congress, and the issue of legal status and relationship to the US has remained an
enduring national controversy (Cabán 1993; Grosfoguel 2003). Although addressing the
history of this controversy in adequate detail is beyond the scope of this overview, it is
important to note the relationship between federal law and its local implementation in
Puerto Rico: the Organic Act of Puerto Rico (39 Stat. 954, 48 USC. § 734) states that
“the statutory laws of the United States not locally inapplicable, except as hereinbefore
or hereinafter otherwise provided, shall have the same force and effect in Puerto Rico as
in the United States” (Cornell University Law School 2010). Thus, as with states, US
federal law applies in Puerto Rico and supersedes any territorial law enacted.
As of the 2010 US Census, Puerto Rico had a total population of 3,979,000
(Census Bureau 2010). The capital of San Juan is the most populous city in Puerto
Rico, with a population of 424,769 in the municipality alone (Census Bureau 2008).
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However, the San Juan-Caguas-Guaynabo Metropolitan Statistical Area encompasses
2,617,089—more than half of the total island population (Census Bureau 2008).
Puerto Rico’s Political-Economic and Socio-Cultural Context
Puerto Rico’s economy is intimately tied to that of the United States. This has
been the case since the US acquired the colony in 1898. Riviera-Ramos (2001) argues
that the American occupation “set in motion a series of profound economic and social
transformations that would eventually change the character of Puerto Rican society”
(2001:59). The economy began to be dominated by sugar plantations and the tobacco
and coffee sector lost importance; proceeds from the plantations were absorbed by the
international corporations rather than being fed back into Puerto Rican society. This
trend continues to the present day (Riviera Ramos 2001). Elites in Puerto Rico
benefited from this transition but not the lower classes, and the nation remains highly
dependent upon aid from the mainland US (Grosfoguel 2003; Riviera Ramos 2001).
The 1940's marked an economic turning point: the agriculture-based economy was
deliberately dismantled in order to make way for industrialization, principally
pharmaceuticals and petrochemicals (Briggs 2002; Grosfoguel 2003; Rivera Ramos
2002). Riviera Ramos (2001) summarizes the economic problems with which Puerto
Rico still contends, much of which can be linked directly to American occupation and
economic intervention over the course of the twentieth century:
“The structural problems of the economy—such as its disproportionate dependence on
foreign investment—were not solved [with industrialization]. In fact, because of the very
nature of the development program, many of Puerto Rico’s most basic problems have
intensified…Puerto Rico remained an export enclave (this time of manufactured goods),
extremely reliant on foreign capital and, largely because agriculture had been
marginalized, very dependent on imports for the satisfaction of the needs of its
population. Local capital was either displaced or subordinated, most of the productive
wealth of the country remained under external control, and Puerto Rico developed a very
high unemployment rate from which it still suffers, all characteristic of developing
economies. Additionally, disparities in income have remained significant. Around 50% of
the population lives below the poverty level” (2001:61-2).
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According to Briggs (2002), the failure of the industrialization program (Operation
Bootstrap) to increase standards of living and decrease poverty was explained through
the discourse of overpopulation. The problems that had ultimately resulted from
industrialization and capitalist expansion, such as the rise of urban poverty, were
conceptualized instead as the fault of the high fecundity of the poor, non-white residents
(Briggs 2002; Colon Warren 2003; Lopez 2008). Lopez (2008) argues that, in many
ways, the eugenics ideology—i.e., Social Darwinism—that was then developing in the
mainland found reflection in the practices and policies of the colony. A two-pronged
campaign was waged by US government officials and Puerto Rican authorities with the
intention of solving Puerto Rico's perceived “overpopulation problem”: emigration and
sterilization. Neo-Malthusionists argued that the only way to solve the underdevelopment issue was through population reduction, emigration being the temporary
"relief" measure and sterilization/fertility reduction being the long-term solution (Lopez
2008). Thus, the Puerto Rican diaspora began, marked by waves of migration
(principally rural farmers) to fill the burgeoning factories of the Northeast (Lopez 2008).
While the first migration waves were taking place in the 1940s and 50s, officials
embarked on the notorious sterilization initiative to stem the seemingly rampant tide of
new births (Lopez 2008). At the time, viable temporary forms of birth control were nonexistent for several reasons: the opposition of the Catholic Church (Colon Warren 2003),
the federal Comstock Law that outlawed birth control, and the machinations of Clarence
Gamble (of Proctor and Gamble family fame) who “turned Puerto Rico into his own
personal birth control laboratory” (Lopez 2008:16) and experimented with his ineffective
contraceptive foams and jellies on thousands of women while preventing the introduction
of other effective temporary methods to the island.2

2

Lopez (2008) argues that the major reason that women were sterilized in such high numbers
throughout the course of the twentieth century was because it was the only effective birth control
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Briggs (2002) has argued that the overpopulation theory is not upheld by the
demographic and economic indicators, but rather it has served as a discourse deployed
at various moments in time to mask the reality behind the failure of the industrialization
program to increase standards of living and decrease poverty—that of colonialist
economic policies channelling wealth from the island and into the coffers of American
corporations. She notes: “in many ways, overpopulation served as a reply to and
encapsulation of this policy concern: something was wrong in Puerto Rico, but it could
not entirely be the fault of the United States” (2002:87)—indeed, “overpopulation” served
as a handier and more attractive excuse for the failure of US economic restructuring to
bring prosperity to the island’s inhabitants and relieve their hunger and poverty.
The ongoing diaspora, sterilization campaigns, and continued political hegemony
of the US have deeply shaped contemporary Puerto Rican society. Many scholars
agree that Puerto Rico is marked by a strong nationalist identity and that “Puerto Ricans
tend to view themselves as a distinct people” (Riviera Ramos 2001:69; see also Bates,
Rankin-Hill, and Sanchez-Ayendez 1997; Grosfoguel 2003), as exemplified by the great
symbolic importance of the Puerto Rican flag, identification of Spanish as the first
language, and other public displays of puertorriqueñista identity both on and off the
island (Riviera Ramos 2001). Puerto Ricans possess a cultural heritage distinct from the
United States, and drawn from Taíno, African, and Spanish roots (Duany 2006). Puerto
Rico is a Spanish-speaking and majority Roman Catholic country, although adherents of
Protestant branches of Christianity and religions such as Judaism, Buddhism, and Islam
are present in small numbers (World Factbook 2010).

option available. Although Puerto Rico’s sterilization campaign has often been framed in blackand-white terms as an example of scientific abuse, Lopez (2008) maintains that the issue is much
more complex, demonstrated by the still-high rates of voluntary sterilization that take place in both
island and mainland Puerto Rican populations decades after the campaign ended.
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CANCER AND HEALTHCARE IN PUERTO RICO
The social, cultural, and political-economic features noted above have relevance
for cancer survivorship research in Puerto Rico. Specific elements such as the health
care and health insurance system, medical tourism, and the impact of the Catholic
Church on reproductive options, must be considered as they play potentially important
roles in the way that survivorship from cancer is constructed and experienced.
The Puerto Rican Healthcare System
As an official territory of the United States, Puerto Rico is subject to the federal
health laws that govern the 50 states, although the colonial relationship that has
persisted between the US and Puerto Rico for over 100 years adds a layer of complexity
to the analysis of any health situation. As Mulligan (2010) notes, this colonial
relationship “affects the health system in a number of ways, the two most important
being that the health system is not completely within the control of local policymakers
and it receives less funding per capita from federal sources than mainland programs”
(2010:311). Many of the same federal entitlement programs also operate in Puerto Rico,
such as Medicaid—however, the federal contribution is often much lower (Hayashi, et al.
2009). For example, the federal matching contribution to Puerto Rico’s Medicaid
program was $219 million in 2005, versus the $1.7 billion it would have been had the US
government used the same calculation it uses for states (Hayashi, et al. 2009).
A healthcare reform was instituted in 1993 (commonly known as la Reforma),
with the goal of expanding health insurance coverage for low-income islanders via
Medicaid and thus decreasing disparities in health indicators and access to healthcare
(PAHO 2007). It was a staged reform, and the process was not complete until 2000. At
its core was the philosophy of privatization and the “[degovernmentalization] of health
care, as Government-run health services were considered both inefficient and highly
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costly for the Government” (PAHO 2007). Prior to the reform, the healthcare system
constituted a combination of both private and public resources; however, now medical
services have been mostly privatized (PAHO 2007). The island government’s role was
drastically altered: once a direct provider of low-cost healthcare, it now regulates private
insurance companies in their eligibility-restricted coverage of care (Mulligan 2010).
While its abiding principle has been to expand access to quality healthcare, a
recent evaluation of the reform conducted by the Puerto Rico Department of Health in
collaboration with the Pan American Health Organization (PAHO) presented worrisome
findings. Although la Reforma succeeded in extending health insurance coverage to 93
percent of the island’s population, the quality of care remains poor, the system is
fragmented, service rationing has become a problem, prevention systems have been
eroded, drug costs have drastically increased, practitioner training has been hampered
by the closure of teaching hospitals, patient-doctor relationships have been damaged,
and dissatisfaction is high among both patients and providers (PAHO 2007). Further, an
evaluation of the community health centers in Puerto Rico post-reform revealed that the
Medicaid system is chronically and seriously underfunded: “federal data on health center
revenue show that Medicaid managed care payments cover less than 12 percent of
health center patient expenditures” (Hayashi, et al. 2009). Finally, Puerto Rico ranks the
lowest on the list of industrialized nations for its health outcomes (PAHO 2007). These
findings are incongruous with the fact that Puerto Rico spends the highest proportion of
its gross national product (GNP) in the health sector than any other nation in the world
(PAHO 2007). As the authors of the community health center evaluation (2009) note:
“The experience of health centers with [the Government Health Insurance Plan]
underscores one of the basic truths about health reform: it is possible to enact reforms
that succeed in giving individuals something called ‘health insurance,’ while
simultaneously setting in motion financing strategies that undermine the fundamental
goals of reform. Contrary to popular belief, expanding insurance coverage does not
automatically increase access to care” (Hayashi, et al. 2009:5).
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Medical Care and Relationship to the US
The colonial relationship is evident in Puerto Rican healthcare, from chronic
federal underfunding of the Medicaid system to the utilization of mainland health
services by Puerto Rican elites. Although no data or literature presently exists to
support this inference, it is common conjecture that because of Puerto Ricans’
citizenship status and thus unrestricted travel to the US, middle- and upper-class Puerto
Ricans often travel to the mainland for the treatment of major illnesses. Thus, islanders
who cannot afford the expense of travel or purchasing health services out-of-pocket
must contend with oftentimes sub-optimal access to healthcare through la Reforma. At
the same time, because Puerto Rico is wealthier than many of its neighbors, it often
serves as the hub for other Caribbean residents seeking higher-quality care. These
trends were a frequent topic of discussion among healthcare providers in this study, and
three of the survivors had traveled to the US to receive at least part of the diagnostic
testing or treatment there. Providers also reported receiving patients from other
Caribbean islands, principally from the English-speaking islands of the Lesser Antilles—
and, more recently—from the continental US, since Puerto Rico is increasingly being
marketed as a lower-cost medical tourism destination3.
This discussion is relevant with regards to cancer care on the island. Qualitative
research with healthcare providers on the island has revealed that even though cancer
treatment standards-of-care are established, la Reforma does not consistently follow
these standards in paying for the full recommended treatment (Simmons, et al. 2011).

3

See, for example, a current study underway by the Foundation for Puerto Rico (2012), which
seeks to “explore the nascent medical tourism industry in Puerto Rico, and its potential to have a
positive impact on both economic growth and local employment.” This involves identifying how
Puerto Rico can prepare for increasing numbers of visitors seeking medical services, and ways in
which it can be into a competitive and attractive destination. A quick online search for medical
tourism in Puerto Rico unearths numerous websites outlining the advantages of Puerto Rico as a
soon-to-be booming destination, such as a recent press release announcing a partnership
between the Puerto Rican government and the Medical Tourism Association (MTA 2012).
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For example, providers report that la Reforma will often not pay for necessary tests or for
second opinions. In these situations, because government health plan members do not
have additional insurance, they must forgo those services or pay out-of-pocket.
The Catholic Church
Healthcare is affected by numerous social and cultural variables. In Puerto Rico,
one of the most important variables is religion, and specifically the Catholic Church.
Religion is important to this study on two levels: (1) impact on access to reproductive
care, and (2) the role of religious beliefs in cancer survivorship.
On the broadest scale, the Church has historically played a definitive role in
regulating access to reproductive care and technologies (Roberts 2006). As was
discussed in more detail in Chapter Three, Catholicism is alone among world religions in
banning in vitro fertilization (IVF) unilaterally (Roberts 2006). However, different Latin
American countries have interpreted this ban in various ways: for example, until
December 2012, Costa Rica had banned all IVF procedures (Tico Times 2013)4, while
Ecuador allows IVF and its providers even integrate core Catholic symbolism into their
practices (Roberts 2006). With regards to Puerto Rico, several infertility clinics do
currently operate on the island and offer a range of services, although, anecdotally, a
stigma exists against the use of ARTs that seems to relate directly to the Vatican’s
dictates on the use of these technologies (Flores 2010, personal communication). Yet,
despite this and the Catholic Church’s official disapproval, in this study there did not
appear to be widespread public condemnation or controversy surrounding ARTs.
Although the Church does influence access to health services, it does not wholly
define popular opinion about reproductive health services in any kind of dichotomous,
4

As noted in Chapter Three, the Inter-American Court of Human Rights ruled that Costa Rica’s
ban on IVF was a violation of human rights on December 20, 2012. In addition to reinstating the
legality of assisted reproduction, the Costa Rican government will financially compensate the
couples who brought the lawsuit (Tico Times 2013).
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black-or-white fashion; rather, it interacts with the current political and social context.
The issue of abortion services in Puerto Rico provides an instructive example in this
regard (Azize-Vargas and Aviles 1997). As a US colony, Puerto Rico was subject to the
Roe v. Wade decision legalizing abortion in the 1970s, and shortly thereafter the Puerto
Rican Supreme Court enacted abortion legislation permitting second- and third-trimester
abortions. Puerto Rico thus has one of the most liberal abortion policies in the world;
however, it also has one of the lowest usage rates. Surprisingly, these rates are also
lower than in many Latin American countries with stricter abortion laws, such as the
Dominican Republic.
Despite a common-sense assumption that there would be much lower abortion
rates among self-identified Catholic women, given that Puerto Rico shares with other
Latin American countries “the traditional forceful opposition to abortion by Catholic
religious officials” (Azize-Vargas and Aviles 1997:57), this is not the case. In a study by
Azize-Vargas and Aviles (1997), abortion rates were similar between Catholic and nonCatholic women who put “necessity above the views of the Catholic hierarchy on
abortion” (1997:61). Tellingly, contraceptive rates are similar between these two groups
as well (Azize-Vargas and Aviles 1997; Herold, et al. 1986). The authors explain that:
“The so-called ‘cultural and religious values/tradition’ do not explain the acceptability or
rejection of a particular practice when it comes to fertility control. State officials were
willing to challenge tradition when they supported eugenic policies, mass sterilization and
clinical experimentation. Women, in spite of blatant misinformation, were willing to
accept these because they were in dire need of contraception” (1997:63).

Thus, the role of the Church is important but not the sole factor in influencing
public acceptance and usage of reproductive services. Religious beliefs, however, do
influence individual experience with cancer and recovery, and numerous anthropologists
have confirmed its important role during illness (Coreil, et al. 2012; Erwin 2008; Mathews
2008). As Erwin (2008) aptly notes, “the inability to access biomedical care; poor
experiences within the world of biomedicine; and the positive outcomes, care and relief
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that result from ‘giving it up to God’ may reinforce the integration of health and religion
for many medically underserved populations” (2008:134).
Cancer in Puerto Rico: State of the Research
A study on cancer survivorship in Puerto Rico will generate important findings
because of its unique relationship to a major world economic power. Despite (or, some
would argue, because of) its relationship to the US, Puerto Rico has very high levels of
poverty, which has resulted in generations of migration to the mainland for those in
search of better economic opportunities, and a continual flow of cultural ideas,
resources, and goods (Bourgois 2002; Briggs 2002). At the same time, rates of major
cancers tend to be lower among islanders than among Puerto Rican migrants in the US
(a situation that parallels other Caribbean populations in the US and follows the pattern
of the “Latino Health Paradox”5), leading some to speculate about protective effects of
island life (Phillips, et al. 2007; Pinheiro, et al. 2009).
Despite this, cancer is a major burden in Puerto Rico, individually, socially, and
economically. A spate of new studies have been conducted since 2010 analyzing
cancer registry data through 2009, culminating in the Puerto Rico Central Cancer
Registry Report 2004-2009, which was released in late 2012 (Figueroa-Vallés, et al.
2012). A total of 12,906 new cases of cancer were diagnosed in 2009, and 5,007
cancer-related deaths were recorded in 2008, the latest year for which information is
5

The Latino Health Paradox in general refers to health indicators among Latinos in the US that
are more favorable than expected given what is known about the social gradient of health, which
holds that as socioeconomic status (SES) declines, health status correspondingly declines
(Acevedo-Garcia and Bates 2008). For example, although they have a low SES, Latino
immigrants have lower rates of low birthweight babies than the correlation between SES and
health would presume (Acevedo-Garcia, Soobader, and Berkman 2005). Many theories have
been posited to explain this paradox, ranging from the Healthy Migrant Effect (people who
migrate are substantially healthier than those who do not migrate), to the protective effects of
social networks that are often stronger in immigrant communities, to a cultural milieu that
encourages healthier behaviors. There is also the possibility that measurement biases, errors and
inconsistencies are explanations for the phenomenon’s observation, or at the very least make it
difficult to identify the full extent of the paradox (for example, “the fact that a US-born comparison
group is not used consistently across studies” [Acevedo-Garcia and Bates 2008:103]).

126

available (Figueroa-Vallés, et al. 2012). Cancer remains the second-leading cause of
death overall (PAHO 2000; Figueroa-Vallés, et al. 2012) and the leading cause of death
in men aged 50 to 69 and women aged 30 to 69 (Ortiz and Cruz-Correa 2010). Between
1987 and 2009, incidence levels in men increased from a rate of 288.9 new cases per
100,000 people to 336.7, and among females it increased from 203.9 per 100,000 to
248.5. Mortality rates decreased during this same time, from 170.1 per 100,000 to 144.5
in men, and from 103.1 per 100,000 to 85.9 in women (Figueroa-Vallés, et al. 2012).
Prostate cancer is the most common cancer among Puerto Rican men,
comprising 41 percent of new cases from 2005 to 2009, followed by colorectal cancer
(13.2 percent), and lung/bronchus (6.4 percent). Among women, breast cancer was the
most common at 30.3 percent of new cases from 2005 to 2009, followed by colorectal
cancer (13.9 percent), thyroid cancer (8.0 percent), and uterine cancer (7.1 percent).
Mortality rates follow a similar pattern for men: from 2004 to 2008, prostrate cancer
caused the most deaths (18.6 percent), followed by lung/bronchus cancer (13.3 percent)
and colorectal cancer (12.7 percent). On the other hand, although breast cancer (18.8
percent) and colorectal cancer (13.1 percent) were proportionately the biggest killers of
women, lung/bronchus cancer also accounted for a substantial proportion of deaths
(10.1 percent) despite its lower incidence (Figueroa-Vallés, et al. 2012).
There are higher levels of infection-related cancers in Puerto Rico—stomach,
cervix, and liver—than in the general US population (Colon-Lopez, et al. 2010; Ho, et al.
2009), and lower rates of screening especially for cervical cancer (Ortiz, et al. 2010). A
recent study published by Torres-Cintrón and colleagues (2012) evaluated disparities in
cancer incidence and mortality by socioeconomic position (SEP) in Puerto Rico, finding
that the poorest SEP areas had lower incidence rates for the most common cancers
than the highest SEP areas. These cancers are screening-sensitive, and the authors
hypothesized that the lower rates reflect decreased access to screening, and thus
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under-diagnosis, among Puerto Ricans in poorer areas. Mortality rates in low SEP
areas were higher for certain cancers, namely stomach and esophageal cancers.
Higher levels of exposure to the risk factors for these cancers correlate to lower SEP in
both Puerto Rico and the US, including H. pylori infection—in the case of stomach
cancer—and behavioral risk factors for esophageal cancers, such as tobacco use, liquor
consumption, and a nutrient-deficient diet (Torres-Cintrón, et al. 2012).
Males and females under the age of 49 accounted for 14.6 percent of all new
cases of cancer between 2005 and 2009, while mortality rates in this group were
correspondingly lower at 8.1 percent of all cancer-related deaths (Figueroa-Vallés, et al.
2012). It is possible to infer from these numbers that the majority of young cancer
patients are surviving their cancer diagnoses. The most common cancers in Puerto
Ricans under age 20 were leukemia, cancers of the brain and nervous system, thyroid
cancer and lymphomas. In women between the ages of 20 and 34, the most common
cancers were breast (16 percent), cervical (10.5 percent), leukemia (10.5 percent), and
non-Hodgkin’s lymphoma (8.3 percent); among slightly older women ages 35 through
49, breast cancer was common, reflecting 37.6 percent of all cancers, followed by
thyroid (17.1 percent), cervical (8.1 percent) and colorectal cancers (7.7 percent).
Among young men between the ages of 20 and 34, 17.5 percent were affected by
leukemia, 14.3 percent by non-Hodgkin’s lymphoma, 11.7 percent by colorectal cancer,
and 9.1 percent by testicular cancer. Among slightly older men, ages 34-39, colorectal
cancer (15.3 percent) and prostate cancer (15.1 percent) were the most common types,
followed by non-Hodgkin’s lymphoma (7.3 percent) and oral cavity and pharyngeal
cancers (6.4 percent) (Figueroa-Vallés, et al. 2012).
A frequent comment among providers in this study was that more cancers among
young adults are being diagnosed in Puerto Rico. While epidemiological data are not
yet available to corroborate these physicians’ observations, incidence among residents
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of the US under age 50 has seen a statistically significant increase since 1997, and
correspondingly, a significant decrease in mortality rates (SEER 2013a; SEER 2013b).
It would therefore not be a surprise if incidence rates were indeed increasing among
young adults in Puerto Rico as well.
In economic terms, the cost is staggering: cancer is the main culprit for
premature deaths in Puerto Rico (accounting for 15 percent of them), which in turn
impacts the productivity capacity of the island and annually is responsible for $64 million
in losses (Ortiz-Ortiz, et al. 2010), a large number for an island of less than four million
people. The total cost of cancer in Puerto Rico was estimated at $1.2 billion in 2006,
which includes $396.8 million in direct costs (e.g., cost of treatment and services), and
$805.5 million in indirect costs (e.g., lost income) (PRCCC 2008).
Cancer research is gaining increased attention on the island (Ortiz and CruzCorrea 2010; Ríos 2010). This is evidenced by two National Cancer Institute-funded
collaborative US-Puerto Rico training programs—a partnership between the University of
Puerto Rico Medical Sciences Campus and MD Anderson Cancer Center in Houston,
TX, and another between the Ponce School of Medicine and Moffitt Cancer Center in
Tampa, FL. However, work on cancer survivorship in Puerto Rico is scarce (Flores
2010, personal communication), which posed challenges to the initial conceptualization
of this research project due to the lack of existing literature. However, the importance of
the issue can be extrapolated from several known facts. With incidence rates on the rise,
but mortality rates on the decline (Torres-Cintron, et al. 2010), more Puerto Ricans are
becoming cancer survivors and will require long-term screening and care. At the time of
this research, it was not yet known how the concept of “survivorship” was interpreted or
perceived in Puerto Rico; however, an inference could be hazarded: American nongovernmental organizations that ascribe to the survivorship paradigm, such as the
American Cancer Society, operate branches on the island. It was not a stretch to
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imagine that the survivorship concept was being incorporated, however incipiently, into
the Puerto Rican cultural context, but the particulars of this process were unknown.
Fertility Clinics and Services
Turning to fertility services in particular, at the time of this writing no government
policy had addressed insurance coverage of infertility in general or fertility preservation
for cancer patients in Puerto Rico. As in the US, assisted reproductive technologies are
largely unregulated on the island. The Fertility Clinic Success Rate and Certification Act
of 1992 is the only federal legislation that currently addresses ARTs in the US; as such,
this applies to Puerto Rico. This legislation requires that fertility clinics report pregnancy
rates to the CDC (CDC 2012). As states and territories may further regulate ARTs if
they wish, this has resulted in the banning or regulation of surrogacy and human cloning,
as well as insurance mandates to cover certain IVF procedures, in a number of states
(CBHD 2010). Currently, Puerto Rico does not regulate ARTs, surrogacy is legal, and
there is no insurance mandate applied to infertility diagnosis or treatment.
Relatively few fertility clinics exist on the island, although most of them offer
some fertility preservation and post-treatment options (such as donor eggs or sperm).
Unfortunately, widespread access to them is restricted by numerous factors. These
include high cost; lack of insurance coverage of services, which can be prohibitively
expensive in a nation where 50 percent of residents fall below the poverty line (PAHO
2007); geographic location (the clinics are located in the San Juan metro area, several
hours travel from other parts of the island); limited public awareness of fertility
preservation options; and a combination of cultural, political and economic factors that
may limit attention to infertility as a recognized problem, a topic to be addressed later.
As of January 2013, there were four fertility clinics on the island. The oldest and
most established had been operating for 25 years in Bayamón, a municipality in the San
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Juan metro area just outside of San Juan proper; this practice employs two obstetriciangynecologists—one of whom is Board-certified in Reproductive Endocrinology and
Infertility (REI), and the other of whom is Board-eligible in REI. Another clinic in Hato
Rey, a San Juan neighborhood, has a Board-eligible REI and an andrologist. A third
operates in Caguas, a San Juan suburb, with a Board-certified REI. A fourth operates in
Santurce, a district of San Juan, with one OB/GYN who travels to Ponce twice weekly to
see patients on the southern coast. Collectively, these clinics offer several types of
fertility preservation services: egg freezing, embryo freezing, sperm banking, ovarian
tissue freezing, and testicular tissue freezing.
Two financial assistance programs exist that aid newly-diagnosed patients in
paying for fertility preservation—the American Cancer Society PR chapter and Niños
que Quieren Sonreir, an organization providing financial aid for pediatric and adolescent
cancer patients. However, it is evident that these programs are not widely known, given
that only two providers cited them when asked directly about available financial aid.
SUMMARY
Despite an increasing focus on epidemiological cancer research in Puerto Rico,
few scholars have focused on post-treatment quality-of-life issues among cancer
survivors. As an American colony since 1898, Puerto Rico has a complex relationship
with the US that impacts many levels of society, including the healthcare system and
quality of care provided. This chapter examined aspects of the sociocultural and
political-economic environment that must be considered in a study such as this because
of the necessity of locating study findings within their relevant cultural and historical
context. The next chapter is the first of four chapters that presents the results of the
data analysis; it specifically considers public perceptions of cancer as evidenced through
an ethnographic content analysis of women’s magazines.
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Chapter Six:
Cancer in the Public Eye: Representations of Cancer in Women’s Magazines
This chapter discusses the themes that emerged from the data related to
representations of cancer as revealed through the media analysis. As argued in Chapter
Four, media content can provide a glimpse of core societal values and meaning-making
regarding health and illness (Clarke 2006), and is thus a critical means through which to
answer questions about how cancer is regarded in Puerto Rican society. Accordingly,
the central purpose in this chapter is to provide a depiction of the mainstream discourses
of cancer, as represented by an ethnographic content analysis (ECA) of three highprofile women’s magazines in Puerto Rico—Imagen, Vanidades, and Cosmopolitan.
First, an overview of the magazines themselves will be provided, including information
on circulation and markets. Then, the type, frequency, and topical focus of cancer
coverage will be analyzed. Finally, the chapter will address the qualitative themes
surfacing in the articles, including issues surrounding authorship, marketing and
advertisement, use of celebrities, and cancer survivor profiles.
OVERVIEW OF MAGAZINES SELECTED
A total of three women’s magazines were sampled—Imagen (Puerto Rico),
Vanidades (Argentina), and Cosmopolitan (US). Recent issues of Vanidades (2008),
Imagen (2010), and Cosmopolitan (2010) were included in the analysis so as to gain a
perspective about current representations of cancer in the magazines. Simultaneously,
back issues of Imagen (1995, 2000, and 2005 in addition to 2010) were sampled in order
to provide a time-depth view, and to allow for an analysis of changing trends in the
132

depictions of cancer. Cancer-related items were identified in a straightforward manner:
articles, news blurbs, or advertisements focusing on cancer of any kind were the object
of the analysis. Cancer did not have to be the sole theme of the article, but it had to be
included as a major topic. The hard copy of every issue of Imagen and Vanidades was
reviewed page-by-page; items that appeared even marginally relevant were read in their
entirety. The procedure differed slightly for Cosmopolitan, since the back issues of that
magazine were available in an online, searchable database. In this case, the keyword
“cancer” was searched, and any corresponding articles retrieved and reviewed.
Vanidades, launched in Miami in 1961 and focusing on “setting trends, fashion,
beauty, royalty, celebrities, health, travel, cooking, and recipes” (Vanidades 2013), is the
most popular Spanish-language women’s magazine in the Americas. While currently
headquartered in Mexico, it releases local editions in several countries, including Puerto
Rico—where the monthly circulation tops roughly 70,000—and the US, Argentina,
Bolivia, Brazil, Chile, Colombia, Dominican Republic, Ecuador, and Peru. Imagen, on
the other hand, is a Puerto Rican publication. According to the publisher’s website,
Casiano Communications, Imagen “chronicles fashion trends and provides information
on beauty, travel, culture, home decor, and other women-oriented topics” through a
monthly circulation of 80,000. Cosmopolitan, a women’s magazine established in the
US in the 1960s, covers topics of fashion, beauty, relationships, health, and career. Its
Spanish-language edition has a monthly circulation of 75,000 in Puerto Rico.
Imagen and Cosmopolitan publish 12 issues per year, while Vanidades has
published 25 until recently—of which 23 from the year 2008 were available. A total of
126 items between the three magazines were evaluated. Of these, 113 were published
in Spanish—every article published in Imagen and Vanidades. Since I evaluated the
English language version of Cosmopolitan (the Spanish language version was
unavailable), all 13 of their articles were published in English. The following section,
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describing the results of the ECA, is first organized by major themes, such as frequency
and distribution of cancer-related news items, and then, within that, by type of analysis:
first, current items, termed “cross-sectional” (from 2008 and 2010), and second, analysis
of Imagen articles through time, termed “longitudinal” (1995, 2000, 2005, 2010).
COVERAGE OF CANCER
Frequency of News Items on Cancer
Cross-sectional: Among the current magazines—Imagen (2010), Cosmopolitan
(2010), and Vanidades (2008)—the publication with the fewest number of articles and
pages devoted to a cancer-related topic was Cosmopolitan (see Table 6.1 below). Its
2010 issues featured a total of 13 articles, comprising 17 pages. Both Imagen and
Vanidades included 35 articles each, but Imagen’s page count was greater. October
took first place among all magazines as the month featuring the most cancer-related
coverage. A total 19 cancer-related pieces totaling 25 pages were published in October,
followed by January with a total of nine articles (15 pages).
Table 6.1. Total Number of Articles and Pages, 2010
Month/
Imagen 2010
Cosmo 2010
Issue
Pages
Articles
Articles Pages
January
5
11
0
0
February
2
7
3
3
March
2
2
0
0
April
1
1
0
0
May
6
14
1
1
June
1
7
1
1
July
0
0
2
4
August
5
5
0
0
September
1
1
1
1
October
10
13
2
2
November
1
1
0
0
December
1
4
3
5
TOTALS
35
66
13
17

Vanidades 2008
Articles
4
0
2
4
1
6
1
3
3
7
3
1
35

Pages
4
0
2
4
1
7
1
3
3
10
3
1
39

Totals
Articles
9
5
4
5
8
8
3
8
5
19
4
5
83

Pages
15
10
4
5
16
15
5
8
5
25
4
10
122

Longitudinal: An examination of Imagen through the 15 years reflects a much
greater inclusion of cancer-related articles in recent years, beginning around 2005. In
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1995, only four articles were included, followed by nine in 2000. Thereafter, there was a
jump to 30 in 2005 and 35 in 2010. The total number of pages dedicated to cancerrelated articles follow a similar pattern: from 12 in 1995, to 32 in 2000, followed by an
increase to 54 in 2005 and 66 in 2010. The month of October was a strong leader in
featuring cancer-related pieces, with a total of 21 article comprising 35 pages (see Table
6.2 below). Articles published in this month steadily increased between 1995 and 2010,
which is no surprise, as October was designated National Breast Cancer Awareness
Month as early as 1985 through a partnership between the American Cancer Society
and a British pharmaceutical–petrochemical company.
Table 6.2. Total Number of Imagen Articles and Pages, 1995-2010
Month/
Issue
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
TOTALS

Imagen 1995

Imagen 2000

Imagen 2005

Imagen 2010

Art’s
0
0
1
0
0
1
0
0
0
1
0
1
4

Art’s
2
2
1
0
0
0
0
0
0
3
0
1
9

Art’s
2
2
5
0
2
1
1
0
2
7
0
8
30

Art’s
5
2
2
1
6
1
0
5
1
10
1
1
35

Pgs
0
0
1
0
0
6
0
0
0
4
0
1
12

Pgs
7
12
1
0
0
0
0
0
0
10
0
2
32

Pgs
2
12
9
0
9
1
1
0
2
8
0
10
54

Pgs
11
7
2
1
14
7
0
5
1
13
1
4
66

Totals
Art’s
9
6
9
1
8
3
1
5
3
21
1
11
78

Pgs
20
31
13
1
23
14
1
5
3
35
1
17
164

Type of Item
One of the aspects evaluated in this study was the type of article published—
whether it was a small blurb located adjacent to other columns, blurbs, or articles; an
advertisement; or a stand-alone, full-page article. It was clear that there was a particular
type that was characteristic to each magazine (see Figure 6.1 below): for example,
Cosmopolitan specialized in news blurbs, and 11 out of their 13 total articles were
published in that format. Similarly, Vanidades published 30 out of its 35 articles as news
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blurbs. Advertisements for cancer-related products or services did not make up a
significant proportion of the news items in either of these magazines. Imagen was
different and preferred the stand-alone article format; the majority of the published items
each year were articles, culminating in 2010 with 22 articles out of a total of 35 items.
Figure 6.1. Types of Current Items: News Blurbs, Advertisements, or Stand-Alone Articles

Vanidades 2008

Cosmo 2010

Imagen 2010
3

2

2

News
Blurb

3

Ad

10
22

30

11

Article

Imagen (2010) included more advertisements than both Cosmopolitan (2010)
and Vanidades (2008). This category includes advertisement for Merck
Pharmaceutical’s Gardasil HPV vaccine, or a cause-related marketing ad. In an
example of the latter, the beauty company Kiehl’s advertised their partnership with Locks
of Love, an organization that fashions wigs for childhood cancer patients out of donated
hair. Imagen’s inclusion of advertisements increased through time, as evident in Figure
6.2 below, from zero ads in 1995 to ten in 2010.
Figure 6.2. Type of Items Published in Imagen between 1995 and 2010

Imagen 1995

Imagen 2010
3

1

News
Blurb
10

3

Ad

22
Article
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Cancer Type and Topic
Cross-sectional: Breast cancer was most frequently featured in the current
magazines: nearly 34 percent of articles focused on it. This was followed by cervical
cancer at 21 percent, “general” cancer at 16 percent, and skin cancer or melanoma at 12
percent (see Figure 6.3 below). Slight differences between magazines are evident:
Cosmopolitan published more articles about skin cancer than any other type, while
Imagen featured more cervical cancer coverage1. The “Other” category included
childhood cancers, as well as cancers of the lung, brain, bone, ovaries, pancreas,
prostate, and uterus.
Figure 6.3. Types of Cancer Addressed by Current News Items, 2010
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Longitudinal: A similar pattern was followed in Imagen through the 15 years of
publication (see Figure 6.4 below): breast cancer was most frequently discussed (35
percent of articles), followed by general cancer (29 percent), and cervical cancer (18
1

It is difficult to compare the 2008 Vanidades coverage with the 2010 issues of Imagen and
Cosmopolitan, because the HPV vaccine—released in mid-2006—was a recent development at
that point. It is possible that by 2010 enough interest in the vaccine had been generated that
Vanidades featured higher levels of cervical cancer coverage; however, since those issues were
unavailable at the time of this research it is impossible to know for certain.
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percent). The most significant finding was the dramatic increase of cervical cancerrelated publications, from zero in 1995 and 2000, and one in 2005, to 13 in 2010, likely
reflecting the news surge surrounding the release of the HPV vaccine.
Figure 6.4. Types of Cancer Addressed by News Items, 1995-2010
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Topical Focus of Articles
In order to further analyze the topics and objectives of the magazine items, each
article was classified into a pre-determined list of categories. They are not mutually
exclusive, and indeed, one article’s main topics might fall under several themes. The
category of “Causation” refers to theories or ideas about why a particular cancer (or
cancer in general) develops; it includes risk factors such as behaviors, genes, or family
history that might possibly play a role in cancer development. “Screening” refers to any
technology or service used to detect a possible existing cancer, such as mammography,
breast self-exam, clinical breast exam, prostate exam, and Pap smear, among others. It
also includes mention of biopsy. “Prevention” entails any behavior or habit urged upon
the reader as a potential way to prevent the occurrence of cancer; for example, eating
more cruciferous vegetables and fruits, losing weight, quitting smoking, and drinking
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more tea, red wine, or coffee. A sub-category of “Prevention,” “Vaccination” refers
specifically to the use of an anti-cancer vaccine to prevent the development of cancer;
this category was used exclusively for the HPV vaccine.
The category of “Treatment,” on the other hand, was generally used with articles
discussing the existing types of treatment used against a particular cancer (such as
chemotherapy or radiation), or a new treatment being offered. “Research” includes any
mention of a research study or project that had uncovered new information about
cancer. Most frequently, this category was used with articles that reported on a research
finding published elsewhere (such as in the Journal of the National Cancer Institute), and
were summarized by the magazine along with the reasons for which these studies were
relevant to the reader—for example, by guiding their dietary choices.
The next three categories are similar. “Survivor/Patient Stories and Profiles” was
used when an article covered the personal story of someone who had survived cancer or
was currently experiencing it. Most often, items classified as such were meant to be
inspirational stories and featured emotional themes with which readers could identify.
“Doctor/Hospital Profiles,” on the other hand, tended to be primarily quasiadvertisements—small news items that profiled the services that a particular hospital or
doctor offered in his or her clinic. “Advocate Profiles” most commonly featured the
activities of a known community member engaged in cancer advocacy work, whether by
founding or leading an organization or participating in other awareness-raising efforts.
“Organizational Fundraising” was a prominent category—it included
announcements by organizations about particular moneymaking initiatives, like Race for
the Cure or other races, partnerships, or initiatives. “Other Organization Activity” was a
seldom-used category for articles that reported solely on particular activities undertaken
by organizations, such as the construction of Hope Lodge, a temporary home for out-oftown patients undergoing cancer treatment in San Juan. Finally, a category “Other” was
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used to classify magazine items not fully relevant to the other categories, such as sexual
health and other quality-of-life issues; these were generally so few and far between that
they did not merit their own category.
Cross-sectional: Items in the three current magazines—Cosmopolitan (2010),
Vanidades (2008), and Imagen (2010), differed considerably in their focus (see Table
6.3 below). Cosmopolitan relied heavily on topics in three categories—Causation,
Screening, and Prevention. Vanidades, on the other hand, concentrated primarily on
articles in the Research category, followed by Prevention and Treatment. The majority
of these articles were concerned with announcing new available technology or treatment
breakthroughs. Imagen’s articles, as will be seen in more depth below, were grouped
primarily in Vaccination, followed by Organizational Fundraising and Screening.
Table 6.3. Main Topics of Current Cancer-Related Magazine Items
Cosmo 2010
Vanidades 2008
Main Focus of Article
(n)
(%)
(n)
(%)
Causation
Screening
Prevention
Prevention (vaccination)
Treatment
Research
Patient/Survivor Profiles
Doctor/Hospital Profiles
Advocate Profiles
Organizational Fundraising
Other Org Activity
Other

8
4
9
1
0
0
2
0
0
1
0
0

32
16
36
4
0
0
8
0
0
4
0
0

5
9
15
0
12
25
1
0
0
0
1
0

7
13
22
0
18
37
2
0
0
0
1
0

Imagen 2010
(n)
(%)
7
8
0
11
5
3
3
6
1
9
2
2

12
14
0
19
9
5
5
11
2
16
4
4

Longitudinal: The main foci of Imagen’s items, although varying a little each
year, were grouped under Screening and Prevention (see Table 6.4 below). A few
interesting trends emerged: first, there was a noticeable surge in vaccine-related items in
2010, reflecting the release of the HPV vaccine. Second, announcements for
fundraisers or organizational money-making partnerships/initiatives played a prominent
role in the magazine’s cancer-related coverage starting in 2000, comprising over 14
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percent in that year from 0 percent in 1995, almost 20 percent in 2005, and 16 percent in
2010. This likely reflected increasing awareness among the general population, and the
increasing number of organizational initiatives taking place on the island. Additionally,
although the numbers do not necessarily seem higher than the other two magazines at
first glance, Imagen featured many more Patient/Survivor Profiles, Advocate Profiles,
and Doctor/Hospital Profiles. These stories were often the most in-depth articles
featured, constituting multiple pages that highlighted local heroes or residents.
Table 6.4. Main Topics of Imagen Magazine Items, 1995-2010
Imagen 1995
Imagen 2000
Imagen 2005
Main Focus of Article
(n)
(%)
(n)
(%)
(n)
(%)
2
20
1
7
6
12
Causation
1
10
3
21
8
16
Screening
2
20
2
14
9
17
Prevention
0
0
0
0
0
0
Prevention (Vaccination)
1
10
1
7
6
12
Treatment
1
10
1
7
3
6
Research
0
0
2
14
1
2
Patient/Survivor Profiles
0
0
0
0
4
8
Doctor/Hospital Profiles
1
10
1
7
3
6
Advocate Profiles
Organizational
0
0
2
14
10
19
Fundraising
1
10
0
0
0
0
Other Org Activity
1
10
1
7
1
2
Other

Imagen 2010
(n)
(%)
7
12
8
14
0
0
11
19
5
9
3
5
3
5
6
11
1
2
9

16

2
2

4
4

QUALITATIVE THEMES IN ALL MAGAZINES
Authorship: Expert, Commercial, and Unstated
By 2005, there was a tendency in Imagen to feature informational articles written
by prominent doctors who were in some way professionally involved in the topic of the
article. For example, a recurring column written by the then-Medical Director of the
American Cancer Society PR Chapter was featured in four months of the year 2005. He
wrote about different forms of cancer, such as skin, lung, or breast cancers, and their
associated risk factors, screening tests, prevention strategies, and treatment options.
In Imagen, this trend continued into 2010, although what was equally evident
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between these years was the reliance on commercial interests to pen some of these
reports. For example, several reports on the benefits of certain medical devices or
techniques were written by doctors or employees of companies/clinics that had also
taken out advertisements in those magazines announcing their services. An example of
this is an article in the October 2010 edition of Imagen, entitled Prevención: Tu Mejor
Herramienta Contra el Cáncer de Seno (Prevention: Your Best Tool Against Breast
Cancer), which was authored by Dr. Gamalier Bermudez Ruiz, a radiologist and
president of Modern Radiology, PSC and Las Vistas Imaging & Diagnostic Center.
These two clinics had taken out adjacent advertisements. The article itself was not
prominently identified as a commercial advertisement, and though there was a very
small line at the bottom of the page marked “Advertorial,” at first glance this article had
the appearance of a journalistic report. These authorship trends contrasted visibly with
Vanidades and Cosmopolitan, whose articles, without exception, were written by staff
journalists with unmentioned credentials.
Marketing and Advertisement
In Imagen, 2005 witnessed the introduction of cause-related marketing. For
example, in the October 2005 issue alone, three articles on cause-related marketing
were published: they discussed, respectively, a jewelry company whose pink-ribbon
specially-designed necklace and bracelet line would donate 10 percent of its profits to
the Breast Cancer Research Foundation; BMW’s campaign in Puerto Rico that would
benefit Komen by donating a certain amount of money for every mile driven; and finally,
a campaign by Ford Motor Company in Puerto Rico that would also benefit Komen.
Interestingly, the advertisement of cancer-related company products was a much
stronger presence in Imagen than it was in Vanidades or Cosmopolitan, perhaps
because it is a strictly local, Puerto Rican magazine and not one imported or adapted
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from publication abroad. By 2010, Komen was frequently advertising its Race for the
Cure fundraiser in October, running advertisements in August, September, and October.
Figure 6.5 below is a Race for the Cure advertisement from the September 2010 issue.
Figure 6.5. Susan G. Komen’s Race for the Cure Advertisement, Imagen 2010 (Sept:134)

Advertisement was not limited strictly to organizational fundraisers. For example, Lilly
Oncology ran an advertisement in a 2008 issue of Vanidades informing readers that as
women get older, their risk for breast cancer increases (see Figure 6.6 below). The ad
urges readers to consult their doctor, and it includes Lilly Oncology’s logo on the bottom
right-hand corner. There is no drug explicitly advertised. Interestingly, the
advertisement is similar to a mug shot—hinting that the woman holding the sign is in
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prison. Whether that prison is created by lack of knowledge about breast cancer that
traps women into late-stage diagnoses is not clear; however, what is evident from the
picture is that screening has the power to liberate.
Figure 6.6. Lilly Oncology Advertisement in Vanidades 2008 (48[8]:103).
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Overemphasis on Preventability of Cancer
In all magazines, there was a disproportionate emphasis on prevention, and this
topic appeared most prominently in Cosmopolitan and Vanidades—much more so than
other topics. Readers were urged to modify their lifestyle in order to “reduce risk” or
“prevent cancer.” It was very common to have small blurbs, drawn from recentlyreleased study findings, displayed on the pages of the magazines’ health sections
recommending that readers eat “X” vegetable—whether it be cauliflower, carrots,
spinach, mushrooms, or another types—because it contains “X” antioxidant, enzyme, or
protein that will ultimately prevent “X” cancer. A common scenario was as follows:
“A powerful way to fight breast cancer is to eat more cruciferous vegetables like turnips,
watercress, cabbage, broccoli, cabbage and cauliflower. Researchers at the Vanderbilt
University Cancer Center in Nashville, Tennessee, found that women with a high genetic
risk for this disease can reduce that risk by 50 percent when they have a diet high in
cruciferous vegetables” (Vanidades 2008, Oct:32).

Prevention was also a recurrent theme in articles that addressed skin cancer,
which predominated in Cosmopolitan. These articles uniformly urged readers to avoid
the sun or to “practice safe sun,” because the etiology of skin cancer is clear—exposure
to UV rays. Cosmopolitan had made this its pet project, termed “Practice Safe Sun,”
with the goal of raising awareness about the dangers of indoor tanning. For example:
"Tanning beds were recently declared carcinogenic, meaning they cause skin cancer
[…] Going indoor tanning before you hit 30 raises your risk of melanoma (the deadliest
form of the disease and the most prevalent type of cancer among women in their 20s)
by a shocking 75 percent" (Cosmopolitan 2010, Oct:NP).
"Don't buy into the hype that you must bake in the sun sans sunscreen or schedule time
at a tanning salon to get your RDA of D—it is totally not true and will backfire by
damaging your skin and possibly leading to skin cancer" (Cosmopolitan 2010, Dec:214).

Reporting Style
Overall reporting and presentational style differed dramatically between the three
magazines. Cosmopolitan overall tended to feature quite superficial reporting of cancerrelated topics and the fewest numbers of articles or news blurbs related to this theme.
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Vanidades, on the other hand, often featured the results of published research studies,
translating them into layman’s terms, for publication in their Health or Medicine sections.
Importantly, a strong tendency in Vanidades was the presentation of studies in ways that
created false expectations. For example, articles would feature a captivating title, such
as Vacuna…Contra el Cáncer de Seno (Vaccine… Against Breast Cancer), that
promised a huge advance in a screening, diagnosis, treatment, or vaccination method,
generating the impression that the development would impact people’s lives immediately
and positively. Then, several sentences later, the reader would find out that this “huge
advance” was only in the mouse-model stage of research and had not even reached the
level of human subjects research. For example, in the above-named article, the first
sentence read as follows:
“A new vaccine developed at Wayne State University in Detroit is capable of delivering a
gene into cells to fight cancer, which then allows the generation of immune system
proteins and cells that destroy the tumors…”

It is not until one gets to the very last sentence of the article that it mentions the fact that
the study has been done in mice, not humans:
“According to the information presented in the journal Cancer Research, the vaccine
eliminated tumors in mice with a type of cancer called HER2 positive, which represents
between 20% and 30% of breast tumors” (Vanidades 2008[48:22]:99, emphasis added).

Similarly, an article entitled Combatir…Los Tumores del Cerebro (Combating…Tumors
of the Brain), had one brief, easy-to-miss mention of the fact that the study was
conducted in mice, not people. Interestingly, it referenced a mouse in the singular sense,
rendering the finding even less immediately applicable to humans than the title suggests.
“A study published in the journal Molecular Therapy provides a new way to fight brain
tumors with gene therapy. Researchers at Massachusetts General Hospital introduced
genes that fight cancer into healthy tissue adjacent to the malignant brain tumor of a
mouse and this prevented its spread" (Vanidades 2008[48:23]:99, emphasis added).

Use of Celebrities
Celebrities were mentioned in four articles throughout all magazines: two in
146

Vanidades, and two in the 2010 issues of Imagen. This was a lower number than
expected, but it is significant that the only celebrity references occurred in the most
recent issue. Perhaps this reflects a growing trend for celebrities to either be public
about their own disease or to be involved in fundraising efforts. For example, Vanidades
featured an interview with Lorena Rojas, a Mexican soap opera star diagnosed with
breast cancer. In another issue, it listed recent celebrities diagnosed with cancer as a
way to call attention to increased cancer incidence in young adults:
“The Mexican actress and songwriter Lorena Rojas, star of the soap opera ‘The Body of
Desire,’ talks about the process of dealing with breast cancer and her determination to
maintain a positive spirit” (Vanidades 2008[48:21]:72).
“The [fact that] show business figures such as Adamari Lopez, Sheryl Crow and the late
singer Soraya have or have had breast cancer certainly pressed the alert button in many
young women. What's going on?” (Vanidades 2008[48:13]:34-35).

Imagen featured reports on celebrities becoming more involved in fundraising, such as
Amaury Nolasco, a well-known Puerto Rican actor who runs an annual golf classic to
raise funds for the pediatric oncology department at the Hospital Pediátrico in San Juan.
Negative Emotions and Stress as Cause of Cancer
An interesting theme was a focus on negative emotions and stress as a potential
cause of cancer—either directly or indirectly by fostering unhealthy lifestyle practices2. In
one article entitled Relájate…Para Evitar el Cáncer de Seno (Relax…to Avoid Breast
Cancer), Vanidades (2008[48:13]:32) reported on the results of a study investigating the
role that stress plays in the development of breast cancer. The study found that women
in high-stress jobs had a 30 percent higher risk of developing the disease, which
researchers speculated could be the result of stress encouraging the adoption of an
unhealthy lifestyle—elevating estrogen levels and in turn increasing risk. Magazines
recommended that readers practice muscle relaxation, describing some techniques.
2

This was also a prevalent theme in the survivor interviews. See Chapter Seven for these
findings, and Chapter Ten for a discussion of this theme in the context of the existing literature.
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Another article reported on the link between anxiety, depression, and cancer:
“Anxiety and depression have an adverse impact on the development of cancer.
Researcher Ronit Peled explained that a negative event—the loss of a loved one or a
marital breakup—can be the mechanism that drives breast cancer in a young woman.
Various sources show that, in the same way, maintaining a positive attitude helps the
healing process of the disease. There are countless programs that promote optimism
during the process” (Vanidades 2008[48:21]:72-75).

Meanings of Cancer and Recovery in Survivor Profiles
Imagen featured survivor or advocate interviews and profiles at a greater
frequency than the other magazines. For example, for three of the four years sampled
(2000, 2005, 2010), the magazine advertised the American Cancer Society’s fundraising
gala by publishing in-depth profiles of five couples or families in which one of the
members had gone through cancer. These profiles offered a rich source of ethnographic
information about conceptions of cancer or survivorship. Valuable themes surfaced in
the survivors’ and family members’ accounts, varying little between years. These same
themes also emerged throughout the interviews with survivors and advocates in this
study, ratifying the prevalence of the ideas in Puerto Rico. Most notably, the survivors
profiled in these articles talk about how cancer was a life-changing event that affected
them positively in many ways, whether it be learning how to live in the moment, or being
able to reprioritize and value more the “important things in life,” such as their family and
children. One of the survivors profiled, a doctor, reported this tendency:
“For Dr. José Arroyo Gau and his wife, Carmen Padilla, the experience of having beaten
cancer twice has meant learning to enjoy the present more and thinking a little less about
the future. ‘We have changed our scale of values in the sense that before we were
accustomed to making long-term plans. We learned to enjoy the day and to only think
about tomorrow a little bit, and that change has been good’” (Imagen 2000, Feb: 189-99).

A survivor profiled in another issue, Mili, reiterated the same theme:
“[Mili, a cancer survivor] reaffirms that the whole experience has been a learning for her.
She learned to value and appreciate the really important things in life, such as family and
good friends. ‘The mind becomes clear in many ways’” (Imagen 2000, Oct:238-242).

Survivors and family members spoke about the importance of positive thinking in
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recovery from the disease and in being able to withstand the trials of treatment—or
perhaps more accurately, the detriment of negative thinking. In an Imagen article
profiling cancer survivors, one survivor noted:
“The medical treatments are not going to have the same effect on a pessimistic person’”
(Imagen 2005, Feb:95-105).

A husband and wife, who been diagnosed and treated for cancer at the same time,
spoke of the importance of a positive attitude in their own recovery after the disease:
“‘The most important thing in this process is the attitude. There are people that without
being ill, have such a negative attitude that they feel things they don’t have’ said Gilberto,
while [his wife] added that they never stopped working and changed as little as possible
in their lives’” (2005, Feb:95-105).

Profiled survivors spoke about the importance of family in a few ways: first, the important
role of family support in their experience, and second, how informing family was the
hardest part of the experience. For example:
When Raymond was diagnosed, “the hardest thing was to inform their children—Ricardo,
Cristian and Richie—what had happened since ‘they’ve always seen me as a strong
person and I didn’t want them to feel sadness or pity for me’” (Imagen 2005, Feb:95-105).

Religious belief was a prominent theme in these accounts as an underlying force for
dealing with the cancer experience and a motivating factor in getting well. For example:
“‘In our faith, we knew that God would work through medical science’ [...] Both express
that their faith sustains them in every situation of life and that God gave them the
necessary peace at the moment Judith was diagnosed” (Imagen 2000, Feb:189-199).
“‘Cancer gave me the opportunity to see life from a totally different perspective, to see it
more spiritually than before’” (Imagen 2005, Feb:95-105).

Very few survivors’ accounts touched upon the possibility of infertility. More often they
discussed how their children were their biggest concern upon diagnosis. For example, a
married survivor remarked that when she was diagnosed with cervical cancer at age 32:
“‘Those words hit us like a bucket of ice water. I'll never forget how I felt at that moment,
that day and the others that followed. But at that moment I decided to make an
appointment fast for the operation [...] I have two children (a five-year old boy and a
three-year old girl), and what went through my mind was their faces, and I could not leave
the matter long so I took fast action [to have a hysterectomy]’” (Imagen 2010, Jan:130-2).
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Despite the fact that the survivor quoted above needed to undergo a sterilizing
procedure as a treatment for the cancer, the article never touched upon her reaction or
thoughts about this aspect. Rather, it focused on the constant stress and worry of
recurrence. Her cancer was depicted as difficult to detect, requiring persistence and
multiple visits to the doctor in order to secure an accurate diagnosis in the first place,
and constant vigilance thereafter. Initially she regarded it as a death sentence, but that
perception faded with time, despite the constant recurrence worries.
Several survivors related how their hair loss (or the threat of it) was one of the
most traumatizing aspects of the experience for them. Others remarked that physical
changes or mastectomies were the most difficult aspect, but one that can be overcome:
“‘When I saw that [my mother’s] hair was falling out, I realized what was happening. To
stop the torture, my dad and I shaved her head, full of emotion, pain and sadness for the
drastic physical change” (Imagen 2010, Feb:111-116).
“‘For a woman, the physical change is the most difficult, the one that you feel the most
because cancer does not hurt. With treatment, I felt bad the first day, but then I was
perfectly fine. The worst thing is to see your body maimed, such a feminine part as the
breast; it’s to see yourself without hair, but I learned to handle all this positively’ says
Annette [...] ‘If you are a person who tries to have inner beauty, that comes out. In that
process, I think that it was the time in my life when I was more beautiful inside because I
started to enjoy and appreciate the little things everyday’” (Imagen 2005, Feb:95-105).

There were references in three years—2000, 2005, and 2010—to the need for survivors
to reach out, to help someone with cancer, or a responsibility to raise awareness. This
speaks to a need to make sense of the experience through serving and helping others.
One couple who had both survived cancer related how they are now involved in many
volunteer activities for other patients, which is part of their learning to value life:
“‘We enjoy and celebrate life. We are involved in the American Cancer Society […] We
belong to the organizing committee for Relay for Life, in Manatí. We value life and
learned to love our neighbor more than we already did. We are part of the American
Cancer Society’s Yo Puedo [educational and support] program. We have so many
people to thank’” (Imagen 2010, Feb:115).

A long article in Imagen’s December 2010 issue profiled a survivor who had started her
own organization to aid others. It explained her motivation:
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“‘El Comité Niños que Quieren Sonreír (The Children Who Want to Smile Committee)
was born because I was a cancer patient at 23 years old. I was diagnosed with
Hodgkin’s disease [a lymphoma] in an advanced stage, but thanks to God, although the
prognosis was somewhat daunting, I was able to recover completely and in spite of being
treated with chemotherapy and radiation I was able to have a daughter who is now 15
years old,’ relates Aidiliza Levis de Buenaga, founder and president of the Comité Niños
que Quieren Sonreír, whose life lesson and gratitude motivated her to reciprocate the
blessings she received” (Imagen 2010, Dec:174-177).

Cervical Cancer Prevention
Cervical cancer was a large presence in the 2010 issues of Imagen. This was
after the Gardasil HPV vaccine had been approved. Several Gardasil advertisements
appeared in Imagen that year, as well as two related articles. One of these articles
reported on the FDA approval of the vaccine in men/boys, and the other was entitled
Merck Solidifica su Presencia y Liderazgo en la Industria Farmacéutica (Merck Solidifies
its Presence and Leadership in the Pharmaceutical Industry). Articles by physicians,
mostly pediatricians and gynecologists, took a clear, positive stance and urged their
readers to consider vaccination. Their arguments were tailored to the controversies at
the time about pre-marital sex, promiscuity, and the possible “dis-inhibitive” effects of a
vaccine against a sexually transmitted infection (STI). These authors argued that if a
vaccine exists to prevent a deadly disease, then it is a responsible parental decision to
vaccinate one’s child against it. For example, one physician wrote:
“‘When you read about new vaccines, we talk about diseases that can be prevented by
them, especially infectious ones like polio, measles, chickenpox, tetanus, pertussis, etc.
Today I am letting you know that there is a vaccine that prevents an infection, just like
the other vaccines, but this one causes cervical cancer. It is a vaccine to prevent the
human papillomavirus’” (Imagen 2010, May:80).

The doctor concluded the article by urging readers to vaccinate their daughters:
3

“Vaccinate your daughter today. Vaccinate her now. It’s free and it’s your
responsibility.”

3

The Puerto Rico Department of Health received federal funding to provide the HPV vaccine free
of charge to residents in the approved age groups whose insurance plans do not cover it.
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Use of Survivor Terminology
In 1995, the predominant term used throughout the articles was “cancer patient,”
“person with cancer,” or, in one case, “cancer victim” (Imagen 1995, Mar:77). The term
“survivor” did not make its appearance until February 2000 in Imagen, in an article that
announced an upcoming gala fundraiser for the American Cancer Society, “honoring
cancer survivors” (Feb:188). It is interesting that the term’s only appearance that year
was connected to the ACS, the largest US-based organization on the island. However,
even though eight people, both under treatment and off-treatment for cancer, were
profiled that year, the term only appeared in the announcement for the ACS gala.
SUMMARY
Examining media representations of cancer can provide an effective means
through which to illuminate cultural constructions of an illness like cancer. An
ethnographic content analysis of three women’s magazines revealed a number of key
themes, the first of which is that cancer-related coverage has increased substantially in
the years since 1995, with major clustering of articles in the month of October. The
magazines varied with regards to their preferred format and topical focus. The presence
of advertisements increased between 1995 and 2010, as did authorship of articles by
commercial interests. In general, magazines exhibited an overemphasis on the
preventability of cancer, and Vanidades in particular featured misleading reports on
breakthroughs in cancer research that exaggerated the direct and immediate relevance
or benefits for people. Celebrities were increasingly mentioned; perhaps as the stigma
related to cancer continues to decrease, celebrities are more comfortable sharing their
personal histories. The survivor terminology was not used until 2000.
Finally, qualitative themes emerging from the survivor profiles revealed important
ways that cancer is approached, thought about, and dealt with in Puerto Rico: it is seen
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as a transformational, catalyzing “wake-up call,” in which positive emotions play a vital
role and negative emotions and stress can be detrimental to health. The role of spiritual
beliefs is crucial in one’s recovery, as is the support of family, although the latter can be
a double-edged sword by adding additional worries and concerns. Infertility was
mentioned very rarely. Appearance-related concerns emerged as paramount,
particularly among the female survivors profiled.
These themes resonate strongly in the interviews conducted among providers,
advocates, survivors, and clergy members for this study. Accordingly, the following
chapter, Chapter Seven, will detail the multiple meanings of cancer revealed through
these interviews. It examines how post-cancer life is constructed by survivors, and how
much of these constructions reflect the mainstream cancer discourses identified by this
media analysis.

153

Chapter Seven:
The Meanings of Cancer in Puerto Rico: Interview Results
This chapter presents the themes that emerged from the data related to
conceptions about the meaning of cancer. It first addresses this topic broadly,
overviewing participants’ responses about public images of survivors and beliefs about
cancer that operate in Puerto Rican society. The chapter then goes on to discuss the
“survivorship” concept or framework that is being used and promoted by the Puerto
Rican chapters of large, mainstream, US-based cancer advocacy organizations. The
central question in this section is how post-cancer life is constructed in survivors’ minds
and lives. The following section, the longest in this chapter, then looks at the elements
that this study can add to an interpretation of the meanings of cancer in Puerto Rico—
considering such diverse themes as ideas about causation; a perception of cancer as a
catalyst for change; the central roles of helping others and the importance of social
communities of survivors; family and friends; and religion, faith, and spirituality.
CANCER IN THE PUBLIC EYE: INTERVIEW FINDINGS
Interview participants generally believed that negative beliefs about cancer
prevailed in Puerto Rico, such as its equation with a death sentence. However, as will
be detailed below, they also believed that these opinions are slowly shifting.
Beliefs about Cancer
The Negative Connotations of Cancer
One of the most ubiquitous themes to emerge from this research concerned the
negative connotations evoked by cancer. Most commonly, participants—primarily
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survivors and the advocates—explained that cancer is seen in Puerto Rican society as a
death sentence. Soledad1, a 34-year old stay-at-home mother diagnosed at age 30 with
breast cancer, stated that:
“People see cancer…First, cancer is like ‘you are going to die.’ There is like a relationship
between the disease and the stigma that you can die, with all the patients’ suffering and
the treatment. It is one of the first things that people think.”

Eva, a breast cancer survivor diagnosed at age 39, responded similarly:
“They see it like…like death […] Then when they find out that someone has cancer, they
think that the person is going to die.”

Nearly half of the participants (n=11) in the survivor group explained that their first
reaction upon diagnosis was to assume that they were going to die, such as Juanita, a
secretary diagnosed at age 40 with breast cancer:
“The reaction in my case, for example, when they discovered that you have cancer, it’s
like ‘you are going to die, you are going to die,’ this like shock, like…tough news,
because the majority of people think that cancer is death.”

Additionally, some participants spoke about cancer as a punishment or test from God.
The quotes below illustrate this theme from the perspectives of an advocate and
healthcare provider, respectively, who commented on the power of this relationship for
their constituents and patients:
“For us the cancer, the word cancer means death, and more than death it was like a
punishment” (Angela, a 57-year old volunteer with a mainstream organization).
“Here we have a large school of patients that are very fundamental religion. And they
think that the cancer that they got is a test from God, and that they have to accept [it] no
matter what. So that's not rare” (Dr. Corzo, an oncologist at a large San Juan hospital).

Participants frequently referenced other stigmatizing associations with cancer. “Cancer
is the most damaging thing that there is,” as Veronica, a survivor of breast and uterine
cancer at age 36, put it. Amanda, a divorced writer and breast cancer survivor
diagnosed at age 39, opined that general society thought of cancer negatively:

1

Pseudonyms have been used in place of participants’ names to maintain confidentiality.
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“[People think of cancer] as a monster, as a monster. As the worst thing that could
happen to anyone. I respect that, because that’s what they feel when someone they love
is diagnosed. That’s how my ex-husband felt and my children felt, that it was the most
horrible thing that could happen to me.”

Marisol, who survived breast cancer at age 36, spoke of cancer as a permanent mark:
“I think the majority of people think about it like it’s a death penalty, and feel so sorry for
you, and will look at you as you have cancer all your life. Still today, I feel that the people
who knew me in the past look at me and see Marisol who had cancer! It’s like your last
name. They think about you as an ill person […] It’s a mark that you’ll have forever.
Everyone is going to be looking and maybe waiting to see if you get cancer again.”

Still others associated cancer with acute fear and anguish, such as Daniela, a young
survivor of recurrent breast cancer first diagnosed at age 32, and Cristina, a young
mother diagnosed at age 32 with stage III colon cancer:
“When I think of the disease, first obviously I was thinking about death, and fear is a
paralyzing disease. When you get diagnosed with the disease, the fear is so much that
you paralyze yourself.”
“When I think of cancer: fear—maybe, fear of suffering. Maybe you think of death,
usually, yes […] The anguish of thinking that something will happen.”

Maria, a three-time cancer survivor, now 62 years old and working as a professor,
bemoaned the linguistic connotations of the word cancer:
“But you still have the expectations in society, the mores, that ‘drugs are the cancer of the
society’ or something like that. They use it as an attack word. There are very few
illnesses that are used as an attack word. And we have to deal with that. You don’t say,
‘drugs are the pneumonia of society,’ or SIDA [AIDS]. You don’t always have to use the
word cancer as a bad word, but that’s it.”

The consequences of these associations were seen to be far-reaching, impacting the
psychological and physical health of both patients and survivors. Alba, an advocate who
founded her own grassroots organization, spoke about how cancer survivors are forced
to deal with the sword of Damocles, always waiting for the ‘other shoe to drop’:
“We in our culture see a person that got cancer and they look at themselves—I am not
good for anything—and what they have behind them is the sword of Damocles, that I’m
going to die because I have cancer.”

Maria, the professor and survivor quoted above, noted that some choose to accept
death rather than treatment because they do not believe that cancer is survivable:
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“Some people, when they receive the diagnosis, they decide to [let themselves die]. They
decide to take their lives out, because they say ‘you have cancer.’ There are so many
people that are very wrong, thinking about treatment: oh no ‘I don’t want the treatment, I
prefer to die!’ No, no, no. So many people still think of that. Even though there is so much
information, and campaigns of many kinds, sadly I think the issue remains.”

These associations can affect how much survivors can or desire to share about their
diagnoses with others, or to even seek help, such as Juanita, a 47-year old secretary
diagnosed with breast cancer seven years prior:
“When I was young, a woman died of breast cancer. But she was diagnosed and she
locked herself in her world, didn’t tell anyone. I don’t think that she went to any doctor
because soon the cancer spread through her whole body and she died. That is why I say
that when you feel something you have to go run to the doctor.”

Interestingly, when the survivors were asked directly if they themselves had
thought of cancer in these ways prior to their diagnosis, the majority answered that they
had indeed viewed cancer as a death sentence, or as a monster, or as a punishment.
Having gone through the experience of cancer, however, had taught them that these
assumptions are not necessarily true. This became clear in Juanita’s testimony:
“Now it doesn’t shock me because maybe before my diagnosis I found out about a
person with cancer and wow, it impacted me, but now it is like so common that people
have cancer, but also it is known that you can survive. […] But there are people that may
have not had a close experience and maybe continue with that same mentality.”

José, a recently-married, 27-year old lymphoma survivor, expressed a similar sentiment:
“Well, at the beginning of this, the first thing that came to mind was that you are going to
die, [but] I think that now that I’ve been through this, no, that is the last thing that people
should think […] The first thing that comes to someone’s mind is that you think the world
is ending, that you’re going to die and things like that, but I think that no, that’s not true.”

On the contrary, the remaining participants responded that prior to their
diagnosis, they had not held these beliefs themselves—these were the beliefs that they
felt that general Puerto Rican society held. They, in contrast, more often had had
exposure to survivors, or they had learned about cancer in other ways; thus, they did not
give credence to the belief that cancer is an automatic death sentence. For example,
Soledad, a survivor of breast cancer diagnosed at age 34, stated:
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“In reality, no [I didn’t think that cancer meant death], because I had the experience of my
mother [who survived breast cancer]. And even in some way I knew that this could
happen, that I could go through it, that it was going to be difficult but it was not that I was
going to die. I was always afraid but I was calm because I knew that you could [survive].”

This tendency of viewing cancer in before/after terms speaks to another theme
emerging from the data. While many participants referenced the lack of knowledge that
the general public has about cancer, they generally believed that the stigma surrounding
cancer was decreasing, being replaced by greater awareness. Whether or not this
opinion is explained by their own realizations following cancer treatment, or because the
level of awareness in the society is in fact increasing, is impossible to tell from the
interviews; regardless, participants such as 46-year old Marisol, diagnosed ten years
prior with breast cancer, generally believed it was part of a larger social trend:
“I think that people think of cancer as a death penalty. You have cancer; you’re doing to
die. [It’s been] 10 years since I got it; I think that maybe today is not like that time. Maybe
now, there is a little bit more knowledge that cancer does not mean necessarily that
you’re doing to die. But at that time, yes, it meant that you were going to die.”

This awareness was seen to spring from two sources: first, there was a belief that there
are more people being diagnosed with cancer now—that “everyone knows someone”
with cancer—and thus, that more people are surviving. This greater visibility of survivors
has led to a questioning of the construction of cancer as a death sentence, evident in
Helena’s quote, a married housewife diagnosed at age 45 with breast cancer:
“I think that by now, after almost nine years [since my diagnosis], it is seen a little
differently; there is still a little bit of worry but with so many people surviving the people
are seeing it a little more calmly. That is my perception. Before there was more fear but
now, there is a little fear but people see so many others surviving that when they see
those marches with so many people surviving, it is going to take care of their health also.
I think that there isn’t as much concern as before, for me, in the people. Now the people
trust more that there are advances […] They have created consciousness.”

Magdalena, diagnosed at age 45 with breast cancer, responded similarly:
“I think that people have changed significantly in thinking badly about cancer because
they have seen enough people that have survived it. I don’t see the fear that existed
before. Before, the word cancer killed whoever, a dirty word. Now it is more in the open,
[and] they have less fear. I see it because when someone is diagnosed people remain
calm, more or less. People now do know what to do, because they see my example, that
‘look, she is here,’ that you get cancer and you can survive it. I think that the population
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still has a little fear because no one wants to get sick with it, but they are more positive in
facing the disease […] They are so familiar with the word; almost everyone has a relative
who had cancer.”

Secondly, this increased awareness was attributed to the work of the cancer advocacy
organizations operating on the island, an influence that will be discussed in greater detail
throughout the rest of the results. Still, participants bemoaned the lack of education
about cancer, and the still-pervasive lack of knowledge in the general public, as
articulated by Elena, a 33-year, two-time survivor of breast and thyroid cancer:
“Currently, there is more knowledge from the television programs, the education of the
different companies, all those things. But there are always some awful myths. For
example, when I had just arrived at the hospital, my second son, who has always been
really caring […] says: ‘is it true that you are going to die?’ Me: ‘why are you saying that?’
‘Because you have cancer.’ And then my reaction—forget it! I said to him: ‘look, they
already took the cancer out of me, do you see this wound that I have here? This was
what they took. And if you get a cold and you don’t take your medication also, you are
going to die.’ And then the boy started to cry and he hugged me. It was a really
impressive moment in my life! […] There is still a lot of ignorance.”

Other Perceptions of Cancer
Other beliefs about cancer were voiced throughout the interviews that were less
negatively value-laden than the common identification of cancer with a death sentence.
For example, several participations raised the idea that cancer is a “chronic disease”
instead, paralleling what also seems to be a change in the mainstream view of cancer in
the US as less an acute disease than a chronic one: for example, Angela, an advocate
working for a mainstream organization, noted that “now cancer is a chronic disease, it’s
not terminal.” Likewise, Lucia, another advocate, noted “the cancer patient is a
chronically ill person that needs daily or weekly medical support.” A few participants
drew an interesting distinction between the North American view of cancer and the
Puerto Rican view of cancer, in that the whole family becomes involved in the process.
For example, cancer was seen as a ‘family disease’ or a ‘family problem’, as in the
comment below by Sra. Benitez, leader of a local support group:
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“Co-survivors are anyone in the family that is part of a family that has cancer. A daughter,
a husband, that’s what we call co-survivors. We work with co-survivors. Because
2
remember it’s not only you; cancer affects everyone in your family.”

Public Images of Survivors
Survivors often spoke about the increasing prominence of cancer in the public
eye—on TV, on the radio, and other media outlets. With rare exception, this increasing
exposure had positive effects by presenting “success stories” to the public, and it served
to raise awareness that cancer is not a death sentence. Julia, a breast cancer survivor
and advocate working for a large mainstream organization, spoke about using this as a
specific strategy to de-stigmatize cancer and to let others know that there is support:
“When I was diagnosed, I always said that I would have liked to see commercials, or ads
or something, of people who had 10, 15, 20 years of survivorship. That gives you hope
that you’re not going to die from the disease if you take care and follow the guidelines. I
think it will help people get diagnosed because it will take away that terror of dying from
the disease and take a more active role. […] I don’t know if it was tied to either shame or
pity and some people don’t want to feel the pity, but I think we [as an organization] have
done a good job in showing happy faces of survivors. It’s good that you can talk about it,
and it’s good that you were diagnosed early, and can be here with your children.”

However, some participants questioned the image that was being put forth in the media.
This is captured in a comment by Daniela, a 32-year old survivor of recurrent breast
cancer, about a recent commercial that she had just seen:
“I don’t remember if it was American or if it was local, but there was a commercial of a
woman in a party in a club, and she would go to the bathroom and she would take off her
wig, and it would say something about cancer survivor. And I was like, ‘I couldn’t go
party! How can she go party? This is not real!’ You know?”

Celebrities were often mentioned and linked to participants’ own experiences, including
Adamaris Lopez, a well-known Puerto Rican actress who was diagnosed and treated for
breast cancer in 2005, and froze embryos with her then-husband. When asked, “when
did they tell you that you wouldn’t be able to have children?” 34-year old Camila, a
healthcare worker and survivor of breast cancer in her early 20s, commented that:
2

See the section later in this chapter, Family, Friends and Partners, for a detailed discussion.
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“I don’t know exactly when I found out, but I’m sure it was probably a year after I had
taken the chemotherapy. And that’s why I was really mad, because you see all the
celebrities that come on the TV, and they immediately go and freeze your eggs, but I
didn’t have that chance, and they never gave me that chance.”

Indeed, the survivor Daniela, quoted above, noted that cancer—particularly breast
cancer—was now a “high-fashion disease,” having caught the attention of companies
and donors who determined that they are worthy causes. As she notes, this new
attention can be dubious:
“Cancer is really fashion right now, or more breast cancer. It has become a fashion
disease. And the funny part, for example, let’s say KFC. KFC painted all the KFCs in
pink, and if you had the bucket, they would give to the cancer association $1 out of that
bucket. But it’s like, your f---g chicken gives cancer! It helps to give cancer! Could this be
more contradictory? […] Now in every bag of groceries that you’re buying and in the gas
station…It’s a disease that, because it has hope, it’s become more publicized. Because,
for example, Alzheimer’s doesn’t get this publicized. It doesn’t have hope […] [Cancer] is
the Prada of all the diseases (laughs). And mostly breast cancer.”

SURVIVORSHIP: FRAMING THE CANCER EXPERIENCE
One way of beginning to understand what it means to have had cancer in Puerto
Rico is to look at the influence of the survivorship concept on the island. As will be
detailed below, the terms “survivor” and “survivorship” are widely used on the island by
individuals, providers, and advocates, although the participants interpreted the terms in a
variety of ways. Resistance to the concept because of its perceived inadequacy served
to illuminate even more about the meanings of post-cancer life in Puerto Rico.
Survivorship and Survivor Identity
At the time of the research, several mainstream North American NGOs were
operating chapters on the island—for example, the American Cancer Society and Susan
G. Komen for the Cure, both prominent and influential cancer advocacy organizations in
the US that utilize the survivorship concept as a way of framing life post-cancer. As
elaborated in Chapter One, survivorship is a “framework used by many healthcare
professionals, researchers, and cancer survivors to understand not only the physical but
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also the social, psychological, and spiritual/existential impact of cancer on one’s life and
for the remainder of one’s life” (Zebrack 2000:239). The term “survivor” has been
directly translated by these organizations from English to Spanish as “sobreviviente,”
which is derived from the verb sobrevivir, or “to survive.” “Survivorship” is translated
directly to “sobrevivencia.”
It became immediately obvious at the beginning of the research that the terms
sobreviviente and sobrevivencia were problematic; participants displayed a range of
reactions to them. However, while the particularities of the actual words’ meanings and
application to participants’ own lives varied, there were several consistent themes that
emerged. The majority of survivors (n=16) had adopted the term survivor for
themselves, and self-identified with it with varying levels of dedication; the rest either
explicitly rejected the term (n=5) or were not sure of their stance (n=1). There was
inconsistency regarding the specific time period in which the participant started
vocalizing this identity: it ranged from immediately after diagnosis, to several years later
after subsequent tests had come back clear. In response to a question about when the
participants started to think of themselves as survivors, Cristina, a colon cancer survivor
diagnosed at age 32, stated:
“I think that since the first day that they told me that I had cancer, [I considered myself a
survivor]. I didn’t know what was going to happen, but inside I knew that no, that this was
not going to kill me.”

Veronica—diagnosed at age 36 with breast and uterine cancer, responded similarly:
“[I felt like a survivor] immediately after the operation. As soon as they operated on me, I
said ‘wow’ […] I said wow, I survived, I could have gotten worse.”

It was evident that for other participants, “being cured” of cancer, or having scans and
tests that came out clean, was a necessary prerequisite for identifying as a survivor. For
example, when asked when they began to consider themselves survivors, both
Soledad—diagnosed at age 30 with breast cancer, and Juanita—diagnosed at age 40
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with breast and thyroid cancer, referenced the connection between survivorship and
successful treatment:
“[I’ve called myself a survivor] personally since I finished my last chemo. I said: ‘okay, it
didn’t kill me, neither the cancer nor the chemo.’ Because when you confront [the first
chemo] then you are afraid of: ‘what will happen [with the second]? We survived one, let’s
go to the next.’ […] There are people that consider themselves survivors since diagnosis
but I personally considered myself a survivor when I finished my last chemo, and I said,
‘okay, this already happened, now I cannot say that I have cancer’ because they already
told me in the last labs that there is no evidence of cancer, and when the doctor told me
that there isn’t evidence of cancer, ‘you are cured,’ then I considered myself a survivor.”
“I would say that from the point of – more or less – once I started the treatment and as
time passed you do the checks and everything is fine. For example, I did it the tests two
weeks ago and everything is fine, everything is perfect, everything is normal.”

The Meanings of Sobreviviente/Sobrevivencia in Puerto Rico
For those with a self-identity as a sobreviviente, the meanings of this term varied,
but one theme did become dominant: that of literally being alive, and of not having died
from the cancer or its treatment. Many participants explicitly tied the identity of survivor
to its literal interpretation—that of living in a physical sense, or not having succumbed to
the disease, as in the following two quotes:
“If one has already gone through the process and now one is [finishing], who has not
come out badly, who has not had a recurrence or anything, then you are already a
survivor because you are alive and you survived that process […] [A survivor is] a person
that has had cancer, they have diagnosed him or her with it, they have taken it out, he or
she has gotten their treatment and has not had recurrences in the cancer” (Andrea,
diagnosed two years prior at age 26 with Stage I angiosarcoma).
“[I consider myself a survivor because I am here. Look at me. I survived the cancer.
There are people that unfortunately do not have the same luck. I saw friends of mine [die]
much younger than me” (Magdalena, diagnosed seven years prior at age 45 with Stage II
breast cancer).

Others layered additional meanings on this interpretation. For some, survivorship meant
that they could continue with their daily lives: Juanita, diagnosed at 40 with breast and
thyroid cancers, noted that a cancer survivor “continues with his daily life, his routine,
works, does thing around the house—he is a survivor.” Pedro, diagnosed at 35 with
lymphoma, noted that cancer survivorship “is something normal. I have continued in my
normal life.” For others, sobreviviente referenced a struggle, a battle that they had to
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face head on, and perseverance, as in the case of Veronica, diagnosed 24 years prior
with breast cancer at age 36:
“The term cancer survivor for me, it has the meaning of a struggle, a battle. To accept it,
to confront it, and to fight it. That is a survivor of cancer. And do not give up.”

The survivor identity also signified membership in a community of fellow survivors, and
the bonding that occurred through shared experiences, understanding and pride at
having lived through a grueling event. This is evident in Pedro’s comment, after he was
diagnosed at age 35 with lymphoma:
“Here at [my workplace] we participated in the program Relay for Life. Although I worked
there [before I was diagnosed], I never participated in the Relays for Life that they had.
[Now] I have to go as a survivor, to put on the t-shirt that‘s different than what everyone
else has. That first moment that I walked in, when we made the first round as a survivor,
it made an impact. ‘Wow, I am a survivor’; I am walking with all these people, I come here
to help, to support all these people and now I am one of that group. [It was] shocking.”

Soledad, a breast cancer survivor diagnosed at age 30 who is now active in the breast
cancer community, responded similarly:
“I am a survivor because I went through it; I graduated with honors, and we are already
on the other side helping other people, telling other people that yes, they can. Yes, of
course—I am a survivor.”

“Surviving is Not the Same as Living”: Alternative Terminology and Meanings
On the other hand, the explicit rejection of the concept of sobreviviente, and the
reasons given for this rejection, often served to be most interesting and illuminating for
describing the ways in which participants negotiated life with and after cancer. Several
participants noted the inadequacy of the term sobreviviente or its English equivalent.
Three women noted that cancer was just “like a cold” or “like a flu,” speaking to the idea
that cancer was just a bump in the road to get over and move past. Two others did not
like the term because they thought that it kept reminding people of their experience with
the disease. Daniela, age 33, diagnosed two years prior to the interview with Stage III
breast cancer that recurred several months after finishing treatment, stated:
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“There are people for whom it is very significant for them to say it. Like saying that word
makes them feel that they conquered the disease. For me, I don't like the term. I think it
excludes you. The point about living cancer is that you could return to normal life. That
you would be normal. For me, always saying ‘I’m a cancer survivor; I’m a cancer
survivor,’ is just reminding myself that I had it. I prefer to say I had, and that’s it.”

Amanda, age 48, diagnosed nine years ago with breast cancer, likened the use of the
term survivor to “recycling” the illness:
“Cancer didn’t determine the life that I have now; it just helped me to watch and to
reconsider how I was living. I don’t even go to the big activities of cancer survivors. No,
no, no, I don’t like that. Because I don’t need self-pity […] What I see is that in some way,
you just recycle the sickness, the illness. You just recycle. If you go to those activities,
you recycle. I am not a cancer survivor—I HAD cancer. So cancer doesn’t define me.”

A vocal contingent of the survivor participants maintained that they do not like the term
sobreviviente, and do not apply it to their lives. They challenged what they saw as the
dominant connotation of the word sobreviviente—that it referenced mere survival, rather
than a state of being more akin to thriving. At first, it seemed as if this critique
referenced the literal meaning of the translated term—which is partially the case.
However, these respondents were also critiquing what appears to be the general
understanding of the post-cancer state in society, which is a social critique in addition to
a linguistic critique. For example, 47-year old Inez, diagnosed with breast cancer nine
years prior, explained her dislike of the term sobreviviente:
“Because it seems as if you were leaving a hole, struggling. We hate it. We do not like
that they call us survivor, at least my group. We say ‘viviente’ or we say fighter, and we
don’t like fighter either. It is because [it means that] you are still there in that struggle. [We
use ‘viviente’] because we do not like that we are surviving, we do not want to survive.
We want to live. We do not want to survive.”

Amanda, quoted above, related ‘survivor’ with victimhood:
“When I think about survivor, there’s a little bit of the victim there, and I resigned the
victim mark, the victim name. I just overcame.”

These participants preferred the term viviente. Viviente, in contrast, speaks to the ability
to thrive, and the participants’ desire to squeeze every last drop out of life, taking
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advantage of opportunities, and valuing life and loved ones more than before.
Francisco, a student diagnosed at age 23, with oral cancer, spoke about this:
“I conclude that the term ‘cancer survivor’ really isn’t the most appropriate but it is the
only one that exists, and I will explain. Surviving is not the same as living; surviving
implies that one goes beyond the situation but not fully. To live, when we talk about living,
the joy of being human beings is living fully. To survive does not imply an abundance, it
implies a limitation, because if you say to a person ‘you are a survivor’—survivor of what?
Now automatically you are reaching the conclusion that there is a limitation. They tell you
that you live and you say, ‘yes, I live, I live well, I am alive, I don’t have a disease, I am in
good health.’ You say to an old person, ‘do you live?’ and they say, ‘I am here surviving
because the diabetes is killing me, this is killing me.’ Now that implies a limitation. Cancer
isn’t an absolute limitation; it is a wall, but like all walls it can be knocked down. [I do not
consider myself a survivor]. I consider myself a ‘viviente in abundance’. Because cancer
is like whatever other type of disease, like whatever type of emotional problem that is
overcome; therefore, it is not an absolute limitation—it’s a situation, it’s not a problem.”

Camila, diagnosed at age 22 with breast cancer shortly after her first baby was born,
referenced similar ideas to Francisco’s:
“[The word] ‘sobreviviente’ actually gets me kinda angry because I’m not surviving, I am
living. If you’re living, you say ‘I’m living; soy viva.’ You use the same term ‘sobreviviente’;
you just add the front part. To me, surviving is that you’re just dragging your life, you’re
just dragging it, and you’re just surviving it because there’s no option. But when you live,
you say ‘yo soy una viviente de cancer.’ I’m not a survivor—I say ‘viviente’ because I live
every day. I get up, I have my children with me, I have work, I have my family, I have a
house, I have a home, and I live every day. I don’t survive. Because when you’re on a
survival mode, you’re trying to make it. And I don’t try to make it, I already am. I’m just
making things work for me. So I get a little bit angry hearing someone say, ‘Oh, you’re a
cancer survivor!’ In English, it sounds better. It doesn’t make me as upset as when I say it
in Spanish […] I don’t survive. I am living life. I don’t drag my life with me. I enjoy it.”

The Role of Organizations
It is important to note here the critical role of organizations in fostering the use of
these terms. On the one hand, mainstream North American organizations utilize the
directly translated terms, sobreviviente/sobrevivencia, and the advocates who worked for
these organizations used the same definitions. Those definitions generally had to do
with the time period at which one should start identifying as a survivor—without
exception, from Day One. This was a point on which the organizations tried to build
awareness, that everyone diagnosed with cancer was a survivor, regardless of stage,
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treatment type, or life expectancy. This is exemplified in comments by two advocates,
Angela and Esteban, who both work in mainstream organizations:
“[This organization] defines survivor as every person that has a diagnosis of cancer from
day one. You are a survivor starting the first day you got the diagnosis. So, somebody
told you, you got cancer, you are a survivor already. In Puerto Rico, yes, they refer to
themselves as survivors, and our organization has had much to do with this. The
education that [we] offer has taught people about the concept of survivor. Before that,
people talked about patients. Now they talk about survivorship. And now they understand
how ‘survivorship’ is different than ‘patient’. The patient is there in the moment; there isn’t
anything else. A survivor has already passed through a process, has already learned,
has already won, have fought, you win, and now you go forward.”
“We’re trying to make sure that people understand that, even while you’re battling with
cancer, you are a survivor. Because when we started talking about cancer survivors, the
idea was that after 5 years, which is the well-known time that a doctor says that you can
be sure that you’re cancer-free, then you become a cancer survivor. And now we are
battling to make sure that people understand that 2 days after you’ve been told that you
have cancer, then you become a survivor. Because you are there, and you are fighting.”

It was possible to see how these organizations shaped participants’ views on the issue.
Alejandra, a 46-year old accountant diagnosed 15 years prior with breast cancer, noted
that she used to see cancer as “like a cold” until she gradually came to realize that it was
a test, and that she was a fighter—and thus, a survivor. Her realization came directly
from her volunteer work at the ACS and her exposure to their definition of survivorship.
“[I began to consider myself a survivor when I started to participate in the workshops and
get wrapped up in and involved more in the American Cancer Society. Several years had
already passed since my diagnosis—I would say maybe four or five years. I had not
internalized in its totality that every patient is a cancer survivor. I was like, ‘what I [went]
through was a cold and that’s it.’ In my mind, it was a cold all the time, where there was a
treatment to follow and some things that were damaged and I had to eliminate it.”

Sra. Benitez, a healthcare provider and support group leader, pointed out her members’
tendency to be very public about their survivorship identity:
“Oh yes [they identify themselves as survivors]. They are very happy with that, and
wherever they go, they have their pink stuff, their pink ribbons […] Wherever we go, we
have our identification, and they are very, very proud. Some of them believe what they
have read, that survivorship means 5 years after they’ve finished. So one day they went
up to the doctor and said, ‘hey doctor, when are we considered survivors?’ And he said,
‘since the first time you came here.’ So for them, at least for my group, they are survivors
the first time they come into the office, because they begin to survive whatever they have
to survive up till now.”
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The leaders of local organizations held varying definitions of survivorship. For example,
Concha, a 65-year old leader of a fundraising organization who had been treated herself
for breast cancer, noted that:
“Survivor for me is a person that has gone through cancer, have gotten all the treatments,
and has achieved being in remission, without any cancer in their body for many years.”

All of the participants who used the terms vivencia and viviente were members or past
affiliates of one grassroots organization that offered self-improvement courses free-ofcost to local cancer survivors. Alba, the 60-year old leader of the group, noted that she
had coined the term viviente herself as an alternative to the term survivor, which at that
time was being slowly popularized by the mainstream groups, in reaction to what she
saw was lacking in the term’s meaning:
“In Puerto Rico, they call everyone who did not die of cancer ‘cancer survivors.’ But when
you break it apart, yes, it is a cancer survivor—hooray, hooray—they survived. And the
rest? Because they did a blood test are they a cancer survivor? And the quality-of-life of
that patient, where is that? I don’t believe in the word survivor, I believe in the word
‘viviente’ and in my workshops I tell the ladies that ‘you are not survivors, you have been
vivientes since you were born; therefore, cancer is a stage of life that you chose to live;
something caused it, the cell is damaged because something in your body wasn’t
functioning, either by nutrition, or the twenty reasons that you might have. But you are not
a survivor, you are still a living being, capable and ready to have a life of excellence and
to create extraordinary results in your life.’ Those are the workshops that we give them.”

As in the earlier quote from the ACS volunteer, it is important to note the organizations’
role in shaping its members’ views about appropriate terminology. The majority of
viviente-adherents referenced the influence of the above workshops in changing their
thinking on the topic, and allowing them to realize the limitations of sobreviviente:
“[I started to use the term ‘viviente’] after I took the workshops. It was there I understood
it. I said, ‘wow, it is true.’ They explained it and I assimilated it. And I said, ‘wow it is true. I
am not going to be surviving.’ Survivor is…I visualize myself on a mountain and they let
you go there and you have to survive. So, no, I am living now. And learning to live all the
days of my life” (Inez, age 47, diagnosed nine years ago with breast cancer).
“One of the most important things that I was allowed to do were [these workshops. They]
helped just to change and to redesign my thoughts and my decisions and my way of life.
Resigning the victim platform that for some time just worked, but I was unaware. And that
is what we learn; that we have to cry to get food, so that is the program that I was living
just before cancer” (Amanda, age 48, diagnosed nine years ago with breast cancer).
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INCORPORATION OF ADDITIONAL CONCEPTS
The use of the survivorship framework in Puerto Rico is complex, and clearly
does not include the full range of meanings that are evident in these interviews. Thus,
the following section details the additional, local meanings of post-cancer life that are not
captured by the mainstream survivorship concept, in an attempt to construct a cultural
model of life after cancer in Puerto Rico. It will touch upon such diverse topics as beliefs
about causation, the impact of cancer in one’s personal and social lives, the role of
family, friends, and partners, and the critical importance of faith and spirituality.
Causation
Participants’ beliefs about the cause or fundamental reason behind the
development of their cancer fell along a spectrum ranging from externally-located to
internally-located sources. A group of responses incorporated elements of both—for
example, while there may have been an “external source,” a cancer’s development also
depended upon the participants’ personal interaction with or reaction to that source.
External Sources
First, several participants believed that prior exposure to carcinogenic
substances was the determining factor in their cancer, such as chemicals in food,
pollution, or other environmental factors. Eva, a 44-year old teacher, diagnosed at age
39 with breast cancer, stated:
“Sometimes I think that something in the environment or the food [caused my cancer]. I
read about the bras that have underwire, and I always used to use the ones with
underwire. Always.”

Marisol, a 46-year old non-profit worker, diagnosed at 36 with breast cancer, opined:
“I think that everyone is a cancer survivor, [even if] you don’t have it. Seriously, think
about everything that we are exposed to, everything that can cause cancer, that you eat,
that you drink, that you are around, the electromagnetic fields, or the chlorine of the
water, everything! We are all so exposed to things that can cause cancer that I think that
everyone is a cancer survivor who is still alive!”
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One woman had been in New York City during the 9/11 attack on the World Trade
Center, and referenced rescue workers’ continuing health problems as an indication that
a similar exposure may have been involved in her cancer. Daniela had lived for some
time in Vieques, the small Puerto Rican island that was the site of decades-long bomb
testing by the US Navy and has recently been in the news for its high cancer rate:
“I lived for a year in Vieques, and it was the practice bombsite for the Marines, and I lived
over there. Sometimes I question myself if that had to do with the cancer, because I used
to eat the food and drink the water over there. There is a really high incidence. I work with
the patients over there […] So sometimes I’m like, damn, you know—I’ve been exposed!
Can it be that? I don’t know! Because I don’t have history of cancer in my family.”

Internal Sources
More interesting from an anthropological standpoint was the large role that many
participants ascribed to internal sources of cancer. The idea that internal emotional
states, thoughts or trauma influenced the incidence and course of cancer in the
individual’s life was prominent. Magdalena, diagnosed with breast cancer at age 45,
linked depression to her own cancer and to those of several family members:
“When my father-in-law died, they gave a book to my ex-husband which said that the
majority of cancers come when a person has a really severe depression. My father-in-law
had a very deep depression and then two or three months later he had cancer, and then
my [own] father. Then, I was the same, curiously, because I had just lost a nephew who
was killed—he was mugged and killed in November, and I was diagnosed in May.”

Amanda, a 48-year old writer, tied her breast cancer to lifelong low self-esteem:
“I invested time thinking about this, and I can define cancer as a response from the body
to all the things that we do to the body. So when my thoughts were ‘you don’t deserve,
you cannot do that, you are not capable,’ the cells just responded to that command. It’s
like an order. And the cancer is the response to the order of our thoughts.”

She went on to note:
“I recognize that in some way—deep, deep, very deep—I wanted to die, for so long in my
life, that my cells just obeyed me. That was the input I was giving my body, because my
self-esteem was so, so, so, so low, that I now recognize that I just wanted to die.”

Stress in particular was discussed as a master factor, a “detonator” that highly increased
one’s risk of cancer. Often, participants could pinpoint single stressful incidents or
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episodes that occurred immediately before their diagnosis, which they believed had
directly contributed to their cancer’s development. This is reflected in comments made
by Sofia, a 42-year old survivor of recurrent breast cancer:
“Sometimes people think that food and the environment [causes cancer], but I think that
the trigger point is stress, or at least the sensation of helplessness in resolving a
particular situation. I think that is significant. Not every person handles stress the same
way. Maybe the same thing happens to you and you are the same. But there are people
that drown in a glass of water, or see themselves without a solution. The sensation of
seeing something without an exit […] When I was diagnosed the second time, for that
reason I became determined to leave my husband.”

As implied by this quote, participants were often not the sole creator of stress in their
lives; many of these causation stories centered on loved ones who had introduced the
stress. For example, several participants mentioned the potential role of marital abuse,
or even a poor marital relationship, in creating illness. This is exemplified in comments
by Alejandra and Inez, divorced breast cancer survivors diagnosed in their 30s who
identified marital discord as a potent stressor related to their cancers’ development:
“I think that stress was the detonator. You think that marriage is always great, but there
were moments…[The stress of living together with my husband] could have caused [the
cancer]. And not only him, because in my case, there had been abuse in my childhood.
My parents’ divorce, physical abuse and verbal. Next I marry thinking that it was going to
all get better and I fall into the same thing, although not as often but…14 years of
marriage and there were some 7 incidents and each time it was increasing.”
“I was going through a divorce situation of some infidelities. I think that my cells burned in
that area. Later, as times passed, I took workshops, I went to support groups, I heard
many things about research; there are relationships of when you go through a very, very
strong suffering and your cells are burned, they are damaged in some area of your body.”

Alba, a 60-year old support group leader, hinted that the members with the worst
prognoses were women who had been abused by their husbands:
“I have two that are really bad and both, when we do the [patient history] profile, they fit
the profile. They are women subjected to constant abuse by their husbands; they do the
workshops but they return to the abuse after the workshop is over.”

Priscilla, an advocate, felt that families should avoid voicing negative thoughts in front of
the patient, as that can detrimentally impact the course of their illness:
“The cancer patient […] needs support from her family; the family will need to be strong
and happy, so if she has that everything is going to be fine for her.”
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In these stories, the effect of stress, depressive emotions and negative thoughts on
cancer appeared to be mediated through the immune system; for example, sadness and
depression suppressed the immune system, which then increased one’s vulnerability to
cancer overall, as articulated by Camila, a 34-year old who was diagnosed with breast
cancer shortly after giving birth to her first child:
“I don’t know if I was developing it as a teenager, because I was only 22 at the time, but I
know now that if you hold back emotions or hold grudges or have different traumas in
your life, they start building up as cancer cells, so that’s another theory that people say.
For me, I’m sure it wasn't there before I gave birth to my son. I didn’t feel it […] I was
severely depressed when I gave birth to my son—when you’re depressed, your immune
system shuts down. So everything bad starts growing in your body. You start getting sick
really often. My theory is that my cancer grew quicker because I was severely depressed,
and my immune system wasn’t responding properly.”

A principal component of these arguments—and one with great implications for patient
support and educational programs—is the need that several participants expressed for
“owning” the cancer diagnosis and taking full responsibility for its occurrence. In what
may seem like a paradox, these survivors argued that the acceptance of responsibility
for their cancer allowed them to let go of their anger and bitterness, and to move forward
positively with their lives. Amanda, quoted above, spoke about how she felt after coming
to this realization:
“[I felt] responsible, responsible. Responsible, and committed to living in integrity with
myself. That’s a very strong foundation to work through. So everything that happens to
me, I have about a 90% of responsibility. So I’d rather go for me or quit.”

Interactions and Overlapping Causes
Often participants offered explanations that drew upon both external factors and
internal responses. For example, several survivors spoke about poor nutrition and food
choices as contributing to cancer, which references both the lack of availability of
healthy, affordable food options on the island as well as their own difficulty giving up
their ‘unhealthy’ diets. Cristina, an accountant and colon cancer survivor in her mid-30s,
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identified the fast pace of life in Puerto Rico as a contributing cause, again speaking to
both a structural reality (the fast pace of life) and the respondent’s own participation in it:
“Here in Puerto Rico there is a really big problem because people are eating non-stop;
right now, I am going to eat because I am hungry, but there are people that are eating
every day, breakfast, lunch, dinner, I mean the pace of life that we live is very fast, and
this is really harmful. […] Eating out, and the speed of our lives, I know that this is why
the incidence of cancer is so high here. Besides, in this environment, we don’t know what
they are giving to us [in our food], because we don’t see it.”

Quite frequently, participants raised the role of family history and genetic traits in their
cancers before negating this explanation. Even if one did not necessarily believe that
this had a particular impact upon their own disease, it was noteworthy that the topic was
raised even as it was simultaneously dismissed—indicating the visibility and significance
of this explanatory model in both medical and popular knowledge.
“In my family, there isn’t a breast cancer history. I couldn’t say if it’s something genetic,
but I don’t think so because I don’t have family with a breast cancer diagnosis. Perhaps it
is…hmm, some cause apart from that, but really I cannot say” (Juanita, diagnosed at age
40 with breast and thyroid cancers).

Only three out of 23 survivors argued that a genetic predisposition played a role in the
development of their disease, such as Francisco, diagnosed at age 23 with oral cancer:
“There is the genetic predisposition and I think that the majority of my doctors concur,
since they did some labs in order to detect whatever HPV, whatever disease, whatever
virus [it might be], and everything came out negative. I only chewed tobacco for maybe 2
months, no cigarettes; therefore, the chewing tobacco isn’t significant in the cancer.
Alcohol was social, really sporadic; I didn’t use much alcohol, I [still] don’t; therefore, that
wasn’t a significant cause either. Those are the most logical [reasons] that I know of and
all the doctors think that it was the genetic predisposition, since my grandfather died of
stomach cancer, my aunt died of breast cancer, and I have other family members that
also suffered from cancer, so everyone thinks that it could have been genetic.”

Related to this idea about ‘transmission’ of cancer were several participants’ comments
regarding their fear of passing cancer onto their offspring, or even in one case through
blood transfusions:
“I believe that my family is destined for this and, yes, that makes me afraid. In this case
having children and thinking that they might have the same thing, or suffer the same luck
that I had of having had the same cancer as my mother, then yes, that makes me afraid”
(Soledad, age 34, diagnosed four years prior with breast cancer).
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“Right now I cannot give blood. Although the tests came out that I am really, really, really
well and I am really positive, and my doctor is still positive, I have not wanted to donate
blood thinking that [cells] can remain or [that it can activate them]…I would not have
dared to have another child thinking that I can transmit the cancer to my child” (Eva, age
44, diagnosed five years prior with breast cancer).

Finally, six participants expressed confusion regarding the cause of their disease when
queried, frequently raising various possibilities before admitting that they “don’t know.”
This type of response is exemplified by Elena, a survivor of breast and thyroid cancers:
“I don’t know because there are so many factors and things that they say it can be a hard
time, the air, the food, or whatever, that in reality, I don’t know.”

Cancer as a Catalyst for Change
Overwhelmingly, the impact of cancer on the participants’ lives was viewed
positively; in the majority of accounts, cancer was credited with multiple benefits. At the
very least, the personal change wrought from participants’ experience with cancer was
seen as something good in the midst of evil. Thus, cancer was perceived within an
overarching framework of “conflicting emotions,” as articulated by Maria, a three-time
survivor: that is, it brings both good changes as well as difficult situations and pain.
Change in Perspective
Participants often viewed their experience with cancer as changing their “outlook
on life.” They learned to appreciate life more, to value “the little things,” to realize what
the important things in the life really are, and to “discover who one truly is”—the nature
of life itself. Cancer was seen in some sense to open them up to this secret, and allow
them to be able to better recognize and appreciate the truly important matters. Camila,
a 34-year old breast cancer survivor, noted that cancer had been a blessing:
“I’ve met some spectacular women in my life because of breast cancer, so to me it’s kind
of like a blessing. And people say, ‘what, are you freaking crazy?’ But breast cancer to
me has been a blessing. After 12 years I can say that it’s a blessing; I didn’t say that
before. It took about 6 years before I could actually see why it was a blessing. And it’s
made me love the little details in life that we take for granted every day, a flower popping
up, a little crab walking on the beach. Any little details that people go ‘aw, yeah,
whatever,’ I see it as a blessing. Every time I see a rainbow, it’s amazing to me. Every
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time I see a butterfly, it’s amazing, because I have a chance to see it […] It’s made me
become a better person and love life more.”

Luisa, a 22-year survivor of adolescent cancer, concurred:
“I seize the moment, take advantage of everything, because my life happens once and it
is to live and enjoy. For me, I live, I enjoy, I have friendships, I tell everyone that I love
you, it doesn’t matter—‘Look, I love you, I love you, you are not alone.’ For me that is
living. I live but I live intensely, I don’t lose time.”

Current Priorities
Indeed, when queried about the three most important things in their life at the
time the interview was conducted, participants’ priorities rested very clearly with a short
list: family and children, their spouse or partner, God, helping others, their own health,
and friends. Interestingly, only one participant answered that she was now one of the
most important things in her life.
“[The three most important things in my life right now are] my relationship with God, my
wife, and my son, in that same order” (Francisco, 28 years old, oral cancer survivor).
“My son, my faith in God, and the support that my family has given me” (Rosa, 44 years
old, breast cancer survivor).

Impact on Relationships
A prominent theme was cancer’s impact on clarifying relationships. Many
participants had experienced improved relationships, or they were now better able to
recognize people that brought positive qualities and experiences into their lives and to
verbalize their love and appreciation. Conversely, they were also better able to identify
those who brought negativity, and to be able to let those relationships go. Magdalena, a
52-year old analyst and 7-year breast cancer survivor, stated:
“It helps you in the sense of vision in life. Why? Because knowing that this is not
permanent helps to have better relationships with your children, with people, with you,
with your co-workers. My relationship with my co-workers has changed 200%. Because I
always had problems, as it is a site of a lot of stress, and now, nothing. I love all my coworkers. But I was the one who changed, obviously.”

Daniela, an artist and 33-year old recurrent breast cancer survivor, had a similar outlook:
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“Everything, everything [has changed since cancer]. It puts your life and priorities in some
perspective. I think the more that I have changed is that I don't have time now to lose life
with people, with situations, with money. It’s not that I have become somebody that uses
people either; it’s not that, but if you’re not going to bring something positive for me than
you are discarded from my life. Get the f-- out of the way! Time is ticking! (slaps her
hands). I am not going to lose time with you.”

Thus, cancer seemed to bring a clarity or distillation of what and, more significantly, who
was most important in survivors’ lives—most often children and extended families. On
one hand, many survivors described the deep love they felt from close friends and
family, and how well-supported they were. Respondents stated that they were able to
better recognize how much they valued these relationships and to pay the attention to
them that they deserved, such as Soledad, a married mother of two:
“I have had the opportunity to see my children and to value my family, and value many
things, and see them from another point of view. That was the most important thing in
that moment.”

On the other hand, some participants noted that cancer (or any major illness) effectively
weeds out those who do not really love or care about you, and only the true friends
remain. Daniela, quoted above, articulates this sentiment:
“At the beginning, I had a friend that is not my friend anymore, because this is something
very characteristic of the disease: it will change your life in many ways, including your
friends. It will really prove who are the ones that really love you and are there for you, and
to see people in different ways.”

In other cases, these realizations resulted in the end of romantic relationships and
frequently in divorce. A number of participants related that as a direct result of their
experience, they had actively sought out a divorce from their current partner—this was
often phrased as wanting to remove a negative influence from one’s life.3
Impact on Career
Others believed that their experience with cancer had been responsible for
guiding them towards a different career, or for improving their ability to perform the job

3

See the subsection Family, Friends and Partners later in this chapter for a detailed discussion.
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that they currently held. Indeed, some participants’ lives were impacted to such an
extent that they changed their career path or refocused on a position that allowed them
to help others, often other cancer patients or survivors. As Sofia, a breast cancer
survivor and rehabilitation specialist, described:
“Right now, in my job, I have dedicated myself to taking care of cancer patients. They see
me as having gone through it twice, and they see that I look fine, that I am fine…Seeing
me serves people. I feel that many people come into my office one way and exit another.”

Maria, a three-time cancer survivor, ended up pursuing a doctorate in psychology
because she was inspired and motivated by her experience. She noted that “where I am
right now in my profession and in my life is the result of this experience.”
Previous Lives
Indeed, participants’ accounts of their pre-cancer lives often were framed as
being incomplete or even misguided in some way. They had a tendency to relate their
stories in a ‘before and after’ manner in which the end result was that they had worked
through the psychological and physical difficulties that cancer presented, and had come
out on the other side as enlightened and improved. For example, Veronica, a 60-year
old retired bank teller who had been diagnosed with breast/uterine cancer at 36, stated:
“Before I was a workaholic. I worked all the time, all the time. After I got cancer, I could
stop and say, ok, I am going to work X many hours and afterwards the rest is for my
children and my family. I would say that I am more conscious of life, of what life really is.”

Magdalena, a 52-year old analyst and breast cancer survivor, related her transformation:
“I was really bitter [before cancer]. I got divorced and I was angry. I lived angry until I got
sick and I took the workshops. And I understood that I had to let go. Because I held on to
a lot – I was really bitter. I was very sensitive; if you do something to me and you hurt me
a lot, I didn’t get over it. It was a really hard childhood; I held onto it here [pointing to her
heart]. I think that a great part of [getting cancer] was those emotional processes. Yes.
When I got divorced, I wanted to control everything. I was left with two small children. I
wanted to control everything. I wanted to be really tough. I had a really bad relationship
with men, because of things in the past, and I became tough. No one could hurt me. (A
lie). Each time, people hurt me a lot, because I took everything really personally. I think
that all those really bad emotional processes of mine, I did really bad things…plus the
stress of my job was excessive. I really think that I healed because I healed my soul [after
cancer]. Because there was no way that I could heal if I continued feeling like I was.”

177

An interesting theme was the tendency of several participants to believe that cancer had
come to their lives to fulfill a purpose. Inez, diagnosed at age 38 with breast cancer,
articulated this sentiment:
“I have the opinion that cancer came to my life to improve certain areas of my life. To
improve and to complement those parts that I needed. I think so.”

Helping Others
A prominent idea in the interviews was the desire to reach out and help others.
Indeed, this was one of the strongest themes to emerge in discussions about life after
cancer, and the meaning of cancer in individuals’ lives. Participants often phrased this
as an “ability” that developed after cancer, an aptitude for speaking and reaching out to
other people that may not have existed in them prior to their diagnosis. They spoke of
having ‘tools’ to deal with situations that they did not possess before. Surviving cancer
was thus framed as providing an opportunity for survivors to better themselves and help
others at the same time. The quotes below exemplify this type of response when
answering the question “Are there things you feel you CAN do because of cancer?”
“Hmm. That’s interesting. […] Use my experience to help other people. I have this tool.
It’s a tool I have that not everybody has” (Marisol, a 46-year old non-profit worker,
diagnosed 10 years prior with breast cancer).
“Maybe talking about it. In the church I have beared witness, and I have been a
volunteer for the American Cancer Society; I have had to talk to groups” (Magdalena, a
52-year old analyst, diagnosed seven years earlier with breast cancer).

This often took the form of educating others, such as attempting to raise other people’s
awareness of the need for screening and early detection, as in the case of Rosa, a stayat-home mother of one diagnosed at age 41 with breast cancer:
“I tell everyone close to me that if they feel something, they have to run to get tested, go
to the doctor because look at me, I’m someone who’s always gone to the doctor. Thank
God I went through that, I told the doctor and there weren’t major consequences.”

Other survivors spoke about reaching out by helping others cope with the diagnosis and
treatment, a form of ‘peer counseling’ from one survivor to another. Their experience
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was seen to prepare them especially well for this role, as was the case for Marisol and
Elena, quoted below:
“When I know a person that had cancer or had a problem or is dealing with someone that
had cancer, I try at least to speak with the person and give the person my perspective
and my experience and try to give the person something” (Marisol, a 46-year old nonprofit worker, diagnosed 10 years prior with breast cancer).
“[Because of cancer, I feel like I am able to cooperate, to talk, to present the happiness
and the life that I have been able to lead, to guide other people […] Because I don’t work
anymore, I can always give a hand in anything” (Elena, a 73-year old retired secretary
diagnosed with breast cancer 33 years earlier).

This idea also emerged as an opportunity. Without exception, survivors saw these new
abilities and tendencies as positive traits, opportunities for helping others as well as
opportunities for social interaction that, in turn, helped themselves. Soledad, a 34-year
old stay at home mother of two who was deeply involved in a local breast cancer support
group, viewed her struggle with cancer as surmountable and worthwhile because it had
allowed her the ongoing opportunity to help others:
“I have had the opportunity to reach out to many people, in order to demonstrate that
cancer is not everything and it doesn’t destroy everything – it can take away your breast,
you can lose your breast – but you are a stronger person and you discover abilities that
you didn’t know that you had. If I hadn’t gone through this experience then probably I
wouldn’t have had [this opportunity]; it is something I thank God for every day. I’ve had
the opportunity to see my children and to value my family, and value many things, and
see them from another point of view […] Getting a patient through the disease and
knowing that it isn’t the end, and they can see the positive side, for me that justifies my
disease. I got [cancer] because I had to help others, not because I had to suffer with my
diagnosis. Yes, there is suffering, but okay, enough, we have to do this because having a
situation like this in my hands without the opportunity to help someone would not have
make sense. However, if I have the opportunity to help others, then it makes sense.”

Social Communities
Support groups were integral spaces for accomplishing these dual purposes of
helping others and helping oneself. First, they provided easy venues through which
survivors could reach out and help others, as was the case for Alejandra, who became
deeply involved in a support group after her breast cancer diagnosis:
“I began to socialize with other people [after cancer]; at work I am more communicative,
with my children more or less the same. But yes, the [support group] really opened a path
towards rediscovering many things. The support group was exceptional and the ACS was
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a link where I could expand the way that I see things, because [before cancer] I didn’t do
anything for anybody, [except for] my kids obviously. I was always in the same circle, so
that I didn’t see outside of the circle; so then to expand my horizons, to have more
communication with other people that were going through the same process, helping
others because I was a volunteer in the ACS – that also helped me to see that I could do
many other things. I was the president of the Survivors Group, giving support. […] So, to
help others is one of the best satisfactions that I have had.”

Second, support groups took on very important roles in survivors’ recovery during and
after treatment, providing material support, emotional support, and lasting friendships.
Breast cancer survivor Soledad, age 34, noted that:
“The importance of the support group in the recovery of the patient for me is
transcendental, often you can call a doctor any time in order to ask them about strange
things that are happening; however, if you can have access to another patient that tells
you ‘look, I’ve been there’ and based on their experience, they will provide some
guidance for you—for me, it’s extremely important.”

The support group had a critical presence even during a recurrence, as Sofia, a 42-year
old recurrent breast cancer survivor, attested:
“When I had my recurrence, the support group began to panic. Terror. [The support
group leader] called me every single day. [I said], ‘you called me–don’t call me anymore!’
[…] It was a huge responsibility, because how I behave, how I face it again, that’s how
the others will if anyone gets it again. Thank God it’s been two years and I took it as a
responsibility not to fail them. I had to – these girls called me all the time.”

Support groups were subtly framed as a tool through which members learned to
live their lives post-treatment, to the fullest extent possible. As noted above, previous
lives were often perceived as incomplete, or as compromised in some way. Indeed, one
commonality across the sobreviviente/viviente identity groups was the importance of
helping others, giving back, reaching out, and being involved in a community of
survivors. While this were not necessarily referenced as an explicit component of these
identities per se, as noted above they were important aspects of what participants
believed their role after cancer entailed more broadly. Some participants—advocates
and survivors alike—directly expressed the idea that helping others was an obligation of
survivors, rather than just a common practice. Esteban, a 52-year old advocate and
survivor employed by a mainstream organization, succinctly summarized this idea:
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“When you declare and embrace the idea that you are a cancer survivor, my feeling is
that you are saying that you had cancer, you did what you had to do, you were
responsible to your family and to your relatives, and most important you are not afraid to
tell others about your experience and especially people who don’t have cancer yet. So
they can go and get tested, and push for legislation or whatever they have to do to make
sure that they have the right for a mammogram, colonoscopy, a Pap test, even an oral
cancer check-up, make sure that if you are going to have to be one of those 10,300
people that get cancer in PR every single year, you have the best of the opportunities.”

Similarly, Maria, a three-time cancer survivor, referenced the obligatory nature of helping
others as a survivor when asked what the concept meant to her:
“Commitment. Engagement. Responsibility. Let me write that down. I would say that
engagement, responsibility, gratitude, and purpose.”

Negotiating Challenges Brought by Cancer Experience
Participants infrequently mentioned the limitations that cancer brought upon their
lives. When they did, it was balanced with the benefits that the situation had provided,
as reflected in a comment by Magdalena, a breast cancer survivor diagnosed at age 45:
“I got cancer, and it took away things but it gave me enough in comparison to what it took
from me. It changed my life positively. The vision of life, now I see life differently, I enjoy it
differently. A wonderful thing happened because it changed my way of thinking and
things have started to happen, good things have started to happen to me. I enjoy each
second. Whatever it is, I enjoy it. A tree, the morning, the noon, the night, whatever it is.”

However, it became evident that their experience with cancer, and resultant change in
perspective, created a central conflict in the survivors’ lives. On one hand, the
importance of taking care of one’s health was clear and participants often spoke about
how this was a personal priority for them. As Sofia, age 42, stated:
“What is most important is my health. There are people that are worried about many
things, like if they cannot pay for the house, but if I have my health, I have it all. Through
my health I have everything. I can continue working, resolving all my problems. That is
the only thing that I have in my mind, to preserve my health. What I have to do to
preserve my health. What I have to do to live.”

On the other hand, this actively conflicts with the often-expressed attitude to enjoy the
moment, take advantage of pleasures, and to avoid stress and anxiety. Dra. Padilla, an
oncologist at a large cancer center, related her frustration at the contradiction between
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her patients’ actual behaviors and what “living like a survivor” should be—in other words,
being careful with one’s health after cancer:
“Many of them are just ‘I have cancer, and because of the treatment I shouldn’t force
myself to do anything.’ When people survive cancer, they are tired of the doctors and the
treatment. They survived the cancer and don’t care anymore about cholesterol, being
overweight, diabetes, whatever. We’re spending this huge amount of money taking care
of them during their cancer, radiotherapy, expensive chemotherapy, surgery, and then
they die because they have high cholesterol or myocardial infarction. Everyone dies,
don’t get me wrong, but this is the way I view it as an oncologist. People have the idea
that if you have cancer, there’s not much time left, so I’m going to focus on the important
things…they are survivors, but they don’t behave and they don’t live as survivors.”

Stable Elements of Perspective
In most instances, participants did not express a complete change in their
general perspective or outlook on life, although this did indeed happen with some—for
example, one participant firmly believed that “How I previously thought, and how I think
now, I am like another person. I think that that person actually died and I am another
person.” Usually, though, cancer was not seen to change someone’s personality or
essence of being. Soledad, a 34-year old stay-at-home mother of two, related this:
“My relationship with my family, my daily life, my strength remains [the same], and the
satisfaction of having achieved what I wanted to achieve. We grow up along the way. But
I’m still the same happy woman and willing to do anything; there is little that can stop me.”

Helena, a 52-year old stay at home mother of three, concurred:
“My behavior, you know, my personality, [is] the same, the same. But with more
responsibility, with more attention to my health, more care.”

In addition, an experience with cancer was not seen to change someone’s deeply-held
values or desires for their lives, such as faith in God or wanting children(or not). These
elements remained stable, and participants phrased these as being reaffirmed by their
experience with cancer. Daniela, for example, a 33-year old artist, had never wanted
children, and her experience with cancer reinforced this commitment:
“This [cancer] experience actually reinforced me to really not want kids. It’s not because
they are bad, nothing like that. I don’t know if I could deal with a responsibility like that in
this moment, plus I need the boyfriend to have it—that’s the extra plus.”
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Future Plans
As a generality, participants’ plans for the future were focused on increasing their
quality-of-life, whether it be physically, psychologically, economically, or socially. Future
plans that were cited with the most frequency involved economic stability or financial
health, often being related directly to the ability to provide for children or other family
members. Cristina, a 34-year old colon cancer survivor, related: “I hope in a few years
to be stable economically, so that my daughter can prosper and go to college, whatever
she wants to do, and to leave her on the right path.” Others echoed these sentiments:
“The economic situation leads me to look for stability for my family […] In the US it is
totally different; there is much more economic stability for a health professional, so for
that reason I’ll move when I finish what I started [a graduate degree]” (Francisco, student,
diagnosed with oral cancer at 23).

In a related vein, many participants spoke about their desire to further their professional
lives, for example, by finishing a graduate degree or opening a business:
“My plans professionally—I want to start a business. I’ve been working from my home for
7-8 years, [making] homemade cakes, and I want to go out to have a small local [café]
that would be combined with coffee. Because I am working on it from my home, but – I
want something more” (Inez, housewife, age 47, breast cancer diagnosed at age 38).

The second most prominent theme concerned family and loved ones. Participants
spoke of their future in terms of being able to care for their family better, to be around to
witness their children grow up and get lives of their own, to spend more quality time with
their loved ones and to value those relationships more. This plan was explicitly framed
around the idea that their values and expectations had changed through their cancer
experience, and their plans were simple but important—valuing loved ones. As a
married, stay-at-home mother of three, Soledad’s comments touched upon this theme:
“A few years ago I had some expectations of my life that were completely different. Right
now, the material is very secondary or minor. I want to see my children grow, I want to
see my children realize themselves. That is my goal and because of that, every day, I try
to enjoy each moment with them. A few years ago, my financial goals were higher, my
economic stability was very important. Now, yes, we continue working so that [the
stability] continues, but it is not necessarily the most important thing. My expectations of
what I want for myself and my future right now are based on what I want for my children.”
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Daniela, who had experienced recurrent breast cancer, echoed the sentiments of living
in the moment and appreciating life despite not being able to make concrete plans:
“That’s something that has changed in me. I am not able to see myself anymore in a
future of like ‘I will be in this house, or I will be whatever.’ It has made me ‘vaga’ – it’s like
I can only concentrate on this day and tomorrow, the plan of tomorrow, but I cannot see
myself anymore in like 60 or 70 or like 80 years. I don’t see it. Not because I don’t want
to; I think it’s because I have learned that life cannot be seen that way. Sometimes we
plan so much for the future, of what we want we want, that we always live in that future
that is not happening at that moment, and we’re wasting the time of the present planning
for the future that we want to happen. I have learned to concentrate more on today.”

Traveling was frequently mentioned as a concrete goal, something that these survivors
“couldn’t wait for” and had to seize the opportunity to chase dreams of travel that they
had held onto for some time. One breast cancer survivor had already booked a trip to
Europe. Another, Marisol, spoke about her recent trip to South America:
“I love to travel. That is something that changes. I like to travel, but after that I got this
dream of seeing glaciers. A few years ago, I said ‘you know what? I’m gonna do it. I’m
not gonna wait until I have another type of cancer. I’m gonna do it.’ And I went and did a
14-day trip. I planned it the way I wanted it.”

Three participants mentioned that they planned on having more children, either
biologically or through adoption if necessary. One man noted, “I want to have a child; I
want to have a daughter, really I do. I would like to have them really badly.” Four
women, divorced either during or immediately following their experience with cancer,
spoke of their desire to eventually settle down again with a loving partner, someone with
whom they can spend time and enjoy life. For example, 34-year old Camila explained:
“I would like to eventually find someone that I can love again and be married. Not now,
but maybe in the future. That’ll be a possibility for me, because I have a lot of love to
give, and it would be nice to have company and have someone to share it with. The joys
and the love that I have for life, and just being here—it’s good to share with people.”

Another theme was social in nature, and specifically concerned future plans to help
others in some way, whether it be volunteering through an organization, continuing their
present activities, or just speaking to others going through the experience. Elena, a
retired secretary and 33-year survivor of breast and thyroid cancer, noted:
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“My future plans, wow! […] To be able to give a hand to other people that are unaware of
cancer, that have other traumas, that have other problems. Actually, we are working with
a project we created ourselves [as a support group]. We created a fundraising activity to
help someone from our group that is right now suffering from cancer again. With what we
collect, we help her pay the light, the water, and all of her things in the house.”

Interestingly, four participants voiced this desire to help by writing and publishing a book.
All of these participants had already written a book and either planned to get it published
or to write another one, such as Francisco, a 28-year old oral cancer survivor:
“I had to fulfill a dream that I’ve had for a long time of writing a book. Before I wrote
poetry, prose, romantic things and deep things…I wrote a book like that, with emotional
depth, a depth of meaning, patriotic. When I am in prayer I say: ‘God, my dream is to
write something with a purpose’ and he tells me: ‘what great depth that you have gone
through in your life and in your teaching that you can sow in the lives of other people who
need it’. I made the decision; I spent two weeks writing and almost finished it.”

Only a few participants talked about plans that involved physical recovery or health.
Eva, a 44-year old breast cancer survivor and teacher, noted that because “the
treatments have effects: they affect the heart, and now the arthritis,” she wanted to retire
from her job as soon as possible in order to free up time to go to the gym. Helena, a
married stay-at-home mom, emphasized the need to care for her health:
“Yes, [my plans for the future are] always with the expectation to take care of myself, to
be more careful with my health in the things I do.”

When queried about their future plans, three women answered that they wanted to
finish their reconstruction surgeries. These surgeries had been unfinished for one to two
years since the completion of treatment, in all cases because of financial, insurance, and
other access issues. In the case of Andrea, a 28-year old angiosarcoma survivor, a
doctor refused to perform the surgery because she was no longer considered a “cancer
patient” even though she had been treated in that facility. Camila, another young
survivor diagnosed at 22 with breast cancer, related her desire for reconstruction:
“I would like to lose a little bit more weight so I can get my breast reconstruction done. I
want to do an abdominoplasty with breast reconstruction, so I can stop using the
prosthesis that I use now.”
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Family, Friends and Partners
The importance of family, friends and partners was one of the most central and
complex themes that emerged in the analysis. Aspects of this theme overlapped with
the majority of others in some way, ranging from causation to beliefs about disease,
gender, provider relationships, meanings of cancer, and religious beliefs. The section
below outlines the most significant subthemes to emerge within this large category.
Family Priorities at Diagnosis
When diagnosed, generally participants’ thoughts and fears went straight to the
reactions of and implications for their family members. Five women with small children
immediately thought of them; others worried for their grandparents or parents and the
pain the news about a cancer diagnosis would cause. Juanita, a secretary and mother
of four diagnosed with breast cancer at age 40, related her first thoughts:
“Regardless of how mentally prepared you are, the diagnosis is a shock, really, a blow
because you think that you’re going to die. I thought that a lot. I have my 6-year old kid, I
said I am going to die, I am going to be sick but I have to go on, because the others are
already bigger, but the little one needs more from me. That was my fear, of dying, or
getting sicker with a 6-year old child who still needed me, was more dependent on me.”

Rosa reported a similar experience when she was diagnosed with breast cancer at 41:
“[When I got the diagnosis, it was] like if they had thrown a bucket of ice water over my
head. I wanted to die. I was with my mother, but I was stronger than my mother. I was
really strong because in my family no one had suffered from cancer…that news was like
death. But afterwards I recovered and I said: ‘I have to fight because I have a child, and
my child was 9 years old. I have to be strong for my son, I have to raise that child.”

The Many Forms of Family Support
Survivors detailed at length the crucial forms of support that were provided by
family and friends. Few had complaints about lack of support (in significant contrast to
my thesis research with cervical cancer survivors in the US [Dyer 2010]). Families
provided multiple forms of support, from physical caregiving to information gathering and
liaising with doctors, to instrumental support (e.g., babysitting, cleaning, cooking,
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transportation), and emotional and psychological support. For example, Inez’s sister
cared for her and her children when she was being treated for breast cancer at age 38:
“I was loved. My sister moved in with everything and her dog. Every 21 days, she stayed
at my house the whole week. She cooked, everything, took care of the children, took
them to school. I picked them up in the afternoon; she worked. The support was good.”

Families provided financial support, as was the case for Andrea during her treatment:
“My whole family has helped [me to afford the treatment], my whole family because my
mother gave me [money to pay for treatments], my brother gave me money, I worked, my
husband worked, my grandmother [gave me money].”

“Everyone in the Family Gets Cancer”
In general the extended family was perceived as part of a community of
survivors. Several advocates actively emphasized the idea that family members were
“co-survivors,” and that the cancer experience was as difficult for them as for the
survivor him/herself. Indeed, a picture of “Puerto Rican survivorship,” when discussed
by participants, always included the extended family, which was seen as very much a
strong, essential part of the culture. Lucia, a long-term advocate and cancer survivor
herself, articulated this clearly in a letter describing her organization:
“The cancer survivors have a large and extended family environment the majority of
times. The concept of extended family is used as a framework [in this support group], and
friends and co-workers are added that want to help in the patient’s recovery. We must
provide knowledge and strategies to that support group of how they can really be of great
help to their family member or friend.”

Likewise, Angela, also a cancer survivor and long-term advocate, stated:
“[Puerto Ricans] are quite family-oriented, so to us the family is important and when
somebody gets cancer everybody in the family gets cancer too. The mother, the father,
the daughter, even the neighbor (laughter) […] The neighbor [says]: ‘Oh you have
cancer, do you want something? I can get you soup, I can hug you, you can go with me—
anything.’ Because we are like this, when someone in the family has cancer, in the
neighborhood you see everyone coming here or looking this way, they bring you food, ‘I’ll
take you’, ‘I’ll bring you’, ‘let’s pray’, so everybody goes to church to pray for so and so.”

Disclosure and Communication
One of the most difficult aspects of the cancer experience for survivors was the
prospect of informing family members of their cancer diagnosis. It was an acutely
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painful experience for participants. This challenge led several to keep the information
secret from various family members in order not to worry them. This was framed as a
protective measure that would spare those family members pain. Even for the survivors
who did not hide the diagnosis from family, great care was taken to project optimism,
strength and a happy face to their loved ones. Veronica, now 60 years old, spoke about
keeping her breast cancer diagnosis secret from her mother 24 years earlier:
“The most difficult thing [of having had cancer] is first to accept it, and then to
communicate it. That was the most difficult thing for me. Really. Because I knew that after
they discovered the cancer, there were many people behind me that would suffer. That
was why I kept it to myself. My mother died and never found out.”

Soledad described her fear of informing her family about any future recurrence:
“I have not been able to remain calm in the aspect that the disease can come back or
having to wait for other results and [breaking] the news to my family; that was another of
the most difficult things that I had to go through. To wait for those results and once I had
the results to tell my family, that was really difficult…Three years have passed and it still
weighs on me. One of the things that still gives me the most fear is that it will come back;
that is like a shadow that always is there, and still my first fear is facing my family with
that. It is not something that has changed with time. [It] has always been there.”

This desire to protect loved ones’ feelings worked the other way around too. It was
noted by a few participants that until recently, it was common practice to hide the
diagnosis from the patient. As the reasoning went, once the patient knew about the
diagnosis, they would decline faster. However, this was seen to be changing quickly
and now it is only the older generation that suggested this. This request was not heeded
by the oncologists I interviewed, such as Dra. Padilla, an oncologist at a cancer center:
“The only issue that we sometimes is that you always have some relatives that don't want
you to give the whole story to the patients. Every doctor is different, but for me it's a nono. I know how to say the words, or the soft way to say terrible things, but people have to
know what's happening […] It's more common, that scenario, in older people. But you
know what I have found is that sometimes it's not the fear to know, it’s the fear of the
reaction of the patient that the relatives have. But, again, they have to know. If they yell or
scream or cry, well, I’m not giving you good news. It’s not that you won the lotto. But you
have to tell them because on the other hand I don't want to give chemotherapy to
somebody who…And you know what I have found, people are not idiots. When you sit
down with patients in these families, patients know. You just say the word, and they say ‘I
know that I have cancer’. They are not stupid. And they know. They always know.”
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Impact of Cancer on Children and Family
As parents, many of the participants described in great, poignant detail the
impact of their own cancer on their children. On the whole, it was something that they
feared greatly and was one of the most difficult, heart-wrenching parts of the experience.
Many spoke at length about how important it was for them to feel like they had trained
their children well in case they died, that they had taught them to be independent and to
get along in the world—driving, cooking, doing the laundry. The prospect of leaving their
children motherless or fatherless was made worse if the survivors felt that their children
were too small, dependent, or unable to fend for themselves. Alejandra, diagnosed at
31 with breast cancer, described her daughter’s difficulties:
“The children are involved directly because they are in direct contact with that person […]
My daughter thought that I was going to die. At one point she had a panic attack…[After
the surgery, she and my mother] came to visit me, but at one point my mother said, ‘ok,
now we are going because mama needs to rest’ and for [my daughter] that was
catastrophic; she went into a crisis—she started to scream that she wanted to be with me
[…] They told me later that they thought they had to bring her to the doctor because she
had a really big nervous breakdown. And she was a baby. She was 11 years old.”

Hair Loss, Appearance, and Family
Cancer treatment’s effect on appearance was one of the most frequentlymentioned impacts of the experience, both in relation to the individual and to the family
members: thus, a detailed discussion is warranted that deals with the interrelationship
between appearance and family. In order to better understand this discussion, the
impact of appearance changes on the individual will first be presented.
Appearance-related effects, such as hair loss, weight gain/loss, or scars were
mentioned in passing as one of a list of effects, but more often were cited as one of the
hardest aspects of the experience, implying that physical changes are a public signifier
of the disease that let other people know that the survivors were ‘sick.’ Daniela, a single
woman diagnosed at 32 with breast cancer, echoed this sentiment:
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“Seeing myself bald was one of the most hard-core things ever. The physical changes. I
have never been a Barbie doll, nothing like that. But I like to take care of myself. I fix
myself, and it was really hard to be so overweight. It was horrible. My nails all got black
from the treatment. That was really tough too because I use to love nail polish, but I don’t
paint them anymore to avoid the chemicals. I always like to put sandals and I couldn’t use
them because of the chemicals. Those were the hardest aspects.”

Angela, an advocate and survivor, explicitly tied the appearance changes to beliefs
about cancer as a death sentence, evident when people see someone who has had
cancer, and comment that the person “looks too well” to have gone through treatment:
“When the person becomes a survivor after the diagnosis, this is what happens: ‘How are
you? Are you okay? Are you sure? Oh you look so good!’ (laughter). ‘Ay, but didn’t you
have cancer? Ay, but you look well! Are you sure that you are okay? You look so good!’
It’s like if you are lying, because they expect that if you have cancer, you’re dying on the
floor. It’s awful! It happened to me, people who have not seen me in years, ‘Hey you look
so hot!’ ‘Ay, but you look so good!’ but with this tone.”

“Before and after” contrasts were drawn frequently by the participants, often with a
nostalgic way of conversation that referenced how much their body had changed
(usually for the worse) since the cancer, but how their mind had grown. Soledad,
diagnosed at age 30 with breast cancer, made this point:
“Physically, it definitely has been a very significant change in what I was and what I am
now. I did a lot of exercise, I was very athletic. I was in the best shape and I felt better.
Now, my lifestyle has dropped a little, but my spirit continues to be strong.”

Discussions of appearance-related effects centered clearly around gender expectations.
Quite often, women were seen to be the ones most concerned about appearance. Long
hair and breasts were associated with femininity, and the loss of either challenged one’s
sense of self. Sra. Benitez, a health provider and advocate, referenced this:
“The men are not that concerned [about hair loss]. I do have two men with breast cancer.
They are not concerned at all. They just want to be well again. Their concern is that
they’re not going to be able to provide for their family or see their children grow.”

Daniela and Camila, diagnosed at age 32 and 22, respectively, with breast cancer, both
spoke about their initial shock and discomfort at their appearance-related changes:
“I asked my doctor to do [a double mastectomy] and he did it. It was really traumatic
obviously to see it, but I think it was a combination of being overweight and not having
hair and not having tits and it was the whole combo that it made me feel so horrible about
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myself. I’m frustrated obviously. It’s really hard to pick up a boy without tits, but it is not as
much as without the other two factors of not having hair and having as much weight as I
had. I wish the reconstruction could be immediate, but it’s not like that.”
“I’ve grown too quick; I’ve had to make choices in life. At 22 years old, instead of thinking
about what short skirt I was going to wear to go party, I was thinking about whether to get
a mastectomy or not. They say, ‘oh you’re a woman because you have breasts and long
hair,’ and I had to deal with the fact that I was going to be ‘half a woman.’ I don’t feel like
that now, but [back then I did].”

Reconstruction was a key feature of many of the breast cancer survivors’ narratives in
two ways: the embodied experience of losing a body part, and fulfilling their need to
replace it, as well as the social difficulties presented by missing a breast, such as lower
self-esteem and body image. As discussed previously, women went to great lengths to
access reconstructive surgery; in fact, this theme dominated two of the interviews with
no prompting. For Isabel, diagnosed at age 31 with breast cancer, losing her breast was
the hardest part of the whole process; she felt that she had lost her femininity:
“I didn’t want my husband to see me in the process of getting [a mastectomy]. I am a
strong woman, but in that moment I didn’t. I was depressed, I had dysthymia.”

Interestingly, it was hair loss that provoked the most detailed response from
participants when they were discussing the impact of cancer on their children and family
members. Hair loss also served to be an “intervention point”: in other words, the level at
which many of the female participants felt that they needed or were able to intervene
with their children, or somehow involve them in the process in order to reduce the
children’s discomfort. It could be that participants’ fears about dying and leaving their
children behind were distilled or projected into a preoccupation with children’s reaction to
their hair loss, given that hair loss is frequently the most visible marker of sickness and
announces to the world that something worrisome is happening. Señora Benitez, a
healthcare provider and support group leader, ratified these ideas:
“Their concern is when their hair falls out, how they are going to see themselves in the
mirror, and then how they are going to see themselves with their husbands and with their
children. I once had a family that they all shaved their hair to support their mom, even the
kids. Every person deals with the situation in a different manner.”
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Interviews with survivors such as Soledad, a married mother of two, and Inez, a divorced
mother of three, strongly reflected these themes:
“I explained to [my children]: ‘mama is going to lose her hair’. I looked for photos of how
patients look without hair, the treatment, for them to be ready for what will come and what
will happen. My biggest fear, definitely, was how they were going to deal with that.”
“It was one of my concerns, not for me, that I wouldn’t have hair, [but for] my son, how he
would react, it if he was afraid, if he was frightened. And I was preparing myself mentally
for when that moment comes to deal with him, because the girls, I explained it to them
and they understood that the hair is going to fall out and I was going be fine, and it was
going to grow. And I prayed to the Lord to give me guidance on how to deal with the hair
loss with my son, and I realized that he himself should cut it when it begins to fall out.”

The Need to Maintain Strength: Family Obligations as Motivation
An overriding concern for family members caused another layer of worry for
survivors, who often tried to carry the burden that they felt they had caused—principally
by putting on a happy face for others, trying to appear strong, and feeling compelled to
do the comforting for the distraught family members. While sometimes this left
participants feeling isolated and alone, at the same time, the converse was also true: in
many cases these social, parental, or other familial obligations bestowed on them the
motivation and will to do “what they have to do.” For examples, survivors related:
“The most difficult [aspect of having had cancer]—I would say that dealing with my family.
For them it was so, so catastrophic; it affected them much more than me, because for me
the truth is that I took it like a cold. But for them, it upset all of them. I had to be the strong
one. Regardless of how I felt, I had to be strong. Strong for them, so that they did not
collapse” (Alejandra, divorced mother of two, breast cancer survivor diagnosed at 31).
“You remember those moments in which you are scared, and you don’t want to see
anyone. People say: ‘I want go to visit him, I want to see him’. That is a lot of support,
and it’s really good, but sometimes it is difficult when you are in those moments of acute
pain, and you don’t want to see anyone. Not because you don’t want to see them, but
because you don’t want to see them in the state you’re in. It’s not that it’s negative, but
that you are going through some things that you want to overcome quickly and without
bothering anyone” (José, recently-married, lymphoma survivor diagnosed at age 26).

Need for Counseling
Another need identified by participants, both advocates and survivors, was
counseling or psychological support for families and particularly children. Several
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believed that it was necessary to include families in counseling and support programs
because they confront the cancer experience too and their needs are often neglected.
This recommendation has a direct relationship to the perception of cancer as a “family
disease,” as noted above, in which all are affected. Other survivors who had attended
life skills workshops, such as Alejandra, voiced their desire for children’s workshops:
“[There need to be workshops for the children] on what it is like to have a cancer patient
at home. Or just some workshops at a psychological level of how to handle the situation.
As far as I know, they aren’t any—just help for the patient. There’s nothing for the family.”

Issues in Romantic Relationships
Divorce
In seven of the 11 cases of separation or divorce in the survivor sample, romantic
relationships came to an end during or shortly following a participant’s bout with cancer.
Divorce was a common phenomenon among survivors. Some of the providers, mostly
oncologists, phrased this as a problem with the husbands; in other words, the male
partners were weak, could not handle the stress of the illness, and left the women. On
the other hand, some advocates and the majority of divorced survivors described the
split as originating from their side. According to them, cancer had clarified their needs,
values, and self-worth, and changed their outlook and approach to life. The husband did
not change; rather, either he could not adapt to the changes the woman underwent, or
the woman herself realized that her marriage was unhealthy and took steps to end it.
Thus, divorce or separation was a means to remove a negative influence from one’s life.
Only a few described being left by their husbands; the others described actively ending
the relationship. Sofia, separated immediately after her cancer recurrence, explained:
“I feel that the decision to separate from my husband was not that he changed; the
change was mine -- I knew that I do not deserve that. He continued being the same. It
was not that he was bad; he was good. He was the same, I was the one who changed.
And I said, ‘for what is left of my life I will not spend next to a person that does not
appreciate me, that does not value me, no—I’d rather be alone.’”

Similarly, Elena, who divorced after her Stage III breast cancer treatment, stated:
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“I know that cancer made me make certain decisions, for example, divorcing my husband
because he was creating problems for me. I am happy and I do not regret the decision.”

Señora Benitez, a support group leader, explained her opinion on the matter:
“There is something that I’ve found out here—many marriages that are not solid. When
the woman is diagnosed, before half of them [are done with treatment], they already end.
We once had a meeting where we talked about this. The survivors say that they change.
They are the ones that change because they begin to realize that they are important; they
have to be healthy for their children, and their priority is themselves. Of the few of them
that have divorced during treatment, all of them say the same thing. It’s not their husband
that changed; they change. I do have a few that as soon as they were diagnosed, their
husband left. But those are not solid—they are exceptions. But they say that they really
change, that their priorities begin to change too. Maybe the husband is not the main
priority anymore. I think that’s something that research can be done [about].”

Intimacy Problems
Many participants complained about the effect of cancer treatment on intimacy
with their husbands—this was always framed as a physical problem that was caused by
the lack of estrogen in their bodies, which is an effect of the treatments for estrogen
receptor-positive breast cancer. This brought about painful symptoms during intercourse
that went unaddressed by oncologists or other doctors, and created major problem in
their lives and marriages. Some of the advocates noted that their support group
members have been able to discuss the impact of sexual problems and strategies for
overcoming them, but at the same time they recognized that it is a topic shrouded in
secrecy and it remains difficult to have open conversations about it even in support
group settings. Many participants, both advocates and survivors, called for additional
attention to this problem, either through counselors in the doctors’ offices or referrals to
specialists who are more equipped to handle cancer patients. Angela, a cancer survivor
and advocate for a mainstream organization, noted:
“We don’t talk about sex in Puerto Rico. Good girls don’t talk about sex in Puerto Rico—
no, no way. For example, in our group to talk about sexuality is difficult. Usually they
begin to talk about this dryness, and it hurts when they have relations. Then they begin to
feel more relaxed, and then they talk. But it happens when you are just making jokes and
it comes up. But they don’t like to talk about the topic; they don’t feel that they can talk it.”
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Quotes from survivors reflect the need for greater attention to this issue:
“There are some issues that have to be addressed, especially sexuality. Doctors think
that we are sexless, but the family has to be involved. Doctors need to get more involved
with the family, especially with the couple, with the mate, with the spouse, because of the
physical changes […] I don’t think they are aware of [the sexuality issue], they just refer
to another person and they just concentrate on the chemical and what they are going to
give you, and the workups and the laboratories, but not the other areas. [All my doctor
said to me was] just ‘buy some gel’” (Amanda, diagnosed at 39 with breast cancer).
“In fact there’s very little that I cannot do with respect to cancer—but if we talk about
intimacy with my partner, yes, there are things that I cannot do that I would love to be
able to do again […] There have been many changes and yes, I can say that I would like
it to be half of what it was” (Soledad, diagnosed at 31 with breast cancer).

One of the three men did voice concern about intimacy problems with his partner,
underscoring the fact that sexual health is an issue that affects all.
Family History: Cancer in the Family’s Genetic Future
When talking about causation, family history was often mentioned as a possible
cause of cancer. While this possibility was ultimately usually rejected by participants
who were speculating about the potential cause of their cancer, it was also part of
discussions about “cancer in the family” in a future sense. Several participants
expressed anguish at the idea that cancer would be passed along to future generations,
and that it was now part of the genetic makeup of their family. A discussion of BRCA
testing highlights this issue; two participants, both young breast cancer survivors, had
been urged by their doctors to consider getting genetic testing for themselves and their
daughters. In both cases, this testing was declined—partly for financial reasons but also
because they did not think that ‘knowing’ would necessarily change anything about their
situation, and in fact might cause psychological or emotional damage. Soledad, a
mother of two diagnosed at age 34 with breast cancer, explained:
“The doctors wanted me to get the BRCA analysis in order to see how big the genetic
factor in my cancer was, but I personally decided that no, that I was not going to do it.
They had talked to me about the risk that my daughter has, but at the same time they
have told me that [having the gene and getting cancer is] one of the probabilities, she
may also have the gene and not develop it, or may not have it and develop the disease
anyway. So, that I decided that I am not going to destroy my psyche with that result like
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that. I don’t want to think, obviously, that my daughter would go through that […] But I
don’t not think that that is going to happen obviously and I am not going to feed my
concern with any exam that they tell me can happen, because I know there is a risk, but
the exam is not going to reduce risk to her, or to me – while this is in my hands I am not
going to make radical decisions that can affect her either. So I will not do it.”

The “Uniqueness” of Cancer Survivorship
An interesting theme, although not the strongest, was that of the “uniqueness” of
being a survivor in terms of the extent to which other people can relate to the
experience. Some participants touched upon how friends and family members who
have not been through cancer cannot truly understand what it is like. Accordingly, they
formed friendship with survivors who shared common interests and had the same
outlook on life. What perhaps was most interesting about this was the ways in which this
uniqueness was discussed: it was hardly ever framed as a criticism or failing of their
existing friends and family (i.e., that they could not understand the survivor’s plight);
rather, cancer was framed as an opportunity to find friends who had interests and a life
approach that was more in line with their own (i.e., other cancer survivors or support
group members). This was the case for Inez, diagnosed with breast cancer at age 38:
“Due to my cancer, after I felt well and [regained my strength], I signed up to take some
workshops, and there I met a group of friends—I have a group of 5 girlfriends and we are
more than friends now, now we have been together for 5 years. I spend more time with
them than with my previous friendships. We do activities, we see each other monthly, we
go out to eat, we go out to the cinema, we cook in someone’s house, we cook at my
house. So we spend time doing that, in that environment. Obviously, my close friendships
and my family are number one, but the others were like baggage, let’s say […] Now, one
focuses on the people that are with you, that have the same vision of enjoying life, of
having a good time, of not harming someone, you know, that vision.”

This theme emerged in an interview with provider Señora Benitez about the beginnings
of a support group that she coordinated:
“[The support group] started because we began to ask the patients if they were willing to
give their phone number to other patients, because even though you have a support
system like your parents or your husband, or your boyfriend, or a friend, if that friend is
not going through the same thing you’re going through, they really don’t understand. It
doesn’t matter – I can be sympathetic, I can be empathic, but I can’t really understand
what you’re going through.”
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Religion, Faith and Spirituality
Religion, faith, and spirituality were a prominent theme. The following section
captures all the ways in which survivors spoke about the role these factors played in
their lives and illness. Providers’ comments about religion were relatively topic-specific
and their remarks are included in separate sections (for example, how oncologists’
religious beliefs influence referral practices for fertility preservation) unless they related
directly to survivors’ comments on religion, in which case they are placed below.
Central Role of God and Faith in Life Experience and Identity
It is easy to conclude from the beginning that participants’ religious beliefs and
faith in God were supremely important. A few did not adhere to a particular religious
tradition, but with the exception of one survivor, all attested that their religious or spiritual
beliefs played a central role in their lives. In many cases, this formed a critical part of
their personal identity, and, when queried about the “three most important things in their
lives,” their faith ranked higher on that list than anything else except for their children:
“God, my family, and myself” (Magdalena, age 52, divorced with two children, breast
cancer survivor diagnosed at age 45, identifies as a Baptist).
“Three things? My Lord, my children and my life” (Alejandra, age 46, divorced with two
children, breast cancer survivor diagnosed at age 31, identifies as Christian).

Often the survivors’ future plans included aspects relating to God—for example,
continuing to serve God and giving thanks for the blessings in one’s life, as in the case
of Helena, a 52-year old Baptist woman and breast cancer survivor:
“My plans for the future [are] to continue going forward serving the Lord and waiting for
what God has in store for me, because we don’t know. Waiting for what God has for me.”

God as Responsible for Current (Positive) Situation
Spiritual beliefs, faith, and adherence to particular religious traditions were
discussed primarily in three overlapping ways: first, God as responsible for participants’
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current situation, usually in a positive sense; second, faith as a support or coping tool
that was utilized during treatment; and third, cancer as a faith-deepening experience. In
the first, participants discussed God as the entity responsible for bringing positive
outcomes into their lives. This idea frequently arose in comments about physical health,
ranging from a successful treatment and the fact that they were still alive, to their lack of
side effects, and the early detection of their cancer. For Maria, a three-time cancer
survivor, God’s hand was evident in the fact that her cancer did not metastasize:
“I was sure that the Lord was with me, that he made my lymph nodes clean. The doctors
[tested] my bone marrow and they were astonished when they saw the bone marrow—it
did not match with the kind of cancer that I had, because it was a beautiful bone marrow.
And I said that that was my miracle, that’s my miracle.”

Inez, a Stage III breast cancer survivor, felt that God had a role in sending her for a
mammogram earlier than she was due:
“[The cancer was caught in a mammogram]. We say it was a routine [mammogram], but
also, you think that it was God also. Well, because I do it every year, and at the 8th
month, my sister called me and said to me, ‘I am going to do the mammogram, come with
me and get yours also.’ And I told her, no, that it’s not time yet. [But, I went anyway and]
they did it for me. I did it 4 months earlier. And that I think that that was what saved my
life, well, because, when the cancer takes hold, the doctors say, in less than a month it
proliferates, and, and I do not know at what stage it would have been 4 months later.”

This theme also encompassed social aspects. God was seen as the one responsible for
sending the “right people” to help throughout the cancer ordeal, as in the case of Sofia, a
recurrent breast cancer survivor and mother of two:
“Many people have helped me, including one of my clients [who] donated money so that I
didn’t have to work for 3 months; they paid for the tuition at my children’s school, they
gave me orthopedic beds, wigs […] I remember that he told me that God touches the
heart of people to do things like that and prayers are answered in different ways. It is
something that I didn’t ask for, [but] this person knew my need. Everything comes. There
are things that I realized that I didn’t have to worry about because everything was solved.
I can tell you that during my difficult moments in life, I’ve felt God’s hand in the process.
It’s not that I’m special or anything like that; in difficult moments one can feel the truth that
everything in life will appear, everything is solved without you doing anything.”

God was seen to bring children into other survivors’ lives, as in the case of Rosa, a
married breast cancer survivor who had one son after a number of miscarriages:
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“I am a high risk [pregnancy] patient— before I managed to have one [baby], I had lost
two, and that was like a miracle from God, that was the only one that I was able to have.”

José, a recently-married survivor diagnosed at age 26 with lymphoma, described God’s
role in bringing the couple’s desired children in the future:
“I talked with my wife and I said to her: ‘if indeed to this day, God the Father has not
given us that child, it is maybe because he has other things for me or for you or for us. I
am going to deal with this [treatment] now, if when I finish this treatment God wants, God
permits us to have children, then God will give them to us.’ I have a friend who was
married for years and couldn’t have children, she got really expensive treatment, she
spent time in treatment, and God rewarded her because God gave her two precious
daughters. He has given her one right after the other. It’s something that you say, wow!
From not being able to have kids, now she has two one after the other. It is possible.”

Very rarely did participants mention this aspect of their faith in God in a negative light—
only a few described losing faith in God during their ordeal with cancer, or believing that
God “sent” the cancer as a punishment—in the words of Andrea, a married, 28-year old
sarcoma survivor with one daughter, “God sent it to grow.” However, gratitude was the
primary response in these instances. For Amanda, diagnosed with breast cancer at age
39, even though she attributed her cancer to God, it was interpreted in a positive light, as
an attempt to enhance her life and deepen appreciation of her blessings.
“People that are diagnosed with cancer in some way have been prepared; God has been
preparing them to go through that. We’ve been trained, and we were chosen. At the
beginning I saw it as a privilege. It’s not the same being in the bleachers than in the
basketball court, so it’s a way that God took you from the bleachers and took you to that
privileged area. It’s a gift; it’s a gift. That was my biggest fear from the beginning. From
the beginning when I was diagnosed I said, ‘okay, God, you chose me. Now I’m dealing
with the Boss, so I cannot disappoint the Boss’. So my sense of responsibility was very,
very strong. [He chose me] because he knows that I won’t betray him. I’ve been always a
leader, and in my family, in my group of friends, in school, I usually was a leader, and
people admire me for most of the things that I’ve done.”

Faith as a Support and Coping Tool
On the whole, participants’ faith in God was a bedrock of support for getting
through difficult times, particularly the cancer ordeal. Their faith was a source of stability,
trust, and confidence, and many survivors reported that it was the main reason that they
had persevered successfully through the trials of treatment, as in the following quotes:
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“Totally, totally and absolutely, my [religious beliefs] served as my rock, my refuge, my
everything, my everything, my everything, my everything, my everything. If it hadn’t been
because I was holding the Lord and I have so much faith and so much adoration for the
Lord… He is my everything. The Lord was my rock” (Alejandra, 46 years old, breast
cancer survivor, identified as non-denominational Christian).
“[My faith] is really important; I think that that is one of the things that has kept me
standing – the power that it can give you in understanding that everything has a purpose
and that God has a purpose in everything and that is a way to see this in a different way.
Yes, I can tell you that what kept me standing was my faith that everything was going to
work out fine and that God was there and was going to help” (Soledad, 34 years old,
breast cancer survivor, identified as Baptist).

Several participants described their reaction to the diagnosis, and attributed their
calmness and lack of fear to their confidence in God’s help and support. Helena, a
breast cancer survivor diagnosed at 45 who identified as Baptist, noted:
“Because I serve the Lord and my confidence is in God, when they gave me the news [of
the diagnosis], I stayed really calm because I have trust in God. I didn’t have a negative
reaction or anything. The only thing I asked the doctor was: ‘and now what is going to
happen? What are we going to do now?’ But calm, calm.”

Participants described relinquishing control over the outcome of cancer treatment, such
as José, diagnosed with lymphoma at age 26:
“My doctor told me the pros and the cons [of treatment], because this is something that
you as a person have to accept, that you have it and you decide if you get the treatment
or not, because it’s not obligatory […] I am really positive about it and I put myself in the
hands of God and I put myself in the hands of the doctor.”

Veronica, diagnosed with breast cancer at age 36, voiced similar sentiments:
“Everything I do in my life is with the consent of God. When I got my cancer, that was the
first thing I did. I had a conversation with God. The only person that I could talk to was
with God, and I put myself in his hands and said to him, ‘this isn’t mine, and I don’t want it
in my body and I don’t know what you are going to do but my children, I want to see them
grow’ and things like that. I always have been really faithful to [him], I believe that he
hears me and I always consult with him about everything.”

Cancer as a Faith-Deepening Experience
Possibly the most interesting way in which faith was discussed was the third way
as opposed to the first two, which were unsurprising given what is known about the
importance of religion to humankind as a whole. Cancer was clearly described as an
experience that deepened and strengthened survivors’ faith in God. Their confidence in
200

God was enhanced and given a new dimension, and they reported a distinct “beforeand-after” effect. However, at the same time, their participation in church activities and
frequency of attendance remained unchanged after the illness. Church participation was
a different matter than one’s personal relationship with God, and it was the latter bond
that was strengthened versus the former. This is reflected in the following quotes:
“Yes, yes, [my faith] has increased […] I go [to church] with the same frequency but I
have God more on my mind than before. Before it wasn’t more than when I went to
church but now no, now it is all the time giving thanks to God and blessing, not cursing
like before” (Rosa, 44-year old breast cancer survivor, Catholic).
“I’m not saying that I am going to go to church now every day, so if I say I talk to God
every day, and I give thanks, it’s because he let me start this day and continue living, and
I give thanks because, in spite of everything, this was in the hands of my doctor, and my
doctor helped me get through this but I know that over those hands there were others,
and I know that maybe they don’t say it but the prayers reach him” (José, 27-year old
lymphoma survivor, non-denominational Christian).

Survivors’ deepened faith in God left them less fearful about the future, and helped them
to realize that physical survival is not the most important thing. For example:
“Through faith in God, it doesn’t matter that we survive or not, what is important is to have
God in the heart” (Helena, 52-year old breast cancer survivor, Baptist).
“My faith in God helps a lot to not be so afraid of whatever is going to come. It helps you
in the sense of vision in life, because knowing that [life] is not permanent helps you to
have better relationships now” (Magdalena, 52-year old breast cancer survivor, Baptist).

Doctors as Instruments of God
As is evident already from several previous quotes, a number of participants
spoke about the relationship of their doctors to God. Doctors (and treatment, vis-à-vis
the doctors) were seen as instruments of God and thus, in a sense, holy and necessary.
These participants perceived that God wanted them to undertake the treatment, and
respect for the doctors and the process itself was a required component of this. God
worked through the doctors, and through the treatments, to heal them. As stated by
Rosa, a Catholic, 44-year old breast cancer survivor: “God provides and the doctor
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gives. God uses the doctors.” Helena, a Baptist, 52-year old breast cancer survivor,
ratified the importance of God working through the doctors:
“[It is your time] when God says and we have to give thanks for the instruments that are
the doctors. If it were not for them also…you cannot stop giving credit to the doctors. I
have some really good doctors. I pray to God that they follow the plan; they are appointed
by God and to highlight what I said, yes, there is hope in God first and after in science.”

Discussions with advocates about their constituency’s concerns reflect the above
themes—the importance of faith in going through cancer, of trusting doctors as
instruments of God, and the idea that one’s successful recovery or current health can be
directly attributed to God’s intervention. In one instance, Alba, a 60-year advocate and
founder of a local grassroots organization, attributed the negative (benign) result of her
own tumor’s biopsy to God’s hand and to her trust in miracles. Lucia, a support group
leader for a mainstream organization and breast cancer survivor herself, incorporated
religious faith into her group materials because of its important role in healing:
“I made a logo for [my support group] patients, an isosceles triangle where I put God at
the apex, because if a person has religion, it doesn’t matter what religion it is, spirituality,
it will make it easier to confront the situation. In one of the legs of isosceles triangle, I put
medical treatment. And the other leg (you know that in an isosceles triangle the two are
equal), I put the self. If I do not believe in healing, if I'm not ready to cope with the
disease, if I'm not willing to do new things, then I'm not going to help the medical
treatment—and then medical treatment will be a failure. The base of the triangle is the
support that I need to cope with the disease; here, there are family members, support
groups, friends. Then I put the sun, because the sun is necessary in order to energize.”

SUMMARY
This chapter presented the interview themes relating to the meaning of cancer in
Puerto Rico. Participants believed that cancer was viewed principally as a death
sentence in Puerto Rican society, although at the same time they had observed that this
view was abating, being gradually replaced with the idea that people can live through a
diagnosis of cancer. Cancer is becoming more visible through the work of organizations,
prominent celebrities who had been diagnosed, and increasing numbers of survivors—
as one survivor stated, “everyone knows someone” who has had cancer.
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The survivorship framework, as defined by various North American
organizations, is utilized in Puerto Rico to a certain extent, along with the associated
terminology: sobreviviente and sobrevivencia. These organizations play a large role in
shaping the terminology used as well as constructing a framework of ideal recovery from
cancer. The survivorship concept and identity is resisted by some, who point to its
inadequate ability to capture their desire to “live” versus merely “survive.”
The local interpretation of what it means to live beyond cancer treatment has
additional layers of components. Beliefs about causation feature a mix of standard
biomedical understandings of cancer etiology and a strong subscription to the role of
negative thoughts, emotions, and stress in the development of cancer in an individual.
Cancer is conceptualized as a transformational agent, with the power to create positive
change in all areas of life—relationships, career, personal priorities, and volunteer
activities. Cancer is a family affair, and extended family members are viewed as ‘cosurvivors’ who play critical roles in the whole process but whose own needs can be
neglected; indeed, family was seen as both a considerable benefit as well as a source of
stress for survivors, because they tended to worry more about their family members’
reactions than their own outcome. Finally, faith and spirituality occupy an essential role
in survivors’ constructions of survivorship; their trust in God and his ‘appointed’ doctors
shaped their confidence in their own survival and continued high quality-of-life.
While this chapter discussed the family and children in a broad sense, the next
chapter will examine more deeply the consequences of cancer in relation to subsequent
infertility and parenthood. It will present findings related to the use of fertility
preservation, perceptions about the technologies among providers, advocates, and
survivors, and how cancer has shaped survivors’ parenthood desires and goals.
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Chapter Eight:
Reproduction, Infertility, and the Healthcare Interaction
This chapter presents the results related to reproduction, infertility, and fertility
preservation. It begins by looking at providers’ and advocates’ perspectives on cancerrelated infertility: specifically, whether or not this is an issue being addressed in the
clinic, whether it should be addressed, and what barriers—provider-related, patientcentered, and structural—restrict access to currently-available fertility preservation
options. The chapter then turns to examining the perspectives of survivors: if this is an
issue they encountered, communication experiences with their providers, and questions
about reproduction and having children in Puerto Rican society more broadly.
PROVIDERS’ AND ADVOCATES’ PERSPECTIVES ON CANCER-RELATED
INFERTILITY
The following section provides an in-depth exploration of cancer-related infertility
and fertility preservation from the perspective of oncologists, oncology nurses, fertility
specialists, gynecologist, and advocates, who offer opinions gleaned from years of
experience with patients and survivors.
Perceived Importance of Issue
The six oncologists and two oncology nurses interviewed noted that they
believed it was important to inform their patients about the possibility of infertility as a
side effect, and to discuss fertility preservation options with them. However, they also
observed that the majority of oncologists in Puerto Rico either do not feel similarly, and
do not inform their patients about the infertility risks and available options. Seven
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advocates voiced their opinion that fertility was an important issue to their patients, some
even saying that it was the most important issue to the younger ones. For example,
Julia, an advocate/survivor working for a mainstream organization, noted:
“I do feel that it’s very hard for people who don’t have children, and it brings up a heavy
burden besides all the things you think about when you’re diagnosed with breast cancer,
because you already had your scare of dealing with the treatment—what’s going to
happen to you—and I am almost sure that when you add the ingredient that, ‘I want to be
a mother and I don’t have kids now’… especially if you know that estrogen can be a
complication and can promote the cancer developing. I know that for them it’s terrible,
and I do feel for those people, because it’s another burden. I really don’t know how well
the doctors are dealing with that, giving them all the options before they start treatment.”

Alba, an advocate who founded a local organization, believed that some newlydiagnosed patients try to convince themselves not to want children:
“There are others that haven’t had children, and in my own opinion, they [sometimes]
conform with saying ‘good, I don’t have kids because if I die I’m going to leave them
alone…how good that I don’t have children because now I don’t have this worry.’ But I
believe that all women in this culture would like to have kids because we’re born for that.”

However, several noted that it was a small population—in other words, that the numbers
of people affected by infertility after cancer, or those that would want or be eligible for
fertility preservation, are low. Dr. Henríquez, a 67-year old male oncologist, explained:
“It's important. It's not extremely common, because most cancer patients are obviously
not in that age. But for the ones that are, it can be a very important issue if they've never
had any children. That happens, for example, with the Hodgkin’s patients, where usually
they’re much younger than the average cancer patient; the patient would be 18, 20, 24
years old, and they've never had any children. Then it really becomes a big issue.
Fortunately, in that very young age group, the risk of infertility is lower, even after
chemotherapy. Most of them will recover it. Obviously it depends also on what kind of
chemotherapy you use, because the alkylating agents (for example, ifosphamide) are
more prone to producing infertility than the non-alkylating agent-based treatment. The
younger the patient is, even if you give them alkylating agents, the higher the chances
are that they will recover their fertility. But obviously you can never predict 100%.”

Several providers and advocates cited that because Puerto Ricans tend to marry and
have children early, by the time young adults are diagnosed with cancer, most of them
already have the children they desire, even though the general trend is towards later
childbearing. Dr. Corzo, a 49-year old male oncologist, detailed this idea:
“Yes, I think that [fertility] is very important, but most don’t want more children. In our
culture—and I think in the States, it is different—people tend to marry very early. They
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have already children at 18, 19 years, so most of them have completed their families
before [the cancer]. In my setting. I know in the pediatric hospital, they get patients that
are adolescents or younger. But in my patients, most of them have completed their
families. I remember two patients because one was going to get married, and the other
wanted more children. But it’s rare to see a patient not married with no children.”

At the other end of the spectrum (as described in more detail below in the
Barriers to Access section) some oncologists voiced their belief that their patients did not
necessarily care about infertility, or it became a low priority when faced with a cancer
diagnosis. Thus, they described taking their cues from the patients. Several oncologists
noted that their patients were too scared by the diagnosis and too distracted by the
thought of dying to devote attention to concerns about side effects. These all became
factors that both providers themselves and advocates noted created barriers to raising
awareness about the importance of disclosure and increasing access to fertility
preservation options. As Dra. Padilla, a 41-year oncologist, noted when asked about the
reaction her patients have when talking about infertility:
“All of them, they don’t care. I told you about the population that I see. They just don’t
care. They’re in the inpatient [unit], they’re sick, there are other things on their mind. I
don’t know what happens in the clinic, when a lady comes with breast cancer and she
has bilateral surgery and now we are recovering from the surgery and can do the banking
before the chemo. That’s another scenario. But in my scenario, they just don’t care”.

Dra. Padilla’s patients were mostly acute leukemia patients, who usually present as a
life-threatening emergency. On the other hand, Dr. Garcia is a 34-year old oncologist in
a community clinic, and he repeated the same idea:
“They ask [about sperm banking], but many of them, they aren't willing--they don't care
about that. I have many patients who don’t want to have any more kids. So that’s easier.”

Notions of gender emerged in participants’ narratives in several key ways. First,
a number of the providers drew distinctions between men and women with regards to
reproductive technologies and how the impact of treatment, and the fertility preservation
options available to them, varies according to biological sex.
“Sperm banking isn't that expensive, compared to what ladies have to go through. For
young women, probably the easiest, most effective and cheapest option is if they are
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already married and have a life partner or whatever, and if they do in vitro fertilization and
freeze it, that can be relatively cheap, relatively” (Dr. Pedreira, 42-year old oncologist).
“With women almost every [fertility preservation] option is experimental. The only
standard is embryo freezing, or moving the ovaries, or shielding the ovaries. But no,
ovarian tissue freezing, egg freezing, everything is investigational” (Dr. Jimenez,
reproductive endocrinologist).

Providers also discussed how the patients’ gender impacts conversation with them:
“When patients are about to have chemotherapy, since females get a pregnancy test, we
discuss about being pregnant, and treatment, and what the implications of treatment and
having chemotherapy on getting pregnant are. So we discuss it. With males, I think it's
different with males, because the issue is not ... they don't bring the issue up that often.
But I mean it's harder for a male to lose their fertility with chemotherapy than in females.
Females it's easier; males it's harder” (Dr. Colón, 43-year old oncologist).
“I think it's easier to orient males for future fertility and that's probably because of the
ease or how simple it is to preserve sperm before chemotherapy. It's probably less
expensive, less invasive, and it's been available for more time than female treatments or
female fertility preservation” (Dr. Cordero, reproductive endocrinologist).

Interestingly, oncologists noted stark gender differences in their patients’
priorities with regards to having children after cancer: women were seen to be more proactive about finding fertility solutions, looking for information, and generally placing more
value on discussing fertility risks and the importance of having children. On the other
hand, providers and advocates generally regarded men as “not caring” about infertility;
rather, they were seen as chiefly concerned about providing for their families:
“I don’t think that [men] feel that [fertility] very important. When I interview a couple, if I'm
talking about infertility, the female is the one that is very concerned, she asks why and
how, and will this be permanent? But the males, they kind of don't talk about those
things. It's interesting” (Dr. Colón, 42-year old oncologist).

When asked if he saw the same reactions in male versus female patients, Dr. Pedreira,
a 42-year old oncologist, answered:
“Very rarely, very rarely. The exception is if it's a young, recently-married man who hasn't
started to have children. You'll actually see more problems from the wife. The man is
scared of the cancer, wants to get rid of it, ‘let's go, doc.’ Social differences, not biologic.
But rarely, especially if they already have children, rarely will the man want to have more
children, once he's done with cancer. You can have a young lady with 2 children say ‘but
I really would like a third one, we are thinking about it. Doc, can we preserve my fertility?’
You're never gonna see that, or rarely, from a gentleman. As a matter of fact, if you flip
that over, the couples' reactions are really interesting. What are those pop psychology
books -- Men are from Mars, Women are from Venus? Whenever I have a young lady
with cancer here and we're talking about this, usually the man says, he'll say ‘kids?
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Forget about kids! Get your chemo now!’ Usually they don't think that far ahead; it must
be something in our DNA (laughing). But they are like, ‘no, get cured! I don't want you to
die. Forget about kids that don't exist.’ It's really interesting. But we do take into account,
a young man in particular who hasn't been married. We always advise them.”

Women were seen by all groups to be inherently maternal, to embody parenthood and
reproduction and to possess a strong instinct to procreate, as illustrated by Esteban, a
52-year old advocate/survivor, and Dr. Pedreira, a 42-year old oncologist:
“In Puerto Rico, 96% of the women want to be mothers. They want to be mothers.”
“In our culture, moms are maternal until YOU are 80. Not until SHE is 80, until YOU are.”

Commonly noted by oncologists was men’s tendency to voice concern about sexuality
rather than infertility, as mentioned by Dra. Padilla, a 41-year old oncologist:
“All of them think [about fertility] one way or the other. Of course in women, I think that
women are more open than that. They clearly say, ‘Am I going to be able to have kids or
not?’ Boys are not that open, but they kind of say ‘can I have a girlfriend? Can I be
sexually active?’ Some men ask about impotence problems—it’s going through their
mind; it’s just that the way that they ask it is not the same. So again I guess that the
answer is yes, they think about [fertility]. Sooner or later, everybody does.”

Several participants, providers, advocates, and survivors alike, drew linkages between
cancer and traditional notions of masculinity (or machismo)—e.g., difficulty in expressing
emotion, in reaching out, in being more resistant to reproductive technologies:
“The physician calls me and invites me and starts describing the history with the
[Caucasian] couple, in front of us. And he says, ‘well he's azoospermic; we can confirm
that with the semen analysis. But we've talked about options, a donor specimen.’ So the
doctor says – ‘it's okay, with the donor?’ And so the guy says, to the wife – ‘you want a
baby, right? Let's do it. I don't care.’ That's one part. That's culture, or education, or
whatever. I was dealing at that specific clinic with 10% of the population which was
Hispanic, and they came to our place because I was there, and I was able to translate and
whatever treatment and everything. Believe me, azoospermic Latinos -- it was really tough
trying to convince them about using a donor specimen. Forget it. And I was unsuccessful
to really convince them that the only way to have a baby -- not biologically speaking, from
his part, is going to be through a donor. Nope, nope...It's culture. It's just the macho thing,
perhaps, the idiosyncrasy. And I was able to distinguish both. Because again, I left Mexico
when I was [young], so I became acculturated to the Anglo-Saxon society, and I knew to
distinguish both. So that part to me is one influence” (Dr. Diego, fertility specialist).

Beliefs about Disclosure
Nearly all providers that worked directly in treating cancer patients—all six
oncologists, one surgical gynecologist, and one of the two oncology nurses—believed
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that newly diagnosed cancer patients should be informed about both the possibility of
infertility as a side effect, and fertility preservation options. The remaining oncology
nurse did not have a firm opinion as the doctor she worked for dealt with these cases
and with the medical side effects of cancer treatment. As Dr. Pedreira, an oncologist,
stated when asked how he decides whom to inform:
“Well, that is really easy. The best policy is not to judge anybody, so I tell everybody of
childbearing age. Everybody. If they are a nun, I would say, ‘Listen you can't get pregnant
during chemotherapy, and you're at risk of infertility.’ Because people change, you know,
people make changes in their lives. So you pretty much have to tell everybody.”

Sra. Acosta, a 34-year old oncology nurse, and Dr. Maldonado, a 37-year old surgical
gynecologist, agreed:
“Oh definitely [patients should always be told about infertility as a possible side effect of
cancer treatment]. Always. I tell the patients the benefits of the surgery and the
unfortunate side effects from the surgery or the chemotherapy or the radiation. So
definitely the patients should be aware of the possible effects of surgery…that's very
important for me when I have to do the informed consent for the surgery or treatment.”
“Yes, of course [fertility preservation should be discussed with the patients]. It is a really
important part of being a human being, it is part of us; we are sexual and everyone wants
to go through the experience of having children and it is necessary for everything.”

Actions about Disclosure in the Clinic
Despite the belief of the providers that all patients should be informed about
infertility and fertility preservation options as the ideal scenario, the situation gets murkier
when talking about whether or not disclosure was in fact happening in their clinics. Most
of these providers qualified their opinions by stating that they counsel only patients for
whom such discussion is appropriate. Definitions of appropriateness varied and affected
decisions about whether the oncologists did in fact inform patients. For obvious
reasons, two oncologists believed that it was not necessary to discuss the issue with
those in menopause or who were older when diagnosed, believing it to be a moot point.
Dr. Colón, a 42-year old oncologist, explained:
“If they are older females and older males, I don't think that we talk about these things
commonly. I don’t know if we assume that they already have family and that this is not
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important to them, but it's something that we don't .... It's not that I think it’s not
appropriate, it’s just not an issue.”

Others described how they spoke only with patients who were facing treatment
that carried a high risk of infertility. A few implicitly referenced the ethical dilemma of
informing patients with poor prognoses. Several oncologists noted that it was impossible
to bring this up with some patients who are in acute stages and need to be treated
immediately. In these instances, the topic of infertility must be dealt with later when the
patient has been stabilized. As Dra. Padilla, a 41-year old oncologist, noted:
“My experience when we admit young patients to the unit is that there are two types.
There are patients where you can actually sit down and say, ‘This type of chemotherapy
will affect your fertility in the future, so let’s see what we can do to preserve your sperm or
ova,’ but the other group of people comes to the door crashing. Really you don’t have
time to do that; you just have to treat them right away. That is really sad, because with
leukemia, once you start the chemotherapy, it’s ongoing treatment, so you don't have
time to give the body a rest […] If we have to treat them today, it’s not brought up at the
beginning. It’s just because we have to start. But if we can wait, we tell them.”

General Barriers to Disclosure
A significant theme in the provider interviews concerned the accessibility of
currently-available fertility preservation techniques. A plethora of barriers were cited,
reflecting a situation described by several providers as technology that is “available but
not accessible”—meaning that the procedures are offered on the island in multiple
locations, but layers of obstacles combine to prevent their usage in most cases of newlydiagnosed cancer among younger individuals. There was general consensus among
providers, including oncologists, infertility specialists, gynecologists, and oncology
nurses, that on the whole in Puerto Rico, newly-diagnosed patients were not being
systematically informed of either infertility as a risk or fertility preservation options. As
oncologist Dr. Pedreira noted, “Having said that we talk about it, we barely talk about it.
Really, people only talk about it in terms of [‘is she of] childbearing age? [Then] she's got
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to consider fertility preservation and then we forget about it.” Other individual and
structural barriers noted by providers are discussed in the subsequent section.
Provider Relationship and Communication Factors
Many obstacles mentioned fell into a category encompassing the relationship
and communication between patients and providers, principally concerning physicians’
lack of disclosure about fertility risks and options to patients. In general, providers
believed that patients were not informed of fertility preservation options and that this
constituted one of the major barriers to usage behind the high cost and lack of insurance
coverage. In explaining this lack of information, fertility specialists pointed to
oncologists’ spottiness in disclosure. Dr. Ramos, a reproductive endocrinologist, stated:
“The only other barrier would be not being aware because the doctor is not giving the
appropriate advice. The doctors have either not made them aware, or the doctor does not
want to offer the fertility preservation treatment to them […] The doctor himself might be a
barrier, you know? Might be a barrier to the patients becoming aware. Obviously
remember when patients have cancer, they only have one thing in mind -- cancer,
cancer, cancer -- they are not thinking about babies. They are not thinking of future
babies. They are thinking that ‘I want to get cured of my cancer.’”

Several fertility specialists noted the lack of time with which oncologists, urologists, or
gynecologists referred their newly diagnosed cancer patients for fertility preservation,
thereby limiting the options available to those patients. When asked how many cancer
patients he sees monthly, Dr. Jimenez, a reproductive endocrinologist, answered:
“Not even per month. Probably 3-4 freezings for sperm for cancer a year. The problem is
that urologists usually tell the patients like 2-3 days before the chemotherapy. It's always
in a hurry, and that's something that the primary doctor -- the oncologist -- has to do more
in advance. Because if you have chemotherapy tomorrow, what can I do?”

Dr. Diego, an andrologist, expressed frustration with how few patients get referred with
enough time to bank sperm, even though he goes out of his way to accommodate them:
“That's one of the things I don't understand. There isn’t a physician, oncologist,
hematologist or whoever, even a urologist, who says ‘I care for this patient, I want to try
to find somebody who does [sperm banking].’ I have friends of mine, urologists and
gynecologists, and we can just arrange something through the phone for the patient.
Those physicians care. But others... […] I used to go to the hospital when they called
me...I just take my microscope, take everything, take my culture media. The kid is in the
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bed because doctors don't want to let him go out of the hospital. He's already prepared
for [cancer] therapy. So I go there, I take my informed consent, I talk to the couple […] I
mean, I understand the situation; again, I’ve been doing this for 30 years. But that's all I
can do, because I got the problem when they bring the problem to me. But if I know in
advance from the physician or the patient what's happening, what's going to happen, if
we can help them, everything can be arranged really nicely.”

Several reasons behind this lack of communication were cited. First, providers do not
think it is an important issue themselves, or they are too focused on the curative part of
the process. As one oncologist noted:
“I don't think many oncologists have this type of conversation, unless it's obvious. Very
young female with no children; or they are taking drugs that says right across the label
‘this is very high risk for fertility problems.’ […] I think that we assume that maybe this is
not as important as treating the cancer. It is like the utmost goal is to have you diseasefree forever, no matter what the consequences. And this is a feeling, this is something
that patients bring to the table, and other physicians also. They think that this war against
cancer, and sometimes they don't think about the consequences of treatment. I don’t
think [that view] is changing. I think I have to work extra hard just to tweak that idea in my
patients to think different, because it's—‘I have cancer, I will die if I don't do this.’ So they
feel like it is obligated, and they have to accept all consequences. And sometimes they
don't think about long-term problems. Those are usually the ones who are unhappy about
the outcomes when they remain with toxicities, neuro-toxicities, or fertility issues. Now
they feel like they are cured; they don't have to worry about dying ... so now they realize
that they should have done something” (Dr. Colón, 42-year old oncologist).

Dr. Cordero, a 43-year old reproductive endocrinologist, voiced similar ideas:
“There are some hematology/oncologists that give orientation about fertility preservation
to patients, but I think those are the [minority]. Most of them are not giving an orientation
about that to patients. I think they think that the most important thing is curing the patient
from cancer, and they don’t put too much importance to fertility after cure or remission.”

Speaking about young patients who do not already have children, Sra. Benitez, a 53year old oncology nurse, stated:
“Some of these chemotherapies do give infertility, and those that do give infertility the
doctor lets them know, so they can decide what they want to do. In Puerto Rico, [that] I
know of, there is no cryo-egg or whatever. I know that in Miami there is one, or in Florida.
So I don’t know what these people do. I don’t know if they decide simply not to have
children and go ahead with the treatment. It depends on their priorities. If they decide that
they want their health, it’s their health, no children. You can live without children.”

Second, providers tended to believe that patients’ priorities were the children they had
already and focused on them rather than fertility preservation, as voiced by Sra Benitez:
“The young guy that had the bone cancer, he just had a kid. We knew he was going to be
infertile, but he has one. It’s not necessary to have 2 or 3. It depends on their priorities.”
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Other themes relating to disclosure among oncologists were not as strongly
developed. For example, a theme that is very well-developed in the US literature of
barriers to fertility preservation is that of time—oncologists refrain from discussing fertility
risks and options with newly-diagnosed patients because they have very little time for
patient consultation, and must prioritize which discussions to have—in this setting,
infertility is often not prioritized (Quinn, et al. 2008). Interestingly, only one physician, an
oncologist, noted that time may be a factor impinging on physician disclosure to patients
about fertility risks and options. The majority of others did not mention lack of time.
“Nowadays, time is always an issue. So I have to say, if physicians are not doing all
things required, it is because of time. But, I think that we assume that maybe this is not
as important as treating the cancer” (Dr. Colón, 43-year old oncologist).

The religious beliefs of patients and providers were seen to have varying levels
of influence on the use of reproductive technologies, specifically fertility preservation.
Four providers—one oncologists and three fertility specialists—personally knew of
oncologists who refused to refer patients or survivors for fertility services based on their
own religious objection to the practice, such as Dr. Cordero, a reproductive
endocrinologist:
“I know for a fact that [because of] the religious vision of a hematologist/oncologist across
the hallway, he doesn't recommend either fertility preservation treatments or even fertility
treatments in patients without any history of cancer. Because of [his] religious beliefs, he
has been an advocate against fertility treatments […] He's a very kind person, but he
doesn't believe in that.”

On the other hand, three providers voiced the opinion that religious beliefs did not affect
providers’ referral practices, such as Dr. Diego, an andrologist:
“I really don't think so. Because again, they might have other interests […] I really don't
know if there is somebody who, just because of a religious plot, believes that what we do
is wrong, and he's not going to refer or visa versa.”

Similarly, three providers, both oncologists and fertility specialists, believed that patients’
and survivors’ religious beliefs impacted their use of fertility services—such as Dr.
Jimenez, a reproductive endocrinologist:
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“There are people who won't tell their priests what they are doing. Or their community
doesn't want to let them know what they are doing. There are people who don't want to
do intrauterine insemination; they just want to do regular intercourse with treatment,
because they think that insemination is not natural. For most of the people, it's not a
problem. But I sometimes find a patient that tells me that she is having problems with her
family, or with her church, or they don't want to do that part of treatment because of
religion. It's not frequent, but I see it once in a while.”

Four believed that religious beliefs were not an issue, like Dr. Pedreira, an oncologist:
“Luckily most religions will see it as a medical issue, and the religions that usually have
something to say about it are against birth control. So fertility preservation – I mean, 90%
of Puerto Ricans are at least non-practicing Catholic, right. Catholics who never go to
church; we have tons of those here. The Catholic Church opposes birth control, but they
don't seem to have an opinion about fertility preservation.”

Fertility Specialists’ Perspective on Disclosure
While oncologists tended to emphasize the cost and insurance obstacles as the
main determinants of fertility preservation usage, fertility specialists, on the other hand,
focused instead on providers’ lack of awareness, particularly oncologists. They believed
that most oncologists were unaware of the existence of fertility specialists or the services
they provide. Dr. Diego and Dr. Figueroa, both fertility specialists, explained:
“Probably on our side, we don't give more information to the physicians than whatever we
have on the website. We assume that everybody is reading the website, but that's not
true. So that's our part. But we are so overwhelmed with so many cases that freezing for
cancer patients is just probably 5% of all the services that we have. Now, the patients
don't receive any education, not even good information from the primary physician. And
the primary physicians, they are probably so overwhelmed with so many cancer patients,
they don’t even have the time, not even a counselor or a secretary, who can follow up
with this couple and find the connections. There are no social workers among us. There's
something that we probably need, either a small center, or the university, that can provide
a small service. [An information clearinghouse]. That would be a win-win for everybody.”
“Even the physicians – not everybody is well-versed on what is available on our side for
fertility preservation.”

Significant portions of those interviews were devoted to discussing strategies that fertility
specialists had considered to more effectively “advertise” their services to the oncology
field in Puerto Rico. Dr. Diego continued:
“I think we are preparing ourselves, getting all the training and everything, and we know
that eventually we will be ready for these two parts -- the patients and the physicians. But
we still need to do our own part, just to go outside and tell them what we can do. Or get
together and do two workshops per year, somewhere, sponsored by a university or a
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company. Like a retreat between oncologists. We have a pretty good relationship with
OB/GYNS and urologists, because they are part of, if you will, what we do. But [we don’t
really work with oncologists]. But there are so many patients that can be treated, or can
be arranged to be seen by both. Because the oncologist doesn't have the techniques for
the procedures in place. So all they do is just recommend, or send the [patients] to the
US. So I think that's our fault, not to go there and say ‘hey, doctor, we are here.’ Some
physicians don’t even know that we’re here, and this is our fourth year already.”

Dr. Figueroa, a 42-year old reproductive endocrinologist, spoke about making
presentations at tumor board meetings to raise awareness among oncologists:
“We want to come up with a fertility preservation network in which we sit down with
different tumor boards and plug our expertise, and add a network of referrals and
physicians where you have standard protocol in which discussing options for preservation
of fertility is part of the protocol, in the same way the breast cancer patient gets her
needle biopsy done, and then she goes for the core biopsy, and then she gets referred
for the general surgeon, the plastic surgeon, and the oncology group. For us to be part of
that set of people that are going to be giving the information to the patient in a systematic
way, not something that some people remember and some don't...or some patients ask
about it and some don't. [Now], it's ‘whatever happens to be the occasion to discuss it.’
We want to write a formal protocol, which I'm sure that people in the States have, so can
provide our expertise as an option for the patients in a formal way.”

Other Barriers to Use of Fertility Preservation
Individual/Patient Access Factors
Cost was the biggest barrier that all providers cited to the use of fertility
preservation methods. This is unsurprising given that roughly 50 percent of Puerto
Ricans live under the federal poverty line (PAHO 2007), and, as in the US, fertility
treatment is not covered by any insurance on the island. Fourteen out of the sixteen
providers interviewed cited high cost and/or lack of insurance coverage as the principal
barriers to fertility preservation usage, particularly for women since the procedures used
on them are much costlier. Several oncologists noted that they had never had a patient
undergo fertility preservation because it was too expensive and not covered by
insurance, especially on top of the high cost of cancer treatment, the loss of work days
and sometimes jobs, and the generally low salaries and high cost-of-living that is the
current economic reality in Puerto Rico. Dra. Padilla explained her hospital’s situation:
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“The other issue is the financial issue, because people need like $1,500 to save their
eggs or their sperm, and most of the people that we see here at the medical center are
on Reforma; they don't have the money for that. And for someone with acute leukemia,
you’re going to be 4-6 weeks on the in-patient unit, which means your relative is going to
be coming every day, paying parking, getting food for them. All those extra expenses. So,
they don’t have the money. The ones that you can see, they say ‘Well whatever, I will
adopt.’ It’s just that, because of the acuteness of the disease, they just can’t.”

Dr. Pedreira, a 42-year old oncologist, related a story about one of his patients:
“You know the #1 block for them doing stuff about this is the economics. No health plan
covers this. For example, the other day I had a young man who was 24 years old, was
planning on getting married soon -- which he did a year later -- who had a Hodgkin’s
lymphoma, and it was a huge tumor. A 24-cm mass. So instead of giving him the routine
therapy I have him a German protocol, which is highly spermatoxic, because it's very
aggressive. I sent him to Dr. ___ for sperm banking, and he talked to his fiancé, and he
said ‘listen doc, I just can't pay that.’ When I first got here it was a little tougher because
there was only 1 person [doing sperm banking]. Now we have two people who are very
up-to-date, but our biggest block is affordability.”

All oncologists, plus another provider, believed that treatment delays created an
additional layer of obstacles for accessing fertility preservation—in other words, because
cryopreservation of eggs and embryos can delay cancer treatment for up to several
weeks (and sperm banking for several days), both providers and patients themselves
were hesitant to take what they perceived as a risk in putting off treatment. For some
cancers, such as acute leukemia, waiting for treatment is simply not an option as it is
considered an emergency situation. Dr. Garcia, a 34-year old oncologist, noted:
“Sometimes the younger people think about it, but they don't...if they cannot do it, they
prefer the cure more than having children in the future, but usually they want to start
treatment quickly, so sending them for an evaluation for preservation of fertility would
take time, especially here in Puerto Rico. That's a problem here.”

Dr. Pedreira related how fear drives patients to seek treatment immediately:
“Another problem besides the economic is the fear. You tell somebody they have cancer;
they don't want to wait until the gynecologist sees them and does procedures and tests.
It's like ‘I want my chemo now’ (pounding desk). It gets rough. I don't treat this sort of
patient because you have to be in a medical center, but young women with acute
leukemia. Now it's a deadly disease, they DON’T have the time -- you have to treat right
away -- and most of those will be sterile afterwards. The chemo is rough. It’s plenty
rough. It kills the stem cells and the bone marrow, so it’s going to be rough on the
ovaries. Sometimes people in the heat of the moment to get it done, you have to tell them
‘listen, there's a risk, but you gotta go; you need your treatment.’”
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Because of key informant feedback early in the study that highlighted the
difficulty of traveling to San Juan for medical care, the interview guide contained a
prompted question about the effect of travel distance on usage of fertility preservation.
All of the fertility clinics are located in San Juan, the capital city, which can be up to a
four-hour drive from distant parts of the island. Four providers saw this as a major
impediment for those who have inflexible jobs or no source of transportation. For
example, Dr. Maldonado, a 37-year surgical gynecologist, stated:
“We don't have a specialized doctor like an REI in the western part […] Being about 2-3
hours from San Juan, it's difficult for most patients to go although there are some basic
treatments that gynecologists (it doesn't need to be an infertility doctor) can do. Very
basic treatments.”

Dr. Garcia, an oncologist located about 2 hours from San Juan, reiterated this theme:
“We don’t have many [fertility clinics], so most of the people don't have much access to
them. Many of the people are poor, or they have [transportation] issues. I’m new here,
I’ve been in the area for one year, and none of my patients are willing to go. When I saw
in San Juan, my younger patients went sometimes because the fertility clinic was closer.
But here, it's not that accessible.”

Interestingly, while those four providers did cite distance as a major barrier (three of
whom practiced outside of San Juan), seven others disagreed, insisting that it is a small
island and thus distance is not an issue needing to be considered. Dr. Ramos, a
reproductive endocrinologist in San Juan, was of this opinion:
“Where there's a will, there's a way. Now, you've got a good point. The distance is not a
problem, because [there is a] the girl who has a brain tumor, and we just did the biopsy of
her ovaries. She lives in the western part of the island, in Mayaguez. So there's no
problem with that. There might be a problem if the patient is hospitalized or whatever, but
that's not the case. Distance should not be a problem, because the island is not that big.
It only takes you at the most 3, 4 hours to come from all corners. If they’re coming to San
Juan for fertility preservation, then they're coming to San Juan for a second opinion or for
another treatment, but I don't think distance is a barrier.”

Clinic/System Barriers
A final level of barrier to fertility preservation concerns clinic logistics and
challenges. Three of the five fertility specialists interviewed emphasized how expensive
it was for them to offer and maintain fertility preservation services for cancer patients,
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given the high level of resources that they are required to contribute in the form of
manpower, materials, and technology, and the comparatively small return they receive.
Because the average income in Puerto Rico is much lower than in the US, fertility clinics
must lower the cost of their services accordingly, even though they use the same
technology and materials. Dr. Ramos, a San Juan reproductive endocrinologist, viewed
fertility preservation as a service rather than a business:
“We have kept the cost as low as possible, and honestly this is more of a service than a
business, you know? This is more of a service. It's a huge responsibility. To have sperm
samples frozen for 5 years, for $950, up to 5 samples, and we need to pouring liquid
nitrogen into the tanks every 6 weeks, and granted that in the tanks there are many
samples -- but the liquid nitrogen has gone from $3 to over $6 a liter, and it's quite
expensive. Imagine the responsibility we have there for keeping somebody's eggs or
sperm frozen for 5 years...if something goes wrong, and all the liability that we could
possibly be getting into. All the expense of the liquid nitrogen, for five years, for $950?
Now, I think that's it's a service that we need to give the patients. I think it's a service.”

Dr. Diego, an andrologist, ratified the expense of storage for the samples:
“[It’s difficult for cancer patients to access infertility services in Puerto Rico] because
there are no health plans paying for services, so everything is cash basis. These services
are very expensive, and the reason is because we use high-tech equipment. Our
equipment is very expensive, and at the end, somebody needs to pay for the equipment.
Somebody needs to pay for the supplies, the culture, the media, everything […] We have
probably one of the lowest prices for [sperm banking]. Although it sounds like -- $600?
(makes expression indicating that it is a lot of money). But out of that $600, they pay
$300 for one year of storage. $300 for the first sample, and the next samples -- anything
they can do within one year, is $150. You saw those two tanks (referring to the tanks
where the sperm samples are stored). I need to refill those tanks almost every other day,
and that's very expensive because I not only use the liquid nitrogen to refill the tanks, but
to freeze [the samples]. I have to do a lot of freezing, and I use a lot of liquid nitrogen,
and that's very expensive here on the island. I’m not sure if they produce all the liquid
nitrogen here, or if they bring the big tanks on a boat from the US. That increases the
prices, but again, we are one of the cheapest places for that service. I don't charge if I
come Saturdays or Sundays, or if I go to the hospital. Because you see the people come
in, and they come with the cash, but I know that they are really, really broke to do that.”

Much of what makes fertility preservation challenging in this environment is the
loss to follow-up that the clinic experiences. Several physicians noted that they have
lost touch with most people who had undergone fertility preservation, and that they did
not know whether the patients were alive or dead. Even though they often do not
receive the yearly storage payments, they refrain from destroying the samples or
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embryos in case the person returns to use them. This situation places them in an
expensive predicament of freely providing the materials and manpower to maintain the
sample indefinitely. As Dr. Jimenez, a reproductive endocrinologist, explained:
“The problem is that we freeze sperm, usually in a rush, and we lose track of many of
them. We have the semen stored year-by-year -- we send them a card to renew if they
want to continue freezing -- and many of them don't call us back or there is no way to
contact them. And we don’t know if they are alive, or if they don't want to continue with
the banking, or if there is any problem with the sperm. That's another problem of why I'm
not trying to get into oocyte freezing, because I have a lot of semen frozen in the tank
with no way to know what to do with it, because we cannot get in touch with them. With
sperm, it's probably not a big deal, but with oocytes and embryos, it's more delicate,
because you have to stimulate the patient and the effort put into it...and that's a problem
that I do not want to deal with. What many places in the US do is freeze and then send
them to another place where they do the storage. But the problem is that with the
vitrification, the process of moving the sample from here to there -- if it's not done
properly, by just taking the straw for a couple seconds out of the liquid nitrate, it can
damage the whole thing.”

As this quote demonstrates, a related concern among fertility specialists was the
logistical challenges of cryopreservation, including maintaining high-level technical
expertise (especially for newer procedures, such as egg freezing), and the storage
facilities and procedures that would most effectively safeguard the samples. Because so
few people in Puerto Rico use fertility preservation, two of the fertility physicians noted
that a centralized cryopreservation and storage system would effectively allow all of the
clinics to pool their resources. However, one physician noted regretfully that because all
of the fertility clinics in Puerto Rico are in stiff competition with one another, this idea was
nearly impossible. Thus, even though all of the clinics participating in this study
described similar logistical challenges, territoriality has circumvented collective problemsolving in the current climate. Dr. Jimenez, quoted above, explained this in detail:
“I think that in Puerto Rico, because we are a small community, the ideal thing would be
to have one center dedicated to this type of process. Not every clinic has its own group of
patients doing it, but just one center decides that we're going to be the oncologic center,
and we have the reproductive tissue, and that center -- or a doctor -- would do the
process over there, and keep the oocytes over there, and they take charge of that
oocytes, so that each individual clinic doesn't have the responsibility of keeping track of
that. That center may have economic help from the government for that particular issue.
Because right now, the patient doesn't have any type of help at all […] And that center
[would develop more] experience [because they would have] more referrals, and make
everything cheaper, and it would be easier for the patients to do it.”
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Providers’ Opinions about Patients’ and Survivors’ Perspectives on Fertility
In general, providers tended to believe that patients’ desires about parenthood
did not change after they were diagnosed with cancer. Only one participant, a patient
advocate, noted that the members of the support group she ran were often too afraid to
have children after cancer because they feared birth defects. But for the majority, if they
wanted children before cancer, the fact of diagnosis and treatment did not alter that
desire. Dr. Pedreira, an oncologist, and Sra. Acosta, an oncologist nurse, explained:
“I don't have many patients who change their mind. Usually if at the beginning they
decide that they want to try to go ahead and have kids they stick with that.”
“[My patients] continue with the idea [of having children]; none of them have said to me
that having been diagnosed with breast cancer or something like that, then afterwards
they give up being a mother -- none, no.”

However, in general the oncologists articulated the idea that fertility and the desire for
parenthood in the future take a backstage to other concerns at the time of diagnosis.
Newly diagnosed patients are overwhelmed, they are afraid for their lives, or they are
concerned by the multitude of other issues that must be dealt with immediately. As time
goes on, however, their childless survivors began thinking about fertility again, months or
years down the line—as Dr. Colón, an oncologist, noted:
“I think patients are very distracted about their diagnosis, and the association that cancer
has with death. Everything else goes to a secondary level. They always think about:
what's going to happen to me? Will I be cured? Will I live? How much will I live? This is
the main issue with patients with cancer. They are very distracted by the cancer
diagnosis. But I know that once their treatment is over and they are cured or fall into
surveillance, then those issues are going to be brought up, and they are going to ask me
why I didn't tell them. So I think it's important because they are not focused on that. They
will think about family, pregnancy. They’ll think in the long-term, when they are over with
treatment. If I don't bring it up, it will never be discussed. If we don't go by proper sperm
banking counseling or tissue, or ovary preservation, it's going to be too late.”

Ethical Boundaries and Ambiguous Situations
Providers related a number of personally-challenging medical situations,
illustrating them with examples of patients and survivors that they had treated. Several
providers gave the example of acute leukemia patients, who must be treated as an
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emergency, in which there is no time to discuss fertility concerns. They described this
as an emotionally difficult situation for them, and one that they do not like to encounter.
Other providers described difficulty with patients who had what they considered to be
questionable priorities in the grand scheme of having cancer. For example, Sra.
Benitez, an oncology nurse, described patients who choose suboptimal treatment to
preserve their hair because they are unable to tolerate being bald:
“They don’t want to lose their hair and they prefer not to have treatment because of it. I
have a fear of those […] I had a patient that didn’t want to lose her hair because she had
two small kids and didn’t want to explain to them that she had cancer. So she negotiated
with the doctor; she wanted the treatment that was less toxic, so that the hair doesn’t fall
out. And you say, hey it’s a risk, but he gave her the treatment she wanted. With that
treatment, she had to have 8 cycles, and already in the 4th or 5th cycle she had cancer in
her other breast because it was very aggressive. Those are the people that do not have
their priorities in place, so I do find a lot of those.”

Some providers described the dilemma of fertility preservation or discussions
about having children with patients presenting with poor prognoses. It is a difficult
situation for the oncologist, who wants their patient to have a certain treatment in order
to give them the best chance of survival, to have a patient choose what the oncologist
might consider to be suboptimal therapy in an attempt to save their fertility. Patients with
poor prognoses or aggressive disease present a counseling dilemma for the
oncologist—they are unsure what course to recommend. Dr. Pedreira, a 42-year old
oncologist, recounted a story about one of his patients:
“That's a very delicate issue, and that is probably where it is hardest to guide a young
woman, but where you really have to be honest. What is the likelihood of the cancer
coming back? Do you really want to have a child if you have a 50% chance of
recurrence? And that gets rough; that gets rough. Because it's a cold reality hitting you in
the face, and saying ‘do you really want to have a kid when there's a toss of a coin
whether he's going to have a mom?’ And that is one of the roughest parts, when there is
a high likelihood of disease recurrence. The other day we treated a 38 year-old lady that
remarried with no children but who was in a relationship for the past couple years and
was planning on having children – she was 37, 38. But an ovarian tumor. Luckily, it was
very limited and the gynecologist just took out that ovary and fallopian tube and left the
uterus and the other ovary, and she saw the [reproductive endocrinologist] and did all the
procedures. I don't know. We treated her. But that sort of stuff makes you really nervous,
because the standard surgery for ovarian cancer is to take out the uterus and both
ovaries, okay? Plus all the lymph node sampling. The standard therapy is to take all the
reproductive organs out. But this woman said, ‘Hey if there's anything you can do.’
Luckily the decision had been made [by the time I saw her]. She didn't ask my advice on
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that. Because I don't know; it's rough. Because of course I gave her chemotherapy, but
she's having suboptimal surgery for a disease that has a 50% cure rate. And she's having
suboptimal surgery so she can have a kid. Sometimes the emotional aspect of what
motherhood means gets in the way and it gets a little rough.”

He ended his story by saying:
“Sometimes it's really hard to tell somebody, ‘Listen I wouldn't do this if I were you. You
don't want to leave your kid without a mom or a dad if you don't have to.’ If you already
have the kid and you get the disease, that's nobody's fault. But if you don't and you have
a high chance of recurrence, it's rough.”

His concluding comment is interesting in that it both denotes his own emotional struggle
with this situation—by recounting how it is difficult to discourage someone with a poor
prognosis from thinking about having children or undergoing fertility preservation—and
implies a negative judgment of patients or survivors that do go forward with this decision.
On the reproductive endocrinology side, several providers referenced the postmortem tissue debate. Briefly, one of the challenges confronting fertility clinics that has
been discussed substantially in the literature is whether or not surviving family members
or spouses should be allowed to use their deceased loved ones’ stored gametes or
tissue to have a genetically-related child. This has surfaced in the fertility preservation
literature, and—as referenced in Chapter Two—the ASRM currently adheres to the
stance that, in the event that the patient or survivor dies, advance directive forms would
either direct the gametes to be destroyed or allow for specified individuals to use them
(ASRM 2005). Providers in this study ended up taking different stances on allowing
relatives of patients or survivors to use post-mortem tissues, with one clinic barring this
procedure altogether in its consent form, and another leaving it open for consideration.
This was discussed as a difficult ethical choice to make in deciding what services to
offer—for example, Dr. Ramos, a reproductive endocrinologist, stated:
“There’s only ONE exclusion that I can think of. The only real exclusion that I can say is
that we, here in the office, only because of our personal reasons -- no law or anything -we don't do post-mortem treatments. If you die, you die. With that dies your reproductive
tissue, whether it has been preserved or not. I believe that it is very emotional, and at this
time, we have about 4-5 frozen sperm samples that every year we send the bill to the

222

patients, and: ‘oh well, I'm sad to say that my son died from the cancer, but I want to
keep it frozen because...’ You don’t revive a dead person and substitute it for another one
using his sperm. Or the wife – ‘I want to use my late husband's sperm to get pregnant’ ...
and especially if you were to be a well-to-do person and there's an inheritance involved.
We don't want to mess around with any of that. So it is in our consent form, it is very,
very, very clearly stated that we don't do post-mortem insemination. We don't use
reproductive tissues after death. Now if you want to use it, you take the vial somewhere
else, and you do it. If someone else wants to do it, fantastic. But we're not going to do it.”

Providers also mentioned other situations that present ethical and moral
challenges for the patients and survivors themselves. For example, fertility preservation
presents inherently “sticky situations,” according to one oncologist, that has to do with
the durability of relationships and raising children. Women without a male partner must
either freeze eggs alone (a less effective procedure than freezing embryos) or select a
male sperm donor, while women with male partners can elect embryo freezing, a
standard-of-care procedure. The challenge presented to single women is clear;
however, an oncologist, Dra. Padilla, noted that even partnered women must face
difficult realities in thinking about whether to use their partner’s sperm in the future:
“They should be told [about fertility preservation], and I think there’s an ethical issue
behind […] You know ‘I have my husband today and maybe we want we decide to do
fertilized eggs and what happens after if we get divorced and you know?’ It’s a big
issue—it’s sticky all around. ‘The good thing it that I survived this cancer and we got
everything together and we have eggs. The other issue is that if we divorce or I die, what
are you going to do with the eggs? Who is going to be raising my kids? That idiot that
you’re going to be marrying later? I don't like this. Or if we divorce, those are my kids,
but…’ In my opinion, just do the eggs and do the IVF later. But that’s not technical advice;
that’s just my opinion. In general I do not get into that detail.”

The challenges facing women with BRCA1/2 mutations were mentioned several
times. Some of the providers had clients or patients who had elected not to undergo
fertility preservation for fear of passing along the mutation to their children. Angela, an
advocate/survivor, commented on this theme:
“This young, 30-year old woman with cancer, whom they told, no, she had to remove the
ovaries in order to reduce whatever the risks of metastasis. She told me ‘I’m not going to
bring children into this world who will go through what I went through.’ She was thinking
about if she had a daughter the same thing could happen to her, so she don’t want to
bring a girl to this world that could develop cancer too. She decided that she was not
going to have children. Painful, painful.”
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Finally, providers and advocates also mentioned pregnancy and cancer. Women
diagnosed with cancer while pregnant face the agonizing decision of whether or not to
abort. This was experienced by Maria, one of the survivors in this study (described later
in this chapter). Dra. Padilla explained the emotional difficulties of this situation:
“Usually when they are in the first trimester, we advise to have them do a therapeutic
abortion, just because the baby won’t make it. And it’s terrible. You have to sit down with
these patients and talk with these people, and everyone will make a different decision
according to their beliefs, but in general in Puerto Rico people like to keep their babies.
‘Whatever you have to do, let me go through it.’ Sometimes it’s just a matter of giving
chemo in modified doses to keep the leukemia counts more or less stable, so it’s kind of
a challenge, but in general every time we could, we do it. But that scenario is very hard.”

Advocates’ Experience with their Children
Several advocates themselves had children when they were diagnosed with
cancer. Their comments reflect the importance of children in their own recovery and
dealing with the treatment. Julia, an advocate/survivor working for a mainstream
organization, recounted:
“For my kids I know they are better human beings because of what I went through. First
off, they are angels. They are now 22 and 18, and they are very sensitive. When I was
doing treatment, my youngest one […] when I lost my hair for him it was very impressive,
because I always wear makeup and whatever, so for him it was very hard to see me
without hair. When I got home from the chemos, he was always waiting there for me. So
you saw his need to help, and he was there sitting with me all the time holding my hand.
When I got home I had to lay down, and he was there holding my hand and I would open
my eyes, and he already had gotten a bath and was in his PJs watching TV in my room
but holding my hand. Before midnight, he would say, ‘you know Mom, I’m going to bed,
but if you need something please let me know.’”

Nina, who was diagnosed and treated for lymphoma in her early twenties and went on to
found a local foundation for cancer patients, was informed about the risk of infertility but
not about early menopause. She had one child right away, assumed she was fertile,
and waited before she tried again. In the meantime, she went through early menopause.
“In my case at the time, they didn’t offer me [fertility preservation], and I was able to have
a kid. I have one daughter, but after that I had early menopause. So at least at that time I
was able to keep some eggs, but I wasn’t told, or I wasn’t advised to do that.”
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However, raising the children during illness presented its own extreme set of
difficulties, as exemplified by Lucia, an advocate/survivor working for a mainstream
organization. The fear of leaving children as orphans was reiterated by many survivors:
“WOW, let me tell you [that having children] is very important; it is a great responsibility—
it is something beautiful—but it is such a huge responsibility, you know, and such great
fear because a mother doesn’t like leaving her children as orphans. A father doesn’t like
leaving his children as orphans, given the uncertainty [of cancer]. And I imagine that in
the present time it is more traumatic than it was in mine […] All that my children
suffered…Because I used to say: ‘what if they have to get used to someone else and I
have not taught them well?’ If they had to make white rice and fried eggs and the rice
was not made properly, I would argue with them tremendously. I was hostile with those
children during that period…They did not deserve that. [The reason] was that I wanted to
get them ready. All that I haven’t done, I wanted to do it in six months. It was not fair. And
after I have had the opportunity to ask for forgiveness, apologize, all those things, okay
[…] I had a very good husband, but I never will forget that at one point he got very
overwhelmed by how I was taking care of the boys, that he said to me: ‘look, don’t worry
because if you die, in six months I am going to look for someone that can help the boys.’
And this made me hysterical, furious. But, you know, every cancer patient has their own
story related to the responsibility of motherhood or fatherhood.”

SURVIVORS’ PERSPECTIVES ON CANCER-RELATED INFERTILITY
Nineteen survivors had children at the time of diagnosis, while four did not. A
total of ten participants reported that, at the time of diagnosis, they had wanted more
children. Three of those had indeed gone on to have another child, in all cases
biologically, while one was in the process of adopting. The rest had not—two because
of sterilization (a participant’s own, and another’s husband), and the rest generally
because of timing issues, or because they were unsure whether to proceed.
Accounts of Patient-Provider Discussions
One of the questions that this dissertation addresses is whether or not the
disclosure conversation is happening with oncologists. From these data, it appears that
it is happening on a very inconsistent level. Eleven participants reported that their doctor
had addressed the issue with them in some form, either to ask if they had children and
wanted any more, or to tell them that their treatment may cause infertility. Sofia was a
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mother of two young children when she was diagnosed at age 38 with breast cancer;
when asked if her oncologist had talked to her about having children, she responded:
“Yes, yes, yes, yes, he asked me, he asked me, yes. The oncologist asked. He told me
that I could—after the treatment the majority of women lose their menstruation and their
ability to have children. He checked me after it was over and told me that in my case,
mine was not affected.”

Soledad also had two young children when she was diagnosed at age 30 with breast
cancer, and her oncologist spoke with her as well before her treatment began:
“He asked me if I had children and that if I wanted to have more, and I told him that I had
children, that I didn’t want any more, so perfect. But he said that from there, as I was not
going to have any more menstruation, it was impossible [to have more children]; yes, he
told me. Yes, he asked me but it was not an issue that we had to delve into, so we didn’t.”

A total of twelve survivors reported that they were not informed; four of these
maintained that their oncologists did not discuss fertility with them because they knew
that they already had either had a tubal ligation or a hysterectomy. Eight others reported
that no such conversation had taken place with their oncologist or other primary
physician prior to the beginning of treatment. Several participants reported that their
doctors should have told them whether or not they had or wanted additional children,
and were upset that this conversation had not occurred.
Obviously, these numbers are only partial as not everyone’s treatment presents
infertility risks, so it is not the best indicator given that exact data on all participants’
treatment parameters and chemotherapeutic agents is unavailable. What can be
extrapolated from this data, however, is that the inconsistency of the conversation is
worrisome. Two layers of information need to be transmitted in order for newly
diagnosed cancer patients to be prepared to access fertility preservation services. First,
they must be informed that infertility is a possible side effect of their particular treatment.
Second, they need to be informed that there are such options as fertility preservation,
and given referrals and information about where they can access them. Providers often
addressed one aspect of this with their patients but not others.
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Two cases are instructive in this regard. Camila, a recently-married, 22-year-old
woman, was diagnosed with breast cancer shortly after giving birth to her first son. Her
treatment, which included alkylating chemotherapies, was fertility-compromising. She
had grown up wanting and expecting a large family of six children. However, no one on
her oncology team described the risks to her fertility or informed her that it was a
possibility; she learned about this one year after having completed the chemotherapy
regimen through another oncologist that she had changed to after dissatisfaction with
her first oncologist proved to be too much. Her anger at this omission of information was
made more intense by the fact that the first oncologist had spent a great deal of time
discussing the prospect of hair loss and nausea with her, and because she would have
been very willing to pursue egg or embryo freezing in order to ensure her chances of
having genetically-related offspring.
“My experience was very bad with my doctors. I went through a lot of doctors, and
unfortunately because I was so young and so ignorant about cancer, I stuck by the first
doctor that I went to, the first oncologist. […] I went with the first thing that he said. And
he only told me, you’re going to be nauseated and you’re gonna lose your hair. He didn’t
tell me that I could become sterile at 22; he didn’t tell me about all the side effects that I
could have, the fatigue. He just focused on ‘you’re going to lose your hair. You’re going to
throw up.’ So it was kind of a surprise when I started having all these other things.”

She offers clues as to why she thinks the doctor did not tell her about infertility: because
she already had a child, telling her about the infertility risks and available options was
perhaps a moot point (which she contests). As she reported:
“[I would have liked to find out about the fertility risks] immediately, because I was so
young. I didn’t want to be greedy or selfish. People would say, ‘oh, but you already have
one child.’ But I don’t think any child is replaceable with one another. You have children
and they’re totally different, and one can’t replace the other one. He knew that I wanted to
have more children. So it was frustrating, and I would have liked to…I was not even
interested in learning whether or not my hair was going to fall out, because it was not
important anymore. It was more important for me to know that I was going to be sterile
than to know that my hair was going to fall out. Because I don’t need my hair for anything;
it just looks nice. So, I mean I got upset and I would have loved to find out even before I
started the treatment, or the possibility of getting chemotherapy.”

Camila went on to discuss how her negative experience has motivated her to counsel
other young, newly-diagnosed patients about seeking out all their options:
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“I don’t know exactly when I found out [the possible infertility], but I’m sure it was probably
a year after I had taken the chemotherapy. And that’s why I was really mad, because you
see all the celebrities that come on the TV, and they immediately go and freeze their
eggs, but I didn’t have that chance, and they never gave me that chance. That’s why
when I hear about a friend of mine who has been diagnosed with breast cancer, or
anyone that has been diagnosed with breast cancer, because I belong to a group…
usually, if she’s young they send her to me right now. So I can speak to them—not to
take treatment; I’m not supposed to say that, but just make sure that you go to 1-2-3
doctors before you choose to take a treatment. And make sure and ask whether, if you
want more babies, whether you can have more babies after chemotherapy or not. I try to
give them the orientation of what I didn’t get, so they can get it before the treatment, and
at least change someone’s life or help them a little bit more, with being this is what I need
to do, or this is where I need to go. I found out really late, and I was really frustrated.”

The other case is that of José, a 27-year-old survivor who was diagnosed at 26
with Hodgkin’s lymphoma. This participant had been recently married and reported that
he and his wife both greatly desired children, especially a daughter. His oncologist, a
prominent doctor on the island, had informed him that his treatment posed a risk of
infertility, and, although it was a relatively low risk, the doctor felt that it was important to
inform him. However, José did not recall being given information on the option of sperm
banking, and was merely told that the oncologist would re-test his fertility levels after the
end of treatment. One of the reasons this omission is significant is that the office of this
oncologist was located directly down the hall from one of the only sperm banking
facilities on the island. José recalled the following exchange:
“I am 27 years old, and I don’t have children yet. The doctor told me that I could become
sterile but there is a small chance of that […] He told me that at the end of the treatment
we’ll verify it, there will be some counts, all these things, and verify that I’m still fertile and
am able to have a child. He explained to me everything since the beginning. It’s not that
he didn’t tell me; I couldn’t say that he didn’t tell me. He took all his necessary
precautions in telling me and I took the risks.”

The two scenarios described above are contrasted with the case of Magdalena, a
woman diagnosed with breast cancer at age 45. She had two adult children from her exhusband, ages 27 and 20 at the time of her diagnosis. She had sought a tubal ligation
after the birth of her second child and her subsequent divorce, because she was
struggling financially and did not feel that it was fair to have another child under those
conditions. In this case, despite the existence of grown children and her previous
228

sterilization, her oncologist had an in-depth discussion with her about her desire for more
children and the fact that the treatment would likely render her infertile. In fact, this was
a pattern in the data: older women were more likely to have had (or to remember) a
conversation with their oncologist about infertility and options before the initiation of
therapy, versus younger patients who are less clearly finished with childbearing. When
asked about this conversation with her oncologist, Magdalena recalled:
“Yes, [my oncologist] asked me questions [about having children]. He asked me if I was
single, if I wanted to have more children, because although they were older, I was 44
when I was diagnosed. But I looked very young. When I told him that I had the operation
[tubal ligation] and I didn’t have a partner and that I, really, didn’t want more kids. I have
my two sons and I devote myself to them […] He asked me if I wanted to have more
children in the future. And I told him, ‘well, no. Because I got the operation for a reason,
really’ […] He told me that the treatment could leave me infertile, and that the probability
[of infertility] was great in my case.”

Importance of Fertility to Survivors
The importance of fertility to survivors depended upon their age, the number of
children they had prior to treatment, and their desires for future children. Generally,
participants did believe that fertility and parenting were supremely important in their
lives; of course, its importance at that moment depended upon the participant’s life stage
at the time of the interview. We can, however, identify some trends: first, those survivors
who had completed their childbearing prior to their diagnosis maintained that other
issues were more important than fertility and parenting. For example, when asked about
how she felt when her oncologist discussed the prospect of infertility with her, Soledad,
mother of two when she was diagnosed at age 30 with breast cancer, stated:
“Since it didn’t make me uncomfortable, with respect to not having children, then it wasn’t
something that caused any pressure or anything, because I already made a decision not
to have more children, [so] in reality it was not something that affected me.”

Despite these survivors’ statement that they did not want further children, many
expressed a profound sadness at the ending of that possibility. Veronica, who had two
young children when she was diagnosed at age 36 with breast cancer, reflected:
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“At first it made me sad, because I come from a big family and I have 4 siblings and it
made me sad because as I said, I only have two kids. One doesn’t know what’s going to
happen with your children next. But at the same time, I said that I have to accept it
because I have to take care of the two that I have, not for the ones that come later.”

Most of these participants, when asked hypothetically how they would feel if they found
out prior to treatment that it would leave them infertile and they did not already have
children, empathized with this predicament and responded that it would have been
extremely difficult. Soledad, quoted above, reflected on this:
“Someone that wants to have children and goes through stuff like this, yes, definitely it
has to be really difficult. It’s not a situation that I would had wanted to go through…in
order to realize yourself as a person, as a woman, as a human being […] It must be really
hard; I would not have wanted to go through that dilemma because it would not be easy.”

Likewise, Magdalena, who had two grown sons when diagnosed at age 45, empathized:
“My God. I would have been affected greatly. That itself would have killed me. Because I
love children and I always wanted to have children. I have my grandchildren; I did not
have grandchildren [when I was diagnosed] and that affected me, thinking that perhaps I
[wouldn’t live to] see grandchildren. Because my children were not married. That had
affected me greatly, honestly. Because no, I cannot visualize my life without my sons,
without having children. I always wanted to have children. Always.”

These participants were very much concerned with their living children, and the
impact of their diagnosis upon them, as discussed more extensively in the previous
chapter under Family, Friends and Partners. Other participants included those who had
not yet finished with their childbearing, who desired to have future children, or even
those who answered that they did not necessarily want more children but for whom the
loss of fertility itself (and the possibility it carried for future children) was quite disturbing.
For these participants, the issue took on greater importance and had greater impact on
their psychological and emotional reactions. This is exemplified by the quotes above by
Camila, whose doctor did not inform her of potential sterility caused by the treatment.
Sofia, mother of two young children when she was diagnosed at age 38, explained that
her concern was for her living children rather than any future children she might have:
“At least in my case, my concern was about living for those who I already had, that is, at
that point my worry was to be alive, [so] to me [infertility] didn’t matter. I can say that I
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went through a lot of physical changes. I was really skinny. I weighed like 133 lbs.,
something like that, and I gained like 15 lbs. with treatment. I didn’t have hair, but my
approach was, ‘this is what I have to do to stay alive’. The issue with children at that time
wasn’t a concern for me, because I wanted to live.”

However, she went on to talk about how difficult the realization about infertility was,
especially since several of her friends were pregnant at that point:
“I am 42 years old [now], when I turned 40 many of my friends were having children at
this point and yes, I got some—it was not jealousy, but I was uncomfortable, [because I
knew] that it wasn’t an option for me if I really wanted to have more children […] I have
two children and I don’t need more. But at that moment of wanting them but not being
able to have them, it bothered me, it made me uncomfortable, not being able to, that
change. I would not be the decision-maker, because it would be the treatment. It must be
very difficult for people who have not had or want to have more.”

Inez, who had three children when she was diagnosed at age 38 with breast cancer, was
upset that she was not informed, even though she had gone through tubal ligation.
When asked about whether her doctor had talked to her about infertility, she responded
that oncologists should always inform their patients about this whether or not that patient
has children—or even if they have had previously been sterilized:
“No, that subject was not addressed, because I had three [children] already, and I was
operated on also. I had been sterilized. [He never talked about it.] No. Never. They never
explained to me either that the chemo could make my ovaries stop functioning. If I would
like to have more children? They did not orient me. [I feel] very sad, because although I
had three already and I did not want more, I think that they should orient you about it,
because if your plans are to have children or if you have one and you want to have
another one—and I know of people that have done it—they should be oriented, of course,
to save their eggs. So, the doctor, without knowing, should orient [the patient]. If you have
children or not. They did not tell me anything; he did not ask me and did not orientate me.
He went from the premise that I had three children and did not wanted any more.”

Views on Adoption
The majority of participants would consider alternatives to having their own
children, principally adoption. One of the participants was actively pursuing this, albeit
abroad because it was too difficult to adopt in Puerto Rico as a cancer survivor.1 Two

1

To my knowledge, there has been no research into adoption by cancer survivors in Puerto Rico.
Limited research in the US indicates that it can be difficult due to adoption agencies’ health
restrictions for prospective parents—thus, discrimination against people with a history of cancer is
not uncommon (cf., Rosen 2005). Further, adoption of an infant can entail long waiting periods.
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others regarded it a real possibility in their future. When asked if they would have
considered adoption had they not had all the children they wanted after their treatment
ended, six others said yes. For example, Alejandra, who had two young children when
diagnosed with breast cancer at age 31, explained why she would have tried adoption:
“There are many children, and I have seen families that have had the privilege of having
an adopted one that have felt as equally realized as parents and sometimes, even though
the child is adopted, it fills them with a lot of satisfaction and many more achievements
and much more happiness than their own. That it is incredible, almost absurd, if I gave
birth to it, if I raised it equally to the other and the [adopted child] is more grateful.”

Magdalena, mother of 2 sons when she was diagnosed, explained her openness to
adoption as arising from a deep love of children, no matter whose they are:
“But maybe I would have considered adoption. Of course. Why? If, for example, I had an
immense desire to have a baby. I think that, the mother is the one that raises them—
because to give birth is [only] a single moment and the pregnancy is only 9 months, in
relation to the whole life that one has to sacrifice. I always have been very, very maternal,
and besides, I love children, I basically took care of all my nephews because I was really
young when compared to my sisters. My sisters are much older than me. I was 13 years
old when they started to have kids. I took care of them all and was enchanted. People
said ‘this baby is so young and she enjoys it,’ and they give them to me. I had 7
nephews/nieces when I was 13, 15 years. They always left the [kids] with me. I love
being with them. I’ve always enjoyed children. I’m fascinated with children. I don’t see
any problem with adopting one. Or maybe [adopting] a family member.”

Elena, age 40 when she was diagnosed with breast cancer, with three children,
explained that she had thought about adopting after her treatment but she decided
against it because of concerns about her health:
“Of course I would have done an adoption. My daughter wanted (us) to adopt another
baby, but I was thinking about my condition, I didn’t risk any more.”

As the last quote above implies, some participants expressed misgivings about adoption
or other third-party reproductive options, mostly relating to questions about the legal
process of adopting. Rosa, for example, had had much difficulty conceiving her only
child, and she explained that, had she not had her child when she was diagnosed, she
would have lived childless after treatment instead of trying adoption:
“Here adoption is so rigorous that it takes years and they never say yes. I think that, no, I
would have conformed to the will of God [and not had any children].”
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Andrea, who had one daughter when she was diagnosed at age 26 with angiosarcoma,
expressed misgivings with adoption:
“[Adoption] would be good, but you would also have to think about it because one has to
make sure that the real mother doesn’t come to take it away from you, you know. You
have to think about it hard to be able to make that decision. Because you fall in love and
afterwards the real parents appear and by law they have the right and they take it away
from you and one is left sadder, you know—it is a really difficult decision to make.”

Changing Views on Having Children
When asked whether their views about having children had shifted because of
cancer, the majority answered that their views had not changed. This is interesting
given how much credence most of the participants had given cancer as a transformer of
life direction, values and priorities, as discussed in the previous chapter. Daniela
explained that the experience of cancer reinforced her already-existing desires for
parenting—in her case, she had never really wanted children, and having cancer
confirmed to her that this was the right choice for her life. She was single, with no
children, when she was diagnosed with breast cancer at age 32:
“Thank god, no [I don’t want children]. Cats are enough. I never wanted children. It’s not
an issue for me. It’s not an issue. [Cancer did not change the way I view having children].
No, no. A person would be a hypocrite to say that—for me, obviously, my opinion. You
would always like to have an alternative. Even if you say you don’t like to have children,
you always think ‘Oh, if I want to I could have it.’ But this experience, because of the
health situation … the experience actually reinforced me to really don’t want kids.”

Marisol, the only other survivor in this sample who did not want children, responded
similarly. She was 36 years old when diagnosed with breast cancer, and had been
divorced prior to her diagnosis because her husband wanted children and she did not.
All other participants either did want children in the future or had children already. This
experience was a common one; cancer had reinforced many participants’ alreadyexisting feelings about parenthood and having children. Francisco, a young student and
oral cancer survivor who had not undergone fertility-compromising therapy, outlined the
various ways that having cancer affected one’s perspective on childbearing—for
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example, he stated that some people are afraid of passing cancer to their offspring, and
because they do not want their child to go through the same experience as them, they
refrain from having more. Others do not think about having children before cancer, but
the experience awakens them to the realization that they want to be a parent before
dying. However, he ended by stating that his own perspective had not shifted—he
wanted children before, and continued to want them afterwards:
“Well, I did not change much. I have always wanted to have two or three, no more, and
my wife also. Before and after also. What did change was my way of sharing with my son
(in fertility there was no change). I share more with my son than before, because I was in
the US without my son for a ton of months; when I returned I nearly tore his head from his
neck because I was hugging him and I did not want to let go.”

Camila, diagnosed at 22 just after the birth of her first child, explained that her desire to
have children did not change after cancer, even though other aspects of her outlook did:
“[The things that have] remained the same…I guess my optimistic view. I’ve always been
like that. I’m not a quitter, but I’ve always been like that. If I get frustrated, if I fall I get up.
But I mean, you change. There’s no possible way that you have cancer and not change.
That comes with the package. I’ve always wanted children and that doesn’t change. I
have my children and I love them. So, you go through a transformation whether you want
it or not […] I’m not the same person I was before.”

There was, of course, some variation in these responses. Some participants were
scared to have children, explaining that their reservations stemmed from fear of
transmitting cancer to their offspring or the risk of birth defects from the treatment. One
young woman had a daughter when she was diagnosed and had planned to have more;
after treatment, however, she stated that she did not want any more children, implying
that she was frightened of the extra layer of responsibility. Cristina, a colon cancer
survivor who had been treated with surgery and chemotherapy, stated:
“Well maybe if someday [my daughter] wants a sibling, [then I’ll think about children]. I’ll
tell her that maybe we’ll have to adopt. I don’t know if those [chemotherapy] chemicals
would affect me somehow. That’s what worries me, that you try to have a baby, and the
baby suffers consequence from those chemicals. In that sense, I won’t carry it at least.”

Likewise, Eva, a breast cancer survivor, was concerned about passing something
cancerous to a future child. Because of this, she would not have another child.
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Reproduction in Puerto Rico
Children are highly valued in Puerto Rican society, according to participants.
They spoke about how the desire for children and/or large families is a cultural trait,
something that is, at its essence, “Puerto Rican.” Therefore, having babies was a strong
social expectation for members of the society. As Magdalena, a breast cancer survivor
and divorced mother of two, stated: “It is part of our culture, of who we are. We are like
that and the great majority of us want children.” Inez, a now-47-year old divorced breast
cancer survivor with three children, voiced her opinion when asked how important
childbearing is to Puerto Ricans:
“To have children for Puerto Ricans? Pffff. It is important, yes. It is cultural. They are
prepared for it, a chip that puts in the information: you are going to study, you are going
to prepare, you are going to get married, you are going to have children. It is like
something cultural. You know, it’s important to have a family. There are very few that
decide not to have children in Puerto Rico.”

Luisa, a partnered 35-year old uterine cancer survivor who was in the process of
adopting, concurred with the above views of children in Puerto Rico:
“Uf! Here? A ton! Because the belief: you marry, you have to have a baby, you marry and
you have to have a baby; yes, here it is important, really important, to have at least one.”

Juanita, a married mother of four who was 40 when she was diagnosed with breast
cancer, spoke about the expectation of children immediately after marriage:
“Our society is driven by the family. They get married, and if you have a couple that
marries and has not had children, then people start to ask them for kids: ‘where are the
kids?’ As a society, like we are driven by, it is grounded in, the family.”

Eva, a 44-year old married mother of two and breast cancer survivor, thought that the
purpose of marriage in the United States was different than in Puerto Rico:
“I think, because at least I know and I come from a big family and…that they want to have
children. I think that the marriage that Puerto Ricans have is more to have children than
the American [marriage]. I have that impression. To create a family.”

Daniela, a 33-year old breast cancer survivor with no children, noted the difference
between rural and urban parts of the island relating to childbearing expectations:
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“Ooooopph. Here people have their babies without finishing high school. We are really
hot people (Laughing—joke). At my age, if you’re not having kids, they think you’re a
lesbian. Or you would not have a boyfriend anymore, your chance is gone. You’re too
old. That’s more people in the [rural part of the] island. People who are more in the city
have another view. More young people. You know—different view.”

Some participants referenced an infertility stigma—for example, Sofia, a divorced mother
of two and breast cancer survivor, stated:
“If you do not have children people criticize you or say whatever atrocity. I have seen
friends of mine who cannot have kids and people say – a really ugly word, like ‘barren,’
which they tell me. Things like that, culturally yes, when you are married everyone
expects you to have kids.”

Others linked the importance of having children to the continuation of a family name,
such as Alejandra, a now-46-year old divorced mother of two and breast cancer survivor:
“Well, there are people that are happy without [children], but I know that the great
majority believe that it’s important to expand the generation and to continue bearing the
name from generation to generation. I have a brother, and my son also, they say, no,
right now I want my name to continue. I think that, yes, for Puerto Ricans it is really
important that the culture continues expanding, the name, everything.”

Alongside participants’ beliefs about the high value accorded to parenthood in
Puerto Rico, and the expectations about large families, was the opinion that the ideal
family size is changing. Families were seen to be getting smaller, with younger
generations desiring fewer children than older generations did. For example, Veronica,
who was age 36 when she was diagnosed with breast cancer, reiterated this point:
“Up until now it was really important to get married and to have children. And now I think
that for young people that are getting married, it is now not as important. My younger son
has been married for like 8 years, almost 9 years, and says that he doesn’t want children.
There is like more consciousness of having some things first, and then having children. I
think that the youth now are more intelligent than [before].”

Comments by other survivors reflect a new emphasis on smaller families and family
planning. Magdalena, who had two sons, mentioned that she had always wanted a
daughter but got sterilized because she could not care for another child adequately:
“I have my two sons and I devote myself to them because I understood that it wasn’t right
[emphasis mine] to have so many children. I was not doing well during my pregnancies.
And the [sterilization] operation gave me a lot of pain because I wanted to have at least
one more in order to have a girl. But I never had the girl, after I got divorced when my
sons were young. We didn’t have children for years when we were married, and then
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when I had the kids, he divorced me. A really curious thing. It was really tough because
financially it wasn’t really good. I thought that it [it would be] an act of selfishness [to have
another child]. I didn’t have a partner, I didn’t have money. So, I didn’t have another child,
or even consider it. Apart from that I had the operation or that my operation is reversible,
because I had my tubes tied. The desire to have a daughter remained, but really
economically I couldn’t do more. I decided therefore to concentrate on my two sons and
to give them as much as I could. I tried to give a good education within my capacity. The
best discipline, love, dedication, everything. I gave everything to them.”

Likewise, Soledad, who was married with two young children when diagnosed with
breast cancer at age 30, related that her children were the result of family planning:
“On my side, my family has a lot of aunts and uncles. Now families are smaller, but I do
think that [having children] is important. In Puerto Rico people really value their family –
for me it was really important to have them and we planned for them and we had them.
We had a planned family and a desired family – I want to think that everyone shares that
way of thinking that we had when we decided to have them.”

Sterilization
It is important to mention the commonality of sterilization in this group of
participants. At the time of the interview, six out of 20 female participants had already
undergone voluntary sterilization (while none of the men had), and an additional three
had received hysterectomies for various reasons prior to diagnosis. Two of the tubal
ligations were regretted. For example, Maria’s pregnancy was discovered immediately
after her lymphoma diagnosis at age 35. She and her husband decided to keep the
pregnancy through the duration of her treatment; she struggled significantly with this
situation, particularly given the pressure by the doctors to end the pregnancy. She
described how they attempted to make her feel guilty for keeping the pregnancy, one
that she had desperately wanted:
“The doctor got mad at me. He said that I was irresponsible because I had 2 other kids,
and there was not going to be any mama because he could not give me the radiotherapy
since it might damage the baby. And if I don't have radiotherapy I will not be a mama.
That was a terrible decision. But I was very at home in my life and in my faith. My
husband and me, and my faith. The oncologist has to respect my decision as the patient.”

The day after the healthy birth of her son (prior to beginning her chemotherapy), she
underwent a tubal ligation at the behest of the doctors. This was the “deal” they had
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made when the pregnancy was first discovered: she could keep the pregnancy if she
underwent a tubal ligation after treatment. It was, as she pointed out, a decision that she
now looks upon as being coercive.
“The situation was that the doctors more than me were the ones that decide to have the
surgery not to have any more children. He was born on September 12 and on September
13 I had la operación. I do remember that I was angry in fact, because I didn’t want to,
but [the doctor] said that I had to for the [other children]—‘you can’t have any more.’ It
was a bad situation, because I think that I shouldn’t have let them tell me to have the
surgery. La operación. But I was very angry for a few months and very scared—upset. I
don’t know, because how did they convince me to do this? I lost a very important part of
me. It was a terrible experience. I don’t know, really, I don’t know how it happened. I
remember I was very ignorant. I was so happy that I was fine, that the baby was
completely without any problem. […] I think that I would have a lot of anger, because I
wanted to have a baby girl. My dream was to have a baby girl. But the situation was that I
chose the [deal]. And the day after I had the baby boy, they did la operación. […] I was so
confused and I was angry at them—why did I do that? Because I would have really liked
to have another baby. How did this happen?”

Many writers and historians have focused upon the coercive nature of the sterilization
project in Puerto Rico, assigning binary categories of “coercive” and “voluntary.”
Magdalena’s case is interesting because it illuminates the shades of gray in how
sterilization has come to be an accepted cultural strategy for birth control. She related
that she had gotten sterilized, but that the operation was temporary since she got her
‘tubes tied.’ This echoes a common belief from Lopez’s (2008) ethnography on
sterilization among Puerto Ricans in New York. Lopez found that many people had an
understanding that “getting your tubes tied” was in fact a temporary procedure, versus
the permanent sterilization procedure; they took the phrase at its literal interpretation and
assumed that the tubes could be untied when desired. This is, unfortunately, untrue:
although reversals can sometimes result in a pregnancy, sterilization is considered a
permanent birth control method. Magdalena had wanted a daughter but was sterilized
because she felt that it was the socially responsible choice in light of her financial
situation. Thus, strictly speaking, while she did elect to undergo the operation, she
ultimately chose it because she felt socially obligated to do so, clouding the question of
voluntariness.
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SUMMARY
While providers generally believe that cancer-related infertility is an important
issue and that patients should have access to fertility preservation, myriad obstacles
conspire to restrict access to it. The most significant of these relate to cost, lack of
insurance coverage, and patient-provider communication problems. Providers also
believe that patients are preoccupied by the diagnosis and want to start treatment
immediately, and that patients’ priorities rest with their existing children and not with
future fertility. For their part, from survivors’ reports it is clear that a conversation about
infertility and fertility preservation happens very inconsistently in Puerto Rico:
approximately half reported that their oncologist had not spoken to them about it.
Survivors’ fertility concerns varied by age and life stage at diagnosis, but their values
surrounding children were reinforced, not changed, by their cancer experience. Most
would consider adoption if they were unable to have children naturally.
The last three chapters have dealt sequentially with the public images and
representations of cancer, meanings of cancer survivorship, cancer-related infertility,
and access to fertility preservation techniques. The next chapter will focus in depth on
health status and issues within the healthcare system from the perspective of all groups.
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Chapter Nine:
Health Status, Healthcare and Cancer-Related Services
This chapter reports on treatment- and healthcare-related issues that emerged
as major themes in the interviews and have not yet been addressed. The chapter
moves in a back-and-forth manner, alternating between the perspectives of providers,
advocates, survivors, and clergy. It first details the overall perceptions that providers
and advocates hold regarding survivors’ main medical and social issues. It then
proceeds to report the self-described health status of survivors and any health concerns
or conditions they have. Health system-related issues are examined, including patientprovider communication and an evaluation of gaps in the medical system. Finally, the
findings related to the two clergy members are presented last. These interviews
addressed many of the themes discussed by the providers, advocates, and survivors—
for example, gender and divorce issues—but their perspective was distinct from the rest
of the groups. Thus, it is more meaningful to discuss these interviews as a whole rather
than dispersed throughout the rest of the findings. The issues presented here lay the
foundation for a discussion of recommendations in the following chapter.
PRESENCE OF NON-GOVERNMENTAL CANCER ADVOCACY ORGANIZATIONS
Numerous cancer advocacy organizations exist on the island, ranging from
Puerto Rican chapters of large US-based organizations, such as the American Cancer
Society, to small grassroots groups operating locally. Representatives from ten
organizations were included in this study, six of which were local groups, and four of
which were Puerto Rican chapters of mainstream US-based organizations.
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Organizational Role and Activities
As discussed by the advocates, the most common organizational roles were
raising awareness, offering educational programs, and providing emotional support and
coping tools. Awareness and education were often ‘co-missions’; advocates regarded
them as linked and these roles were framed as critical first steps in improving the lives of
cancer patients and survivors in Puerto Rico. For example, it was considered essential
for one of the larger organizations to raise awareness about the importance of early
detection and simultaneously to provide information about where to obtain screening;
this was accomplished through public relations and advertising campaigns, fundraisers,
the distribution of educational brochures and materials, and the provision of small grants
to support community organizations. Other organizations were involved in advocacy
work to expand access to services, particularly early detection and screening.
Several of the organizations concentrated directly on providing emotional support
and addressing coping and psychological needs. They found that their services are
critically needed and fill a vital role. These services include the provision of support
through groups that double as informational sources, offering life skills workshops,
organizing group social activities, and focusing on the formation of strong bonds
between patients and survivors that supported them through treatment and beyond.
Two organizations concentrated primarily on fundraising for financial assistance, both for
individuals and to support the efforts of larger organizations.
Relevant to this research study, several advocates who worked for the US-based
organizations described how their organizations advocated the “survivorship concept”
and have had success in promoting this idea. They mentioned that people are starting
to become aware of what a survivor is in Puerto Rico, and are starting to take pride in it.
When discussing this issue, Angela, a 57-year old advocate working for a mainstream
organization, reflected:
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“They [people who have been diagnosed with cancer] refer to themselves as survivors,
and on this the [organization] has had much to do with. The education that [we offer] has
taught people about the concept of what a survivor is. Before that, people talked about
patients. Now they talk about survivorship. And now they understand how ‘survivorship’ is
different than ‘patient’ […] And yes, in the last few years there has been a lot of talk about
it. There is a lot of publicity about survivors, because there are many activities for them—
a Relay for Life. Many, many activities for survivors, so people become accustomed to it
and are sympathetic.”

Julia, a 50-year old advocate/survivor working for another mainstream organization,
talked about how important it was to make survivors visible in order to combat stigma:
“[The term survivor is used more frequently now], maybe because we have people talking
about it more. And especially in the areas of breast cancer we have come a long way in
our organization. I don’t know if it was tied to either shame or pity and some people don’t
want to feel the pity or whatever, but I think we have done a good job in showing happy
faces of survivors, and it’s a good thing. And it’s good that you can talk about it, and it’s
good that you were diagnosed early, and can be here with your children.”

One advocate/survivor, the leader of a support group, wrote to me in a letter that
eloquently described the need to “Puerto Rican-ize” the US-based support program by
drawing upon local culture, customs and expectations. Lucia noted:
“You ask me to explain to you what I mean when I say I can “Puerto Rican-ize” [our
support group]. The cancer patient-survivors have a large and extended family
environment the majority of times. The concept of extended family is used as a
framework, and friends and co-workers are added that want to help in the patient’s
recovery. We must provide knowledge and strategies to that support group of how they
can really be of great help to their family member or friend. The parenting style,
education, customs and even the traditions are taken into account that can strengthen
the patient in coping with the disease in the most effective way. Our Puerto Rican
survivors need a lot of love/caring in action. In the area mentioned here, it requires an
intervention of 16 hours in seminar workshops of 4 hours through psychologists
recognized in the treatment of cancer patients. The materials that are used have
relevance for Puerto Rican cancer patients. In relation to nutrition, the food pyramid is
used, making use of the foods that are consumed at the Puerto Rican table. They are
taught the nutritional value that our products have and the benefits of being wellnourished during and after the treatment. We offer Puerto Rican cooking recipes that can
and should be used for the benefit of the survivors. We emphasize the use and
management of our ecological environment in the healing process. It is the use of our
nature/environment that is a tool in the process of healing and spirituality of our body.
The music and the humor have to be framed in the healing process and have to have
relevance to the experiences and the cultural heritage that we possess. Note that
although we have similar objectives, the strategies and content must meet our needs and
be framed in our culture and our environment.”

The above quote is a rich source of information about the aspects of Puerto Rican
culture seen to be essential to healing and recovery after cancer. This includes a
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traditional diet and food, cultural heritage, the use of the land and ecological resources,
the incorporation of extended family, friends, and co-workers, and the explicit tailoring of
informational materials so that they address Puerto Rican values and beliefs. Although
this advocate worked for a US-based organization, she was highly conscious of the need
for a locally relevant context. In fact, she implied that healing would not be able to occur
at all without incorporating these important aspects of Puerto Rican culture.
Collaboration with Others
The organizations included in this research often collaborated on projects, both
with physicians and with other organizations. Most groups were dependent on good
working relationships with physicians, and advocates described what amounted to a
symbiotic relationship: doctors send patients with unfulfilled needs to the organizations,
while organizations in turn transfer feedback to the physicians on changes they should
address in the future. Angela, working for a mainstream organization, explained:
“We maintain a cordial relationship because they [the physicians] provide a service, we
have a good relationship, they provide a service, they help us on many occasions, giving
information to groups that we organize. However, we are very attentive to what type of
services they offer so that we can give them feedback on what the patients need. There
is no antagonism, there’s none, we are not fighting with them. We understand that the
services that are given can sometimes be improved—and we are willing to work together
with them. In fact, we refer them patients so that they can take care of them, they refer
patients to us—if a patient is not going to be able to pay, we pay for them instead. We
have a relationship of collaboration—it is not a relationship of fighting or struggle, it is of
collaboration, of assistance. We help each other.”

Organizations often formed collaborations with each other, both between the big,
mainstream groups as well as between mainstream and local grassroots groups.
Though partnerships between the local groups were not evident in the organizations
included in this study, these alliances may exist. Esteban, working at a mainstream
group, discussed a grant received from another big, mainstream organization:
“Yes, we have programs with [a large mainstream organization]. [They] do not grant
money for treatment, so what they’ve done is that they gave us a grant of $10,000 so we
can help breast cancer patients. So we have $10,000 from [them], and we—who in our
bylaws can do that—will give that money for treatment and of course it’s going to be an
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understanding that they will get the proper recognition when we provide the letters and
everything to the ladies. So we work with [them], we work with the Comprehensive
Cancer Center, we work with the oncology hospital here in San Juan, and [we work with
a lot of support programs].”

However, tensions in these collaborations did arise. One of the advocates
working for a mainstream organization, Lucia, noted how doctors often become angry at
her because she promotes the idea that patients and survivors need to demand wellpriced services from their physicians, and be advocates for their own healthcare:
“I have to teach the cancer patients to demand that that doctor who is going to take care
of them is up to date with the latest treatment, at the least possible cost. One of the
things that I want is that the doctors in Puerto Rico drive Mercedes Benzes, I want the
doctors to have BMWs, but that they get it with honesty and integrity, not at the cost of
the cancer patients. And I’m telling you, in all theses places where I’ve been invited to
give talks to doctors, some become furious with me.”

The tension among organizations is best exemplified by the “survivor/viviente” debate
that surfaced throughout many of the survivor interviews (see Chapter Seven). While
the mainstream organizations promoted the idea of “survivorship” and “survivors”—
sobrevivencia and sobrevivientes, respectively—one of the advocates strongly disliked
the term and instead promoted the use of “viviente” by her members.
Differences in organizational ideology among these groups were apparent,
contrasting most between the mainstream and grassroots organizations. An advocate
from one of the grassroots groups detailed how she had worked long and hard to get
funding from mainstream groups for years, to no avail, and how they did not agree with
portions of her life skills workshops. Many of the ideas promoted in these workshops
centered around individuals taking responsibility for their cancers, and that stress and
negative emotions can sprout the seeds of cancer—ideas that are currently not widely
accepted in the mainstream cancer community. While these tensions were not directly
addressed by representatives from the mainstream groups, they simmered under the
surface and were subtly referenced by advocates from several organizations.
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Advocates’ Personal Reasons for Involvement
Five of the six advocates who had been diagnosed with cancer in the past
became involved in their organizations because they felt that they should “give back.”
They may have also identified a need in the cancer community and were attempting to
fulfill that need. This was illustrated by the response of Julia, an advocate and breast
cancer survivor, who had been working for a major organization for nine years:
“I was diagnosed with breast cancer in November 2003 […] Since I was diagnosed, I
have been helping patients go through the news, what to expect, because when I was
diagnosed no one told me what was going to happen, how I was going to feel. Even
though I had a great oncologist, he just said—‘come next Wednesday, we’re going to
start the chemo’ but nobody said what the side effects were going to be. Even with the
hair, when I got there the nurse said ‘oh, by the way, cut your hair because between 7
and 14 or 21 days you’re gonna lose all your hair, and sit down.’ You know, nobody gave
you kind of an easy way to know it, or where you should buy the wig. That is information
that is really important…So after that, I knew that people needed to have that information.
You get scared of the information you don’t know.”

Concha, another advocate, explained that her experience with breast cancer inspired
her to fundraise for the hospital where she received treatment:
“I arrived in the hospital in 2007 with a diagnosis of breast cancer. They did surgery on
me, a radical mastectomy in 2008. I was in the hospital [as a patient]. But in 2009 I asked
the hospital if I could help raise funds for sick patients.”

Those who had not been diagnosed with cancer in the past were involved because they
had identified a clear need and wanted to take steps to fill that need. For example, Alba
had gone through a near-cancer diagnosis; a breast tumor was discovered that later
turned out to be benign. This experience gave her insight into the plight of cancer
patients and survivors. The other non-survivors described similar experiences of
identifying existing needs, such as Sra. Benitez, leader of a local support group:
“[The doctor] asked me if we could try to invent something to help the patients to feel
better, to stay in the treatments, because when you have depression or all that type of
stuff, nothing really works.”

Victoria, a 48-year advocate, founded her own organization after identifying unfulfilled
needs by working at other groups in the area:
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“I was volunteering [at another group]. I was an activities volunteer. Then I saw the need
– and to raise funds and to try to do every type of activity for survivors and for caregivers.
I said: ‘well, we have to have an organization where [women] can get more support.’”

PROVIDERS’ PERCEPTIONS ABOUT THEIR PATIENTS’ NEEDS
Oncologists and oncology nurses had a range of perceptions on the prevailing
concerns their patients and survivors harbored. Much of these concerns have been
addressed in other sections; thus, this description will be brief and largely a summary of
what has been touched upon elsewhere. The healthcare issues from the perspectives of
the survivors and advocates are covered in the last section in this chapter, Evaluation of
Healthcare. The three major patient issues from the perspectives of the providers were
concerns about recurrence, hair loss and appearance, and loss of work due to cancer
treatment. These were mentioned with similar frequency. First, survivors were seen to
be preoccupied with the effectiveness of their treatment and whether it will produce a
cure, and secondarily, after the treatment has ended, a gnawing worry about recurrence
that replaces the original fear. This is demonstrated by quotes from two oncologists:
“I think patients are very distracted about their diagnosis, and the association that cancer
has with death. Everything else goes to a secondary level. They always think about:
what's going to happen to me? Will I be cured? Will I live? How much will I live? And this
is the main issue with patients with cancer” (Dr. Colón, 42-year old oncologist).
“So you have these young people having cancer and living longer. These issues of
fertility are concerns but you know people are more afraid of having the cancer back.
And that kind of fear is the center of their lives, so they are very anxious to know how
often you are going to do the CT scan, to figure out whether this thing is coming or not”
(Dra. Padilla, 41-year old oncologist).

Second, providers noted that appearance was a major concern of newly-diagnosed
cancer patients as well as those currently undergoing treatment. Several providers
believed that this was one of their patients’ chief concerns—if not the most important
one—sometimes trumping other considerations such as treatment or more lasting side
effects. One of the oncology nurses explained this:
“[They are worried most about] their hair! I can’t believe it—their hair. I tell them that this
is the best time to be blonde, to be red-haired, this is the time for you to be someone
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different. So that’s how I work that part. And we talk about how to prioritize your main
things; it’s not your hair, it’s your health. So you have to change that vision. It’s not how I
look, it’s how I feel, it’s how I’m going to be better. Because your hair grows back. […] But
the main thing they go through is their hair. Forget it, it’s their hair. Their hair and their
children. Hair, children. Hair first, children later. Hair first. (laughs).”

As Dr. Colón summarized, hair loss and changes in appearance take on significant
dimensions in younger patients and survivors because they are the markers of sickness:
“The immediate social issue is appearance. For example, these patients have to deal
with mastectomies or hair loss, which is the most important in that age. And it's the most
striking. They feel that having no hair will pinpoint them as having cancer, or dying, or
being sick. That is the thing that bothers them the most. For the females, it's actually
having the breast surgery.”

Third, providers noted the many instances in which they have seen their female patients
deal with issues surrounding marital stress, divorce, and problems with intimacy. For
example, Dr. Henríquez, a prominent oncologist, noted:
“For some patients, particularly patients with breast cancer, there are other issues
associated with that, like sexuality issues. Frequently they get divorced. I can’t tell you
exactly what the statistics are, but I know that there are many young patients with breast
cancer, that end up divorcing when they are very young. Sometimes we have patients as
young as in their 20s with breast cancer. And they do have problems with their spouse or
their boyfriends -- it's not uncommon that they will get depressed and run into problems.”

Two oncologists noted that fatigue is a common complaint, and linked it to depression as
a reality of post-cancer life. Dr. Corzo, a 49-year old oncologist, explained:
“Fatigue is common even among patients that are free of disease. It continues. Chronic
fatigue syndrome […] The main thing is fatigue and depression after the treatment.”

Dra. Padilla, the oncologist quoted above, described her concern about survivors’
general health post-treatment. She argued that survivors and doctors alike cultivate a
sense of “taking it easy” after treatment, which is well-intended but may ultimately have
the consequence of fostering co-morbid conditions such as diabetes or obesity1:

1

While this oncologist was the only one to mention these issues, her comments parallel a
growing concern in the survivorship literature—co-morbid conditions following cancer and their
contribution to increased suffering, recurrence, or mortality. Weight gain after treatment is
common for survivors of certain cancers (Aziz 2007), which is worrisome given the association
between obesity and recurrence of breast and prostate cancer (Aziz 2007; Chlewbowski, et al.
2002; Freedland, et al. 2004; Nuver, et al. 2002). Further, cardiovascular disease, osteoporosis,
hypertension and hyperinsulemia create significant suffering among survivors (Aziz 2007).
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“When people survive cancer, they are kind of tired of the doctors and the treatment. So
they stop looking. They survived the cancer and they don’t care any longer about
cholesterol, being overweight, diabetes, whatever […] We physicians are on the other
side, giving chemotherapy to these people and whatnot, so when you sit down you say,
wow, I should have done better […] Because you realize that there are many things you
miss because of the treatment. We are giving chemo to these people; we see them every
3 weeks. So it’s sad that we don’t take the opportunity to give them a little bit more than
treatment in terms of education, and we’re not helping them to transition to survivors.”

This provider goes on to discuss other issues that she sees in survivors after
treatment—from the challenges of picking a primary physician that has experience
working with cancer survivors, to screening for late effects and planning for the future.
Although her comments were not widely echoed by the other oncologists and oncology
nurses interviewed, they are significant because they were the most detailed
descriptions of post-treatment challenges that arose in the interviews with oncologists:
“I think when you’re talking to survivors, it’s the issue of ‘I don’t know if my primary care
physician knows how to be with me, because I’m somebody special.’ And I agree with
them. For example, we have a lot of these kids that are surviving; sometimes they get
ALL [Acute Lymphoblastic Leukemia] when they are children and they come in as adults
…they come to us later with acute leukemia. We just sit down to talk with them, and there
was no screening, for example, for secondary malignancies, if you got radiotherapy in
your upper torso when you’re a kid or young, and you have to start screening
mammography when you’re 25 years old. They don’t. They just follow the regular 40
years or later. Insurance has a hard time with that. You have to sit down and make a
couple of calls. I realize that I can do that sometimes here, because I have support. But if
I was a primary care physician, I would have to see 80 patients a day, then there is no
way that I can do that. So the issue of screening for secondary malignancies is an issue.
The other issue is that in general, once they survive the cancer they kind of get into this
loop that we socially have with obesity and all the co-morbidities with the caveat that they
will be more sick. We know that these people, because of the treatment that we gave, are
at higher risk of developing cardiovascular disease, but on top of that they are overweight
and they don’t follow the call for having a myocardial infarction and dying at 42 years old.
So I would say that again, the issue of this cancer coming back, the social issue of how I
fit – should I make plans to have a doctoral degree or just a 2-year college and get a life?
The issue of getting pregnant – ‘if I can get pregnant will the kids be normal?’ and that
kind of thing. ‘And if I have kids, am I going to be around enough to raise them?’ Those
are the main issues […] In general they survive the treatment and they are doing good
enough to have a normal life. But I see something in the psychology of them, and the
psychology of us as physicians, you know ‘take it easy, don’t stress yourself too much,’
and I don’t know if it’s helping them. You have to push people to live their lives.”

Advocates’ comments about patients’ and survivors’ needs often mirrored those
of the oncology providers—recurrence was the top concern cited, followed by worries
about job loss, unemployment, or paying for the treatment. However, they differed from
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the oncology providers in the sense that, as a group, they did not dwell on the
importance of appearance and hair loss. This was mentioned, but usually in passing,
whereas in the provider group this was often the first concern mentioned and the one for
which they offered the most detail. Advocates also had on the whole more nuanced
understandings of life after cancer than the providers, and mentioned other needs such
as allowing families the opportunity to make closure with the cancer experience, and the
stages of adjustment that survivors pass through after time goes on. For example,
Angela, a 57-year old advocate and survivor, discussed the stress of recurrence:
“In general, the main concern is, is it going to happen again? If it’s going to happen again
how do I know? Sometimes they say I don’t mind, doesn’t matter to me, I already fought
it, I’m okay now. Many times the patient assumes an attitude of ‘it’s over’—but deep
inside they are worried. The main concern is if it’s going to happen again, and when.
Then if happens again, how am I going to pay? When you have a diagnosis and you can’t
work, the financial aspect gets affected; thus if you have cancer that could come back at
any moment, then you’re worried about the financial aspect, how will my family survive?”

Several advocates touched upon the stress that survivors undergo related to the threat
of recurrence—worrying with every pain or questionable symptom. Esteban, a 52-year
old advocate and survivor working for a mainstream organization, explained this:
“Right at the beginning, their biggest concern is to learn to identify when to worry and
when not to. Because for like a year, you are worried. Every single pain, shooting pain,
itch, rash, whatever you feel it’s like ‘Oh My God.’ And you keep pushing your doctor—
see this, do you think this is? Feel this! The first year it’s the biggest worry. I listen to
them, and it’s all the time, a lot of concern about every single thing that they feel. Any
discomfort becomes a flag. Then the second year you start reading and getting more
knowledgeable in terms of what to eat, what are facts and what is just fiction and you
start to be more intelligent and more in control of what you believe or what you
disbelieve, and what things you get more information on and what things you just don’t
think about. Like, if you drink from plastic bottles or not. If you cook or don’t cook or warm
up your food in a plastic bowl, and if it’s true that you shouldn’t keep your cell phone
close to your vital organs. Things like that, you start being like, ‘yeah, yeah, yeah’. You
start being more aggressive in that area, what is fact and what is fiction.”

Advocates echoed providers when they discussed the stress of losing workdays, of
being compromised at work or laid off, or if they would qualify for disability:
“[It’s important] that the employer understands that a patient undergoing chemotherapy
has particular needs in terms of tasks that they do, the money that is needed to pay for
their disease, the support they need from their peers, because there are days that the
effects of chemotherapy can last for a long time. The fatigue, the exhaustion that occurs
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on a few key days and you have to go to work because you need to work, and sometimes
neither employees nor co-workers have the sensitivity to realize what their co-worker
needs” (Lucia, 70-year old advocate and survivor, mainstream organization).

Esteban spoke eloquently about the phases of adjustment after cancer treatment, how
one eventually begins to make long-term plans and the related challenges that they
subsequently confront, such as insurance discrimination:
“Then you start making plans. Like, for example, will I be able to buy a new house and
insure that mortgage? Will they allow me to buy more life insurance? Those long-term
plans come with responsibilities that you don’t know if the system will allow. Like for
example, my cancer insurance was good, but there is a better one and I’m waiting for my
fifth year to buy more insurance. But will they allow me? Probably they’ll do this battery of
tests in order to discriminate you, not because you’re a cancer patient, but now you have
hypertension or you have this or that. Those are the worries. Those are the things that
make you wonder, because you have cancer and now you could be discriminated or you
could be in disadvantage, in order to achieve the things you would like to achieve in the
long run. ‘But you were a cancer patient and you could kick the bucket at any time.’”

As in the provider and survivor interviews, advocates also touched upon the issue of
marital problems, and how divorce tends to be common after a cancer diagnosis.
Priscilla, a 40-year old advocate working for a local group, noted:
“I heard about a lot of people that had problems with their husbands; they would leave,
the husband doesn’t stick by them, he’s weak when he sees his wife like that [with
cancer] and he leaves her. I think because they are cowards, because they are afraid
that she is going to die, and they don’t know how to deal with the fear.”

Julia, a 50-year old advocate and survivor, spoke about the necessity of closure for
families after treatment is over, and the emotional needs that often go unaddressed:
“We noticed that survivors all had some needs for closure. For example, in [our support]
group there were 2 sisters. One was a survivor, one was not. The survivor said that she
felt—not betrayed—but very hurt because when she went to treatment, her son was 20something, and he never asked her how she felt. She felt that no one cared about what
she was going through. Her sister was there and she started crying and said ‘actually we
thought you didn’t want to talk about it; we saw you as so strong, you were doing so
many things, we thought that you didn’t need our support.’ And they started crying and
hugging. Those are little issues that are there, and nobody takes care of them.”

POST-TREATMENT HEALTH STATUS
Survivors reported a range of health problems. Some were direct results of the
treatment, and others were co-morbid conditions. Table 9.1 below details the complete
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list of health problems currently being experienced by the sample. This likely reflects
underreporting because the health problems were not prompted. Lymphedema was the
most common health problem; five people experienced it. This was followed by sexual
health problems (n=4), thyroid disease (n=3), general pain (n=3), skin problems/burn
(n=3), and fatigue (n=3). Two participants reported secondary cancers.
Table 9.1. Survivors’ Self-Reported Health Conditions
Lymphedema
5
Cardiovascular
2
problems
Thyroid disease
3
Obesity/weight gain
2
General pain
3
Osteoporosis
2
Skin problems/burn
3
Fibromyalgia
2
Vaginal dryness
3
Circulatory problems 1
Fatigue
3
Erection problems
1
Secondary cancers
2
Neuropathy
1
Diabetes
2
Gastritis
1

Chronic urinary tract
infections
Chemobrain
Rheumatoid arthritis
Bone pain
Pulmonary scarring
Burned ribs
Dental problems
Sleep apnea

1
1
1
1
1
1
1
1

EVALUATION OF HEALTHCARE
Patient-Provider Interaction and Relationship
The experiences of survivors with the healthcare system were mixed; some
survivor participants recounted very negative experiences, while others clearly had
experienced the opposite. What was interesting about these cases is that in almost all
of them, the positive aspect of the experience had to do with the survivors’ relationship
with their doctors. Participants often expressed warm feelings towards these providers.
José, who had private health insurance and was diagnosed with lymphoma, stated:
“Those two [nurses], I love them, they are two angels. I tell everyone and I tell them. They
are super special. There should be many more people like them because this isn’t easy.
How they treat patients gives you a lot of optimism, and a lot of strength to keep going… I
go visit them and they love me, they adore me, they hug me; when I arrive I feel like I’m
at home. And my doctor is super, I give thanks for him, because he was born to do this,
and he’s in this because he knows what he’s doing.”

Similarly, Daniela, who is on la Reforma for her breast cancer diagnosis, explained:
“The people in this hospital are excellent, really excellent. It is really sad that they don’t
have funding, and they make miracles—miracles—with what they have. The doctor that
you met—he is really sacrificing. He attends 40 people a day, and he will attend you as if
he is seeing you for the first time. Not hurried or trying to get you out of the office

251

because he has somebody. No, he’ll treat you like the first time he’s seen you. After he’s
done with the clinics he goes upstairs, and sees all the patients in the hospital. He’s done
every day like at 9 or 10pm at night. So he’s an example of every doctor in this hospital,
and everybody loves him. He is a really good person. So that gives a lot of calmness to
the situation too of dealing with a disease like this.”

It was clear that many survivors had a profound trust and near-reverence for their
doctors. This was further apparent when, in many of the comments, “my doctor” was
mentioned in the same breath as “God” when they recounted who was responsible for
their healing. Concha, an advocate/survivor working for a local group, commented:
“The first thing that we learn or should learn, as a cancer patient, is that we are not in
absolute control of our life. That we have to learn to trust the doctor and those healthcare
professionals that try to provide help and you trust them as you trust God.”

Magdalena, a 52-year old breast cancer survivor, made this point as well:
“I could have died and I didn’t die. I won over the disease. I conquered it. It was a
complete team really, first God, and then me, my doctors that are very intelligent.”

Some of these participants described with pride how they had followed the doctor’s
every piece of advice, not missed one appointment, or complied with whatever treatment
was prescribed. Magdalena, quoted above, described this dynamic:
“I asked the basics. I didn’t want to know a lot. After that I stopped reading a lot because I
was always reading information, and after that I stopped reading. I said no. I am not
going to read more. And what I did was to trust the doctors, trust in God, trust in the
treatment and put a lot on my part. That is, I never missed an appointment, never missed
a treatment, I was really rigid with the treatment, really consistent with the treatment.”

José, diagnosed at 26 with lymphoma, preferred following the doctor’s orders; he did not
want his family members pressuring him to adhere to a certain course of treatment:
“When we [my family and I] started this treatment, we all sat down to talk; I said what I
wanted to do…I was going to do everything but step-by-step, and without anyone – I did
not want this – pressuring me on one side, ‘do this, to that.’ We are going to do
everything, based on what the doctor says.”

Interestingly, as discussed in more detail below, this tendency was critiqued by
one of the advocates: she noted that patients she encountered often had a blind trust in
their physicians, which inhibited them from getting necessary care if they were in a
situation in which they were being neglected. At the same time, it was also clear from
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the data that there were many providers who took great pains to nurture healthy, trusting
relationships with their patients. Questions were welcomed and care was taken to
address them comprehensively. These providers described partnerships that evolved
between the two parties that ultimately furthered their patients’ recovery and healing. As
a general trend in the provider data of this study, it can be concluded that the providers
greatly valued time spent in discussion with their patients. Dr. Maldonado, a 37-year old
surgical gynecologist, described how his training influenced his communication style:
“Fortunately for me, I was highly trained in infertility problems, so I can talk with patients
and relate to patients, whenever they talk to me about it, going through this treatment, so
I know exactly what to do. So saying that we be more open to the patient and talk to her
about her options for infertility is the way that I trained. But knowing also that many
gynecologists didn’t have that training, so I have to be aware of that. I don’t want my
colleagues to feel like I’m stepping on their toes. I have to be very cautious especially
when I talk to the patients and they say ‘well my doctor didn’t tell me that.’ So I tell them,
‘well you know I was very fortunate to be in the right time and the right place, and I have
the experience. Maybe your doctor knows more about other things better than me.’ I don’t
want them to feel like they can’t trust their gynecologist anymore, because it is different. I
try to balance that a little bit. Trying to tell them ‘these are your options.’”

Similarly, Dra. Lopez, a 58-year old gynecologist and cancer survivor herself, described
her desire for all patients to be well-informed and communicative:
“I’m so happy when they come to me and they say, ‘I don’t want to take this drug. I want
to take this other drug.’ And so they come…and that’s exactly what I want. That’s what I
did [when I was treated for cancer myself]. That’s exactly what I would love patients to be
able to do. To be really motivated, to learn about it, to make their own decisions and
choices. I do have some patients who are very knowledgeable and they come with
choices that I have never thought about. And they would say, ‘why don’t we do this or
why don’t we do that? Has anyone done this?’ And that’s actually what drives science, I
think. If you get this person’s idea and you have them be part of this activist group or
some group, that idea might become part of a project. And I think we need that.”

Sra. Benitez, an oncology provider, connected her ability to relate to her patients with
her own experience with a life-threatening disease:
“They tell me – ‘you’re so different than all the others’. And yes. Number one, I’ve been
near death, so I know what that is. I have lost my hair, so I know what that is. I lost the
movement of my left side, so I know what it is to be in bed. So that’s what makes me
different than other nurses, because I’ve been through a series of things that other
people haven’t been. That’s why I think we’re so close [my patients and I], because I
really understand. I let them know that I understand. When they say, ‘no you can’t
understand what I’m going through!’ I say yes, I can understand. I lost my hair, I had this,
I had that. ‘Oh, so...’ So the communication gets even better. I know things from my
patients that the doctor doesn’t know. Sometimes they come to me and they tell me what
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they are feeling. And when they go to the doctor they don’t tell […] That means that they
have a lot of confidence in me as a nurse, as a trained nurse, as an oncology certified
nurse, so they have a lot of confidence. And they call me; they have my phone number.
That’s another thing—I’m very accessible, so that helps a lot. And that’s a big difference.”

Several survivors spoke about the special treatment and favors they received from their
providers, from free medications or tests to reduced waiting time for surgeries. Some
stated that their doctors were their good friends, and because of this they received
extras that other patients did not, such as Amanda, a 48-year old breast cancer survivor:
“I had a kit that was made by Sanofi-Aventis—it was great […] It was a nice kit that I got,
but not every patient gets that. I was the doctor’s preferred patient, we were almost
friends—she was like, ‘I got this for you!’”

In a related vein, several survivors implicitly pointed to the partnership they had formed
with their doctors, as evidenced by their “negotiation” of healthcare decisions. From
some survivors’ descriptions it was clear that their doctors took into account their
treatment preferences and concerns and tailored the treatment plan together. For
example, Camila and Soledad, diagnosed with breast cancer at 22 and 30, respectively,
both spoke about their decision-making process regarding breast surgery:
“They wanted to do a mastectomy at the beginning, because [the surgeon] freaked out
when she saw how big the lump was, because it was the size of a golf ball. She told me
that if I [had been] in the States, she would have done a mastectomy. So I told her ‘study
the case, don’t give me an answer yet, and I’ll come back and we’ll talk about it. Because
I am not getting a mastectomy yet at age 23. I know I’m cancer-free, so you can do all the
tests that you want to prove that I’m cancer-free.’ So that’s what she did; when she came
back, she said – ‘just let me do the surgery again; let me clean out your margins better,
and I’ll be okay with that.’ So I said okay.”
“The doctor thought it prudent to bring me back to the operating room in order to re-clean
the area and make sure that the cancer hadn’t gone to another area of the breast. Given
that I had to return to the operating room, together with my doctor, we made the decision
to do a bilateral mastectomy, more prophylactic, and next started reconstruction.”

Personal Finances
On the whole, financial and insurance woes were almost uniformly unmentioned
throughout the survivor interviews until the specific question was asked; thereafter, the
nature of participants’ responses combined with the provider and advocate responses
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reflect the monumentality of financial and insurance issues in structuring patients’ and
survivors’ experiences with cancer treatment. Concern about money was voiced by
providers most often as the top example of barriers to the use of fertility preservation by
their patients, as discussed in Chapter Eight. On a broader level, physicians correctly
inferred that finances are one of their patients’ biggest concerns. Unsurprisingly—given
that this study took place in the middle of a recession that has hit Puerto Rico particularly
hard—this was a major problem voiced by the majority of survivors. They described how
their financial and job-related concerns have been exacerbated by cancer in numerous
ways: by the high cost of treatment that is partially or totally uncovered by insurance,
high deductibles and co-pays, and miscellaneous expenses that add up to significant
amounts. Many survivors were forced to take time off work, or to quit and seek disability
coverage. These themes are evident in survivors’ responses to the question, “There are
many problems that we face every day. What are the biggest problems facing you now?”
“As a married couple we fell into bankruptcy, Chapter 13. That was the impact [of
cancer], yes” (Alejandra, diagnosed at 31, Bachelor’s degree, annual household income
for 2 people of $15,000-20,000).
“I am getting divorced and I have problems with the health plan. That is my major
problem right now. Because my spouse, it’s from his work and now I have to see how to
handle it. I have had cancer twice and I receive Social Security, they give me Medicare,
but at the same time I am working and I have to leave the other in order to continue
working” (Sofia, diagnosed at 38, Bachelor’s degree, annual household income for 3
people of $70,000+).

Miscellaneous expenses such as parking, transport, and lymphedema sleeves2,
which are not covered by insurance, created a large burden for participants. As noted
above, several advocates pointed out that their organizations attempted to fill this gap:
“A health plan could pay for an MRI, but they can’t pay for the transportation, or example.
La Reforma or a private one, whatever. Any of them. They can’t pay for the transportation.
Maybe his health plan pays for the actual tests, but they have no money to move to San
2

A lymphedema sleeve is a compression stocking that is used to alleviate the swelling caused by
lymphedema by preventing fluid build-up in the affected area (NCI 2013). Patients must receive a
prescription and the sleeve needs to be custom-fitted by an expert. Lymphedema garments are
sometimes covered by insurance (though not Medicare), and the price ranges from $50 to $300
depending on the area of the body (UCLA 2013).
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Juan, for example, to get the MRI he needs. Another example is that the health plan is
supposed to give you money for the bra and the prosthesis; that’s the law. But in the case
of lymphedema, the health plan pays for the massage for lymphedema, but they don’t pay
for the bandage that you need to wrap the arm and a sleeve that you need to use”
(Angela, 57-year old advocate and survivor).

Relevant to the theme of fertility and parenthood, several advocates noted that
survivors might not want information about having a baby after cancer, or about fertility
preservation, because it is so expensive and particularly unaffordable after the expenses
incurred by cancer treatment. Angela, quoted above, explained:
“I would think that maybe they’re not interested in the information because they’re
thinking about how they’d deal with another baby after a treatment that is so expensive.
Cancer is a very expensive disease, and to raise a baby is really expensive so maybe
they don’t seem interested in another baby because they’re thinking about money.”

Still other survivors were forced into debt because they could not afford to pay
the treatment costs immediately. This often arose in the context of paying for
reconstruction, and was a frequent topic of conversation for breast cancer survivors who
often went to great lengths to fund their reconstruction surgeries. The Women's Health
and Cancer Rights Act (WHCRA), signed into federal law in 1998 (ACS 2012) and
therefore applicable to Puerto Rico, requires most group insurance companies to cover
breast reconstruction if they also cover mastectomies. However, according to several
advocates, plastic surgeons in Puerto Rico do not take any insurance, thus (intentionally
or not) skirting around the federal requirement. Patients or survivors must thus come up
with the money to pay for the reconstruction out-of-pocket. This process is highlighted
by Andrea, a 28-year old survivor with a household income between $15,000 and 20,000
for three people, in her account of how she is attempting to pay for her reconstruction.
She was in the preparatory stages of reconstruction, which takes a few months, when
the government health plan changed and her surgeon no longer accepted the insurance:
“The cost of the [reconstruction] operation [is the biggest problem I’m facing right now].
The reconstruction and to take out the expander that was damaged from the treatment.
The whole operation [is not covered]. The plan pays only the anesthesiologist and the
hospital. It doesn’t pay the whole cost of the surgeon. Afterwards the plan reimburses you
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but it doesn’t reimburse you all the money. [It costs] $7,000-8,000. I have the government
plan, but that doesn’t cover me because they don’t have a doctor [surgeon] right now [in
the public hospital that can perform the operation]. But, as the Centro Medico [surgeon] is
much cheaper for patients, in Hospital Oncológico, then the surgeon there is attending
only to cases that are cancer [on active treatment]. Since they already took out my
cancer, I am not considered a patient or eligible for surgery there. He only takes patients
that have cancer. What he was taking care of [with me] remains up in the air. They give
you a date but every time you call them, they change the date, because another [cancer]
case came up. He was the cheapest; the other doctor charged me almost $20,000. On
February 1st, they‘ll operate on me, but I have to pay that money completely. I got a
[personal] loan to pay for it. Afterwards, the medical plan reimburses me—but they never
reimburse all the money. $1,000 or so, whatever it is. […] I’ve been fighting with the plan
for a year now, and there’s no result; they don’t fix or do anything, so I have to get myself
into debt in order to achieve what I want to achieve.”

The topic of insurance engendered varied responses. Nineteen of the
participants had private insurance at the time of treatment, while four had public
insurance. Only one participant had not had any insurance when diagnosed, but she
subsequently was accepted into Medicaid before treatment commenced. Thus, all
participants were insured both during cancer treatment and at the time of the interview.
Many participants, all of whom were on private insurance, described vast sums of money
spent on high deductibles and co-pays. However, almost all of the women on the public
insurance at the time of treatment spoke about how good their experience had been:
“At least in my case [la Reforma] has helped me a lot, and I haven’t had to pay
deductibles like other people that I’ve heard say ‘I have had to pay so much with this
disease, and this leaves me so much.’ But in my case it’s covered everything. […] With
the special coverage I don’t have to look for a referral. It’s a letter that I always have to
bring when I come here, instead of going to the doctor for a referral then I have the letter
that covers everything: the referrals, medications, tests, all the labs that I do” (Rosa,
diagnosed at 41 with breast cancer, annual household income of <$5,000 for 2 people).
“Thanks to God, the plan covered everything for me. The one little thing yes, this – a
vitamin or something then you paid for it, but thanks to God the plan covered everything.
Well, [I like the public plan], seeing the work that other people go through with the private
plans, at least thank God the one that I have covers everything. Other people [with the
private plans] have to [pay more]—my own aunt had to pay $5,000 for the doctor, for not
having a public plan—yes, it is a blessing, that plan” (Helena, diagnosed at 45 with breast
cancer, annual household income of $5,000-10,000 for 2 people).

Daniela, a 33-year old breast cancer survivor and professor making $15,00020,000, gave qualified praise of the program. While it had worked well for her, she noted
that she had a flexible job that allowed her the time to fulfill all of the referral
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requirements that la Reforma imposes—while for others, this may be too large a burden.
For example, she received a letter from the plan that absolved her from having to obtain
referrals for every service that she received related to her cancer care. Other la
Reforma users must visit their primary doctor for every referral, missing work for both the
referral appointment and the actual service itself:
“It’s ridiculous. [By the time you get the referral, the test and the results], it’s like two
weeks out of work. And then they complain. They say, ‘people who take la Reforma don't
work, they are lazy people.’ Well, you know what? If I am employed by McDonalds, for
example, McDonalds is not going to understand nothing of this happening. They are not
going to understand it. In my job they can understand it because it’s a different kind of
job, but a job where you’re just a number, they don’t care like Starbucks, McDonalds, etc.
You lose it. I can understand how they lose their job. I can understand also why people
can’t work, because apart from this, if you don’t have a car …for me to get here at
7:30am I had to wake up at 5am just to get transportation. I don’t think la Reforma is
effective. In that way, it mistreats the patient. If you have been treated for cancer and you
have to do all this shit, I can understand how people could surrender to this disease, and
it happens. They get tired, they get tired of going here, there, there, every day, you
know? Apart from that, it’s the best plan, at the same time. Because you don’t pay
deductibles that other people pay. For example, I have a friend in the university and she
has cancer too, and her PET scan deductible is $150. I don’t pay anything.”

It is interesting to note the variable strategies by which participants attempted to
cover their expenses and pay for treatment that they deemed both necessary (as in the
case of cancer treatment) and desirable (such as breast reconstruction). In the majority
of cases, extended family and friends helped out with expenses, either loaning money or
making gifts for specific bills, treatments, or surgeries. This happened in Camila’s case:
“My mother took out a loan to help cover my trip to [a US hospital]. We had to pay up
front, and then would get reimbursed. To this day, I don’t know how much my mother
paid, but I wouldn’t be surprised if it was $6,000-7,000 or more.”

Sofia, a survivor and healthcare provider herself, described a client who donated a large
sum of money so that she could afford to take time off work. Echoing a common theme
discussed in the Chapter Seven, she noted that God had put the right people in her life:
“I’ve received a lot of [financial] help because thanks to God, God put the right people in
my life—for example, I had to pay for my operation, the reconstruction, the plastic
surgeon, and my mother-in-law paid for the $6,500 bill. The nurses cost $1,000, and a
doctor friend paid for it. Each time that I’ve to do a PET scan (I have done a ton, like 5 or
6), it’s $2,300. A doctor gave me one for free, other doctors of mine got me another free
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one, another got me one for $1,500, but the last I had to pay completely, I didn’t have any
money then. Always I’ve had people who’ve given me a hand. Always thanks to God.”

As in the above quote, other participants described receiving concessions from their
doctors, particularly those that they considered their friends, such as Maria, a three-time
cancer survivor first diagnosed at age 35:
“I also had the support of individual doctors for the tests. I had a cardiologist friend, and
he decided to give me [money for a test]. He wanted to do it. He is a member of our
church. And the principal oncologist that was in charge of me, because Interferon was
very expensive at that time, he said ‘I’m going to buy it as a doctor for my office, and then
you are can pay if you can.’ He gave me a low price and a way that I could pay.”

Other help came from organizations such as the American Cancer Society, NGOs that
provided small financial assistance grants, their support group or from co-workers.
“I was fortunate that in Puerto Rico there are many organizations that help you, apart
from my employer’s help; they give you a small part and you pay the rest […] The ACS
has a lot of really good programs. They gave us workshops on how to eat, how to apply
makeup, they give you wigs, they encourage you a lot. You know other people that have
gone through the same thing. I received a lot of help from them” (Magdalena, diagnosed
at 45 with breast cancer, annual household income of $30,000 for 1 person).

One woman was on a need-based pharmaceutical financial assistance program for her
long-term medication. Others embarked on home projects, such as selling cookies, or
sought additional outside employment to cover the costs of medical care. One of the
clergy interviews was interrupted by a couple who were selling cakes to recoup some of
the costs of the wife’s cancer treatment. Similar strategies were noted by others:
“The plan will cover certain things but others no. [My mother] had to sell everything,
biscuits; she cleaned houses in order to cover the therapies, primarily the chemo and the
psychotherapy […] It was really hard, a huge impact because they didn’t expect it” (Luisa,
diagnosed at age 13 with uterine cancer, worked as an engineer making >$70,000/year).
“I was out of work a ton of time. We raised funds before the surgery, for the transportation
expenses and all that and it helped me a lot that we were in the newspaper, Primera
Hora. The sales helped us; we were selling cakes—we did like 300 dozen. The church
helped us, gave us a contribution, of course that helped us to prepare the cakes but even
so the medical expenses…we are in a financial crisis and more when I’m the only one
that works. My wife doesn’t work; at least my family helps me” (Francisco, diagnosed at
23 with oral cancer, student with household income of $15,000-20,000 for 2 people).

The financial help that participants received figured prominently into their illness and
recovery narratives, and speaks to the critical importance that social networks play in
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weathering a medical emergency. The help that participants received in many cases
urged them to return it when they felt ready, by donating to other people currently under
treatment or by volunteering for the organization that had originally helped them.
“[The insurance] didn’t cover the anesthesia or the two operations. I paid the first, and the
American Cancer Society paid the second. That’s why now I help them so much” (Eva,
diagnosed at 39 with breast cancer, household income of $30,000 for 4 people).
“Now, I have patients in my office that don’t have any means to pay. I take care of them.
If they have to buy a compression sleeve, I give it to them, ‘you can pay me when you
can, you need it today, you don’t need it tomorrow.’ And maybe that is my way of giving
back what I received” (Sofia, diagnosed at 38 with breast cancer, household income of
>$70,000 for 3 people).

La Reforma
Despite the fact that la Reforma covers the majority of islanders without private
insurance, several major problems were frequently noted by advocates participating in
the study. Formidable barriers restrict access to reconstruction, not only among
privately insured participants but among la Reforma members as well. Another issue
mentioned by advocates was la Reforma’s capitation scheme. Capitation in insurance
plans indicates a set-up whereby providers are given a lump sum of money to take care
of a plan member, irrespective of the particular healthcare needs or tests that he or she
may require. Thus, the more tests the provider refers this member to, the less money
the provider retains him/herself. According to several advocates, this framework sets up
inherent ethical problems and conflict-of-interest among doctors; it has resulted in underdiagnosis across the board because physicians are conservative in their referrals, either
because la Reforma did not grant them enough money to pay for that particular patient
or because they want to retain more of that person’s allotted money for themselves.
Julia, an advocate and survivor working for a mainstream organization, explained:
“People with la Reforma…it’s tricky because these people are charged by capitation, so
the more tests and the more things they send their patients to, the less money they get.
That has been an ethical and moral issue.”
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Esteban noted the treatment-orientation of the Reforma plan—according to him, there is
a lack of emphasis on prevention in the plan. Many routine screening tests are not
covered, such as colonoscopies, leading to later-stage cancer diagnoses:
“If you look at our cancer statistics, you will notice that mortality is not really tied to any
type of cancer. It’s more tied to the staging of those cancers. People come in when their
lumps are huge, when they are in stages 3, 4 […] Although the government HMO is very,
very good once you have cancer, or once you are diabetic, or once you are a coronary
cardiac patient, in the stage before you become real ill, it’s not so good. It’s a system that
is based on cure, it’s not based on a prevention orientation. Most screenings are not
covered with the Reforma. For example, in Puerto Rico, colonoscopy is not a screening
procedure. It’s a diagnostic procedure, so doctors [have to] write in that you feel
something, that you have bleeding, or that you have acute pain, or that you cannot empty
your bowels. [Only then can] he right away prescribe you a colonoscopy. Otherwise he
cannot; it’s not like I can say, ‘hey, I’m 50, I’m ready for my colonoscopy!’ He would say,
‘I’m happy for you but there is nothing I can do because you are a healthy person. Do you
feel something?’ So it’s not that people are not dying of cancer. They are diagnosed in
the late stages too much […] it’s not quality care.”

Drug Costs
A common theme among both advocates and survivors, though not the
healthcare providers, was the high cost of drugs, and the inability of many people to
secure quality treatment because of these costs. Lucia, an advocate and survivor
working for a mainstream organization, explained:
“[The biggest problem here is] the high cost of cancer drugs. We do not gain anything by
continuing to discover [medicines] if patients can’t acquire those drugs. I would not pay
more money on research that can’t be available for the working class of a country,
because if I am researching merely for the rich people of a country that can spend money
on chemotherapy each time they get it, $3,000 dollars... And a cancer patient, I can tell
you, sometimes spends $265,000 in treatments. Where [do they get that money]? How
can you live if you have to spend that amount in treatment? It is sad; it is sad that we
continue to research, and not to make use of those drugs because patients can’t afford
those costs. Sometimes you see a cancer patient, because the platelet count is low, the
hemoglobin count is low, needs an Epogen. And the Epogen costs $300, $400 dollars,
that’s a two weeks’ salary (if any) of a public employee, and it is one [dose], and s/he
needs four [doses]. And then the medical plans get more restrictive each day.”

Health Information
Advocates and survivors alike outlined major problems relating to provision of
information by providers. According to many, there is rampant misinformation and lack
of information about issues relating to both quality-of-life and the long-term sequelae of
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treatment (however, most survivors responded that their physicians told them what to
expect as far as side effects during treatment). Information or physician referrals
pertaining to nutrition, weight control or exercise, reconstruction, lymphedema,
psychological support or therapy, infertility and fertility preservation, sex/sexuality, and
breastfeeding were rarely provided to patients or survivors. The following is an excerpt
from an interview with Esteban, a well-connected advocate/survivor working for a
mainstream organization. Although long, it perfectly articulates common themes from
other interviews about the current gaps in cancer care:
“The [staff] all day long takes phone calls from people who are requesting things like
psychological and emotional support; it’s not provided by hospitals. You don’t even get a
referral to see the psychologist. If you start acting crazy, they will send you directly to the
psychiatrist. They don't have that chance […] The other thing is that you don’t get a
referral for lymphedema therapy right after your mastectomy and you’re taught about
reconstruction, but there are not (that I know) insurance companies that cover it. So you
have to do it on your own. You have to pay for it. Although the insurance company sends
out a letter saying that they are complying with the Women’s Act of 1990, the surgeons
won’t take any insurance for that sort of surgery. Plastic surgeons don’t take insurance.
Not even for that, which is a regular reconstruction and it’s not because you are not
pretty; it’s because you were sick. I understand that you don’t take insurance to make a
face-lift or a tummy tuck, [but] that is something else. You don’t get…the referral for
lymphedema or reconstruction or emotional support.
The dietician and the nutritionist, it’s something that you get if you push and push and
push and push. Otherwise it’s not part of the whole, it doesn’t go with the flow; it’s not
part of the whole thing—it should be a chain, where you go from one thing to the other to
the other. With cancer patients who had colorectal surgery, unless they pay for it they
don’t get a dietician to tell them what to eat or what not to eat, or people who have had
their polyps removed thinking they cannot eat this and this and this and this in the future,
because that is the thing that causes the polyps. But they don’t know, so they would say,
‘okay, from now on I won’t eat corn.’ Fact? Fiction? We’ll never know.
Those are the things that I would say would make a great deal of difference not only in
your life as a survivor, but in your lifestyle, your health and in how you embrace this new
life. You habits, new things. They would tell you something like they did to me—‘you have
to do more exercise.’ Okay, but they don’t know if I have a lesion on my back. What sort
of exercise should I do? Walk, run? Lifting, pumping iron? What?! It’s just that ‘prostate
cancer survivors should do exercise. You should exercise every single day.’ What?? Up
and down those stairs? I walk the stairs -- is that enough? I mean, I know because I read,
but a regular person will have just half the information. That would be my definition. After
they tell you that you’re cancer free, you get half of the information. You have to eat well.
You have to exercise. You should take care of this, or that, or you shouldn’t take calcium,
or vitamin D, or you shouldn’t take—I don’t know—soluble or non-soluble fiber. But you
get half of the information. No one gives you the whole picture; sits with you and tells you,
‘Doña Maria, you have to walk at least 15 minutes every single afternoon. It has to be a
stroll. Please don’t do it when the sun is out; do it in the afternoon. Do it with someone
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else, because you could faint because of one of the long-term problems of the medication
that you are taking. Make a group of friends.’ No, no, no. You get half the information.”

Esteban went on to discuss the state of long-term screening for survivors in Puerto Rico,
arguing that even though doctors provide information on the “big” long-term effects of
treatment, such as cardiotoxicity, the “little things” that can have a significant impact on
quality-of-life are ignored:
“There are very good doctors in Puerto Rico; they will give you the major things, the big
issues—like if you had Adriamycin, then one of the things that you will be facing in the
future is heart trouble, because this is cardiotoxic. Those are the big, big, big things. But
those little things that can make your life miserable, you don’t get that information. It’s so
easy for your doctor to tell you, ‘make sure every afternoon that you put up your arm, just
to rest it, don't press it, don’t push it, and do that every single day.’ One day [the patient]
will notice that the watch doesn’t fit, and she’ll [say]: ‘Doctor, I’ve been noticing that I’ve
been taking on water, I’ve been retaining water more in my arm.’ ‘Ohhh… you’ve got
lymphedema.’ Now you have to buy the sleeve (shaking head). You see? Those are the
little things that you can do the next day after surgery, that can really make your life
easier […] And those are the little things like I said that most people don’t read. You’re
responsible; I mean, it’s your cancer, your body, your life. So you have to take a little bit
of responsibility. But someone has to show you where to look up for that information, and
that’s not happening. It’s not happening.”

Indeed, Francisco, a 28-year old oral cancer survivor, described his experience with a
gamut of doctors, and the small amount of information that he received from them:
“The doctors are not objective because they leave out a lot of information—for different
reasons, time, not wanting to worry the patient. Many of them don’t know [if it’s relevant
to the patient], even though they have the information.”

Related to this were providers’ and advocates’ assertions that newly-diagnosed
patients should seek second opinions to fill the gap in information, and to find physicians
who are more willing to provide comprehensive education. Alba, an advocate at a local
organization, described a blind faith that she thinks many people have in their doctors:
“That’s one of my biggest concerns, misinformation. In one of my talks, I asked a woman:
‘what did your doctor tell you?’ ‘He talked with my husband.’ ‘Your husband comes with
you to the appointment?’ ‘No, I go alone.’ ‘You don’t have a daughter, a son that can go
with you to the oncologist appointment and ask questions? You don’t write down 10
worries that you have?’ ‘Ay, no, not for the doctor, girl, he tells me everything.’ Total
misinformation. I think that each hospital should have an information center with staff
trained on these issues. That is a must.”

Dr. Maldonado, a surgical gynecologist, described his openness to second opinions:
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“I’m very open with my patients; I give them some ideas and I tell them ‘I’m just
recommending the different options that you have and you can choose; sometimes very
limited options, but those are the options that you have. If you want to do this, you can do
it, or I’m always open to a second opinion.’ I always think that the best … the more
information you give to a patient, the better outcome for the patient. So if a patient wants
a second opinion or wants to do something extra, I’m always very open to that.”

Providers and survivors alike described the difficulties that patients encounter
absorbing complex information about their diagnosis—pointing to a need for frequent
repetition of facts and an emphasis on continual education. Sra. Benitez stated:
“That’s why it is very important to have a very good nurse, to receive the patient first,
because they have to be very calm when they go in to see the doctor, because they won’t
receive half of the information. Even though he’s giving the information you only take like
half of the information, and you forget the rest because you’re so scared.”

Marisol, diagnosed with breast cancer 10 years prior to the interview, echoed the
difficulty in absorbing all of the information:
“My other surgeon told me that I have cancer and she needs to do a surgery. And she
began reading me the result. So she read everything to me, you know, speaking in
Spanish now because the only word I understand right now is ‘cancer.’ Carcinoma. So,
explain to me what is happening. You have this, you have this, you have this. Okay.”

“I Am Not a Lymphoma”: Fragmentation in the Cancer Care System
According to advocates—including Esteban’s excerpt at the beginning of this
section—care is fragmented along the entire cancer care continuum, from primary
treatment all the way to follow-up monitoring. This situation has resulted in duplication of
tests and care, or worse, the risk of patients and survivors “slipping through the cracks.”
Several survivors referenced the fragmentation and overlapping of care as an aspect of
their own experience that needs improvement. Julia, and advocate/survivor, explained:
“People get so specialized, and nobody has a head physician that oversees everything. I
think it’s a huge gap that people, even among the team, they don’t speak to each other.
They have an oncologist, they have a radiologist, they have this, they have the surgeon,
they have the plastic surgeon for people who get their reconstruction right there. And it’s
amazing how they never talk to each other; nobody communicates with each other what
they’re going to do. The patient is delivering the message to everybody, and I don't think
that is fair for the patient. In my group they all work in the same place and I think they’re
very good in communicating with each other. For example, when I finished my treatment,
my gynecologist (who wasn't from the group), said ‘if you were my wife I would take out
your ovaries and your uterus. You already have your kids and it won’t be a risk. You take
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away the estrogen.’ So I consulted with my oncologist, and I said I think it’s a good idea.
So they communicated and he wrote a referral, and I had my oophorectomy almost a
year after I finished my treatment, and everything has been great. They were able to
communicate, but there are a lot of patients that don’t have that. I think they miss a lot of
opportunities, or have double or triple studies that they don’t need.”

Sofia’s description of her second diagnosis speaks to the above quote by the advocate.
She was shuttled back-and-forth between doctors and was put into the uncomfortable
role of messenger in an unclear situation:
“[My doctor] told me, yes, do a sonogram. I did a sonogram, but the sonogram was read
wrong and said that I had a cyst with fluid. Me: ‘a cyst with fluid?’ The doctor said: ‘ask
the doctor if I can drain it’, because she was my friend. And when I returned to the doctor
I said: ‘she wants to know if she can drain it.’ And he told me: ‘there are no fluid-filled
cysts there. Tell her to do it again.’ He told me to get a PET/CT scan. When he told me
that, ha, I got petrified, it can’t be. I phoned the doctor and she did another sonogram.”

Maria, a three-time survivor, recounted how the most difficult aspect of her cancer
experience was the in-fighting between all the doctors who were involved in her care.
Her case was unusual in that she was pregnant during treatment:
“It was more difficult to deal with the 12 doctors – because I have four oncologists, 4
gynecologists, and another 4 doctors, and I don’t know now if there are 12 or 9 or 10, but
it was more difficult to deal with all these 9 or 10 opinions than was any of this. That’s the
core of the situation. It is so difficult to deal with the medical opinion, and I was fighting
with them. They have to fulfill each other, not dominate each other. It would have been
easier if they were not so pressured during that time, especially the first [diagnosis]
because of my special situation [pregnancy during cancer treatment]. All of these
opinions and different medical specialists all saying you ‘have to do this’…”

Accordingly, several advocates recommended the use of universal guidelines for
follow-up care and monitoring, so that it becomes standard-of-care. Several survivors
noted that information about recurrence was not routinely provided, creating a
dangerous situation in which survivors did not seek medical attention for symptoms that
were likely related to recurrence or a late effect of treatment. For example, Sofia, a
recurrent breast cancer survivor and healthcare provider, recounted her experience:
“The doctors [say], “no, no, no, you are going to be okay. You finished your treatment and
you move on. You’ll see.’ And the reality is that many people get it again. They don’t
improve. Things change. They don’t tell you that possibility from the beginning. […] Since
I am a health professional, I knew it could happen. But many people don’t know it and fail
to recognize symptoms […] But many doctors don’t know how or what to say to patients.
Sometimes women come to my office…I look at them and I see that they are already in
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the last stage. And they come because they have a swollen arm, but it had swelled
because it was full of tumors and [it’s not lymphedema like they thought]. I see them and
no one has said anything. They see me [to get treatment] for the lymphedema but they
have tumors that have exploded to the outside so that you can see bones around it.”

Julia, an advocate/survivor working for a mainstream organization, echoed the lack of
long-term monitoring and care planning:
“There are very few oncologists who have a long-term plan for patients—so ‘you’re gonna
finish,’ and this is our goal. To lose weight, to maintain your weight, to see a nutritionist or
an internal medicine physician,’ to kind of have a whole care, [few people have that].”

Finally, some survivors—including Marisol, a breast cancer survivor, and Maria, a threetime lymphoma/melanoma survivor—spoke of the depersonalization of the healthcare
system, and in particular, of their relationships to their doctors and other providers.
“Suddenly my tits were a public domain. Every single doctor, they had to see my tits.
Every conversation had to be [about] my tits. Suddenly my tits became just like my legs,
like my hand, not a sexual part or a taboo part that you can’t show […] At the same time,
suddenly you realize that you’re just a piece of meat. When I had my first appointment
with the radiation oncologist, they did a proctal test; I had never done it before. And it was
a shock for me, because when I got home, what I said was that ‘I just feel like a piece of
meat, you are nothing, you lost everything.’ Everyone will feel everything of yours.”
“My doctor used to bring his students. He has students always. And he would bring
students to see me when I was receiving chemo. One of them called me ‘the lymphoma.’
And I said, ‘I am not a lymphoma; I am Maria.’”

CLERGY INTERVIEWS
Interviews with two members of the Catholic clergy also ratified the above points
by the survivors, providers, and advocates, although their perspectives were of course
slightly different. Both of these Catholic priests were trained in pastoral counseling, and
they spoke about the different stages of grief in which they see parishioners with illness.
Both saw their role as one of “accompaniment,” or going through the process with the ill
person in an attempt to bring them closer to the Church and to God. As they stated:
“First, I am not hopeful, because that is not my role; I try to accompany them in the real
situation that they are living. I talk about the deterioration of the body and I maybe talk
about the treatment, the effects. [They ask] ‘Oh, but Father, how much time?’ That is not
one that I can answer” (Padre Díaz).
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“In my case, I am seeing where that person is, at what stage. According to the different
stages—I use much of Kubler-Ross’s [work] on the stages [of grief]—and depending on
where they are, [my role] is to accompany the person, and in that sense few reach that
last ultimate stage. Almost always when they come, it’s when they are not yet at the end
stage, but rather when they receive the first news, especially those who are of faith—they
come to look for alternatives or when they’re in the stage of anger, especially with God. I
have perceived it also that there is a transference: as a priest, in some way I represent
God. You see the transference, and [my role] is to accompany them; in those moments it
is especially to listen, in others when they ask for some reason, light” (Padre Santiago).

Both priests spoke about how the main issues with which they deal are
depression and anxiety related to cancer diagnoses, and fear of being unable to provide
for the family. Both underscored the importance of mental healthcare. Of course, in
their context, mental health is attained through a healed and strengthened faith in God,
and their purpose in counseling is to facilitate this process—not to offer promises or false
hope. One spoke of the ‘mercantile faith’ he often sees, where church members see
faith as a trading tool: “I give to God and God has to give to me.” In these cases, they
must re-focus the person in an attempt to broaden their conception of what faith
constitutes. They both emphasized the ability of a difficult experience such as illness to
serve as a faith-deepening experience, where one can strengthen their link to God:
“In the case of survivors, often these events of discovering, really, the sickness, many
times it turns into a trigger event for a person to take care of the spiritual aspect, or
somehow the process links them with the experience of God and with the commitment of
the Church. For those that already have the commitment, it helps them to deepen the
faith because there is a question of life, and naturally the spirituality gives them a
response and a sense of the disease process itself” (Padre Santiago).

He goes on to note that an experience such as cancer can also lead survivors to begin
to confront and deal with their fear of death, eventually coming to a resolution. Both of
the priests echoed survivors’ experiences in that these ordeals change peoples’
worldviews such that they are now able to appreciate and value the important things that
they do have. Padre Santiago explained:
“There is like a re-evaluation, they start to value life and to value the time and the quality
of the time that is shared, and they start to attach more significance to what before didn’t
have significance […] There is more depth, especially in relationships, because they start
to value what they really have. We have so much of a tendency, as Americans say, we
take for granted many things, and the important things are lost to us.”
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Divorce
The priests were asked to add their interpretation of the relevant issues that had
been emerging throughout the participant interviews, such as marital stress, gender
issues, fertility/reproductive technologies, and the use of the survivorship concept. On
these points, the clergy represented a full spectrum of opinion. Regarding divorce,
Padre Díaz did not see this—though he speculated that marital discord is common after
cancer because it can change the intimacy between a couple. He noted that a strong
faith helps to patch up problems between couples. Padre Santiago had indeed seen
divorce after a cancer diagnosis often, and related it to the different socialization
processes of men and women:
“Well, yes, there is a lot [of divorce]. What has occurred a lot, the woman when they have
to remove a breast, that starts a whole process, where she herself has to handle how to
address this issue, if she feels less of a woman because she doesn’t have a part, like the
spouse. Now I also have found that there has been abandonment, more of the man to the
woman when she has a condition, than the woman to the man. [I think that is because of]
the culture factor. The culture teaches women to be more nurturing and that the man is
not created precisely for that. In fact, anthropologically in the beginning of man, when a
man observed that a woman became pregnant, he didn’t feel like he had taken part in
that process. That’s the primitive man, and so starting from there, there has been a
detachment. So there is your problem, then ‘I do not have a reason to be a caregiver.’ I
see it much more from that cultural or anthropological dimension, in the processes that
we still have to purify, of what is a man, of what is a woman, the questions of gender.”

This priest went on to discuss how he addresses these issues with women, who he
states are usually the ones abandoned by their spouses after a diagnosis. He first helps
them to prioritize and clarify their own feelings of self-worth and self-value, and to
engage in introspection, a healthy task but a difficult one particularly for men because of
their socialization.
Gender
The above quotes directly relate to another emergent theme, that of gender.
Both priests discussed the hazards of the gendered social expectations placed on both
men and women. Specifically, men do not learn how to self-reflect or to be introspective,
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as noted above, nor are they taught or expected to engage in household tasks or
caregiving for the spouse or children. It is important to emphasize here the sentiment
behind the priests’ commentary on this theme: they believed that neglecting these
important aspects in the social rearing of men left everyone at a disadvantage—men
were disadvantaged by the inability to emotionally cope with a disease like cancer, while
extra burdens were placed on women who became the emotional caretakers of children
and were taught to value others more than themselves, often with unhealthy personal
consequences. Consequently women were often left abandoned by both their spouses
and children, yet had not developed the capacity of valuing oneself. Padre Díaz noted:
“The parents are more protective during childhood, but then what happens? They do not
give them a number of tools and when they reach adolescence they want to require
things that they were not given before in the process of growth, like responsibility. Men
cannot wash, men cannot mop, then there is conflict between the sister and the brother.
Because the guy is watching TV and the sister is scrubbing, but that is cultural and it is in
the educational process – why can’t he scrub?”

The quote below speaks to how women tend to value others more than
themselves, manifested in being concerned primarily about loved ones’ reaction after a
cancer diagnosis. As Padre Santiago noted, this is a double-edged sword—serving as
both motivation and a source of increased anxiety:
“What I have encountered the most, in my experience as a priest, it is almost always that
there is an attachment, not to the material thing but to people with whom they have a link,
a family member with an emotional bond. That bond and the attachment that they have
for the person is their major concern…what is going to happen with the children, what is
going to happen with my mother, what is going to happen with my spouse? And often that
process of attachment and of worry for that significant other is stronger than their own
concern about themselves. I would say that in our culture—because there is a cultural
dimension in the construct of how the person conceptualizes herself—her understanding
of herself is that she is [meant] for the other person. Naturally, when the sense of life’s
purpose is to live for another, even in those moments of difficulty and of crisis in which
one is at risk of losing their life, you see that even then their concern for the others
prevails. Then her fight is not for herself, but in being able to stay alive for the others.
That adds a condition to the disease that in some way can be an instrument of support
for her, or of motivation to maintain the fight for life. It can also be another ingredient in
their anxiety, so in that sense it could go two ways.”

This theme was upheld quite strongly in the survivor interviews, especially among the
women, who frequently emphasized that the hardest aspect of their cancer ordeal was
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telling their loved ones, particularly children, and dealing with those family members’
fears, distress, and anxiety.
Infertility, Parenting and Reproductive Technologies
The priests also addressed the topic of cancer-related infertility, but in a broader
sense than merely physical inability to reproduce. They spoke about the importance of
having children in Puerto Rican society and how couples can become wrongly focused
on parenthood as the sole purpose of marriage, rather than the relationship between the
couple. For these priests, the couple itself is the most important aspect of marriage,
while children are a “consequence” of that love, as Padre Díaz explained:
“Marriage is seen as for [the purpose of] creating families […] The idea they give to us is
that the marriage is like that, and the boy and the girl and the little dog and the cat, so
one proceeds with that construction. Because of that, I ask them to examine ‘what is the
construction of how they have thought about what marriage is, and what the family is?’
Do they understand that [you are not] incomplete if you aren’t a mother or a father? The
children are a result of the relationship between them. The Church changed a long time
ago to put emphasis on the couple’s love and not in procreation […] [Children are] part of
the fruit that’s received and welcomed but they don’t have anything to do with my fullness
of life as a man or as a woman. They [as a couple] are complete. If a family comes, that’s
great, they love and adore them, but it doesn’t necessarily have to be like this.”

Padre Díaz goes on to emphasize the importance of a healthy relationship with God.
This thinking extended to his view of using reproductive technologies to get pregnant—
he believed that if the couples’ relationship with each other, and with God, was healthy,
opting for technological intervention for reproduction was a personal decision:
“[In the Church] in vitro – all of that – is prohibited. How do I treat those [infertile]
couples? For example, I have two excellent professionals. They are older now, they have
not had children; I always talk about the relationship that they have with God. If you have
a healthy relationship with God, then you are the ones that decide. Because I think that if
God put the science to work, these things are so technologically advanced…of course
you have to be careful in these processes, because the other sperm are alive and
sometimes discarded, that is true…this couple is really conscious of this; they said, ‘well,
if others are reproduced and eliminated, if there is life we are killing.’ [But the decision] is
personal […] I think that that relationship with God has to be free; it cannot be otherwise.”

On the other hand, Padre Santiago projected a more ‘party line’ approach to
using ARTs, explaining the grounds on which the Church does not allow them and going
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on to relate it to potential future abuses like eugenics. When asked whether he had
spoken to any parishioners who wanted to use them, he said:
“For that type of thing, it is rare that they come for guidance because they already know
beforehand what the position of the Church is, which is that it cannot be done. For us all
that is not natural, because human beings are not created in a laboratory or test tube.
Just like there are a ton of people out there that have kids and that should not ever have
been fathers or mothers, the worst thing that they have done was to engender children. In
principle the Church believes in the processes of life that are natural. I mean, out of
respect for what a human being is, we cannot create it. Because that can lay the basis for
a ton of terrible things, because if that continues…in fact there has been with Hitler…to
create in a laboratory a perfect man. Then, the human being [as opposed to that created
in the lab], that child born with diseases or conditions: ‘is it worthless?’ We would get to
the point in which we would ‘customize’ a child, since this is a spiral that when we start,
we continue [downwards]—sometimes arguing for health reasons or any other [reason],
like stem cells, or whatever. But this usually goes in a spiral that can reach a world that
then decides to fabricate human beings, the human beings that exist would have to be
fabricated in a laboratory so that they are perfect. With that you have to be very careful.”

Importantly, the Catholic Church position on IVF did not emerge at all among the
survivor sample. This, along with the fact that only one of the priests referenced the
decree, underscored the variability with which religious doctrine is incorporated into
peoples’ everyday reproductive lives.

SUMMARY
This chapter addressed the healthcare experiences and needs of survivors that
were unrelated to infertility and fertility preservation, which was discussed in Chapter
Eight. Survivors reported a range of health conditions, the most common being
lymphedema, general pain, sexual health problems, thyroid disease, and skin problems.
Other less common but serious health conditions were diabetes, cardiovascular
problems, and secondary cancers. Survivors also identified gaps in their care and
cancer-related problems that went beyond merely physical: financial problems were of
greatest concern, as well as lack of information received about quality-of-life and longterm effects of treatments, especially—as one of the advocates noted—the non-lifethreatening concerns that have some of the biggest effects on quality-of-life, such as
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lymphedema. Problems with la Reforma, fragmentation of care along the cancer
continuum, and drug costs were identified by providers, advocates, and survivors as
issues of major concern in Puerto Rico.
Providers assessed the needs of their patients, citing concerns about recurrence
and death, hair loss and appearance, and loss of work as the top worries. Advocates’
perceived assessments mirrored providers with the exception of appearance as a major
concern. They tended to have more nuanced understandings of their clients’ worries
and cited other issues such as the need for families to make closure with the treatment.
Clergy also echoed many of the survivors’ biggest concerns—such as divorce and fear
of death, but their comments also reflect many of the themes that emerged in Chapter
Seven among survivors. For example, many survivors spoke of cancer as a faithdeepening experience, and this was a major theme among the clergy as well.
This chapter was the last of the four chapters that discussed results. The
upcoming chapter, Chapter Ten, will present a synthesis of these findings and the
existing literature on cancer survivorship, infertility and fertility preservation. It will offer a
set of practical recommendations and suggestions for future research directions, and will
conclude by linking the theoretical framework outlined in Chapter Three with the
research questions and study findings.
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Chapter Ten:
Discussion, Recommendations, and Conclusions1
This chapter will present a detailed synthesis and discussion of the findings from
the media analysis, key informant interviews, and semi-structured interviews. The
findings will be tied to both previous literature and to the study’s research questions,
identifying any remaining gaps in our current understanding. This chapter concludes by
offering a set of recommendations grounded in the literature and the insights of the
participants, posing future avenues for research, and presenting plans for dissemination.
It is anticipated that the results of this study can aid in the design of programs to
increase patients’ and survivors’ access to necessary services, including fertility
preservation. They can also be used to strengthen educational programs for healthcare
providers on the importance of these long-term effects.
EXPERIENCING SURVIVORSHIP
One of the study aims was to examine the experience of survivorship among
people with a history of cancer. To this end, the following section will describe
important, distinctive elements of “experiencing survivorship” that surfaced in the media
analysis and interviews, focusing on aspects such as cancer stigma, gendered aspects
of the cancer experience, the transformational nature of cancer, and causation theories.
Before examining each of these elements in turn, however, it is worthwhile to
consider the linkage between the two types of data collected in this study, and how
combining these methods can triangulate, or support, the final conclusions drawn. Two
1

Portions of this chapter have been previously published (Dyer, Mitu, and Vindrola Padros 2012)
and are utilized here under the fair dealings exception of UK copyright law.
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examples are instructive in the ability of media analysis to frame the ethnographic
interview findings. First, quantifying the news items and pages devoted to cancerrelated issues over the course of 15 years supported interviewees’ perception that
cancer had indeed recently experienced increased recognition and publicity. It also
affirmed the cancer survivorship movement’s increased visibility since the late 1990s.
Second, as noted in the Chapter Four, a main objective of the current study was to
understand the cultural aspects, norms, and values surrounding cancer in Puerto Rican
society. The magazines’ patient/survivor profiles encapsulated, in microcosm form, the
major issues that were voiced in the interviews; this validated the magazines’ cultural
constructions of cancer and also linked the interviewees to the media’s reach.
One of the major questions in media analysis is whether the media messages
shapes the cultural context, or whether it is shaped by the context itself (Bird 2003).
Though impossible to answer with certainty, these findings suggest that the former may
be a more accurate answer in this case. The major cancer-related themes evident in the
patient and survivor profiles of the media analysis, such as the transformative nature of
cancer and the need for a positive attitude, are not explicitly Puerto Rican. Rather, they
are overarching, dominant discourses of cancer circulating in North American society.
Thus, given the incipient shift in Puerto Rico from cancer’s construction as a death
sentence to one that incorporates these overarching discourses, the magazine articles
may not be reflecting the current state so much as they are helping to shape those
perceptions from the ground up. Further studies can investigate this linkage further by
incorporating discussion of media into the interviews themselves, documenting survivors’
reaction to the stories and their level of agreement with the portrayals offered.
Bird (2003) writes, in reference to anthropological research methods: “Few
anthropologists study complete, self-contained societies anymore (if they ever did), but
write ethnographies that explore specific questions and issues. Their holistic
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perspective emerges in the attempt to see these questions and issues in context, and
linked to other aspects of the culture; in that regard holism is still an important
anthropological credo, even as we understand that it is no longer a pure reality in an
interconnected world” (2003:7-8). Media analysis is a powerful tool in ethnography,
especially in concert with other ethnographic methods, because it allows for a holistic
view that recognizes that issues are embedded in a cultural context but increasingly
linked to global forces and trajectories—that link often occurring primarily through media
avenues (Bird 2003). In a study such as this, media analysis clearly illuminates popular
discourses circulating about the issue under study and allows researchers to identify
underlying tensions and controversies that may not otherwise be evident or
documentable by other methods.
Cancer and Death
One of the themes that garnered almost unanimous support through all
participant groups was that of the equation of cancer with death. Most oncologists and
oncology nurses believed that this was the cause of their patients’ greatest worry and
concern upon initial diagnosis, and comments by the survivors themselves supported
these observations. Advocates, who had a more subtle interpretation of survivor issues
than providers, noted that this fear gradually abated but never truly disappeared—the
initial fear being replaced by a preoccupation with recurrence.
Two things are important to note about this theme. The first is that all signs point
to a decrease in the level of association of cancer with death, and the introduction of
hope in survival. According to the perceptions of these participants, this change is
associated with the greater visibility of people with cancer who have survived and are
more comfortable speaking out, participating in events, and in general being more visible
to others (although perhaps we cannot claim that it is a causal association). This has
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coincided with an increased visibility in the media—particularly in women’s magazines,
as demonstrated by this analysis—of various aspects of cancer including prevention,
treatment, social and relationship aspects, fundraisers, and, importantly, profiles of
celebrity cancer survivors such as Adamaris Lopez and Sheryl Crow. This increasing
visibility and its origins are inextricably linked—awareness among individuals and
decreasing feelings of shame, survivors in the media spotlight, an increasing number of
organizations and events dedicated to the cause, improving survival rates, and
increasing incidence rates leading to a greater number of people who have lived through
cancer. The heightened awareness parallels what has happened in the US in the last 20
years: incidence and survival rates increasing at the same time, leading to a greater pool
of survivors whose concerns are gradually recognized and made publicly visible.
However, bearing this in mind, it is significant to consider the extent to which the
association of cancer with death still pervades nearly every aspect of an individual’s
experience with cancer. A few examples include: the newly-diagnosed patient’s
obligation to appear strong in front of family members, thus restricting that patient’s
expressions of distress and need; the preoccupation with changes in appearance such
as hair loss and the way it signals “sickness” to the rest of the world; and the panic with
which newly-diagnosed patients seek out immediate treatment rather than considering
long-term implications of the diagnosis and treatment. Surely, a life-threatening
diagnosis is bound to bring about these issues, but it is a matter of degrees: the more
likely the specter of death is, the more heightened and extreme these reactions become.
Hair and Appearance: Public Signifiers of Illness
The importance of hair loss and appearance-related changes was also a nearuniversal theme among all participant groups. Survivors discussed how traumatic these
changes were—particularly hair loss—with some of them noting that they constituted the
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worst aspect of treatment. Although this finding is not unique to this study and is noted
consistently in nursing and psycho-oncology studies, it is worthwhile to consider why this
effect has such a clearly negative impact on survivors. Anthropologists have argued that
hair is not merely cosmetic and superficial, nor just an evolutionary vestige; rather, it is a
deeply meaningful cultural symbol. Hanson (2007) notes that “throughout history, hair
has universally been a powerful symbol of the relationship between individuals and
society, denoting religious affiliation, and has acted as a symbol of the social, cultural,
and political status quo. Hair loss, which is often perceived as a loss of individuality and
attractiveness, has been related to the absence of status in these areas” (2007:15). As
a public signifier of sickness, it thus serves as communication of an abnormal state and
a loss of prestige or social position—it is thus an unambiguous announcement of the
sick role. It has also been traditionally a symbol of womanhood, femininity and sexuality
(Hanson 2007), and there is a deeply gendered dimension to hair loss. In a study of
stigma and hair loss, sociologist Rosman (2004) found that women linked hair loss to a
threatened identity or loss of sense of self, and made explicit their confrontation with a
deadly disease. Accordingly, those who had chemotherapy-induced hair loss were
vulnerable to stigmatization, and most attempted to mitigate or avoid this suffering by
using wigs and other cosmetic strategies to “pass” as normal (Rosman 2004). Men, on
the other hand, were more likely to describe hair loss as an expected temporary effect of
treatment, or even to regard it as a sign that the treatment is working (Rosen 2004).
This parallels women’s reactions to breast loss. Nearly all breast cancer
survivors in this study had undergone breast reconstruction following mastectomies; the
rest were actively planning for it and some were willing to go into substantial debt to
undergo the surgery. For example, Andrea, a 28-year old survivor diagnosed two years
prior, had taken out a personal loan to cover a $20,000 surgery—equivalent to her total
annual household income for three people. She anticipated receiving only minimal
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insurance reimbursement. It is significant that survivors are willing to go to such lengths
for this surgery, and may partially be explained by Soledad’s equation of reconstruction
with normality. In order to ensure a “return to normalcy,” reconstruction is required.
Breasts are, of course, a deeply sexualized symbol of womanhood in Western culture
(Langellier and Sullivan 1998; Olson 2002). According to some participants, hair loss
combined with breast loss undercuts two very meaningful connections to womanhood, at
the same time that cancer presents a threat to one’s survival. Langellier and Sullivan
(1998) take this analysis one step further; in their study on “breast talk” among breast
cancer patients, they argue for the complex and often contradictory multiple ways in
which women with breast cancer engage and perceive their breasts and bodies. Instead
of being de-sexualizing or de-feminizing, many women in their study associated their
breast loss with a lack of wholeness: “their breasted experience embraced issues of
feeling whole and healthy, of being able to engage in physical activities, of sensation and
touch, of sexuality and spirit, as well as the look of the breast” (1998:91). In this sense,
reconstruction can serve as a return to normalcy, health, and well-being, rather than
merely a return to femininity.
Gendered Aspects of Cancer Experience
As is evident in the above section, issues of gender were salient in many parts of
this study, and were not confined to issues of appearance and hair loss. This has
precedent in the literature. Reay, Bignold, Ball and Cribb (1998), in their qualitative
study on gender dynamics in families coping with childhood cancer, found that important
aspects of dealing with the crisis fell strongly along gendered lines: the mothers became
totally immersed in the care of the child while the fathers maintained their jobs and
remained distant from the treatment and caregiving processes. Further, the emotional
expression of each parent was predictably gendered: women felt a strong need to talk
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and share, usually with other mothers in the hospital, while complaining that their
husbands were emotionally distant and maintained a stoic, overly optimistic front. The
consequences for both partners were worrisome: women often reported “drowning” in
the experience with no more available emotional space, while many stress-related
illnesses were diagnosed among the husbands at this time (such as ulcers and
ulcerative colitis). The authors concluded that the result of this emergency in the family
was to “increase already existing inequities in the divisions of both practical and
emotional labor between men and women” (1998:39). Rivero-Vergne, Berrios, and
Romero (2008) found similar patterns in their study of caregiving for children with cancer
among families in Puerto Rico—so much so that the article title references the “mother
as protagonist.” They explain that mothers bear the brunt of the burden of childhood
cancer, becoming responsible for all aspects of care—both for the child, the husband,
and the rest of the children at home—as well as being the facilitator between the
treatment system participants (doctors, nurses) and their sick child. The authors provide
support for Reay and colleagues’ (1998) finding about exaggerated gender roles in a
time of crisis, and note that it is particularly true for societies like Puerto Rico, “where
women are still expected to be the primary caregivers of their children and have the
responsibility of their household, even if they are part of the workforce; thus, this
unconditional commitment is taken for granted” (1998:817).
While these researchers are chiefly writing about gender roles in division of labor,
and in relation to childhood cancer rather than cancer in young adulthood, their ideas are
useful in interpreting the many perceived gender differences noted in this study. For
example, providers as well as advocates in this study both observed that men and
women, when diagnosed with cancer, have predictably gendered concerns: women are
concerned with their appearance and hair, while men are concerned with being unable
to provide for their families. Further, women are the only ones who are seen to “care
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about fertility” and the loss of it to cancer treatment; in many interviews, providers
observed that “men just don’t care.” Thus, women are inherently maternal, while men
detach themselves and “do what they need to do.” Interviews with survivors supported
these observations: women were very concerned about changes in appearance, weight,
hair loss, and breast loss, and did see themselves as inherently maternal. They
repeatedly noted that they were more concerned about their loved ones’ reactions than
they were about themselves, and felt that it was their obligation to stay strong and keep
the family together. Further, they related that the main reason for undergoing treatment
was to keep themselves alive for their family, particularly their children. In the three
interviews with men, although expressions of stoicism surfaced, this latter theme was
absent. Significantly, this was a major topic of concern for the priests interviewed; they
observed that female patients care for others to their own detriment, believing that
others’ lives were more important than their own.
In short, survivors in this study expressed and performed essentialized gender
roles—women as inherently maternal caregivers concerned with appearance and
beauty, and men as practical, stoic providers. These findings support the idea,
formulated by Reay and colleagues (1998) and Rivero-Vergne and colleagues (2008),
that gender expectations are exaggerated during a traumatic experience such as cancer.
In a broader context, it seems apt to suggest that extreme experiences, which fracture
the routine and familiar life expectations and trajectories, crystallize and essentialize the
gender roles and expectations that lie under the surface of everyday interaction. As the
authors note, in coping with serious illness “there are costs for both men and women in
complying with cultural norms” (Reay, et al. 1998:45). Female survivors run the risk of
neglecting themselves and their own health, immersing themselves in concern for
others, while men find themselves without space for emotional expression.
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However, at the same time that certain gender expectations are crystallized, the
situation of divorce challenges this easy categorization. Most of the women reporting
post-cancer divorces explained that they initiated this change. The woman started
valuing herself more, and the husband’s burdensome needs lost their priority status. In
these stories, this is the crux of the stress that the marriage could not handle, and the
couple could not accommodate themselves to the changing dynamic. The woman
rejected the gendered expectation of female-as-nurturer (of the husband, in this case), at
the same time that she highly prioritized other traditional aspects of womanhood, such
as beauty, a feminine body, children and the maternal instinct. The juxtaposition of
these two processes belies easy explanation.
The Transformation Discourse: Cancer and Relationships
An overarching theme in this research was the transformational power of the
cancer experience—cancer was imbued with catalytic qualities and was seen to
generate positive and beneficial changes in one’s post-treatment life. Life after cancer—
what has been termed survivorship or recovery—involved living in accordance with the
transformations that were created by the diagnosis and treatment. Therefore, when
speaking of future plans, survivors often wanted to continue the growth and realization
process—for example, continuing to appreciate loved ones, the “little things in life,” and
their relationship with God—as much as they had learned to during cancer.
This response to cancer is increasingly being documented in the literature;
indeed, one of the dominant discourses relating to breast cancer survivorship in
particular is the transformation and rebirth discourse (King 2006). Similar to what is
reflected in this study, the transformation discourse focuses on cancer as an agent of
change, a catalyst that spurs positive growth and self-discovery, and generally has a
beneficial impact on one’s life. This explains the frequently-noted comment of “cancer is

281

a blessing in disguise,” in this study and many others (see, for example, Coreil, et al.
2004). Coreil and colleagues (2012) argue that dominant discourses often frame
people’s engagement with a disease such as cancer, providing a lens through which
people can understand or talk about their own experience with others. However, while
these dominant discourses provide the initial structure, they are imbued with local
meanings that are relevant to a group’s experience, leading to particular and varied
cultural constructions of survivorship (Coreil, et al. 2012; Dyer and Coreil 2011). For
example, Coreil, Wilke and Pintado (2004) found that the transformation discourse
among middle-class, Caucasian breast cancer survivors in Florida was that of individual
growth and development, such as getting over long-held fears, and was “likened to a
personal journey of discovery upon which the survivor embarks” (Dyer and Coreil 2011).
Applying this concept to the current study highlights the cultural construction of
survivorship in the Puerto Rican context. What is most evident is that survivors’ framed
their transformation in a social or relational way; in almost every case, a participant’s
transformation involved managing their relationship to others or to the wider world,
including God. For example, survivors learned to appreciate loved ones to a much
greater extent and to devote more time to them than before; they framed this change as
“realizing what is most important in life.” While they grew personally—their realization of
the value of loved ones was an individual change—this transformation is fundamentally
social because it affects the energy and time that survivors invest in others. Another
frequently-noted point of transformation involved being able to see relationships more
clearly; this idea emerges clearly in survivors’ discussions of divorce and separation.
These were most often linked to a survivor’s greater clarity regarding healthy versus
unhealthy relationships, and whether or not their partners valued them to the extent they
should. On a side-note, the idea of cancer’s cause resulting from stress and negative
feelings was most often discussed in a social framework as well: other actors in a
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survivor’s life usually caused the stress (for example, an unfaithful or ungrateful
husband, or a parent’s death), which then set the stage for the development of cancer.
A highly important impact of cancer on survivors’ lives was an orientation towards
helping others. Almost universally, survivors reported feeling prepared, inspired, and
even obligated to spend their energies helping others. This “pro-social behavior”
resulted from a new ability to help others, whether it took the form of being able to
empathize with others because of one’s own difficult journey, or being able to talk more
openly than one was able to before. These opportunities to give something back were
discussed in a universally positive manner. There is precedent in the literature for this
pattern; survivors become more socially conscious and devote more time and
importance to being helpful for others, especially those who are in the initial stages of
cancer diagnoses (Coreil, et al. 2012; Corvin, et al. In Press; Dyer 2010). Interestingly,
survivors paid little attention in these interviews to the potential consequences of taking
this obligation to its extreme: the risk of sacrificing and ignoring one’s own needs.
The transformation discourse emerging in this study also encompassed
survivors’ relationship to God. Cancer was described as a faith-deepening experience
both by survivors as well as clergy. Survivors on the whole did not attend church more
frequently, or partake in the “socially visible” activities related to organized religion;
rather, one’s personal relationship with God was strengthened and the social pressure of
appearing pious and devout to others seemed to hold less weight. For some, God’s
positive influence in their lives extended to the role of their doctors, who were often seen
as God’s instruments and, to some extent, divinely inspired. One must question here
whether linking the doctors with God can serve to silence any misgivings or hesitation
among survivors, dampening their will to seek a second or third opinion.
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Beliefs about Causation
Causation as Critique?
In her work on the moral reasoning of cancer, Hunt (1998) argued that individuals
create meanings behind why they themselves develop cancer, given that biomedicine
has failed to articulate with any certainty its fundamental cause. To this end, Kleinman’s
elaboration of explanatory models (1978) has generated much useful research in
cancer; however, “with increasing familiarity everywhere with biomedical practice,
technology and theory…these explanations are offered in conjunction with biomedical
explanations as underlying more proximate reasons for disease” (Manderson 2012:327).
Thus, causation stories are often drawn from personal experiences, cultural frameworks,
and biomedical knowledge, in an attempt to “rectify biographical disruption and provide
an explanatory framework (Bury 1997)” (Schoenberg, et al. 2005:184). In doing so,
individuals create meaning of their illness (McMullin and Weiner 2008), which can
ultimately serve to guide their actions surrounding healthcare-seeking and self-care.
Thus, it is important to consider the myriad explanations that survivors offered for
their own disease, blending external causes, such as environmental exposures, with
causes originating in their own bodies, such as an inherited genetic susceptibility. Of the
latter, the most significant theme was the ability of negative emotions, such as stress,
anxiety, depression, and pessimistic thoughts, to ultimately bring about cancer. The
immune system was the pathway through which these emotions caused cancer—stress
was framed as a “master detonator” that lowered the immune system, thus increasing
susceptibility to cancerous cells “taking over” the body. Most participants who voiced
this connection pointed to a specific stressful, difficult event or time period immediately
preceding their cancer—such as going through a divorce or the death of a loved one.2

2

A caveat is necessary: the participants who expressed these beliefs most strongly were
members of one local grassroots support organization. The impact of support groups and
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The idea of stress as causative in cancer has emerged in other qualitative
studies. For example, Manderson and colleagues (2005) found that Australian women
diagnosed with gynecologic cancers implicated stress “in their own public and domestic,
physical, and emotional lives as the dominant factor contributing to cancer” (2012:327).
It is also a central theme in research on other conditions that have an ambiguous
biomedical etiology, such as asthma (Pohlman and Becker 2006) and diabetes
(Schoenberg, et al. 2005). Pohlman and Becker (2006), in their review on the stress
discourse relating to asthma attacks, argue that the stress explanation is, fundamentally,
an implicit critique of modern life. “Stress,” as it exists now, is a relatively modern
concept, written about first in the 19th century and then elaborated by a series of
researchers after WWI. The concept of stress is now ubiquitous and “permeates
American culture generally” (Pohlman and Becker 2006:276). Even though these
authors are writing about stress and asthma, they could just as easily have been writing
about stress and cancer, another disease of modernization: “although the condition
known as asthma has existed for centuries, its contemporary incarnation is replete with
references to modern forms of living and its perceived complications” (2006:266). Their
participants argue that stress lowers the immune system, leading to an attack’s onset.
As far as the other causes cited by survivors in this study are concerned, the
stress explanation is not the only one that can be regarded as a critique of modern life.
Consider that survivors offered these reasons: the “fast pace of life” nowadays and how
that wears one’s body down, the lack of nutritious food available in Puerto Rico, eating
too much hormone- and chemical-containing meat, using underwire bras, and chemical
exposure while living in Vieques, a small island that was the decades-long site of bomb
advocacy groups more broadly in structuring participants’ understandings of cancer and
survivorship will be explored in more detail later in this chapter. Other participants who were not
members of this group did express the belief that stress and negative emotions can impact
cancer, reflecting perhaps a more widespread assumption that also appeared in the magazines;
however, it is critical to consider the interaction of these beliefs with organizational initiatives.
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testing by the US Navy. This last explanation is especially interesting, given the history
of political protests that preceded the military withdrawal from Vieques and the
increasing public knowledge about the negative health impacts of the bomb testing on
the residents of the island (including, significantly, higher rates of cancer). Thus,
participants “contextualize the experience of stress, drawing on both specific events in
their autobiographies and life circumstances that expose them to demanding conditions
and environments” (Schoenberg, et al. 2005:183-4).
Referencing Pollock (1988), Pohlman and Becker note that stress can be a “way
of organizing a variety of ideas about the social order” (2006:389). I would venture that,
in this particular case, it is not just stress that involves a critique of the social order:
rather, participants’ causation theories more broadly seemed to express a dissatisfaction
with the forces acting on their lives before cancer. For example, in this study nearly all
the “negative emotions” that were seen to cause cancer—stress, depression, and
anxiety—were brought about by others. Depression and anxiety caused by divorce was
commonly cited (always in the context of an unappreciative and unworthy husband), as
were toxic colleagues and bosses. Other explanations included the difficulties and
demands involved in single parenthood and, in one case, the sudden death of a loved
one. This underscores a theme that pervaded the interviews—large families and social
networks were one of the most valued and recognized aspects of Puerto Rican culture.
However, as social support researchers well know, big families bring support as well as
serious obligations and responsibilities—and it is often not possible or acceptable to
attempt to avoid them. In this study, negative emotions and stress as causes of cancer
were nearly always socially-induced; perhaps they provided a way for participants to
express anguish or displeasure about some aspect of social disharmony in their lives
pre-cancer that may not, because of cultural norms, be acceptable to express otherwise.
The corollary of negative emotions causing cancer is the ability of positive
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emotions to prevent it, or to aid in recovery. Not only did this theme repeatedly emerge
in the interviews, according to a number of authors (Ehrenreich 2001, 2009; King 2006),
the maintenance of a positive attitude in the midst of trauma and life-threatening illness
is an overarching discourse of cancer in the West more generally. Although some of
these authors are writing about breast cancer in particular, I would argue that it is
applicable to cancer more generally. The potential power of positive thinking (or
conversely, the detrimental effects of negative thinking) and the role that this can play in
survivors’ lives was emphasized repeatedly in interviews. Survivors disapproved of
expressing negative emotions such as anger. Women who did so were seen to
suppress the efficacy of their own treatments, inviting further illness upon themselves.
In their classic piece, Good and colleagues (1990) argue that optimism and hope
play foundational roles in American oncologic practice. The creation and maintenance
of hope before and during treatment are critical goals for both providers and patients;
oncologists in their study viewed this task as one of their primary obligations as healers.
This emphasis on optimism extends to the popular literature, which embraces and extols
the beneficial health effects of a positive attitude, as well as the scholarly literature,
which tends to take a more critical gaze regarding the unintended consequences of the
“tyranny of optimism.” Whether or not this aspect of American oncology pervades
oncologic practice in Puerto Rico—and to what extent—was not an explicit focus of this
study, but it would not be surprising given that many of the providers interviewed had
spent at least part of their medical education studying in US institutions.
Stress and Allostatic Load
Circling back to the idea of negative emotions and stress as causative of cancer,
it is worthwhile to consider one final question—the degree to which these beliefs are
reflective of biomedical research on stress and disease causation. It has been a topic of

287

exploration, albeit with ambiguous results: a recent meta-analysis of high-quality
epidemiological studies exploring a link between stressful life events and subsequent
breast cancer development concluded that no strong association was evident (Lavinas
Santos, et al. 2009). However, when they analyzed the effect of what they termed “high
intensity stressors,” the analysis suggested that “an association may exist, and a
statistically significant effect was observed in the studies with the largest sample size”
(Lavinas Santos, et al. 2009:S459). Yet another meta-analysis found no association
between stress and breast cancer (Duijts, Zeegers, and Borne 2003).
This is not to say that it is not theoretically possible. The concept of allostatic
load has been elaborated in detail in the past couple decades, principally by Bruce
McEwen at Rockefeller University (see, for example, McEwen and Stellar 1993; McEwen
2004). McEwen argues that stress, within reason, promotes biological adaptation to
stressors through the release of stress hormones—a process known as allostatis, or
“maintaining stability, or homeostasis, through change” (2004:1). However, prolonged
exposure to chronic stress and the resultant hormones produced can lead to “wear-andtear” on the body—otherwise known as allostatic load (McEwen 2004). He explains:
“Allostatic states can produce wear and tear on the regulatory systems in the brain and
body. Therefore, the terms allostatic load and allostatic overload refer to the cumulative
result of an allostatic state (e.g., fat deposition in a bear preparing for the winter, a bird
preparing to migrate, or a fish preparing to spawn is allostatic load). Allostatic load can be
considered the result of the daily and seasonal routines that organisms use to obtain food
and survive and to obtain extra energy needed to migrate, molt, breed, etc. Within limits,
they are adaptive responses to seasonal and other demands. However, if one
superimposes on this an additional load of unpredictable events in the environment,
disease, human disturbance, and social interactions, then allostatic load can increase
dramatically and become allostatic overload, serving no useful purpose and predisposing
the individual to disease” (McEwen 2004:3).

Research has linked allostatic load to immunosuppression and other conditions, such as
obesity, bone demineralization, brain nerve cell atrophy, atherosclerosis (McEwen
2004), migraines (Borsook, et al. 2012), and depression and anxiety disorders (McEwen
2004). This research is important and compelling; however, as far as I can tell, the
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concept of allostatic load has not been applied directly to cancer, and it has not widely
trickled into the mainstream resources on cancer. A PubMed search for “allostatic load
and cancer” revealed a small number of articles in psycho-oncology journals (see, for
example, Parente, Hale, and Palermo 2012; Ronson 2009). While it suggests an
important area of continuing biological research, I would argue that it has not yet
influenced mainstream understandings of cancer etiology. Although the larger discourse
on stress and disease is certainly prevalent, its pathway—allostatic load—is not.
Individual Responsibility and Cancer
Researchers must be wary when researching disease etiology. It is necessary to
tread carefully in acknowledging the compelling nature and explanatory potential of
biological processes such as allostatic load, while avoiding an individualistic discourse
that ultimately blames the victim for both the onset of the disease as well as continued
survival after cancer and the avoidance of recurrence. These concepts must be placed
within a social and historical context: for example, the theory that particular personality
characteristics and depressive tendencies cause cancer is not new. It has appeared in
some form or another since the time of Galen, who proposed that the cause of cancer is
an excess of black bile, otherwise known as melan chole (McMullin and Weiner 2008;
Olson 2002; Patterson 1987). In modern times, the “cancer-prone personality” or “type
C personality”—in which C stands for cancer, and references someone who reacts to
stress with depression, submissiveness, and hopelessness—has a long and colorful
history in psychiatry (DiGiacomo and Sumalla 2011). The latter perspective argues that:
“The typical cancer patient is a person who responds as a victim in all areas of life.
Unable to cope ʻnormallyʼ with the stress of unmet emotional needs and unresolved
interpersonal conflicts, the cancer-prone individual ʻescapesʼ into illness in order to avoid
having to take responsibility for his or her own life…The afflicted person can help the
physician restore health by acknowledging ʻparticipationʼ in the emotional states that led
to cancer, and by making a conscious and conscientious effort to overcome them. The
answer to the inevitable and anguished question ʻWhy me?ʼ is clear: Because you have
brought it upon yourself” (DiGiacomo and Sumalla 2011:13).
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While the participants in this study who subscribed to this tenet found it beneficial
and liberating, I argue that they may be the exception rather than the rule, and the larger
ripple effects of this kind of approach can make it dangerous. Apart from blaming and
stigmatizing those who are diagnosed with cancer, therein creating even higher levels of
stress by holding them totally accountable for their own survival, it is has implications on
resource allocation. Instead of, for example, devoting time, energy, and resources to the
study of structural, environmental, or genetic bases of cancer—which, quite frankly, are
more likely to yield actionable information—since the 1950’s, decades of scientific
funding and self-help writing have been devoted to the cancer-prone personality.
DiGiacomo and Sumalla (2011) argue that the victim-blaming discourse still
lingers within the survivorship concept, noting that “victim” and “survivor” are two sides of
the same coin. As they point out, the key to the survivor identity is active engagement
with the disease, treatment, and the outside world—versus the more passive identities of
patient or victim. But, the way in which the survivor discourse has been invoked in
psycho-oncology has created the dominant expectation that survivors will undergo a
positive identity transformation in the process of confronting cancer. They argue:
“While the cancer survivor represents a significant improvement over the image of the
cancer victim, the former has yet to liberate itself from the latter. […] The survivor, in
psycho-oncologic discourse and practice, is the person who has achieved ‘real growth’ in
facing the ongoing trauma of cancer diagnosis and treatment […] However compelling
and attractive this idea may be, an undeniable whiff of moral superiority attaches to the
image of the person capable of positive self-transformation in traumatic circumstances:
the survivor is supposed to be a better person. In addition to remaining subject to the
victim identity hovering in the background and framing the questions, the survivor may
feel obliged to show that he or she has been changed positively by the experience of
illness, and this in turn may lead people to repress or dissociate from negative emotions,
or feel that they have failed if they do not survive physically having transformed
themselves into new persons. The victim is thus not only blamed for his or her illness,
but pressured to respond to it in particular ways on several levels” (2011:15).

Critiques of the survivorship discourse point to the “tyranny of optimism” that pervades
the social expectations of a survivor and challenges the validity of negative emotions.
Taken to the extreme, these negative emotions are made dangerous because they are
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seen to invite recurrence and ultimately death.
While this discussion in no way negates the personal and life-changing
transformations that survivors in this study spoke about, it is important to consider the
role of the above critique. Perhaps, as DiGiacomo and Sumalla (2011) suggest, the
change that survivors speak of occurs as an intense, embodied learning experience,
versus the identity change as conceived by the psycho-oncology literature, “in which
new truths—either positive or negative—are drawn out of a close encounter with
mortality” (2011:16). This learning experience prompts survivors to share what they
have learned with others who are going through the process, explaining one of the
ubiquitous themes in the literature that also appeared in this study—an overriding need
to give back and help others. This is a strong theme even in the small body of research
with Latina cancer survivors (e.g., Buki, et al. 2008). The authors note that this learning
and knowledge about “‘how to live’ is not ‘coping’ (a thin description) or illness
management, but existential. Service work such as this is one dimension of that ‘how to
live,’ a way of crafting a life through the telling and sharing of stories in all their
complexity” (DiGiacomo and Sumalla 2011).
MODELING SURVIVORSHIP: THE ROLE OF ORGANIZATIONS AND SUPPORT
GROUPS
It is important to note the role of the group context in the interpretation of these
findings. Both support groups as well as larger organizations, such as the ACS or
Susan G. Komen for the Cure, impacted survivors’ experiences on a variety of levels.
Specifically, destigmatization of cancer, ideas about causation, the recovery framework
or identity (“survivor” vs. “viviente”) and the responsibilities that it entails, were all
intertwined with the roles and activities of support groups and advocacy organizations.
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Cancer Advocacy in Puerto Rico
The first question concerns the impact of the advocacy organizations on the
broader context of cancer in Puerto Rico. There was a general consensus that the
increasing destigmatization of cancer was largely due to organizations’ activities and the
escalating exposure in the media. The media analysis confirms that there has been
more coverage, at least in Imagen—a Puerto Rican publication—between 1995 and
2010. A wide variety of groups, both non-profit and for-profit, sponsored advertisements
by the years 2005 and 2010, announcing fundraising strategies and events, as well as
general awareness-raising (such as the one-page spread by the pharmaceutical
company Lilly Oncology that urged women to get their yearly mammogram). Given this,
it seems relatively safe to say that participants’ perceptions are correct, and cancer is
more “in the news” now than it was a few decades ago, or even one decade ago. As
one of the mainstream group’s representatives stated, they have done a good job of
showing the faces of happy survivors in an effort to decrease the fear and stigma
associated with the disease.
This increasing exposure is not without ethical questions. As one participant
noted ironically, Komen’s partnership with KFC did not send an appropriate message to
the public because “their chicken causes cancer,” and their alliance thus reeked of
hypocrisy. This is a good illustration of the difficult boundaries that organizations face
between maintaining financial viability and partnering only with organizations perceived
as socially responsible; such a dilemma is often faced by non-profits that must decide
whether to take pharmaceutical money in order to expand their programs, or decline the
funds and operate on a much smaller scale. Inevitably, scholars argue that this choice
tempers organizations’ ability to challenge the status quo or to create more radical
systemic change (cf., Kamat 2003, 2004).
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In the US, a continuum of approaches to cancer activism has taken shape,
creating a spectrum of organizations with more and less radical agendas. Less radical
organizations tend to promote the sharing of information and work on awareness-raising,
support, and educational programs that help patients communicate with their providers
more equally and advocate more competently for their own healthcare. On the other
hand, according to Anglin (1997), radical groups have different agendas:
They seek “direct representation of their membership in decision-making about cancer
research and health policy, and point to the need for research on unconventional cancer
therapies as well as state-of-the-art biomedical treatments, call attention to the political
and economic contexts of [cancer], and critique what they refer to as ‘the cancer industry’
for its profiteering” (Anglin 1997:1406).

Anglin (1997) observes that within these two poles lie a multiplicity of organizations that
do not identify entirely with either extreme: at times they “[serve] as power brokers who
draw their strength from a growing constituency, and other times [they work] through
grassroots channels to change the terms” (1997:1406) by which patients are treated.
With breast cancer in particular, a strong critique of mainstream approaches has
characterized many of these more politicized organizations in the US and the breast
cancer movement at large (Anglin 1997; Kaufert 1998; Ley 2006). Ley (2006) argues
that feminist breast cancer activism has sought to situate the problem “within the cultural
legacy of sexism and gender discrimination that has historically been a part of
biomedicine, the life sciences, and society more generally” (2006:108). Driven by this
framework, activists have critiqued the mainstream conception of cancer etiology as
resulting from improper lifestyle choices or habits on the part of the individual women,
such as poor nutrition, smoking and lack of exercise, and risk factors that
overemphasize women’s reproductive strategies in the industrial world, such as
breastfeeding practices and age at first childbirth3. The focus instead, they argue,

3

Epidemiological research has pointed to higher rates of breast cancer in women who do not
breastfeed, as well as those who never have children or have children after age 30 (CDC 2013).
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should rightly lie on the structural factors that constrain women’s choices, the historic
lack of attention to women’s health in the scientific research arena, and the role of
environmental factors in cancer etiology. The individual-level causal associations are
seen to blame women for their disease and to divert attention from the responsible, and
more powerful, factors and parties (Anglin 1997; Kaufert 1998; Ley 2006).
These more radical organizations have critiqued their fellow advocacy NGOs for
what they perceive as their mainstream, depoliticized response to breast cancer—
embodied by such phenomena as the pink ribbon and National Breast Cancer
Awareness Month—which, they argue, perpetuates traditional conceptions of femininity,
as well as heteronormativity (Ehrenreich 2001; Ley 2006). Ley (2006) observes that
these activists believe that this type of response:
…“encourages women to learn make-up techniques so they can look prettier after their
treatments instead of encouraging them to ask what causes their cancer. Moreover, they
believe that this disease culture cultivates optimism that breast cancer is a blessing in
disguise instead of cultivating anger at a social system that values financial profit over
women’s health” (2006:112).

For example, Breast Cancer Action has targeted certain pharmaceutical companies
because of their conflicts of interest—they manufacture chemicals that may play a role in
the development of cancer, while at the same time produce chemotherapies and other
treatment modalities designed to cure it (BCA 2009). They are, in effect, creating both
the sword and the shield. Interestingly, National Breast Cancer Awareness Month
(NBCAM) is funded in large part by the spin-off non-profit foundation of a multinational
chemical and pharmaceutical company, AstraZeneca4 (Ley 2006; NBCAM 2009).

4

The role of AstraZeneca and its pesticide-producing parent company, Imperial Chemical
Industries (ICI), in NBCAM would make any hardened conspiracy theorist shudder. Dr. Samuel
Epstein, professor of Occupational and Environmental Health at the University of Illinois School of
Public Health, stated that, “This is a conflict of interest unparalleled in the history of American
medicine. You've got a company that's a spin-off of one of the world's biggest manufacturers of
carcinogenic chemicals, they've got control of breast cancer treatment, they've got control of the
chemoprevention [studies], and now they have control of cancer treatment in eleven centers—
which are clearly going to be prescribing the drugs they manufacture” (Batt and Gross 1999).
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The participants’ perspectives about the roles of patient advocacy organizations
in cancer care in Puerto Rico fell in two distinct directions, albeit less radical than those
outlined above. The advocates voiced most strongly the idea that organizations in
Puerto Rico, including their own, fill gaps or needs in the system: they provide services
and products not offered by the hospital facilities, doctors, or public and private health
plans. This role centered around granting money to patients to supplement the
expenses that were not covered by insurance, such as transportation and parking fees,
co-pays, medications, lymphedema sleeves, and psychological support. They
addressed the information gaps by creating educational materials, seminars, and
advertising campaigns to raise public awareness about cancer and related issues.
Less often but still significantly, advocates’ perspectives on the role of cancer
advocacy organizations in Puerto Rico focused on the idea of “changing the system”—
such as advocating for changes that they see as necessary for ensuring the quality-oflife of patients and survivors. This is exemplified by the comment that the ACS’ mission
largely was to undertake advocacy related to expanding access to care and screening
modalities. Another example would be advocacy by Komen on the need for follow-up
care guidelines for survivors following treatment. However, with one notable
exception—that of a small, local organization that is attempting to change what the
founder perceives as the misguided nature of the “survivorship” movement and
misperceptions about cancer’s etiology (i.e., she believes that it is caused by negative
emotions and stress)—the cancer advocacy landscape in Puerto Rico leans toward the
more conservative, filling-gaps-in-services model of engagement, at least on the level of
the organization’s official mission, if not always the individual advocates themselves.
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Sobrevivencia and Vivencia: Models of Recovery from Cancer
The Puerto Rican chapters of US-based organizations used the concepts of
survivorship and survivors and actively sought to promote their use through awarenessraising and fundraising activities. Many local organizations used these concepts too in
what seems to at least partly be a response to the activities of the mainstream groups.
However, as noted above one local organization used a local model of cancer recovery
that contested the survivorship concept espoused by others. While survivorship is
regarded as merely living in a physical sense, a “viviente” means that one is squeezing
every last drop out of life, living to the fullest degree possible, leaving no opportunity
behind, and centralizing love and appreciation for God and family in one’s life. While I
would argue that these characteristics are in some ways not significantly different from
the survivorship model commonly used by organizations and individuals in the US, the
articulation of the values that it espouses points towards a “Puerto Rican” model of
recovery—one that incorporates loved ones and God as the center of post-cancer life.
Learning How to Be a Survivor
A related theme concerning cancer organizations—particularly support groups—
can be distilled down to the idea of “learning how to be a survivor.” Support groups
shaped people’s terminology and thinking about what it means to have cancer. Thus,
they served several vital functions in this regard: individuals learned (1) how to identify
themselves to others and how to situate themselves in the larger world vis-à-vis cancer;
and (2) what obligations, responsibilities, expectations and meanings come with different
identities—and more broadly, how to live one’s life post-cancer. An important example
of this concerned the idea of helping others, a very prominent theme. Support groups
provided the space in which people helped themselves psychologically and emotionally,
but almost more importantly, they provided the venue through which to help others. It is
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hard to tease apart whether this was a value brought into the group by an individual
survivor, or whether it was something that was learned in the group itself; regardless,
helping others was encouraged both explicitly and implicitly as a responsibility of being a
survivor, and the cause was actively taken up by support group members.
Previous research has investigated the cultural models created by support
groups. These authors argue that these groups develop templates of survivorship
experiences and recovery that, through time and group processes, become shared and
embraced among their members (Coreil, et al. 2012, 2004; Corvin, et al. [In Press];
Mathews 2000, 2008). For example, Mathews (2000, 2008) studied the creation of a
breast cancer support group for African American women in which the resulting cultural
model of breast cancer “transcend[ed] some of the boundaries of ethnicity, class, and
age by articulating a view that all group members can share and by aiding them in
arriving at a meaningful understanding of their illness experiences” (2000:409). In
addition to considering the idea of learning survivor responsibilities and obligations, this
body of research is particularly relevant when we consider the causation theories
espoused by some of the survivors. As noted earlier in this discussion, a prominent
theme was that stress and negative emotions act to depress the immune system, which
ultimately causes cancer. All of the participants who believed this took personal
responsibility for their disease (a view that they claimed, almost paradoxically, freed
them of a huge psychological burden). Most of these participants were members of one
group whose leader undertook to offer them life skills workshops in which they learned
about the role of negative emotions in cancer causation, and it was there that they
learned, simultaneously, how to live with this responsibility. At the same time, the theme
arose among other participants, albeit less explicitly, as well as the media analysis—
reflecting the interplay of cultural models of cancer and survivorship created by some of
the groups studied here, and wider discourses and understandings of cancer.
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CANCER, INFERTILITY, AND FERTILITY PRESERVATION
A second major research focus concerned cancer-related infertility and the use of
fertility preservation methods on the island. The following section will analyze the major
themes that emerged from data on reproduction, focusing on provider communication
issues, and historical and social context that shapes current reproductive options.
Provider Communication about Infertility and Fertility Preservation
Of the many barriers to fertility preservation, provider disclosure has received a
good deal of attention, in part because it was conceptualized as the first step in the
process—and one that was not happening, as in Schover and colleagues (2002b) study
about the scanty 10 percent of oncologists who systematically informed all their eligible
patients about fertility preservation. Thus, this withholding of information has often been
framed as the dominant reason why newly-diagnosed individuals do not seek out fertility
preservation—because they do not know about infertility in the first place, because they
do not know about fertility preservation, or because they find out that information after
treatment has begun and it is too late to do anything about it. Moreover, it has often
been framed as a “breakdown” in a one-way information flow from the provider to the
patient, and the most important factor that impacts upon patient decision-making
capacity—and thus, the resulting lack of use of these technologies.
There was general consensus among the healthcare providers interviewed that,
on the whole in Puerto Rico, newly-diagnosed patients are not being systematically
informed of either infertility as a risk, or fertility preservation options available to them,
even though 100 percent of these interviewees believed themselves that it is important
to disclose this information. One oncologist noted, “having said that we talk about it, we
barely talk about it. Really, people only talk about it in terms of [‘is she of] childbearing
age? [Then] she's got to consider fertility preservation and then we forget about it.” This
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inconsistency is also mirrored in the interviews with reproductive-aged survivors—half of
whom had had a conversation with their doctor about it, and half of whom had not.
A logical question to thus ask is: why is this information provided so
inconsistently? Several themes were dominant in the provider data: first, as reflected in
the literature (e.g., Quinn, et al. 2008) some providers were too focused on the curative
part of the process and tended to believe that anything relating to quality-of-life posttreatment was not a priority. They generally believed that patients’ first priority lay with
their existing children and they preferred to focus on them, rather than consider fertility
preservation; thus, they did not need more children since they already had one or two.
They also spoke extensively about what they framed as “pressure from the patient.”
According to some providers, patients just wanted their treatment—they wanted the
cure, and they did not care about anything else at that point. These oncologists felt
obligated to respond to that urgency, although one particularly reflective one noted that
as the months or years pass, their childless patients began thinking about fertility again;
the issue never truly disappears.
Oncologists also expressed personal difficulties about the complexities and
ambiguities of fertility preservation, and thus informing patients about it. This seemed to
happen most noticeably in discussions with patients who had poor prognoses. It was an
emotionally difficult situation for the oncologists, who wanted their patients to have a
certain treatment in order to give them the best chance of survival, to have a patient
choose what might be considered suboptimal therapy in an attempt to preserve their
fertility. Patients with poor prognoses or aggressive disease presented an excruciating
counseling dilemma for the oncologist—they were unsure what course to recommend.
Social scientists writing on patient-provider communication, such as Lazarus
(1988) and Roter and Hall (2006), have argued that it is a revealing topic on many levels
of analysis: the personal beliefs, values and knowledge among physicians, the ethical
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conundrums that arise as these beliefs, values and knowledge collide with those of
people entering the system as patients, and the constraints that are placed upon both
patients’ decision-making capacity and physicians’ information-providing ability by the
structure of the cancer care system itself and the asymmetrical power relationships that
exist between the two parties. As Manderson (2012:331) notes:
“Upon diagnosis, health providers and patients face two ethical-medical dilemmas. Health
providers must decide what to tell patients, and what advice to offer them in terms of
treatment, care, and prognosis. In response, patients must make relatively quick decisions
about the medical and surgical interventions, and if they are told or surmise that they have
cancer, they must also decide whether to tell others. The ethnographic accounts of
disclosure, truth telling, and decision-making demonstrate the profound difficulties that all
people face in this context. There are no clear lines to guide the actors.”

Roter and Hall (2006) argue that there are two dominant perspectives on the
withholding of medical information—in other words, why physicians withhold information
or give incomplete information. First, physicians “believe that most patients are
unprepared to evaluate and comprehend the complex information they may receive […
and second], information is power, and an informed patient is a possible threat to the
physician’s professional status and control of the therapeutic situation” (2006:128).
Further, they argue that “physicians and patients often disagree as to the likely outcome
of the disclosure, and consequently what it is in the patient’s best interest” (2006:128).
What is clear from this data is that there is a gate-keeping in the process of
information-provision. Oncologists do not necessarily see their role as simply to educate
on all possible outcomes of treatment; rather, they tend to cherry-pick who they think is
most appropriate for that information for reasons that were not wholly based on medical
realities. This is most evident in the comments of some oncologists who noted that they
sometimes do not broach the topic with very low-income patients, because “nothing
could be done about it anyway.” In addition to this assumptions about patients’
socioeconomic status and the financial feasibility of fertility preservation, other rationales
included assumptions about a patient’s family-building goals, assessments about their
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partnership status and how well these would fit within the narrow framework required by
fertility preservation. The information is fractured, inconsistent, and filtered by doctors'
and nurses' perception of the impact of both cancer and infertility on their patients’ lives.
The concerns of the oncologist who spoke about his discomfort of broaching the
topic of fertility preservation with patients who had poor prognoses hints at the latter
arguments. By not raising the topic, the oncologist avoids a potentially uncomfortable,
ambiguous situation: a patient with a poor prognosis choosing a less-aggressive
treatment in order to lessen that risk of infertility, something that the oncologist may
regards as suboptimal. While the patient may be balancing their need for cancer
treatment with preserving their autonomy and ability to pursue life goals, the oncologist
is often not trained to see this as a balance, viewing it instead in a more dichotomous
fashion—that cure is most important thing. By avoiding the conversation, they therefore
avoid the challenge to their professional training and sense of purpose as a clinician.
Alternatively, another reason for this silence and non-disclosure about infertility
and fertility preservation is the ethical ambiguity of the situation. A concept called moral
distress has been explored to a great extent in the nursing literature, and recent work
has called for further articulations of the phenomenon in physicians and other healthcare
professionals. According to McCarthy and Deady (2008), moral distress in healthcare
providers references “an umbrella concept that captures the range of experiences of
individuals who are morally constrained […] in short, they know what is the right thing to
do, but they are unable to do it; or they do what they believe is the wrong thing” (254). It
can have serious impacts on providers, including negative psychological repercussions,
burnout, quitting, and avoidance of patient interaction (McCarthy and Deady 2008). The
original formulation of moral distress defined it as occurring when a healthcare provider
is prevented by institutional constraints from following a morally correct course of action,
and is thus at the mercy of external influence to some degree (Jameton 1984).
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This can be a useful concept when we consider the situation facing oncologists
when they see a newly-diagnosed cancer patient for the first time. The literature has
documented numerous systemic barriers to disclosure, including lack of time, an
overwhelming number of (oftentimes emotionally-difficult) topics to address, and
expensive treatments juxtaposed with financially-vulnerable patients. Accordingly, the
combination of these barriers leads many oncologists in these studies to dispense with
the conversation altogether. While lack of time was not widely cited in this particular
study, the latter issue (expensive treatments and low-income patients) had particular
resonance. Oncologists believed that infertility was an important issue to patients; at the
same time, they widely pointed to cost as the major deterrent to utilization of fertility
preservation and implied that many colleagues only inform well-to-do patients. They
also expressed moral anguish in several instances: at the prospect of patients choosing
less-effective cancer treatments in an attempt to preserve fertility, or patients and
survivors with poor prognoses electing to either undergo fertility preservation or have
children after treatment. This data suggests that, while they hold the issue to be
important and believe it is ethical to inform every patient, they often feel constrained in
doing so by the wider financial realities and by the threat of being confronted with an
ethically ambiguous or morally distressing situation.
For their part, patients are obviously not just passive receivers of information;
information is gathered by them from various sources in complex ways, and organized
somewhat hierarchically in terms of the value and prestige accorded to that information
and its source. An important question is why, among oncologists who do inform patients
and who do refer them to fertility clinics, people are not frequently using these services.
They have the information and they have it in an appropriate timeframe, but this does
not translate into using these alternatives—clearly, a linear relationship does not exist
between information provision and uptake of technology. However, the information is
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also given or discovered at the worst time; cancer is still largely equated with a death
sentence despite rising survival rates, and people are forced to confront and make
decisions about two hugely significant life trajectories in a single moment—first, the
treatment that will prevent their own death, and second, technologies that would
symbolically preserve their ability to live on genetically through their own children even if
that capacity is subsequently destroyed in their own bodies.
Here it would be helpful to look at the process of information-getting. The
available literature is heavily focused on one of the main elements of the decisionmaking process with regards to fertility preservation—having information available to
evaluate one’s options—but not so heavily on another element, the process of
information-getting. Was the information delivered at the best time? Did the person
have the space to understand the information in the first place and the emotional
capacity to process and act on it in accordance with their life goals? Newly-diagnosed
patients commonly forget much of the information they received during the course of
diagnosis and initiation of treatment. As Manderson (2012) notes, “patients who are
given their diagnosis frequently report their inability to make sense of information
provided to them at the time of disclosure, because of the limited time the clinician
spends with the patient, because of the use of biomedical language, and because of the
patient's own sense of shock and inability to focus" (2012:332). Thus, some survivors
quoted in this study who reported not receiving information about infertility may not be
reflecting a lack of provision but rather an inability to recall the conversation. This is
obviously an important distinction. However, the overriding lesson is that the ways that
we provide information to newly-diagnosed patients must take account of the inability to
absorb massive quantities of life-changing information at one time.
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Reproduction in Historical Context
The few fertility clinics that operate on the island do offer both fertility
preservation and post-treatment parenthood options. However, as this study has
detailed, widespread access to them is restricted by numerous factors such as high cost,
lack of insurance coverage of fertility services, geographic location, limited public
awareness of and provider knowledge about options for fertility preservation; and—as
will be discussed next—a social milieu that may limit attention to infertility as a
recognized problem (Dyer, Mitu, and Vindrola-Padros 2012).
Regarding the latter, since the early 20th Century, the “official” discourse in the
US surrounding Puerto Rico has been that of overpopulation, as discussed in Chapter
Five. Puerto Rico became the site of a population-reduction program encompassing
significant migration to the Northeast, a decades-long experimentation in birth control,
and a notorious sterilization campaign, all intended to improve the island’s economic
condition. Attention from both Puerto Rican and American officials to the so-called
overpopulation problem spanned decades (Briggs 2002). As mentioned in that chapter,
Briggs (2002) has argued that the population discourse served as a more acceptable
excuse for the failure of the industrialization program to improve economic and living
conditions, a way to deflect attention from the unjust economic policies that funneled
money from the island back to American corporations.
Regardless of the demographic data, the construction of a nation as
overpopulated can have ripple effects that are ultimately reflected in access to health
services. In Puerto Rico, it is possible to argue that a socially constructed discourse of
overpopulation is connected directly to access and non-access to specific health
services—clearly to sterilization and birth control in past decades, and in the present
day, to assisted reproductive technologies. The situation in Puerto Rico—whereby few
infertility clinics exist and the “overpopulation problem” has been the overarching
304

discourse throughout much of the 20th century—can be said to reflect a general trend
that was referenced in Chapter Three: in countries that have historically been viewed as
overpopulated (generally developing countries), infertility and access to ARTs are often
treated as a non-issue by scholars, funding agencies and government officials alike
(Inhorn 2003). ARTs are neither covered by insurance nor offered through public clinics,
and infertility treatment thus become available only for the elites (Inhorn 2003). One of
the healthcare providers referenced this: when asked if he knew of any financial
assistance programs that helped cancer survivors access fertility preservation, he
replied: “I don't see how the government can deal with all of that. On the contrary, they
want to probably control the population somehow.” Tellingly, little research can be
located that discusses infertility or ARTs on the island. In essence, the availability of
ARTs to cancer patients and survivors (or anybody else) in Puerto Rico reflects larger
questions about universal access to assisted reproductive technologies, whether or not
access to infertility treatment, and, more broadly, reproduction, is a right or a privilege,
and how it applies to contexts in which half of the population falls below the poverty line.
Sterilization
A note on sterilization in the Puerto Rican context is necessary. Puerto Rico has
historically had one of the highest rates of sterilization in the world, reaching 39 percent
of reproductive-aged women by 1982 (Vasquez-Calzada and Carnivalli 1982). Indeed,
in this study alone six out of 20 female survivors had undergone voluntary sterilization,
with two of them voicing regret retrospectively, and another under the active assumption
that it was a temporary and literal “tying” of the knots that could easily be untied.
Feminists have wrestled with the high numbers of voluntary sterilization still taking place
in Puerto Rico, given that the sterilization campaign in Puerto Rico has long been
perceived as coercive. In this regard, anthropologist Iris Lopez (2008), in her
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ethnography of sterilization among first-, second- and third-generation Puerto Ricans in
New York, argues for a middle ground, seeking to expand the heretofore binary,
simplistic, and linear conception of reproductive rights in general, and birth control
(sterilization) in particular. She argues that the debate over sterilization in Puerto Rico is
polarized between those who see that women actively seek out sterilization and interpret
it as evidence that there are no longer any issues with abuse, and those who view
women solely as victims of the state and the history of colonial oppression in Puerto
Rico. The reality, however, lies in the degrees of choice, agency, or freedom that women
experience and within which they make their decisions regarding birth control. Many
women do exercise choice by opting for la operación, which reflects agency; however,
this does not necessarily prove the existence of complete reproductive freedom.
Lopez details her own framework for understanding sterilization among Puerto
Rican women, which she terms the Integral Model of Reproductive Freedom. She
argues that reproduction experiences necessarily entail elements of the personal (i.e.,
women's desire to limit their family size because they cannot afford another child; they
do not want to have another child with an abusive husband, etc.); the cultural (i.e., the
socialization into sterilization by older generations of women—they are familiar with it
and comfortable with the idea); the social (i.e., the social-structural constraints that act
upon a woman's reproductive choices—in particular, the lack of availability of any other
temporary birth control, the skyrocketing price of the pill, and dangerous, crime-ridden
neighborhoods that make it unsafe for children to play outside); and the historical (i.e.,
Puerto Rico's neo-colonial status, its history as a "laboratory" for experimentation with
the birth control pill and other forms of contraceptive foams and jellies). All of these
elements contribute to reproductive decision-making and use of sterilization. She
cautions that “a distinction needs to be made between decisions based on a lack of
viable alternatives”—which has contributed a great deal to Puerto Rico’s continuing high
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sterilization rates—versus “optimal reproductive freedom” (Lopez 2008:142). It is clear
from the experiences of several women in this study that agency indeed exists; many of
these women either actively sought out sterilization when they had decided they did not
want to have any more children. However, the other end of the spectrum is evident as
well. In two cases the operation was regretted—with one, it was relatively clear from the
survivor’s narrative that the operation was coercive, and the woman was taken
advantage of in an emotionally difficult and vulnerable time. With the other, the survivor
did not want the operation but felt socially compelled to undergo it—thus, it was seen as
a social responsibility and one not desired on its own merit.
RECOMMENDATIONS
This research highlighted several potential areas for attention or improvement.
There are many areas in which policy work would prove beneficial for filling gaps
identified by study participants: for example, instituting a prevention focus in la Reforma
that would cover screening for common cancers, most notably colonoscopies to detect
colorectal cancers. Other policy reforms might target insurance coverage for fertility
preservation, school health educational programs, and mandating that plastic surgeons
accept insurance coverage for reconstructive surgery. Finally, as mentioned by one
doctor, a joint effort between fertility clinics in Puerto Rico to centralize fertility
preservation services in one clinic would help these providers to maintain their expertise
even with low service usage rates and to reduce uncompensated expenditures.
However, while these changes would have the widest-reaching impacts, they are
unlikely to occur without significant political will, resources, and time investment; thus,
the following section concentrates on concrete, actionable areas that can be addressed
by groups, organizations, or individual providers. These recommendations center on
information, provider communication and awareness, and future research directions.
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Information
There is a large information gap in relation to the long-term and late effects of
cancer treatment, including infertility and fertility preservation. This information gap
could be addressed relatively easily by providing survivorship care plans for individuals
as they transition off of active treatment, so that they are aware of their own treatment
information as well as of necessary screening and precautions they must take regarding
potential late effects. Some of this information is available in Spanish from leading
organizations in the US, such as Livestrong and the National Coalition of Cancer
Survivorship (NCCS). These care plans should also include information on particular
areas that have substantial effects on later quality-of-life; as mentioned by advocates in
this study, this would include information on lymphedema, nutrition, sexuality and sexual
health, reproductive health and breastfeeding, and where to obtain psychological
counseling and referrals. This last point was made particularly strongly in this group of
participants, especially with regards to the psychological needs of family and children.
Many survivors reported a lack of information in their families about cancer, often
phrased as “ignorance,” which ultimately had a difficult effect on the survivors
themselves because they constantly had to battle against stigmatizing conceptions of
cancer (for example, that it is contagious or incurable). One-on-one peer counseling,
support or navigation programs would be highly beneficial so that survivors can assist
patients in dealing with cancer treatment and transitioning off of treatment; many
survivors in this study explained that they did not know what to expect when diagnosed
and their providers did not prepare them. In all of these instances, materials should be
created to respond directly to the cultural norms; for example, regarding nutrition,
information should be incorporated on the local diet and foods available in Puerto Rico.
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Provider Communication and Awareness
Provider communication and awareness is an important target area. A strong
theme was that oncologists and oncology nurses are unaware of existing fertility
preservation services; it would be easy and low-cost to distribute a pamphlet to
oncologists, gynecologists, urologists, and even primary care physicians about cancerrelated infertility and the various services available through local clinics. At the time of
this writing, one of the reproductive endocrinologists had begun undertaking outreach
efforts to oncologists, giving lectures through the Puerto Rico oncology association.
A key piece of missing information are the financial assistance programs
available to aid with fertility preservation and other treatment expenses: the American
Cancer Society, Niños que Quieren Sonreir for patients under age 18, and the Fertile
Hope/Livestrong Sharing Hope program in the US. The ACS usually runs transportation
programs for treatment-related appointments; expanding this service to include fertility
preservation or post-treatment parenthood services would help to mitigate the distance
and transportation barrier for individuals outside of the San Juan metro area.
Provider communication related to other important quality-of-life issues emerging
in this study is an essential area upon which to focus: for example, concerns related to
sexual intimacy and health, contraception—including tubal ligation, breastfeeding, and
body image. According to survivors, these topics were highly important but generally
neglected by their physicians. As such, they will be included as focus areas in the
summary of results to be distributed to physicians and other providers.
Directions for Future Research
Finally, this study points to numerous paths for future research. Because of the
scarce amount of social research on quality-of-life issues among cancer survivors in
Puerto Rico, this study was exploratory—it described the big picture in order to identify
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concerns, needs, and issues. Further research on the above concerns is warranted,
particularly sexual health, sexuality, body image, and breastfeeding.
The research was limited by the difficulty of finding young adult survivors who
had not had children before treatment. Future research should concentrate on exploring
these issues in greater detail among survivors who have used fertility preservation, or
among newly diagnosed young adults, in order to assess their decision-making
processes about the technologies as well as access to them. It is important to further
investigate providers’ communication strategies with regards to premature ovarian failure
above and beyond the issue of infertility, given the ongoing health concerns presented
by that condition. Similarly, future research should describe providers’ conceptions of ‘at
risk’ patients. Another area to explore would be doctor-patient communication related to
age; for example, in this study, why did older women report higher levels of disclosure
surrounding infertility than younger women? Are they seen by doctors as more
deserving of information? Do older women ask more questions, or are they just more
likely to remember these interactions?
Future research should also address alternative strategies for parenting in Puerto
Rico, including adoption, fostering, and child-free living. This study suggests that
adoption and fostering, both official and unofficial, are quite accepted forms of parenting.
What is unknown, however, is how feasible official adoption is for cancer survivors there.
DISSEMINATION OF RESULTS
These results of this research project will be disseminated in a variety of ways. A
book chapter in an edited volume has already been published (Dyer, Mitu, and VindrolaPadros 2012), and another is currently being developed. Findings from the data were
presented at the 111th Annual Meeting of the American Anthropological Association, San
Francisco, November 14-18, 2013. A preliminary Executive Summary has been drafted
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and will be circulated to participants and key informants who had voiced interest in giving
feedback. Finally, a one to two-page information sheet on the major applied findings will
be created and distributed to the providers, advocates, survivors and researchers, with
contact information for obtaining the full Executive Summary if they desire a copy.
FINAL CONCLUSIONS
Returning to the theoretical questions from Chapter Three, this study’s location at
the intersection of diverse strands of theoretical work endows it with the possibility of
contributing to a number of salient issues related to cancer survivorship and
reproduction in the context of Puerto Rico. First, fertility preservation and post-treatment
parenthood options in Puerto Rico are often prohibitively expensive and their cost is
rarely borne by insurance carriers. Roughly half of the young adults in this study
reported that they did not have a conversation with their oncologist about infertility,
pointing to an inconsistency with which information on this and other side effects, as well
as other parenthood options, is provided, mirroring the US literature. This occurs for
various reasons, one of which is the lower priority status that is accorded to issues
having to do with quality-of-life. In this way, as in the US, reproduction by cancer
survivors reflects Ginsburg and Rapp’s (1995) notion of stratified reproduction.
Parenthood by this group is devalued, deemed a lower priority by both providers and
patients themselves at the time of diagnosis. For many, it is simply impossible, given the
prohibitively expensive nature of the procedures, the few number of fertility clinics on the
island, and, for those outside the metropolitan area, the clinics’ inconvenient locations.
Most infertility research to date has been conducted with healthy couples (Snyder
2007), while this study aimed to examine those issues among individuals who have
experienced significant and life-threatening illness in order to determine how parenthood
changes in such a context. Survivors in this study reported a multitude of ways in which
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their experience of cancer had transformed their lives by re-focusing their priorities, their
social lives, their relationships with God, and their future plans. However, what
remained constant was their desire for children and the importance that they accord to
parenthood. Indeed, cancer was not seen to change one’s essence of being nor
fundamental life desires or values such as parenthood; what it transformed was their
awareness of those priorities and their ability to bring their everyday life practices in line
with these values. For example, an often-reported idea was that survivors spent more
time with their children because they realized “what was truly important in life.” Thus,
this value did not change through cancer; what changed was their ability, or will, to live
their daily lives in accordance with those steady, foundational values.
Third, this research aimed to examine how “survivorship” is experienced outside
of the US and whether the survivor identity is a salient concept in a different cultural
context (Kaiser 2008; Mathews, et al. 1994). Findings revealed that participants drew
from some of the overarching discourses of survivorship—such as transformation and
the importance of optimism and positive thinking—as well as from essentialized
elements of Puerto Rican culture in the crafting of a local model of life after cancer.
Here, the term “essentialized elements” refers to aspects of culture that were seen by
participants to be uniquely and essentially “Puerto Rican.” This includes the high value
placed on extended family, social relationships, and religious beliefs. This local model of
survivorship thus constructed emphasizes the transformative power of cancer, especially
in its ability to change social relations into meaningful, deep, and more satisfying
connections with others and with God, and to centralize the importance—and, indeed,
obligation—of helping others going through the same experience. It re-centralizes one’s
family and children as the most important aspects of life, and sharpens survivors’
awareness of this fact—removing the “noise” or distractions that were in place before
cancer. The local model incorporates the critical role of optimism and the potential
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danger of negative thoughts, emotions, and stress in quality-of-life, as well as in the
onset of disease and ongoing survival from cancer. Life after cancer is thus
painstakingly crafted (Frank 2003) from dominant, mainstream discourses of cancer
survivorship as well as from aspects of Puerto Rican culture. Survivorship and survivor
identity, as set forth by the relevant US patient advocacy organizations and the National
Cancer Institute, are simultaneously embraced and rejected.
All of these processes take place in a colonial context between Puerto Rico and
the United States, a point of utmost importance. This is particularly salient when we
consider reproduction among cancer survivors, fertility preservation among patients, and
the substantial obstacles that exist to accessing these services for the majority of Puerto
Ricans with cancer. The history of the overpopulation discourse—coupled with
Americans scientists’ experimentation with birth control, the sterilization campaign, and
the institutionalized push for migration to the US as a population-reduction strategy—
may partially explain the lack of scholarly attention to infertility or to assisted
reproductive technologies on the island, the non-existent peer-reviewed literature on the
fertility loss experiences of individual patients and survivors, and the limited patient
education initiatives currently taking place. However, incidence rates are increasing for
many cancers in Puerto Rico, and mortality rates are declining, creating a situation in
which these concerns will continue to garner attention and consideration. An applied
perspective in anthropology can identify the primary needs relevant to these increasing
numbers of survivors, at the same time that it considers the importance of the social,
historical, cultural and political-economic context in the shaping of those concerns and
potential solutions for them.
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Table A1. Articles Reviewed by Tschudin and Bitzer (2009)
Reference

Year

Type of
Study

Methods

Sample

Pilot survey

Purpose-built mail questionnaire
including SF-36 for QoL

132 patients from a tumor registry
(89 females; 43 males)

Zapzalka et al. 1999

Survey

Postal questionnaire

46 oncologists

Dunn and
Steginga

2000

Mixed

Schover et al.

2002a

Survey

Schover et al.

2002b

Survey

Postal questionnaire

Green et al.

2003

Qualitative

Semi-structured interviews

Thewes et al.

2003

Qualitative

Crawshaw et
al.

2004

Qualitative

Zebrack et al.

2004

Qualitative

Schover et al.

1999

2 focus groups; 4 in-depth
interviews; 3-round iterative
survey
Purpose-built postal
questionnaire

23 breast cancer patients
(Australia)
201 patients from two cancer
centers
162 oncologists from two cancer
centers
15 male cancer survivors

4 focus groups; 8 semi-structured 24 early-stage breast cancer
interviews; Quantitative ranking
patients
22 health and social work
Semi-structured interviews
professionals
Semi-structured telephone
32 childhood cancer survivors
interviews
657 members of Young Survival
Web-based survey
Coalition (breast cancer
survivors)
Telephone interviews and postal
164 breast cancer patients
questionnaire
51 patients from one center with
Postal questionnaire
cryopreserved sperm

Partridge et al. 2004

Survey

Duffy et al.

2005

Survey

Saito et al.

2005

Survey

Thewes et al.

2005

Survey

Postal self-report questionnaire

228 breast cancer patients

Zanagnolo et
al.

2005

Survey

Postal questionnaire

68 ovarian cancer patients

Achille et al.

2006

Qualitative

In-depth interviews

20 male patients; 18 oncologists

Burns et al.

2006

Survey

Cross-sectional purpose-build
questionnaire

50 families (childhood cancer)

Chapple et al.

2007

Qualitative

Narrative interviews

21 male patients (UK)

Goodwin et al.

2007

Survey

36-item questionnaire

30 healthcare professionals
(nurses, nurse practitioners,
physicians)

Quinn et al.

2007

Qualitative

In-depth interviews

16 oncologists from one center

Van den Berg
et al.

2007

Survey

Postal questionnaire

117 parents of male childhood
cancer survivors at one children’s
hospital

Zebrack et al.

2007

Survey

Web-based questionnaire

1088 young cancer patients

Survey

Piloted questionnaire

Survey

Questionnaire

Survey

11-item questionnaire

Oosterhuis et
2008
al.
Van den Berg
2008
and Lengeveld
Ginsberg et al. 2008

*Adapted from Table 1, Tschudin and Bitzer (2009), pgs. 589-591
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40 pediatric cancer patients at
one center
117 families (parents of childhood
cancer survivors at one center)
45 patients intending to bank
sperm; 46 parents

Appendix A (Continued)
Table A2. Additional Articles Not Included in Tschudin and Bitzer (2009)
Reference

Year

Type of
Study

Methods

Dow

1994

Qualitative

Semi-structured interviews
Chart review

Avis, Crawford
and Manuel

2004

Survey

Cross-sectional survey

Carter et al.

2005

Survey

Self-report survey

Connell et al.

2006

Qualitative

Semi-structured multiple
interviews

Reebals, Brown
and Buckner

2006

Survey

Questionnaires

Nieman et al.

2007

Qualitative

4 focus groups

Clayton et al.

2008

Survey

45-item survey

King et al.

2008

Qualitative

1 focus group
8 in-depth interviews

King et al.

2008

Qualitative

1 focus group
2 In-depth interviews

Quinn et al.

2008

Qualitative

Subset of above interviews
= 24 in-depth interviews

Quinn et al.

2009

Survey

53-item questionnaire

Vadaparampil et
al.

2008

Qualitative

24 in-depth interviews

Forman et al.

2009

Survey

19-item survey

Mancini et al.

2010

Survey

Telephone questionnaire

Rabah et al.

2010

Survey

9-item survey
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Sample
16 breast cancer patients
204 breast cancer patients
and survivors
20 gynecologic cancer
survivors
13 breast cancer patients
27 hematology/oncology
nurses and nurse
practitioners
2 FGs: adult female
survivors of adolescent
cancer; 2 FGs: parents
210 pediatric oncology
nurses
15 oncology nurses, all
female, from outpatient
clinics of one institution
7 oncology social workers at
single institution, 100%
female
Same as above
613 oncologists (149 F, 363
M)
24 pediatric oncologists at
13 centers in FL (15 male, 9
female)
36 oncologists at a single
institution
4270 former cancer patients
(France)
103 oncologists (Saudi
Arabia)
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1. INTERVIEW GUIDE: SURVIVORS
1.

¿Cómo se describiría usted a sí mismo? (How would you describe yourself?)

2.

¿Cuáles son las tres cosas más importantes en su vida? (What are the three most
important things in your life?)

3.

A diario nos enfrentamos con muchos problemas. ¿Cuáles son los mayores
problemas que usted está enfrentando en este momento? (There are many
problems that we face every day. What are the biggest problems facing you now?)

4.

Cuando usted piensa en el cáncer, ¿cuáles son las tres primeras cosas que vienen
a su mente? (When you think about cancer, what are the first 3 things that come to
your mind?)

5.

¿Me puede usted hablar un poco acerca de su experiencia con el cáncer? (ej.,
diagnostico, tratamiento, etc.) (Could you tell me a little bit about your experience
with cancer? Ex., diagnosis, treatment, etc.)
a. Seguimiento: ¿Todavía asiste a visitas de seguimiento? ¿A dónde va a recibir
estos cuidados? (Do you still have follow-up appointments? Where do you
receive your healthcare?}
b. Seguimiento: ¿Qué cree le pudo haber causado cáncer? (What do you think
caused your cancer?)

6.

¿Tiene algún problema de salud que haya resultado del tratamiento con la que este
bregando todavía? (Do you have any cancer-related health issues that you still
have to deal with?)
a. Seguimiento: ¿Estas fueron discutidas con su médico? ¿Cuándo? (Did your
doctor discuss these with you? When?)
b. Seguimiento: ¿Cómo las maneja? (How do you cope with them?)

7.

Cuando usted piensa en la persona que usted era antes de ser diagnosticado/a y
en la persona que es usted ahora, ¿qué cosas han cambiado? (When you think
about the person you were before you were diagnosed, and the person you are
now, what kinds of things have changed?)
a.

8.

Seguimiento: ¿Qué cosas se han permanecido igual? (What things have
stayed the same?)

¿Cuáles son sus planes para el futuro? (¿Que se visualiza haciendo?) (What are
your plans for the future—what would you like to see yourself doing?)
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9.

¿El cáncer ha cambiado el modo en el que ve usted su futuro? ¿Cómo? (Has
cancer changed the way you view your future? How so?)

10. ¿Tiene usted hijos? (Do you have children now?)
a.

Seguimiento: ¿El cáncer ha cambiado su manera de pensar en cuanto a tener
hijos? ¿Cómo? (Has cancer changed the way you view having children? How
so?)

11. (*Si él/ella tiene hijos antes el tratamiento y no quiere más): Mencionó que,
después del tratamiento, no quería tener más hijos. Pero, imaginemos por un
minuto que querían tener más hijos después del tratamiento. ¿Cómo se hubiese
sentido si al finalizar el tratamiento le hubiesen dicho que no podría tener más? (If
he/she has children before treatment and doesn’t want more: You mentioned that,
after treatment, you did not want any more children. But, pretend for a minute that
you did want children after treatment. How would you have felt if, at the end of the
treatment, they told you that you could not have any more?)
a.

Seguimiento: ¿Trataría métodos alternativas para tener hijos (ej, adopción)?
(Would you try any alternative methods of having children [i.e., adoption]?)

b.

¿Por qué o por qué no?

12. ¿Ha conversado usted con su oncólogo/a acerca de tener hijos? (Did you have a
conversation with your oncologist about having children?)
a.

Seguimiento: ¿Qué le dijo él/ella? (What did he/she say?)

b.

Seguimiento: ¿Cómo se siente usted acerca de eso? (How do you feel about
that?)

13. ¿Hay cosas que a usted le gustaría hacer pero que no puede (debido al cáncer)?
(Are there things you would like to do but cannot [because of the cancer])?
a.

Seguimiento: ¿Hay cosas que usted siente que PUEDE hacer debido al
cáncer? (Are there things you that you feel you CAN do because of cancer?)

14. ¿Ha escuchado usted el término “sobreviviente de cáncer”? (Have you heard the
words “cancer survivor” before?)
a.

Seguimiento: ¿Se considera usted un sobreviviente? Por qué/Por qué no? (Do
you consider yourself a survivor? Why/why not?)

b.

Seguimiento: Si es así, en qué punto comenzó usted a considerarse un
sobreviviente? ¿Cuánto tiempo después del diagnostico? (If yes, at what point
did you begin to consider yourself a survivor? How long after diagnosis?)

c.

Seguimiento: ¿Qué significado tiene para usted el término “sobreviviente de
cáncer”? (What do those words mean to you, if anything?)
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15. ¿Cuáles han sido los aspectos más difíciles de haber tenido cáncer? (What have
been the hardest aspects of having had cancer?)
16. ¿Qué cosas lo hubiesen hecho más fácil? (What things could have made it
easier?)
17. ¿Cuál ha sido el rol de sus creencias espirituales durante y después del
tratamiento? (What has been the role of your spiritual beliefs during and after the
treatment?)
18. ¿Tenía seguro de salud durante el tratamiento? ¿Ahora? ¿Cuál cree usted ha sido
el impacto económico del cáncer en su vida? (Did you have health insurance
during treatment? Now? What has been the economic impact of cancer on your
life?)
19. ¿Cómo cree usted que la población en general ve el cáncer? (How do you think
the general public views cancer?)
a.

Seguimiento: ¿Cree que esto le aplica a usted? [¿Qué piensa usted de eso?]
(Probe: Do you think that this applies to you? What do you think about this?)

20. ¿Cuán importante usted cree que es tener hijos para los puertorriqueños, en
general? ¿Por qué? (How important do you think having children is to Puerto
Ricans in general? Why?)
21. ¿Usted busca información sobre el cáncer? (Do you seek out information on
cancer?)
a.

(Si es así) Seguimiento: ¿Dónde consigue la información? ([If yes] Where do
you get your information from?)

b.

Seguimiento: ¿De los recursos que ha encontrado, cuáles han sido los mas
útiles? ¿Por que? (What sources have you found most helpful? Why?)

22. ¿Hay algo más que le gustaría añadir que no hayamos cubierto hoy? (Is there
anything else you would like to add to this that we haven’t already covered?)
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Información Demográfica (Demographic Information)
Género (Gender):
Estado Civil (Marital status):
Edad (Age):
Edad a Diagnostico (Age at diagnosis):
Número de hijos (Number of children):
¿Cómo se identifica usted étnicamente? (How do you identify yourself ethnically?)
Lugar de residencia (Place of residence):
¿Cual es su ocupación? (What do you do for a living?)
Nivel más alto de educación (Highest level of education):
Rango de Ingresos del Hogar (Range of household income):
$0-5,000
$30,000-40,000
$5,000-10,000
$40,000-50,000
$10,000-15,000
$50,000-60,000
$15,000-20,000
$60,000-70,000
$20,000-30,000
> $70,000
Número de personas que viven en el hogar (Number of people living in household):
Tipo de cáncer y etapa (Type of cancer and stage):
• Tratamientos específicos recibido (Specific treatments received):
• Fechas de tratamiento (Dates of treatment):
• Hospital/Clínica (Hospital/Clinic):
• ¿Cómo se diagnosticó el cáncer? (How was the cancer diagnosed?):
¿Cómo se enteró de este estudio? (How did you hear about this study?)
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2. INTERVIEW GUIDE: ONCOLOGISTS
GENERAL QUESTIONS & SERVICES: I am first going to ask you a little bit about the
general issues that your patients deal with, and then we’ll talk specifically about fertility
and having children.
1. [FOR NURSES]: Can you describe for me what your job involves?
2. Can you describe your general patient population for me?
a. What is the average age of your patient?
b. What is the most common cancer diagnosis?
3. Can you describe the general process of diagnosis, referral, and treatment for
me?
a. Who do you usually get referrals from?
b. Do you see both men and women?
4. When you think about your younger patients (for example, those between the
ages of 18 and 45), what are some of the long-term medical (treatment-related)
issues that your young patients have to deal with?
5.

What are the long-term social issues that your young patients have to deal with?

FERTILITY AND PARENTHOOD:
6. Based on your experience, how important do you think having children (or more
children) is to your younger patients?
a. Do your patients express concern about this when they learn their fertility
may be affected due to treatment? Or after treatment?
b. Do you think your patients’ views on fertility change during treatment or
even after, as survivors?
c. What are their main concerns? Do patients mention this directly to you or
do you hear it from parents? Partners?
P/P COMMUNICATION:
7. When you get a newly diagnosed patient who is in their reproductive age
(between 18 and 45), do you discuss fertility issues with that patient?
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a. If no, why not? Is it you or someone else?
8. How do patients react to these discussions?
a. What type of information are they most interested to know about related
to fertility?
b. Do they usually learn about fertility preservation beforehand? How?
9. Do you have patients that use fertility preservation services, such as sperm
banking and embryo freezing?
a. [If yes] Where do they go?
b. How do you find referrals for patients who are interested in seeing a
fertility specialist?
10. Do you think that patients should be told about infertility as a possible side effect
of treatment?
11. Do you think fertility preservation should be discussed with patients? Why/why
not? [probe for whether they think all patients should be told]
a. Are there some patients with whom you don’t think it’s appropriate to talk
about this?
b. Who should be the person to have these discussions with patients?
12. Is there a case that stands out in your mind of a newly-diagnosed patient who
was concerned about his or her ability to have children?
13. Is there a case that stands out in your mind of a cancer survivor who came to the
clinic after they had finished treatment, and who was concerned about his or her
ability to have children?
FERTILITY PRESERVATION: The next few questions have to do with using fertility
clinics on the island.
14. What fertility preservation techniques are you aware of? Are these all available
on the island?
a.

[If they don’t know] Are you learning about this as a result of the interview
or is there another reason you do not focus on it?

15. In your experience, who tends to use these services?
16. What do you think about these technologies?
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17. How easy is it for cancer patients in (Ponce/San Juan) to use fertility clinics?
a. What are the barriers that patients deal with when they try to use these
services? [probe for each]
b. Does distance between the fertility clinics and other parts of the island
impact cancer patients’ and survivors’ ability to use them? [probe for
clinics all being in the metropolitan area].
c. What kinds of things would help patients to be able to use these services
more easily? [probe for each]
d. Can you estimate the magnitude of the need among cancer
patients/survivors for these services in Puerto Rico?
e. How important do you feel this issue is for Puerto Ricans in general?
18. Where do you get your information on fertility preservation?
a. Do you know of any professional guidelines that address cancer and
fertility?
19. In your experience, what is the role of your patients’ religious beliefs in using
infertility services—whether they are cancer patients or not?
a. Do the religious beliefs of providers play a role?
20. Do you have any resources that you give to patients or survivors?
21. We are almost done except for a few demographic questions and questions
about your practice. But first, is there anything else you would like to add to this
that we have not already talked about today?
Practice & Patient Information
1. Specialty:
a. What professional organizations do you belong to?
2. Where do the patients that you see come from, in general (i.e., catchment area)?
3. Where did you receive your medical/nursing training?
a. What year did you graduate?
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b. In your experience, was cancer-related infertility talked about in medical
school? How much did they talk about survivorship, infertility, etc.?
4. What is the average number of patients you see each week?
5. (If not already answered) What is your patients’ average age?
6. (If not already answered) About how many male/female patients do you see that
are of reproductive age?
7. (If not already answered) About how many male/female patients do you see that
have used fertility preservation?
Additional Demographic Information
1. Age:
2. Gender:
3. Ethnic background:
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3. INTERVIEW GUIDE: INFERTILITY SPECIALISTS
GENERAL QUESTIONS & SERVICES: I am first going to ask you a little about the
general services that you offer, and then we’ll talk specifically about cancer patients and
survivors.
1. [FOR NURSES/STAFF ONLY]: Can you describe for me what your job involves?
2. Can you describe your general patient population for me?
a. What is the average age of your patient?
3. In general, what services do you offer?
CURRENT PATIENTS/FERTILITY PRESERVATION: The next set of questions is
specific to cancer patients: by this, I mean people who have just been diagnosed.
4. Do you see newly diagnosed cancer patients in your practice?
a. Approximately how many do you see per month?
b. What services do you offer for them? What services are typically used?
5. Can you describe the general process of diagnosis, referral, and treatment?
a. Who do you usually get referrals from?
b. Do you see both men and women?
6. Do the demographic characteristics of this group of patients differ from your other
patients? (e.g., where they are from, how old they are, gender).
7. Is there a case that particularly stands out in your mind of a newly-diagnosed
patient who was concerned about his or her ability to have children?
SURVIVORS/POST-TREATMENT PARENTHOOD: This set of questions are specific
to cancer survivors: by this, I mean people who have a history of cancer – who are
finished with treatment – and who are coming to see you for help with having children.
8. Do you see cancer survivors in the clinic?
a. Approximately how many do you see per month?
b. What services do you offer for them? What services are typically used?
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9. Can you describe the general process of diagnosis, referral, and treatment?
c. Who do you usually get referrals from?
d. Do you see both men and women?
10. Do the demographic characteristics of this group of patients differ from your other
patients? (e.g., where they are from, how old they are, gender)
11. Is there a case that particularly stands out in your mind of a cancer survivor who
came to the clinic after they had finished treatment who was concerned about his
or her ability to have children?
GENERAL ACCESS TO SERVICES IN PR: This next set of questions is about general
access to infertility services in Puerto Rico.
12. Based on your experience, how easy is it for cancer patients and survivors to use
infertility services in Puerto Rico?
b. What are the barriers that patients deal with when they try to use these
services? [probe for each]
c. Does distance between the fertility clinics and other parts of the island
impact cancer patients’ and survivors’ ability to use them? [probe for
clinics all being in metropolitan area].
d. What kinds of things would help patients to be able to use these services
more easily? [probe for each]
e. Can you estimate the magnitude of the need among cancer
patients/survivors for these services in Puerto Rico?
f.

How important do you feel this issue is for Puerto Ricans in general?

13. In your experience, what is the role of your patients’ religious beliefs in using
infertility services—whether they are cancer patients or not?
a. Do the religious beliefs of providers play a role?
14. Do you have any resources that you give to cancer patients or survivors?
15. Do you have any exclusion requirements for clients in general?
a. For cancer patients/survivors specifically?
b. Do the services you offer differ if a patient is single or married (in
general)? For cancer patients and survivors specifically?
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16. We are almost done except for a few demographic questions and questions
about your practice. But first, is there anything else you would like to add to this
that we have not already covered today?
Practice & Patient Information
1. Specialty:
a. What professional organizations do you belong to?
2. Where do the patients that you see come from, in general (i.e., catchment area)?
3. Where did you receive your medical/nursing training?
a. What year did you graduate?
b. In your experience, was cancer-related infertility talked about in your
training? How much did they talk about survivorship, infertility, etc.?
4. What is the average number of patients you see each week?
5. (If not answered) About how many cancer patients do you see for fertility
preservation?
6. (If not answered) About how many cancer survivors do you see for posttreatment services?
Additional Demographic Information
1. Age:
2. Gender:
3. Ethnic background:
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4. INTERVIEW GUIDE: GYNECOLOGISTS
GENERAL QUESTIONS & SERVICES: I am first going to ask you a little about your
general practice, and then we’ll talk specifically about cancer patients and survivors.
1. Can you describe your general patient population for me?
a. What is the average age of your patients?
2. How often do you see patients who get diagnosed with cancer?
CURRENT PATIENTS/FERTILITY PRESERVATION:
3. If one of your younger patients gets diagnosed with cancer, can you walk me
through the process of what happens? In other words, what is the general
process of diagnosis, referral, and treatment?
a. How important to you is discussing fertility with that patient?
b. How would you discuss these issues with that patient?
c. (if applicable) How do patients react to these discussions?
d. What kinds of options are available for those patients?
e. Based on your experience, how important do you think having children (or
more children) is to your younger patients?
4. Is there a case that particularly stands out in your mind of a newly-diagnosed
patient who was concerned about his or her ability to have children?
SURVIVORS/POST-TREATMENT PARENTHOOD:
5. How often do you see cancer survivors—after they have finished cancer
treatment—that are trying to have a baby?
a. If you have a patient who is a survivor and has been treated for cancer in
the past, but is having difficulty getting pregnant, what do you do? For
example, who do you refer them to?
b. What kinds of options are available for those patients?
6. Is there a case that particularly stands out in your mind of a cancer survivor who
came to the clinic after they had finished treatment who was concerned about his
or her ability to have children?
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7. What should be the role of the gynecologist in dealing with cancer-related
infertility?
GENERAL ACCESS TO SERVICES IN PR: This next set of questions is about general
access to infertility services in Puerto Rico.
8. Based on your experience, how easy is it for patients and survivors to use
infertility services in Puerto Rico?
g. What are the barriers that patients deal with when they try to use these
services? [probe for each]
h. Does distance between the fertility clinics and other parts of the island
impact cancer patients’ and survivors’ ability to use them? [probe for
clinics all being in metropolitan area].
i.

What kinds of things would help patients to be able to use these services
more easily? [probe for each]

j.

Can you estimate the magnitude of the need among cancer
patients/survivors for these services in Puerto Rico?

k. How important do you feel this issue is for Puerto Ricans in general?
9.

In your experience, what is the role of your patients’ religious beliefs in using
infertility services—whether they are cancer patients or not?
a. Do the religious beliefs of providers play a role?

10. We are almost done except for a few demographic questions and questions
about your practice. But first, is there anything else you would like to add to this
that we have not already covered today?
Practice & Patient Information
1. Specialty:
a. What professional organizations do you belong to?
2. Where do the patients that you see come from, in general (i.e., catchment area)?
3. Where did you receive your medical/nursing training?
a. What year did you graduate?
b. In your experience, was cancer-related infertility talked about in medical
school? How much did they talk about survivorship, infertility, etc.?
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4. What is the average number of patients you see each week?
Additional Demographic Information
1. Age:
2. Gender:
3. Ethnic background:
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5. INTERVIEW GUIDE: CANCER ADVOCATES
Organización/Grupo y Rol [Organization/Group & Role]
1. ¿Con qué frecuencia trabaja usted con pacientes de cáncer? Con los
sobrevivientes? [How often do you work with cancer patients? With survivors?]
2. ¿A qué se dedica su organización/grupo? [What does your organization/group
do?]
3. ¿Cuál es su rol dentro de la organización/grupo? [What is your role within the
organization/group?]
a. ¿Es usted voluntario/a o empleado/a de la organización? [Do you
volunteer or are you an employee of the organization?]
4. ¿Cómo se involucró en este tipo de trabajo? [How did you get into this work?]
5. ¿Cuál cree que es el rol de las organizaciones de apoyo a pacientes de cáncer
en el cuidado del cáncer en Puerto Rico? [What do you think is the role of
cancer advocacy organizations in Puerto Rican cancer care?]
a. ¿Cuál es su relación con los proveedores de cuidados médicos
relacionados con el cáncer? [What is your relationship with cancer care
providers?]
b. ¿Trabaja su organización con otras organizaciones/grupos en Puerto
Rico? [Does your organization work with any other organizations/groups
in Puerto Rico?]
c. ¿Trabaja su organización con alguna organización en los Estados
Unidos? [Does your organization work with any organizations in the
United States?]
Sobrevivencia y Fertilidad [Survivorship & Fertility]
6. ¿Con respecto a los pacientes y sobrevivientes con los que trabaja, cuáles son
sus preocupaciones inmediatamente después de terminado el tratamiento?
[Regarding the patients and survivors that you work with, what are their concerns
immediately after treatment has ended?]
a. ¿Cuáles son sus preocupaciones a largo plazo? [What are their
concerns long-term?]
7. ¿Qué me podría decir sobre el cuidado médico que los sobrevivientes de cáncer
reciben en Puerto Rico después de que su tratamiento ha terminado? [Can you
tell me about the healthcare that cancer survivors get in Puerto Rico after their
treatment has ended?]
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a. ¿ Qué tipo de seguimiento se le brinda a los sobrevivientes a largo
plazo? [Are they monitored for long-term side effects of treatment?]
8. ¿Ha oído del concepto de "sobrevivencia" que se utiliza en los EE.UU.? [Have
you heard of the concept of ‘survivorship’ that is talked about a lot in the U.S.?]
a. Si es así, ¿qué entiende usted por ese término? [If so, what have you
heard?]
b. ¿Se utiliza este concepto en Puerto Rico? [Is this concept used in Puerto
Rico?]
c. ¿Qué cree que significa para los puertorriqueños? ¿Ve usted alguna
diferencia entre cómo se entiende aquí y en los EEUU? [What do you
think it means to Puerto Ricans? Do you see any difference in how the
term is understood here and in the U.S.?]
9. ¿Usted cree que el cáncer cambia el modo en que los pacientes ven su futuro?
¿Cómo? [Does cancer change cancer patients’ views of the future? How so?]
10. Basándose en su experiencia, ¿qué importancia cree usted tiene para los
pacientes de cáncer el poder tener hijos? [Based on your experience, how
important do you think having children (or more children) is to the patients you
work with?]
a. ¿Cree usted que el punto de vista de sus pacientes acerca de la fertilidad
cambia de alguna forma durante el tratamiento o después, como
sobrevivientes? [Do you think your patients’ views on fertility change
during treatment or even after, as survivors?]
11. ¿Cree usted que los/las pacientes y sobrevivientes desean obtener información
sobre cómo tener hijos después del cáncer? [Do you think patients and survivors
want information about how to have children after cancer?]
a. ¿Qué información buscan usualmente? [What information do they
usually look for?]
b. ¿Existe alguna razón, que usted sepa, por la cual a algunos/as pacientes
o sobrevivientes no les interese esta información? [Is there any reason
that you know of why patients/survivors wouldn’t be interested in this
information?]
12. ¿Cree usted que los/las pacientes y sobrevivientes desean obtener información
sobre métodos de preservación de fertilidad? [Do you think that patients and
survivors want information about fertility preservation?]
a. ¿Existe alguna razón, que usted sepa, por la cual algunos/as pacientes o
sobrevivientes no interesen esta información? [Is there any reason that
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you know of why patients/survivors wouldn’t be interested in this information?
13. ¿Hay algo más que le gustaría añadir que no hayamos cubierto hoy? (Is there
anything else you would like to add to this that we have not already covered
today?)
Información Demográfica (Demographic Information)
Género (Gender):
Estado Civil (Marital status):
Número de hijos (Number of children):
Edad (Age):
¿Cómo se identifica usted étnicamente? (How do you identify yourself ethnically?)
Lugar de residencia (Place of residence):
¿A qué se dedica aparte de su trabajo con la organización? (What do you do for a
living?):
Nivel más alto de educación alcanzado (Highest level of education):
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6. INTERVIEW GUIDE: CLERGY

1. ¿Con qué frecuencia trabaja usted con pacientes de cáncer? Con los
sobrevivientes? [How often do you work with cancer patients? With survivors?]
2. ¿Con respecto a los pacientes y sobrevivientes con los que trabaja, cuáles son
sus preocupaciones durante el tratamiento? [Regarding the patients and
survivors that you work with, what are their concerns during treatment?]
a. How do you help them to deal with these concerns?
b. Do you see any differences between younger people (for example, those
under 45) and older people in their concerns during treatment?
3. ¿Cuáles son sus preocupaciones a largo plazo, después de terminado el
tratamiento? [What are their concerns long-term, after treatment has ended?]

a. How do you help them to deal with these long-term concerns?
b. Do you see any differences between younger people (for example, those
under 45) and older people in their long-term concerns?
4. ¿Cómo cree usted que la población en general ve el cáncer? (How do you think
the general public views cancer?)

5. There are some specific issues that we have noticed when talking with some of
the other participants, and we wanted to get your thoughts about them.

a. [Marital problems/divorce]: Some of the female participants experience
marital problems during or after their treatment, which sometimes leads to
divorce. Have you witnessed this? Why do you think that this might be
so? How do they get resolved?

b. [Social support]: Can you tell me about the type of support that cancer
patients and survivors get from their family and friends?

c. [Stigma]: One of the things that we’ve heard a lot is that people think of
cancer as a death sentence. Have you witnessed this? Have any of your
members talked to you about this? What effects might this have on the
members of your congregation who have been diagnosed with cancer?

d. [Parenthood/existing children]: One of the major difficulties encountered
by a lot of the participants during and after treatment was the impact of
their cancer on the well-being of their children. Can you talk to me a little
about this?
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e. [Fertility]: Basándose en su experiencia, ¿qué importancia cree usted
tiene para los pacientes de cáncer el poder tener hijos? [Based on your
experience, how important do you think having children (or more children)
is to the patients you work with?]
6. ¿Cree usted que el punto de vista de sus pacientes acerca de la reproducción
cambia de alguna forma durante el tratamiento o después, como sobrevivientes?
[Do you think your patients’ views on reproduction change during treatment or
even after, as survivors?]
7. One of the potential side effects of cancer treatment on younger patients is
infertility. Have any members of your congregation wanted to pursue fertility
preservation—for example, sperm freezing or embryo freezing?
a. If a patient came to you and wanted advice about whether to undergo
fertility preservation (for example, freezing their eggs, embryos or sperm),
how would you counsel them?
8. Does the Church have an official position on fertility preservation?
a. On using assisted reproductive technologies?
9. ¿Ha oído del concepto de "sobrevivencia" que se utiliza en los EE.UU.? [Have
you heard of the concept of ‘survivorship’ that is talked about a lot in the U.S.?]
d. Si es así, ¿qué entiende usted por ese término? [If so, what have you
heard?]
e. ¿Se utiliza este concepto en Puerto Rico? [Is this concept used in Puerto
Rico?]
f.

¿Qué cree que significa para los puertorriqueños? [What do you think it
means to Puerto Ricans?]

10. ¿Usted cree que el cáncer cambia el modo en que los pacientes ven su futuro?
¿Cómo? [Does cancer change cancer patients’ views of the future? How so?]
11. ¿Cuán importante usted cree que es tener hijos para los puertorriqueños, en
general? ¿Por qué? (How important do you think having children is to Puerto
Ricans in general? Why?)
12. Is there anything that you can think of that would help to improve the lives of
cancer patients and survivors in Puerto Rico?
13. ¿Hay algo más que le gustaría añadir que no hayamos cubierto hoy? (Is there
anything else you would like to add to this that we have not already covered
today?)
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Información Demográfica (Demographic Information)
Género (Gender):
Religious Affiliation:
Position (i.e., priest, etc.):
Parish Location:
Size of Parish/Church/etc.:
Edad (Age):
Estado Civil (Marital status)—if applicable:
Número de hijos (Number of children)—if applicable:
¿Cómo se identifica usted étnicamente? (How do you identify yourself ethnically?)
Lugar de residencia (Place of residence):
¿A qué se dedica aparte de su trabajo con la organización? (What do you do for a
living?)—if applicable:
Nivel más alto de educación alcanzado (Highest level of education):
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